{"meta":{"query_hash":"7b6849c69662","filters":{"venue":"Journal of Viral Hepatitis"},"cohort_total":245,"direct_labels_cover":1,"predictions_cover":245,"exported":245,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7b6849c69662","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Viral+Hepatitis"},"results":[{"id":"W1505220350","doi":"10.1111/jvh.12415","title":"Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the <scp>ETHOS</scp> study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Health and Medical Research Council; Department of Health and Ageing, Australian Government; NSW Ministry of Health; Australian Government","keywords":"Medicine; Hepatitis C virus; Logistic regression; Hepatitis C; Internal medicine; Cohort; Observational study; Family medicine; Immunology; Virus","score_opus":0.04585300704938643,"score_gpt":0.3752158171919371,"score_spread":0.32936281014255064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505220350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953801,0.00017046978,0.00022364185,0.000105722414,0.00053958804,0.0029559885,0.00013838358,0.000020901782,0.00046518465],"genre_scores_gemma":[0.9923559,0.0057882913,0.00028343772,0.000043210875,0.0006911034,0.0002454096,0.00002301007,0.00006245331,0.0005072128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638766,0.0008556363,0.0009743078,0.00033175098,0.0010245752,0.0004260459],"domain_scores_gemma":[0.9961573,0.0016666134,0.00067623367,0.00042648465,0.0006452075,0.0004281819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016949293,0.0004147989,0.0012550678,0.00031281836,0.00022386327,0.00015169926,0.00013232988,0.00013743437,0.000018257213],"category_scores_gemma":[0.0008794104,0.0002503983,0.00038079167,0.00030572157,0.00016005928,0.0004075043,0.00005028216,0.00030228574,0.000005027278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004228604,0.001223386,0.91908246,0.00006614801,0.0006014968,0.00012075173,0.005728381,0.0000872594,0.0001370646,0.0000226232,0.00083229615,0.07167524],"study_design_scores_gemma":[0.00927057,0.09486739,0.88327193,0.00028606335,0.0007571081,0.000042437932,0.0003296119,0.0013894883,0.0032724827,0.000034343848,0.006385897,0.00009266526],"about_ca_topic_score_codex":0.052221805,"about_ca_topic_score_gemma":0.0207451,"teacher_disagreement_score":0.09364401,"about_ca_system_score_codex":0.0020991862,"about_ca_system_score_gemma":0.00050061225,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W1508173073","doi":"10.1111/j.1365-2893.2011.01440.x","title":"Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population‐based cohort study, 1992–2007","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"Medicine; Incidence (geometry); Population; Hepatocellular carcinoma; Cancer registry; Cohort; Hepatitis B virus; Hepatitis C; Internal medicine; Cohort study; Hepatitis C virus; Confidence interval; Demography; Immunology; Environmental health; Virus","score_opus":0.03273309271260132,"score_gpt":0.29226536986619106,"score_spread":0.25953227715358973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508173073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978734,0.0005161896,0.0001031557,0.00006506778,0.0003778963,0.00057826575,0.00005342816,0.000015439617,0.00041714608],"genre_scores_gemma":[0.99675345,0.0009777194,0.0017476132,0.00011634386,0.00016447327,0.00011684901,0.000010347531,0.000042332897,0.00007087815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996153,0.00026956125,0.001976229,0.0002830407,0.0009827138,0.00033547048],"domain_scores_gemma":[0.99748796,0.00016337806,0.0011453462,0.0004056523,0.0006122225,0.0001854595],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007771542,0.00031674054,0.0013689593,0.0012880205,0.000054961973,0.000009622858,0.000173113,0.00015573173,0.0017213273],"category_scores_gemma":[0.0004537656,0.0002630875,0.00037672816,0.0009933516,0.0001447637,0.0003915714,0.00008789689,0.00037933738,0.000006587455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090930535,0.0014749998,0.99089986,0.0001767812,0.00022026776,0.001601839,0.0012815987,0.000004561073,0.000036587655,0.00001074547,0.00032701108,0.0030564626],"study_design_scores_gemma":[0.002250614,0.005250804,0.9887324,0.0007287126,0.00043132523,0.0000991421,0.000026990469,0.00024022568,0.0018865467,0.00005343421,0.0000773366,0.0002224744],"about_ca_topic_score_codex":0.23085234,"about_ca_topic_score_gemma":0.093638495,"teacher_disagreement_score":0.13721384,"about_ca_system_score_codex":0.00037541354,"about_ca_system_score_gemma":0.00021017088,"threshold_uncertainty_score":0.9999821},"labels":[],"label_agreement":null},{"id":"W1527146943","doi":"10.1111/j.1365-2893.2012.01632.x","title":"Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Public Health Agency of Canada; University of British Columbia","funders":"Government of Canada","keywords":"Hepatitis B virus; Genotype; Viral quasispecies; Virology; Biology; Genetic diversity; Hepatitis B; Circumpolar star; Hepatocellular carcinoma; Indigenous; Haplogroup; Population; Genetics; Virus; Medicine; Hepatitis C virus; Gene; Ecology; Haplotype; Environmental health","score_opus":0.016669232241017126,"score_gpt":0.2530437090083711,"score_spread":0.23637447676735396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527146943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901707,0.009712632,0.00015697729,0.00005909757,0.00042607632,0.00028926527,0.00011364078,0.00001732587,0.00020791632],"genre_scores_gemma":[0.9808705,0.015637899,0.002724932,0.00021021048,0.00047465978,0.0000032044052,0.0000039313886,0.000031839885,0.000042862168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975946,0.00014527042,0.00083906436,0.00016187227,0.0007693295,0.0004898497],"domain_scores_gemma":[0.99813575,0.00012203819,0.00076044083,0.00022032189,0.00036896404,0.0003924608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005393171,0.00025037976,0.00085579266,0.00035644977,0.00028813622,0.000020091959,0.0001804194,0.00016902486,0.00016189496],"category_scores_gemma":[0.00026954713,0.00022514474,0.00021105411,0.00020653647,0.00031742823,0.0005001457,0.00033258612,0.00037557288,0.00001882848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004439066,0.00023671101,0.9796729,0.00013546199,0.00043520858,0.00014746217,0.008261829,0.0000012517041,0.0019197792,0.000021629736,0.00046822816,0.008655162],"study_design_scores_gemma":[0.0008908727,0.00106935,0.9924154,0.0002065682,0.0004990821,0.00032993,0.000048169357,0.0000070243455,0.003415599,0.00017464228,0.00074299425,0.00020031362],"about_ca_topic_score_codex":0.02844447,"about_ca_topic_score_gemma":0.004210918,"teacher_disagreement_score":0.024233554,"about_ca_system_score_codex":0.00017343351,"about_ca_system_score_gemma":0.00011692306,"threshold_uncertainty_score":0.9780252},"labels":[],"label_agreement":null},{"id":"W1533496726","doi":"10.1111/j.1365-2893.2012.01610.x","title":"Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cells","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Interferon; Hepatitis C virus; Transcriptome; Biology; Virology; Gene; Gene expression; Gene expression profiling; In vitro; Immunology; Virus; Genetics","score_opus":0.011244186275248223,"score_gpt":0.2765785060300632,"score_spread":0.265334319754815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533496726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669427,0.0021157274,0.00004112507,0.000083163795,0.00016380969,0.00042511476,0.000024177758,0.000013822944,0.0004388068],"genre_scores_gemma":[0.9955425,0.003674426,0.00043981374,0.00006072907,0.00020246273,0.000004880687,0.0000035913122,0.000033275923,0.000038322625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838465,0.0002007126,0.00050808897,0.00019377854,0.00034235264,0.00037039843],"domain_scores_gemma":[0.9986451,0.0004162703,0.00031114722,0.00013182189,0.00014821827,0.00034743277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040472022,0.00023546247,0.0006825986,0.00033442365,0.000084953586,0.000047863537,0.000051872175,0.00012877883,0.000018896433],"category_scores_gemma":[0.00034906674,0.00019004334,0.000062192696,0.00012784656,0.00029465754,0.00035088926,0.00013610977,0.00043190736,0.0000028658171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031325896,0.00012585812,0.7638984,0.00063572626,0.00011360659,0.00011215953,0.00040048972,4.3058172e-8,0.20174468,0.000039378407,0.00009911488,0.03251729],"study_design_scores_gemma":[0.0025537948,0.004139439,0.9431641,0.0010612645,0.00013688582,0.00023579998,0.000014983648,0.0004249051,0.04779383,0.000026537644,0.00027862322,0.00016984185],"about_ca_topic_score_codex":0.00037901785,"about_ca_topic_score_gemma":0.000048693484,"teacher_disagreement_score":0.1792657,"about_ca_system_score_codex":0.000078340374,"about_ca_system_score_gemma":0.000066069086,"threshold_uncertainty_score":0.7749742},"labels":[],"label_agreement":null},{"id":"W1546630735","doi":"10.1111/jvh.12429","title":"Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Canadian Institutes of Health Research; Burnet Institute; Meso Scale Diagnostics; Schering-Plough; National Institutes of Health","keywords":"Medicine; Cohort; Virology; Hepatitis C virus; Cohort study; Virus; Internal medicine; Intensive care medicine; Immunology","score_opus":0.03352694238214234,"score_gpt":0.3559713813057324,"score_spread":0.3224444389235901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546630735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943878,0.0004052955,0.0001769396,0.0020345533,0.0007814475,0.001249409,0.000055190318,0.0000316667,0.0008777087],"genre_scores_gemma":[0.99081546,0.004819735,0.0028047292,0.0004285823,0.00024625144,0.000069884554,0.000015235037,0.00005304863,0.00074706273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594885,0.0009131224,0.0010503217,0.0003151681,0.0012276951,0.00054485706],"domain_scores_gemma":[0.9972425,0.00025945267,0.00032958217,0.00031056275,0.00097622414,0.00088164833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016896223,0.0003004595,0.00089089695,0.00092987134,0.00008377172,0.00008006494,0.00013523434,0.0001800375,0.00012180928],"category_scores_gemma":[0.0029516795,0.00026233567,0.0002646949,0.0011695153,0.000054813336,0.0005514567,0.000065269254,0.00027644294,0.00016487508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068051624,0.0006065797,0.9515356,0.000013768608,0.0002727086,0.0036020514,0.00300822,0.000105905005,0.0068160025,0.0000035874114,0.0029089155,0.024321537],"study_design_scores_gemma":[0.0102187125,0.01082456,0.90907043,0.00063707924,0.00018123747,0.00013917683,0.00015729776,0.0007177394,0.010722059,0.00004189291,0.056970317,0.00031949405],"about_ca_topic_score_codex":0.023626475,"about_ca_topic_score_gemma":0.040560164,"teacher_disagreement_score":0.0540614,"about_ca_system_score_codex":0.0038782451,"about_ca_system_score_gemma":0.0015295562,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W1563158585","doi":"10.1111/j.1365-2893.2010.01330.x","title":"Hepatitis B Virus Genotype G forms core-like particles with unique structural properties","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Health Canada; Public Health Agency; Public Health Agency of Canada","keywords":"Virology; Genotype; Core (optical fiber); Hepatitis B virus; Biology; Virus; Genetics; Gene; Computer science","score_opus":0.021560886267495055,"score_gpt":0.2657926835769595,"score_spread":0.24423179730946445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563158585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969192,0.00057978695,0.00012782792,0.0006313996,0.0007115753,0.0003745088,0.000034883844,0.000058224236,0.0005625669],"genre_scores_gemma":[0.98868006,0.0021385923,0.0075038285,0.00075490895,0.0005237528,0.000016515514,0.000006318837,0.00006174286,0.00031428755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762523,0.000051528285,0.00082492665,0.00023166883,0.00076160295,0.00050504954],"domain_scores_gemma":[0.99791455,0.00005809145,0.0005273182,0.0003402049,0.0008211474,0.00033865776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002926765,0.00033336369,0.0007552914,0.00020082522,0.0002425293,0.00007635137,0.00022060877,0.00015595702,0.00031655704],"category_scores_gemma":[0.00024974364,0.00020783558,0.00019694983,0.00023797313,0.0003969552,0.0006320772,0.000079847996,0.00084893464,0.000043469347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006406902,0.00009389309,0.91209596,0.00008586102,0.0002723274,0.00064885634,0.0008599938,0.000006146474,0.073910676,0.00060100475,0.0011683624,0.009616211],"study_design_scores_gemma":[0.002159045,0.004098122,0.9275798,0.00038435796,0.00030676104,0.0022738972,0.000048446807,0.0005056037,0.054486547,0.0012300096,0.0065053175,0.00042208025],"about_ca_topic_score_codex":0.011432437,"about_ca_topic_score_gemma":0.08142686,"teacher_disagreement_score":0.06999443,"about_ca_system_score_codex":0.00014236514,"about_ca_system_score_gemma":0.00036136992,"threshold_uncertainty_score":0.9951505},"labels":[],"label_agreement":null},{"id":"W1594353271","doi":"10.1111/j.1365-2893.2010.01356.x","title":"Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Yukon Health and Social Services","funders":"","keywords":"HBsAg; Genotype; Hepatitis B virus; Virology; Population; Molecular epidemiology; Arctic; Hepatitis B; HBcAg; Circumpolar star; Biology; Medicine; Virus; Genetics; Environmental health; Gene; Ecology","score_opus":0.024431970609219027,"score_gpt":0.30472546811972767,"score_spread":0.28029349751050864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594353271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957802,0.0014711209,0.00010433184,0.001735269,0.00020970435,0.0003611113,0.00023299901,0.000007805784,0.00009740568],"genre_scores_gemma":[0.990099,0.007797382,0.0007568821,0.001085896,0.00013207138,0.000011878234,0.000095616604,0.000018717521,0.0000025662598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967579,0.0009844467,0.0010028576,0.00027280572,0.00053339265,0.00044855624],"domain_scores_gemma":[0.997255,0.0007084588,0.00047881727,0.00032131252,0.00090599415,0.00033037402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023576876,0.00025958405,0.0008900178,0.0002308571,0.00020941836,0.00003244361,0.00022896733,0.00027526138,0.000051286006],"category_scores_gemma":[0.0066200504,0.00017530481,0.00022356257,0.0005337001,0.00072893314,0.0002500825,0.000045130604,0.0011183316,0.0000032325322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014685419,0.00014489211,0.99422514,0.000037975806,0.000097861026,0.0008001864,0.0002643733,9.5009005e-7,0.0009113555,0.0018140482,0.00019702197,0.0013593204],"study_design_scores_gemma":[0.0006641937,0.0016982412,0.9894316,0.00014565256,0.00015103041,0.00079328433,0.000017108005,0.000058898604,0.00012178945,0.0063027106,0.0004481223,0.00016735087],"about_ca_topic_score_codex":0.8394011,"about_ca_topic_score_gemma":0.96988493,"teacher_disagreement_score":0.13048379,"about_ca_system_score_codex":0.000115749746,"about_ca_system_score_gemma":0.00031098397,"threshold_uncertainty_score":0.79252964},"labels":[],"label_agreement":null},{"id":"W1597470062","doi":"10.1111/j.1365-2893.2010.01370.x","title":"Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Hepatitis C virus; Hepatitis C; Cirrhosis; Gastroenterology; Liver biopsy; Biopsy; Virus; Immunology","score_opus":0.1057075708704663,"score_gpt":0.38981218046303684,"score_spread":0.28410460959257056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597470062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790496,0.000026087862,0.00038667978,0.0002684165,0.00037978764,0.0006398395,0.00013697821,0.000016262344,0.00024099636],"genre_scores_gemma":[0.9964253,0.00085497694,0.0012160299,0.00004048439,0.000518767,0.000015200978,0.00005607371,0.000038886537,0.0008343118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998098,0.00009396049,0.0006298128,0.00022247159,0.0005670824,0.00038865913],"domain_scores_gemma":[0.9985709,0.00016490587,0.0003992671,0.00016528669,0.00029214678,0.0004074668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036854637,0.000254052,0.0006575916,0.0004028017,0.00009609145,0.00008906039,0.00007412608,0.00019586404,0.00030032537],"category_scores_gemma":[0.00031894798,0.00018664314,0.00016241289,0.00024139615,0.00012989312,0.0003029419,0.00002094842,0.0005714831,0.0000032733028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016934193,0.00030558044,0.98281616,0.0000204629,0.00018662662,0.00013792669,0.00041438968,0.0000034440156,0.002124286,0.00011739632,0.0006695174,0.013034847],"study_design_scores_gemma":[0.0047398256,0.0048155673,0.98416317,0.00020989691,0.0001443846,0.000026197506,0.00001434522,0.00015095533,0.002220208,0.00014487722,0.0031903526,0.00018019794],"about_ca_topic_score_codex":0.036566716,"about_ca_topic_score_gemma":0.29641944,"teacher_disagreement_score":0.2598527,"about_ca_system_score_codex":0.0008660034,"about_ca_system_score_gemma":0.00080458575,"threshold_uncertainty_score":0.9698489},"labels":[],"label_agreement":null},{"id":"W1597912542","doi":"10.1111/j.1365-2893.2011.01471.x","title":"Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Chongqing Medical University; Chongqing University","keywords":"Interferon; Gene; Alpha interferon; Immune system; Biology; Immunology; Gene expression profiling; Gene expression; Hepatitis B virus; Virus; Cancer research; Medicine; Genetics","score_opus":0.027008661669630812,"score_gpt":0.2706603731699786,"score_spread":0.24365171150034778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597912542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978235,0.000077681194,0.00048761486,0.00013834295,0.000095320036,0.0009939885,0.000023071769,0.000010212349,0.00035028515],"genre_scores_gemma":[0.9978634,0.0008435791,0.0007416415,0.00038274573,0.000035132613,0.000022751949,0.000006361771,0.00005155589,0.000052807387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698484,0.0004490676,0.0010199323,0.00026179597,0.0009015541,0.0003828329],"domain_scores_gemma":[0.9979279,0.0001738462,0.0005796319,0.00031433185,0.0008225047,0.00018177068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059659174,0.0002665326,0.0006274139,0.0006812822,0.000038777354,0.000022028646,0.00031261204,0.00016332783,0.00036670984],"category_scores_gemma":[0.00029307886,0.00016752224,0.000110155575,0.0008772147,0.00014250637,0.000463879,0.00008651569,0.0008963136,0.000011868062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024051886,0.0010982216,0.93816173,0.000040815867,0.00013972279,0.00017232633,0.0045375265,0.000038003207,0.007710931,0.000004384165,0.0001022686,0.023942214],"study_design_scores_gemma":[0.005900918,0.02749802,0.92476547,0.0023815865,0.000033886074,0.000027015392,0.000021852667,0.0005381893,0.03855089,0.000011963075,0.00009496457,0.00017522539],"about_ca_topic_score_codex":0.014039925,"about_ca_topic_score_gemma":0.017147912,"teacher_disagreement_score":0.03083996,"about_ca_system_score_codex":0.0006669775,"about_ca_system_score_gemma":0.00049513014,"threshold_uncertainty_score":0.9925257},"labels":[],"label_agreement":null},{"id":"W1600644808","doi":"10.1111/j.1365-2893.2010.01408.x","title":"Persistent pro‐inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment‐induced depression","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Depression (economics); Cytokine; Medicine; Peripheral blood mononuclear cell; Internal medicine; Tumor necrosis factor alpha; Beck Depression Inventory; In vivo; Endocrinology; Pegylated interferon; Immunology; Gastroenterology; Chronic hepatitis; Virus; Biology; In vitro; Ribavirin; Anxiety; Psychiatry","score_opus":0.024405714237924057,"score_gpt":0.26555426885557853,"score_spread":0.24114855461765447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600644808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987866,0.00005068588,0.0000095534615,0.00020038884,0.00038942817,0.00030497136,0.000008307445,0.000018381936,0.00023166245],"genre_scores_gemma":[0.9991563,0.00053186464,0.000022786766,0.00015861596,0.00006382798,0.000012693245,0.0000025040176,0.000019659694,0.00003176982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852425,0.00022220999,0.00046933262,0.00016537227,0.00042783038,0.00019098987],"domain_scores_gemma":[0.99884355,0.00019105665,0.00065035466,0.00014405773,0.000120069584,0.000050903316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023697867,0.00016628498,0.0002714876,0.00020838855,0.00014275554,0.000046772995,0.00014584954,0.000117441006,0.00005753605],"category_scores_gemma":[0.00033149833,0.000101576275,0.00023623952,0.00035134962,0.00006223363,0.0004955382,0.000015312986,0.00030818817,0.0000018465291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001396931,0.00022804075,0.6080667,0.000004844144,0.000048857226,0.000055932574,0.0014402325,0.00003182372,0.37782913,0.000010650508,0.000028023826,0.012116102],"study_design_scores_gemma":[0.002465134,0.0014978108,0.6875348,0.00014049695,0.000025496018,0.00004005538,0.00003549369,0.0004820099,0.3074863,0.00009724478,0.00007561644,0.00011950765],"about_ca_topic_score_codex":0.0008494278,"about_ca_topic_score_gemma":0.0034794924,"teacher_disagreement_score":0.07946816,"about_ca_system_score_codex":0.00010975087,"about_ca_system_score_gemma":0.00011990272,"threshold_uncertainty_score":0.41421604},"labels":[],"label_agreement":null},{"id":"W1641474530","doi":"10.1111/j.1365-2893.2010.01279.x","title":"Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; AIDS Vancouver; BC Centre for Disease Control; University of Waterloo","funders":"Canadian Institutes of Health Research; Ministry of Health, British Columbia","keywords":"Cohort; Medicine; Hepatitis C virus; Virology; Virus; Hepatitis B virus; Internal medicine","score_opus":0.04537107984875106,"score_gpt":0.3817210227460529,"score_spread":0.33634994289730186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1641474530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857974,0.00005188903,0.000037271882,0.000058222227,0.00016315369,0.00044674586,0.000203447,0.000011738397,0.00044780227],"genre_scores_gemma":[0.996658,0.002938491,0.00016663125,0.00008842843,0.000050788098,0.0000067534684,0.000039775823,0.000030001425,0.000021082198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650246,0.0007957296,0.0012425699,0.00016175672,0.0009522847,0.0003452005],"domain_scores_gemma":[0.99744374,0.0003412488,0.0007773834,0.0004663221,0.00068653456,0.00028475095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024940337,0.00022694719,0.00085593853,0.00081382354,0.00008246007,0.000021296933,0.00017572971,0.00029559954,0.0004185767],"category_scores_gemma":[0.0013067708,0.00019413792,0.00028568733,0.00047409485,0.00025479306,0.00033442117,0.00008994676,0.0021288977,0.0000061618994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054077216,0.0014294321,0.97504884,0.00017196528,0.00054961693,0.00031465766,0.0003200891,0.000021687407,0.019805348,0.000028503911,0.00023566182,0.0015334331],"study_design_scores_gemma":[0.0034171033,0.0040217675,0.98208636,0.0005187471,0.00019365724,0.000057799498,0.0000036380973,0.0010391104,0.008332264,0.00014493302,0.00004699033,0.00013760963],"about_ca_topic_score_codex":0.2566148,"about_ca_topic_score_gemma":0.11994853,"teacher_disagreement_score":0.13666627,"about_ca_system_score_codex":0.0003058007,"about_ca_system_score_gemma":0.0004218975,"threshold_uncertainty_score":0.924912},"labels":[],"label_agreement":null},{"id":"W1665613262","doi":"10.1111/j.1365-2893.2011.01553.x","title":"Interleukin 28B polymorphisms are the only common genetic variants associated with low‐density lipoprotein cholesterol (LDL‐C) in genotype‐1 chronic hepatitis C and determine the association between LDL‐C and treatment response","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; National Institute of Allergy and Infectious Diseases; National Health and Medical Research Council; University of New South Wales; Institute of Infection and Immunity; Gastroenterological Society of Australia; Medical Research Council; Gilead Sciences; American Association for the Study of Liver Diseases","keywords":"Interleukin 28B; Ribavirin; Genotype; Hepatitis C virus; Internal medicine; Hepatitis C; Pharmacogenetics; Medicine; Gastroenterology; Biology; Immunology; Genetics; Gene; Virus","score_opus":0.018614786632539057,"score_gpt":0.2759267810727396,"score_spread":0.25731199444020053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1665613262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951141,0.0012972754,0.000032061114,0.0025357828,0.000101312056,0.00079812476,0.000072880146,0.000013089225,0.000035411078],"genre_scores_gemma":[0.9969916,0.0018378597,0.00010488481,0.00028962508,0.00045141048,0.000026704756,0.000010245953,0.00004499442,0.00024271217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963563,0.0012870622,0.00073307817,0.00021871821,0.0008161356,0.0005887237],"domain_scores_gemma":[0.99754095,0.0008299408,0.0007879861,0.0003286873,0.00023188106,0.000280525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019187434,0.00029421382,0.00072927726,0.00024595892,0.00022492066,0.00011208469,0.00018541381,0.00021028347,0.00003320924],"category_scores_gemma":[0.00070589664,0.00017229479,0.00010151067,0.00029768172,0.00018513613,0.00032676183,0.000104911516,0.00070090784,0.000009403309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061297615,0.00016948312,0.90682113,0.000018206978,0.00031427902,0.00024983488,0.0011366932,0.0000016734042,0.0008876884,0.0000016002783,0.000055330205,0.08973109],"study_design_scores_gemma":[0.003515847,0.0037051062,0.98958117,0.0006677772,0.00028635495,0.0002748563,0.000032284905,0.00026403318,0.001186077,0.00002588314,0.00029046132,0.00017016551],"about_ca_topic_score_codex":0.013045457,"about_ca_topic_score_gemma":0.06351992,"teacher_disagreement_score":0.089560926,"about_ca_system_score_codex":0.0021559196,"about_ca_system_score_gemma":0.00035284707,"threshold_uncertainty_score":0.99352676},"labels":[],"label_agreement":null},{"id":"W1715978924","doi":"10.1111/j.1365-2893.2010.01293.x","title":"Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Memorial University of Newfoundland; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Coinfection; Hepatitis C virus; Virology; Human immunodeficiency virus (HIV); Hepatitis virus; Hepatitis C; Medicine; CD8; Biology; Virus; Immunology; Immune system","score_opus":0.020662202815348654,"score_gpt":0.3083317766132821,"score_spread":0.28766957379793345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1715978924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971623,0.00039307642,0.00029642085,0.00082903693,0.0010559099,0.00035820156,0.000065177475,0.000032333275,0.007253641],"genre_scores_gemma":[0.9871038,0.0067287832,0.003144564,0.00020436278,0.00091155694,0.000014836112,0.000014823984,0.000064128486,0.0018131153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966103,0.00030356867,0.0011202223,0.00029414587,0.0011020463,0.00056972983],"domain_scores_gemma":[0.99790096,0.00028727824,0.00040669937,0.00042423885,0.00056165835,0.00041918264],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011894056,0.00027431693,0.0006811509,0.0010160743,0.00010949707,0.000090583504,0.0002486774,0.0002775575,0.0023165743],"category_scores_gemma":[0.0005848713,0.00025010953,0.00029184858,0.0005127107,0.00019909811,0.0005877181,0.00007334106,0.0019247006,0.00037987315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007125065,0.00045176904,0.78012675,0.000046340236,0.000032711083,0.0014552845,0.00020384003,0.0000053329454,0.18461655,0.00013115893,0.0103071425,0.021910641],"study_design_scores_gemma":[0.0040365136,0.0021763453,0.8110688,0.0002496736,0.000046616584,0.0005983254,0.000026845239,0.00038759765,0.047578715,0.00023398708,0.13327365,0.00032296486],"about_ca_topic_score_codex":0.0034440556,"about_ca_topic_score_gemma":0.011005584,"teacher_disagreement_score":0.13703783,"about_ca_system_score_codex":0.0003887551,"about_ca_system_score_gemma":0.00048266252,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W1800803354","doi":"10.1111/j.1365-2893.2010.01426.x","title":"Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Université du Québec à Montréal; Jewish General Hospital; College of Family Physicians of Canada; McGill University; McGill University Health Centre","funders":"College of Family Physicians of Canada; Public Health Agency of Canada","keywords":"Medicine; Family medicine; Hepatitis C; Guideline; Hepatitis C virus; Multivariate analysis; Nursing; Internal medicine; Immunology","score_opus":0.023734401468603443,"score_gpt":0.29365809719264024,"score_spread":0.2699236957240368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1800803354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999333,0.003555879,0.000029025905,0.0002319531,0.00008556794,0.0003657749,0.00022652656,0.000009623373,0.0055022864],"genre_scores_gemma":[0.99722385,0.0018605712,0.00028248085,0.00024781082,0.00007159813,0.000008065445,0.000025392306,0.00003889407,0.00024135954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827427,0.00017225841,0.00043074944,0.00016330401,0.0005903051,0.0003691278],"domain_scores_gemma":[0.99803275,0.000081217804,0.0003440025,0.00020898115,0.0010134884,0.00031957365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032332193,0.00018487187,0.0004854752,0.00024217194,0.00015444792,0.00002801159,0.0002080716,0.00012215335,0.00005603938],"category_scores_gemma":[0.00012948219,0.0001230726,0.0001141106,0.00028736997,0.00030740132,0.00022887999,0.000039731196,0.00047780955,0.0000047402064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089594316,0.00021715448,0.9235873,0.00007357631,0.00016994134,0.00030716977,0.0035287745,2.6598076e-7,0.0009548084,0.000026823698,0.009711732,0.06133286],"study_design_scores_gemma":[0.0011890683,0.00344319,0.9890983,0.00081602455,0.00019657679,0.000037018253,0.000334341,0.00004529875,0.0025051988,0.000010583526,0.002172746,0.00015161786],"about_ca_topic_score_codex":0.23427102,"about_ca_topic_score_gemma":0.4769603,"teacher_disagreement_score":0.24268928,"about_ca_system_score_codex":0.00035794528,"about_ca_system_score_gemma":0.00074255234,"threshold_uncertainty_score":0.77082807},"labels":[],"label_agreement":null},{"id":"W1822176756","doi":"10.1111/j.1365-2893.2010.01393.x","title":"Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update","year":2010,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Suicidal ideation; Medicine; Depression (economics); Psychiatry; Hepatitis C; Ribavirin; Population; Antidepressant; Suicide prevention; Poison control; Chronic hepatitis; Internal medicine; Immunology; Anxiety; Medical emergency; Environmental health","score_opus":0.0615420616424336,"score_gpt":0.43200108091394884,"score_spread":0.37045901927151526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1822176756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047494538,0.950221,0.0000061962614,0.00031368775,0.0003335628,0.0013107074,0.00012466246,0.000015496486,0.0001801762],"genre_scores_gemma":[0.0011349358,0.9968455,0.0007077637,0.00040328264,0.0005913346,0.000035839144,0.000023789662,0.00012071652,0.0001368519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936117,0.0012198449,0.0033343146,0.0005490173,0.0007097394,0.0005753676],"domain_scores_gemma":[0.99614096,0.0005502843,0.0017788822,0.0005468966,0.00033374663,0.0006492584],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030077521,0.0006154677,0.0050287116,0.00076137786,0.00009435964,0.00009187207,0.00036144833,0.00066350546,0.00035322702],"category_scores_gemma":[0.0017080072,0.00045440102,0.0008082707,0.0004136162,0.00035826798,0.00035570026,0.00026980907,0.0048142755,0.000045702665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075804106,0.00012134755,0.14176306,0.013379741,0.0003310755,0.0012133764,0.000022287837,4.258345e-9,9.2397704e-7,0.000004147349,0.0004795913,0.84260863],"study_design_scores_gemma":[0.0023772046,0.0021095101,0.045931898,0.11375519,0.0018015123,0.0023153618,0.0000018485188,0.000007731239,0.000002664192,0.000052426123,0.83118194,0.00046268906],"about_ca_topic_score_codex":0.0016628825,"about_ca_topic_score_gemma":0.002789853,"teacher_disagreement_score":0.8421459,"about_ca_system_score_codex":0.0002559266,"about_ca_system_score_gemma":0.0006764145,"threshold_uncertainty_score":0.9997908},"labels":[],"label_agreement":null},{"id":"W1871529692","doi":"10.1111/jvh.12464","title":"Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Merck; Eisai; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Gastroenterology; Adverse effect; Hepatitis C virus; Clinical endpoint; Randomized controlled trial; Virology; Virus","score_opus":0.03152031339558758,"score_gpt":0.31713514824875794,"score_spread":0.28561483485317035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1871529692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951693,0.0007494678,0.0002018243,0.00025557884,0.00044637916,0.0018674723,0.000034139557,0.000020717522,0.0012551568],"genre_scores_gemma":[0.991138,0.007138478,0.00073807075,0.0001170839,0.00041627424,0.000081939026,0.000027440256,0.000048050417,0.00029465678],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99672943,0.00061142124,0.001051766,0.00028829198,0.0009104387,0.00040867587],"domain_scores_gemma":[0.9978155,0.00023439304,0.0005051841,0.00025013112,0.00067552103,0.0005192695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008994383,0.000330912,0.0015194378,0.00059404224,0.0000649476,0.00007946082,0.00010714249,0.00016221404,0.00013193631],"category_scores_gemma":[0.00078537234,0.00022904082,0.00024504116,0.00033449853,0.0002547682,0.0005292255,0.000059438775,0.00048268403,0.00003520847],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.410579,0.0005209693,0.56920946,0.00003156793,0.0002544094,0.00043136347,0.000710868,0.000012261144,0.000017435292,0.000022804968,0.00039499244,0.01781487],"study_design_scores_gemma":[0.81453156,0.01923219,0.16127092,0.0003929644,0.0002971098,0.00011359803,0.000012357297,0.000480131,0.00017468771,0.00017795707,0.003066537,0.00024999774],"about_ca_topic_score_codex":0.022802353,"about_ca_topic_score_gemma":0.0124912,"teacher_disagreement_score":0.40793854,"about_ca_system_score_codex":0.0012402764,"about_ca_system_score_gemma":0.0007138698,"threshold_uncertainty_score":0.98370486},"labels":[],"label_agreement":null},{"id":"W1899262468","doi":"10.1111/j.1365-2893.2012.01583.x","title":"Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Proportional hazards model; Hazard ratio; Diabetes mellitus; Hepatitis C; Retrospective cohort study; Cohort; Gastroenterology; Endocrinology; Confidence interval","score_opus":0.010746353106375173,"score_gpt":0.255405303560368,"score_spread":0.24465895045399283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899262468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937006,0.0047851335,0.00015810315,0.00010398099,0.00023386357,0.00054789014,0.0001718907,0.000013715757,0.00028479268],"genre_scores_gemma":[0.99147266,0.00480107,0.0030140756,0.000052913423,0.00034956264,0.000016772447,0.000023029235,0.00006940758,0.00020053162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967348,0.00022122377,0.00094050035,0.000234655,0.0012158154,0.00065299444],"domain_scores_gemma":[0.9972873,0.00013968976,0.0008338299,0.00037160967,0.00077107915,0.0005965425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046646863,0.00032076493,0.00091955875,0.00037240493,0.000097245684,0.000025739913,0.00017020201,0.00016069104,0.00035768113],"category_scores_gemma":[0.00017799769,0.00024012857,0.00024058942,0.00026527626,0.0002630433,0.00068086386,0.00009226712,0.0006091732,0.000015598427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007166173,0.00035699786,0.9631084,0.00023560594,0.00023959989,0.00010110967,0.00051548536,0.0000030286533,0.0015431027,0.000026470268,0.00027753663,0.032876033],"study_design_scores_gemma":[0.0052094623,0.005649035,0.9765865,0.00061865663,0.00033885677,0.00005347193,0.000016710414,0.00030533632,0.0066784224,0.000028453931,0.004269937,0.00024513848],"about_ca_topic_score_codex":0.006614738,"about_ca_topic_score_gemma":0.00065635913,"teacher_disagreement_score":0.032630898,"about_ca_system_score_codex":0.0003854433,"about_ca_system_score_gemma":0.00019622146,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W1918498751","doi":"10.1111/j.1365-2893.2012.01634.x","title":"Hepatitis C therapy in non‐genotype 1 patients: the near future","year":2012,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"NS5A; Ribavirin; Daclatasvir; Sofosbuvir; Virology; Boceprevir; Simeprevir; NS3; Telaprevir; Medicine; Hepatitis C virus; Hepatitis C; Virus; Hepacivirus","score_opus":0.04470723838587006,"score_gpt":0.359725048334704,"score_spread":0.31501780994883394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918498751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007941382,0.9866203,0.000009228265,0.00035670795,0.0017927049,0.0016757719,0.00012088277,0.000015224567,0.0014677648],"genre_scores_gemma":[0.002533321,0.9924643,0.00045325074,0.0004948908,0.0033984263,0.00006999926,0.00009242033,0.00016979132,0.00032362592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944444,0.0007837316,0.0019113198,0.00033684535,0.0016522674,0.0008714729],"domain_scores_gemma":[0.99637544,0.00030098963,0.0013572519,0.0007535113,0.00075560506,0.00045721102],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013255905,0.0006727804,0.0029246253,0.00062953815,0.00017913761,0.00013122667,0.00080017006,0.00068866723,0.0010563921],"category_scores_gemma":[0.0002650601,0.0003923365,0.0012252218,0.00096659624,0.00022656939,0.00043463876,0.0001535041,0.0029135044,0.0004110882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007594006,0.0003520804,0.08239741,0.0018409473,0.000319781,0.00030911676,0.00027379228,1.9358603e-7,3.3052112e-7,0.000014724111,0.0053442214,0.90907145],"study_design_scores_gemma":[0.0014356206,0.0017431675,0.03669724,0.00642147,0.00045931226,0.0001734052,0.000007750397,0.000009608615,0.0000014473229,0.00001751054,0.95268977,0.00034367412],"about_ca_topic_score_codex":0.0016648198,"about_ca_topic_score_gemma":0.00097084965,"teacher_disagreement_score":0.94734555,"about_ca_system_score_codex":0.00090836897,"about_ca_system_score_gemma":0.0012994984,"threshold_uncertainty_score":0.99985677},"labels":[],"label_agreement":null},{"id":"W1924815855","doi":"10.1111/j.1365-2893.2010.01375.x","title":"The optimal cut‐off for predicting large oesophageal varices using transient elastography is disease specific","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transient elastography; Varices; Medicine; Cirrhosis; Elastography; Gastroenterology; Internal medicine; Endoscopy; Liver disease; Receiver operating characteristic; Esophageal varices; Alcoholic liver disease; Portal hypertension; Radiology; Ultrasound","score_opus":0.01329517016859205,"score_gpt":0.27336104075417034,"score_spread":0.2600658705855783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924815855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275625,0.0039212806,0.00091096637,0.000782051,0.0008919739,0.00041024655,0.00025211505,0.000011728383,0.000063409694],"genre_scores_gemma":[0.9941671,0.0017380044,0.002772103,0.00025282448,0.0009896087,0.000017638633,0.000010832715,0.000024519502,0.000027395783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986024,0.00003155717,0.00045936293,0.00016219838,0.00043009518,0.0003143962],"domain_scores_gemma":[0.99871296,0.00016163936,0.00029300613,0.0001853102,0.00025501216,0.00039207845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709632,0.00016521782,0.0002726134,0.00011219645,0.00036203457,0.000085131964,0.00012271025,0.00005226221,0.00010796531],"category_scores_gemma":[0.00003794217,0.0001039938,0.0005481571,0.000115546616,0.000071517185,0.00021690509,0.000019175108,0.00026483784,0.000003068234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011408351,0.0014406056,0.9780745,0.00007981029,0.00068581203,0.00048243548,0.0006900973,0.000031249896,0.0006360877,0.00026730733,0.0035755772,0.012895704],"study_design_scores_gemma":[0.004586005,0.0014627872,0.95876604,0.0002527902,0.0014757841,0.0001206174,0.00014854297,0.004442704,0.0010269196,0.00016750177,0.027376575,0.00017371186],"about_ca_topic_score_codex":0.00003023426,"about_ca_topic_score_gemma":0.000029547928,"teacher_disagreement_score":0.023800999,"about_ca_system_score_codex":0.00005244771,"about_ca_system_score_gemma":0.00014360498,"threshold_uncertainty_score":0.4240744},"labels":[],"label_agreement":null},{"id":"W1937881082","doi":"10.1111/j.1365-2893.2010.01333.x","title":"Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Laboratory of Public Health; Public Health Agency of Canada; University of Alberta","funders":"","keywords":"Medicine; Interquartile range; Viral load; HBsAg; HBeAg; Genotyping; Hepatitis B virus; Transmission (telecommunications); Hepatitis B; Gestational age; Cohort; Pediatrics; Genotype; Asymptomatic; Obstetrics; Immunology; Pregnancy; Internal medicine; Virus; Biology","score_opus":0.0109901932013065,"score_gpt":0.23702482210928366,"score_spread":0.22603462890797715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937881082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882793,0.0001906333,0.000025271787,0.00042477745,0.00006974905,0.00022014881,0.00005315181,0.0000061529954,0.00018218906],"genre_scores_gemma":[0.9983279,0.001133296,0.00039206736,0.00005631409,0.000035052697,0.000001741856,0.0000057668553,0.000024899175,0.00002292199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985593,0.000052563777,0.0005969067,0.00013610863,0.0004118918,0.00024322966],"domain_scores_gemma":[0.99865645,0.00012621192,0.00027787802,0.00011459426,0.00038487103,0.00043999875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025629147,0.00018600936,0.00076581456,0.00047775777,0.000068162655,0.000010841871,0.000066123124,0.0001665076,0.00010996177],"category_scores_gemma":[0.0004091702,0.00012974736,0.000079862555,0.0002708376,0.00022466654,0.00019748414,0.000016459759,0.00041236606,1.7523533e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008452792,0.000061241466,0.9904134,0.00006147224,0.00036178034,0.00008330768,0.0008951023,6.01888e-7,0.006182049,0.000019918187,0.0002901109,0.0015464614],"study_design_scores_gemma":[0.0015686112,0.0013968319,0.9896163,0.0006306296,0.00032071845,0.00004539779,0.000041424104,0.0001374278,0.005851768,0.00002904157,0.000241285,0.00012059284],"about_ca_topic_score_codex":0.22270606,"about_ca_topic_score_gemma":0.7266351,"teacher_disagreement_score":0.503929,"about_ca_system_score_codex":0.000062486135,"about_ca_system_score_gemma":0.0002237527,"threshold_uncertainty_score":0.78247},"labels":[],"label_agreement":null},{"id":"W1952890674","doi":"10.1111/j.1365-2893.2009.01263.x","title":"Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Liver fibrosis; Chronic hepatitis; Fibrosis; Medicine; Internal medicine; Test (biology); Gastroenterology; Pathology; Virology; Biology; Virus","score_opus":0.009182802171521487,"score_gpt":0.24509422902230565,"score_spread":0.23591142685078417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952890674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780756,0.0007646836,0.00001839221,0.00019063796,0.00040710793,0.00047068595,0.00013742755,0.000020105203,0.00018337139],"genre_scores_gemma":[0.9951957,0.0032905508,0.0007195211,0.00015449671,0.0003331361,0.00003427345,0.00005136934,0.000042466523,0.00017849314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787825,0.000052526713,0.0006810641,0.00029239818,0.00070703716,0.00038873864],"domain_scores_gemma":[0.99822867,0.00020278139,0.0005009319,0.00030742437,0.00044770297,0.00031246903],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118487726,0.000314546,0.0006145628,0.00028496643,0.00010409241,0.000099472796,0.00018093278,0.00014303139,0.0011199791],"category_scores_gemma":[0.00013896135,0.00023233777,0.00026198442,0.00026924282,0.00012607775,0.000772223,0.0000616762,0.00046055723,0.00009886083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003966467,0.0015727861,0.9838045,0.00014075477,0.0002029377,0.000431311,0.00030096265,0.0000042842607,0.002108679,0.000018293682,0.001161443,0.009857396],"study_design_scores_gemma":[0.0048410045,0.0043506846,0.96539795,0.00089961715,0.0003849132,0.000030547268,0.000008161676,0.00005960608,0.023420252,0.00002664134,0.0003359714,0.00024467477],"about_ca_topic_score_codex":0.002976549,"about_ca_topic_score_gemma":0.0063807326,"teacher_disagreement_score":0.021311574,"about_ca_system_score_codex":0.0003561997,"about_ca_system_score_gemma":0.0002729889,"threshold_uncertainty_score":0.9997931},"labels":[],"label_agreement":null},{"id":"W1959794404","doi":"10.1111/j.1365-2893.2011.01442.x","title":"Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Virology; Persistence (discontinuity); Medicine; Antiviral therapy; Virus; Hepatitis C virus; Hepatitis B virus; Hepatitis a virus; Immunology; Chronic hepatitis","score_opus":0.03249988046259781,"score_gpt":0.29087298839275205,"score_spread":0.2583731079301542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1959794404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959564,0.000118740776,0.0003537515,0.00073542516,0.00027652705,0.0018745073,0.00019920427,0.000054640186,0.00043076172],"genre_scores_gemma":[0.9875149,0.001537031,0.0070048906,0.0028036248,0.00028865392,0.00016545967,0.000012696716,0.00013284879,0.0005398781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933928,0.0009716235,0.0015511755,0.0007552689,0.00205816,0.0012709438],"domain_scores_gemma":[0.99605346,0.00024276892,0.00046012286,0.00075544405,0.0013839481,0.0011042422],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013423634,0.00068053475,0.0015285661,0.0013711796,0.000165126,0.00011461633,0.00063700543,0.0003536064,0.0015121297],"category_scores_gemma":[0.00097537704,0.0004794507,0.0003369403,0.0013231433,0.00029137818,0.0007978086,0.0002357831,0.0010656957,0.00020069718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096128084,0.0012835871,0.8735066,0.000039667586,0.00016106921,0.004621395,0.003448029,0.0000039365755,0.0022685302,0.0000044476333,0.00063956005,0.017895063],"study_design_scores_gemma":[0.0071905637,0.05403036,0.9328648,0.0005487964,0.00006525031,0.00009188349,0.00009299747,0.000034743756,0.0024603216,0.000020528525,0.0020182044,0.0005815903],"about_ca_topic_score_codex":0.011107859,"about_ca_topic_score_gemma":0.026336528,"teacher_disagreement_score":0.08893752,"about_ca_system_score_codex":0.00085940235,"about_ca_system_score_gemma":0.0006420765,"threshold_uncertainty_score":0.9997657},"labels":[],"label_agreement":null},{"id":"W1960860169","doi":"10.1111/j.1365-2893.2010.01357.x","title":"Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Core protein; Virology; Biology; Hepatitis C virus; Virus; Cell biology; Computational biology","score_opus":0.033146576781207304,"score_gpt":0.29263226770535683,"score_spread":0.2594856909241495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960860169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967404,0.0002043957,0.0006161505,0.0010552502,0.0003596817,0.00047998072,0.00011436372,0.000022125927,0.00040762464],"genre_scores_gemma":[0.99333537,0.00025220262,0.0047164494,0.0003199938,0.00068993866,0.000037210633,0.00004529341,0.00004179549,0.0005617699],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997747,0.00008549979,0.0005346233,0.00024354609,0.0010569892,0.00033235],"domain_scores_gemma":[0.9983731,0.00005919208,0.0002995965,0.00017858909,0.0007403905,0.00034912617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034495507,0.00023168554,0.0004432545,0.000302619,0.0002815753,0.00012679512,0.00008809867,0.00016162716,0.0006253626],"category_scores_gemma":[0.00009543532,0.00018258588,0.00011000705,0.00013937008,0.00033940907,0.00042979515,0.000027342983,0.0009025578,0.00001296427],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039943442,0.00018217911,0.06488064,0.00015675051,0.00010246202,0.00053423224,0.00019847584,0.0000028570857,0.92714864,0.00075458846,0.0008694823,0.004770257],"study_design_scores_gemma":[0.005335381,0.004547822,0.8190492,0.0014971133,0.0002939833,0.0027301984,0.00007318638,0.0009366662,0.15528652,0.0005426671,0.0091885,0.000518771],"about_ca_topic_score_codex":0.0009421779,"about_ca_topic_score_gemma":0.009329266,"teacher_disagreement_score":0.7718621,"about_ca_system_score_codex":0.00011643131,"about_ca_system_score_gemma":0.00024342634,"threshold_uncertainty_score":0.7445636},"labels":[],"label_agreement":null},{"id":"W1969093502","doi":"10.1111/jvh.12308","title":"Hepatitis B virus (<scp>HBV</scp>) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (<scp>CHB</scp>) disease phases","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Science Centre for Human and Animal Health; University of Calgary","funders":"","keywords":"Peripheral blood mononuclear cell; Virology; Hepatitis B virus; Immune system; Biology; Virus; Hepatitis B; Immunology; Hepatitis C virus; HBeAg; HBsAg; Genetics; In vitro","score_opus":0.007012449109743854,"score_gpt":0.2145890430288494,"score_spread":0.20757659391910555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969093502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940698,0.0025196252,0.00016771916,0.00010936872,0.001091844,0.0011187152,0.0003408874,0.00012273155,0.00045929017],"genre_scores_gemma":[0.96483374,0.032424234,0.00057150243,0.00029339088,0.0009212076,0.000093354574,0.00003353685,0.00020165196,0.0006273905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99313176,0.0006006285,0.0023300243,0.00094037794,0.0015332671,0.0014639178],"domain_scores_gemma":[0.99540985,0.0007059177,0.0013643563,0.00068115245,0.0004696843,0.0013690197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050217827,0.0010531042,0.0022049968,0.00073967926,0.000504466,0.0002421006,0.00038510672,0.00033452924,0.00016002874],"category_scores_gemma":[0.001574095,0.0009629224,0.0005721684,0.0004195356,0.00051837164,0.00096374203,0.00038563152,0.0010892021,0.000029711651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012904305,0.001126745,0.97122306,0.00050220214,0.00063578977,0.003876383,0.0022084895,0.00027690124,0.013256948,0.000034435125,0.0022000372,0.0045299483],"study_design_scores_gemma":[0.0068509993,0.00397328,0.9529293,0.002011468,0.0008171489,0.00035730473,0.00006636478,0.008123014,0.023124821,0.00030369934,0.0011182032,0.0003243975],"about_ca_topic_score_codex":0.014836437,"about_ca_topic_score_gemma":0.02558705,"teacher_disagreement_score":0.029904608,"about_ca_system_score_codex":0.0009493412,"about_ca_system_score_gemma":0.0002999795,"threshold_uncertainty_score":0.9992821},"labels":[],"label_agreement":null},{"id":"W1969504669","doi":"10.1046/j.1365-2893.2000.00249.x","title":"Serum cytokine values and fatigue in chronic hepatitis C infection","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatology; Internal medicine; Cytokine; Alanine transaminase; Gastroenterology; Hepatitis C; Hepatitis; Immunology","score_opus":0.017365794220710395,"score_gpt":0.3042415332430818,"score_spread":0.2868757390223714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969504669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594456,0.0019838684,0.00004569775,0.00071353273,0.00011141691,0.00018066914,0.000009024657,0.000014102655,0.0009971461],"genre_scores_gemma":[0.9778429,0.020523543,0.00034474093,0.000023878005,0.00016885114,0.0000045068678,0.000006119031,0.00002160853,0.0010638372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840385,0.00010386432,0.0005479944,0.00015659386,0.0004681252,0.00031955674],"domain_scores_gemma":[0.9993757,0.00005123039,0.00012927961,0.00014586023,0.00011647428,0.00018146966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034530638,0.00015185197,0.00042728367,0.0003049565,0.00006177171,0.000032516193,0.00006988304,0.00011990656,0.002022457],"category_scores_gemma":[0.000060721442,0.00012914972,0.000117703035,0.00027722635,0.000110930225,0.00033681822,0.000022682001,0.00049130264,0.00003245359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001741978,0.00014539094,0.9005324,0.00086309155,0.00009549971,0.0007896576,0.00029418,0.00010224882,0.0032718242,0.000043939403,0.001560609,0.09212691],"study_design_scores_gemma":[0.0026533531,0.0035431385,0.9849028,0.0015942378,0.000045688732,0.0015834001,0.000007263561,0.0016501539,0.0022089765,0.0006341839,0.0010393184,0.0001374568],"about_ca_topic_score_codex":0.003422942,"about_ca_topic_score_gemma":0.0003880084,"teacher_disagreement_score":0.09198946,"about_ca_system_score_codex":0.00061419536,"about_ca_system_score_gemma":0.0003604408,"threshold_uncertainty_score":0.9988898},"labels":[],"label_agreement":null},{"id":"W1975218884","doi":"10.1111/j.1365-2893.2008.01062.x","title":"An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO<i>Spect</i> II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Medicine; Gastroenterology; Ribavirin; Liver biopsy; Internal medicine; Fibrosis; Hepatitis C; Stage (stratigraphy); Biopsy; Surrogate endpoint; Liver disease; Chronic hepatitis; Immunology; Biology","score_opus":0.020590479425951973,"score_gpt":0.3473560578726174,"score_spread":0.32676557844666543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975218884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953425,0.0019314714,0.00039202077,0.0007330469,0.0001432084,0.0011597145,0.000106777145,0.000022995613,0.00016826365],"genre_scores_gemma":[0.9940568,0.004156516,0.0011324233,0.00010051699,0.00035324,0.000022553646,0.00003171119,0.00004485001,0.000101367805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971248,0.0001868217,0.0010494343,0.00035689824,0.0008352211,0.00044686263],"domain_scores_gemma":[0.99801165,0.00014275122,0.00064284576,0.00027543516,0.00060577167,0.00032153685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056436565,0.00032134072,0.0010026838,0.00036527275,0.00028700978,0.00009406973,0.00018753977,0.00016870281,0.000105007806],"category_scores_gemma":[0.00011088239,0.00028920404,0.00019359277,0.00020435645,0.00019380581,0.00069686904,0.000067929985,0.0005626626,0.0000011923687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023115082,0.0007152927,0.82675034,0.00019790285,0.00017062371,0.00003885352,0.0014438471,0.000010836795,0.06756021,0.00013839707,0.00035811376,0.10030407],"study_design_scores_gemma":[0.009403783,0.025790863,0.88572496,0.0006194535,0.00009323879,0.00011706493,0.000043466312,0.0014876643,0.07546392,0.0007614813,0.00025453634,0.00023957217],"about_ca_topic_score_codex":0.001105766,"about_ca_topic_score_gemma":0.0010782069,"teacher_disagreement_score":0.10006449,"about_ca_system_score_codex":0.0004936399,"about_ca_system_score_gemma":0.0002003106,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W1975750281","doi":"10.1111/j.1365-2893.2004.00523.x","title":"Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg <i>vs</i> 100 mg of lamivudine daily*","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Columbia Centre for Disease Control; GlaxoSmithKline","keywords":"Lamivudine; Viral load; Virology; Medicine; Chronic hepatitis; Population; Viral replication; In vivo; Hepatitis B; Immunology; Gastroenterology; Kinetics; Virus; Internal medicine; Biology","score_opus":0.012440042785060104,"score_gpt":0.2575285913966709,"score_spread":0.24508854861161078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975750281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949423,0.001750706,0.00027310578,0.00059650955,0.00028970715,0.00040957134,0.0002001601,0.000019883244,0.0015180245],"genre_scores_gemma":[0.9830556,0.010571344,0.005481926,0.00009112013,0.00030857537,0.000010425755,0.000010634926,0.00006602036,0.00040435823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615544,0.00008785145,0.0018620613,0.0002707857,0.0011565788,0.00046729142],"domain_scores_gemma":[0.99636304,0.00009035256,0.0016864052,0.0004484268,0.0011752847,0.0002364729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021242631,0.00043995382,0.0018128317,0.00037922617,0.00006868102,0.000011232592,0.00022670272,0.0001628577,0.0001435643],"category_scores_gemma":[0.00016141776,0.0003373004,0.00044949588,0.00039787075,0.00044093077,0.00027096402,0.00009273732,0.00032106592,0.00000948962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001958122,0.0016578682,0.83690506,0.0007385788,0.0012091785,0.00083506334,0.0020606203,0.0002821436,0.15058216,0.00016383627,0.00040477945,0.003202559],"study_design_scores_gemma":[0.013291924,0.028739097,0.54001904,0.0028628283,0.0009742137,0.0006211809,0.00008330121,0.00003989504,0.41159236,0.00022703022,0.0011853428,0.0003637774],"about_ca_topic_score_codex":0.018565007,"about_ca_topic_score_gemma":0.01086474,"teacher_disagreement_score":0.29688606,"about_ca_system_score_codex":0.0009664321,"about_ca_system_score_gemma":0.00045997437,"threshold_uncertainty_score":0.9999079},"labels":[],"label_agreement":null},{"id":"W1984604958","doi":"10.1111/j.1365-2893.2009.01230.x","title":"Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"","keywords":"Medicine; Hepatitis C virus; Transmission (telecommunications); Population; Odds ratio; Hepatitis C; Demography; Cross-sectional study; Sexual transmission; Environmental health; Immunology; Human immunodeficiency virus (HIV); Internal medicine; Virus","score_opus":0.012041178231496422,"score_gpt":0.3124106742223875,"score_spread":0.3003694959908911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984604958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749684,0.0010943771,0.00005536025,0.00025812286,0.00012001089,0.0005657043,0.00024129523,0.0000151570985,0.00015310328],"genre_scores_gemma":[0.97900575,0.020549176,0.000103294864,0.00008530004,0.0001290088,0.00001367962,0.000014236769,0.000026782805,0.00007273982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964374,0.00062727154,0.0010608117,0.00026365655,0.0010692077,0.00054168387],"domain_scores_gemma":[0.997977,0.00017535739,0.0008935271,0.00023859774,0.00031504713,0.00040043486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001170848,0.00026310803,0.00074496085,0.00046869295,0.00020920142,0.000053295662,0.0001798495,0.00015202453,0.00015003061],"category_scores_gemma":[0.0002797245,0.00019499543,0.00016839066,0.00036812012,0.00031034194,0.00054609,0.00004989871,0.0010360326,0.0000012011674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017396298,0.00016895469,0.9551997,0.0001476126,0.00005083511,0.00011644571,0.014726424,0.000013465021,0.00009294327,0.000013434647,0.00018592265,0.029110309],"study_design_scores_gemma":[0.0013586191,0.0042631626,0.9923287,0.0004992947,0.00005565134,0.000034818942,0.0005249954,0.0002210691,0.000406898,0.00010217355,0.000046608577,0.00015799158],"about_ca_topic_score_codex":0.1661486,"about_ca_topic_score_gemma":0.03814434,"teacher_disagreement_score":0.12800427,"about_ca_system_score_codex":0.0011103442,"about_ca_system_score_gemma":0.00033438124,"threshold_uncertainty_score":0.979407},"labels":[],"label_agreement":null},{"id":"W1990099284","doi":"10.1111/jvh.12165_3","title":"O115: Assessing the role of intra‐familial transmission in the ongoing propagation of the Egyptian hepatitis C virus epidemic","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Transmission (telecommunications); Demography; Environmental health; Residence; Respondent; Logistic regression; Odds; Odds ratio; Proxy (statistics); Internal medicine","score_opus":0.01730694888308674,"score_gpt":0.3135686466270036,"score_spread":0.29626169774391686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990099284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921333,0.00074568036,0.00053302135,0.0038943738,0.00016998171,0.0008482233,0.000011248176,0.00000600849,0.0016581294],"genre_scores_gemma":[0.9960878,0.0022763333,0.000875869,0.0004084572,0.00026050213,0.000021903521,0.0000029192854,0.000027249627,0.00003896732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957629,0.0010195567,0.0013678259,0.00015765223,0.0013412075,0.00035085107],"domain_scores_gemma":[0.99760586,0.00052856404,0.00083280494,0.0004051655,0.0005198261,0.000107770946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067524,0.00018868424,0.0005462623,0.00023223218,0.00016081025,0.000057223024,0.00058284425,0.00014675406,0.00021040281],"category_scores_gemma":[0.00086569117,0.00009164848,0.00031061002,0.00057711796,0.00030720668,0.00056845084,0.00006280973,0.0010248537,0.000009543192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006304561,0.00019446923,0.61948466,0.00011259938,0.000057033274,0.000026399945,0.002344108,0.00004996683,0.13924631,0.00011407019,0.00053534453,0.23777196],"study_design_scores_gemma":[0.0011186354,0.00079008477,0.9213912,0.0014353783,0.00010608689,0.00012879087,0.0004352229,0.010216339,0.060561694,0.0016959937,0.0019965193,0.00012409134],"about_ca_topic_score_codex":0.019709235,"about_ca_topic_score_gemma":0.0021565272,"teacher_disagreement_score":0.30190647,"about_ca_system_score_codex":0.00019718255,"about_ca_system_score_gemma":0.00047514983,"threshold_uncertainty_score":0.9868186},"labels":[],"label_agreement":null},{"id":"W1992745758","doi":"10.1111/j.1365-2893.2005.00684.x","title":"Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxyribozyme; RNA; Hepatitis C virus; DNA; Virology; Cleave; In vitro; Biology; Ribozyme; Virus; Computational biology; Gene; Biochemistry","score_opus":0.033677375639859015,"score_gpt":0.31089932455563607,"score_spread":0.27722194891577706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992745758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172723,0.0019034428,0.0008487011,0.0023895565,0.000098178214,0.00068156584,0.00004250913,0.000013448367,0.002295367],"genre_scores_gemma":[0.99175,0.0051185726,0.0018264801,0.00048008177,0.00042223016,0.000019909563,0.000012912448,0.000041583557,0.00032823993],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964584,0.0003352987,0.0012614522,0.00021015434,0.0012673165,0.00046734707],"domain_scores_gemma":[0.99825716,0.0001883666,0.00065346464,0.00037388707,0.00032731172,0.00019980002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012486873,0.00023609161,0.00068772613,0.00039703204,0.00009184718,0.00004534268,0.00043720717,0.0001889476,0.00016317081],"category_scores_gemma":[0.00061823,0.00017440418,0.000248343,0.00047965534,0.00022094786,0.00044910042,0.00006220119,0.0010196703,0.00003085242],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007828516,0.0010730205,0.42834046,0.00033489722,0.00017590405,0.0031822731,0.0023519555,0.000013955341,0.29931164,0.00088000624,0.06574818,0.19780487],"study_design_scores_gemma":[0.007267673,0.0069378,0.14388773,0.0034050574,0.00021801383,0.0013320028,0.0003845756,0.0032911368,0.73875254,0.0007801147,0.09305073,0.00069258694],"about_ca_topic_score_codex":0.0032661622,"about_ca_topic_score_gemma":0.001963535,"teacher_disagreement_score":0.43944094,"about_ca_system_score_codex":0.00034508167,"about_ca_system_score_gemma":0.00023625557,"threshold_uncertainty_score":0.71119964},"labels":[],"label_agreement":null},{"id":"W1993607717","doi":"10.1111/j.1365-2893.2006.00816.x","title":"Therapeutic issues in HIV/HCV‐coinfected patients","year":2006,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; National Institute on Drug Abuse; Vertex Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Ribavirin; Coinfection; Pegylated interferon; Hepatitis C; Hepatitis C virus; Internal medicine; Population; Immunology; Intensive care medicine; Human immunodeficiency virus (HIV); Virus","score_opus":0.04664782216823437,"score_gpt":0.3968295823683239,"score_spread":0.3501817602000895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993607717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012610765,0.9933613,0.000018184579,0.00012649587,0.00042354284,0.0009327736,0.00009648579,0.000021933194,0.0037581993],"genre_scores_gemma":[0.00095140276,0.99595606,0.00040620775,0.0001134733,0.00074921304,0.000026242911,0.00016949444,0.00012384339,0.0015040395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497753,0.0006069259,0.0021868225,0.00030966193,0.0013243053,0.0005947734],"domain_scores_gemma":[0.9974336,0.00023602501,0.0010810808,0.00040684323,0.0005801005,0.00026235665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005940535,0.00052220654,0.0032184178,0.0013942407,0.000050556137,0.000067728484,0.00037942696,0.00050160097,0.0004662069],"category_scores_gemma":[0.00038372193,0.00039045094,0.0009386384,0.0007789159,0.00011025521,0.00026010984,0.00009052235,0.0017656903,0.0003115642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033492568,0.00046840633,0.06706313,0.004687856,0.0002152074,0.0009159811,0.00003362856,3.0953305e-7,4.6627306e-7,0.000020432424,0.010342296,0.9162188],"study_design_scores_gemma":[0.001478119,0.0011439414,0.0126956245,0.018935278,0.0005452163,0.00010127538,0.0000013060757,0.000012307258,0.0000021252415,0.000067810935,0.9647108,0.00030622957],"about_ca_topic_score_codex":0.0010955647,"about_ca_topic_score_gemma":0.00042797456,"teacher_disagreement_score":0.9543685,"about_ca_system_score_codex":0.00094320794,"about_ca_system_score_gemma":0.00090139423,"threshold_uncertainty_score":0.99985474},"labels":[],"label_agreement":null},{"id":"W1995670220","doi":"10.1111/j.1365-2893.2008.00959.x","title":"Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"NS5A; Virology; Vaccination; Vaccinia; Transfection; Dendritic cell; Immune system; Antigen; Virus; Immunity; Biology; Hepatitis C virus; Immunology; Cell culture; Recombinant DNA; Gene; Hepacivirus; Genetics","score_opus":0.01493295281332378,"score_gpt":0.241688471623288,"score_spread":0.22675551880996422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995670220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877396,0.0071821865,0.0041200193,0.00006472983,0.0003845392,0.00034498208,0.000027474754,0.000017659047,0.00011879114],"genre_scores_gemma":[0.99434453,0.0040875915,0.0011300957,0.000076734934,0.000050424682,0.00001721312,0.0000055118153,0.000025672902,0.00026223986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873304,0.00027731428,0.00045866167,0.00014539858,0.000062866,0.00032269454],"domain_scores_gemma":[0.99890333,0.0002679471,0.00039349182,0.00014506046,0.00026485315,0.000025336407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003243204,0.00020392434,0.0004512649,0.00019824099,0.00056003046,0.000042689895,0.00017603274,0.00016897277,0.00007268978],"category_scores_gemma":[0.00005890612,0.00016167482,0.00011982494,0.000108725595,0.00035400735,0.00060534367,0.00003235817,0.00046567633,0.000008322377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021959036,0.00016105188,0.028411333,0.00006269962,0.0006487032,0.0001184337,0.004836281,0.000016886142,0.95552695,0.00029275983,0.00043801643,0.00729096],"study_design_scores_gemma":[0.005375027,0.007857086,0.19150269,0.0006399626,0.000115786504,0.0054658027,0.0019909055,0.000018068551,0.77994585,0.0009956523,0.005548424,0.00054473657],"about_ca_topic_score_codex":0.0015012274,"about_ca_topic_score_gemma":0.00014369687,"teacher_disagreement_score":0.17558111,"about_ca_system_score_codex":0.000067028384,"about_ca_system_score_gemma":0.0002800241,"threshold_uncertainty_score":0.6592908},"labels":[],"label_agreement":null},{"id":"W1997115629","doi":"10.1111/j.1365-2893.2004.00556.x","title":"Sustained response after a 2‐year course of lamivudine treatment of hepatitis B e antigen‐negative chronic hepatitis B","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Lamivudine; Medicine; Internal medicine; Gastroenterology; Hepatitis B; Hepatitis B virus; Chronic hepatitis; Immunology; Virus","score_opus":0.011989512207874215,"score_gpt":0.29128609742873535,"score_spread":0.27929658522086115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997115629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914428,0.0048490064,0.00033141644,0.0015004213,0.00039640255,0.0007368181,0.0004419665,0.000029091625,0.00027205274],"genre_scores_gemma":[0.9632469,0.03183826,0.003904023,0.000115166506,0.0004266599,0.00003882109,0.0000138902315,0.00007649623,0.00033979423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959689,0.00030456632,0.0018400454,0.00033950488,0.0009485272,0.0005984498],"domain_scores_gemma":[0.995852,0.0003446327,0.0013819198,0.0005120772,0.0015914333,0.0003179703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005430667,0.000509685,0.0018620967,0.0005622547,0.000105945976,0.000019024705,0.00020379767,0.0002124752,0.00042169576],"category_scores_gemma":[0.00062501995,0.00041467976,0.0007405675,0.0005735183,0.0005721482,0.0003743981,0.000103478604,0.00029845614,0.000024936417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062704133,0.001701621,0.9670945,0.00029020288,0.0013755887,0.0024446358,0.003987109,0.000050572107,0.008534637,0.00019916116,0.0004888303,0.0075627742],"study_design_scores_gemma":[0.009507052,0.024757074,0.8943566,0.0014660108,0.0005366857,0.00033873328,0.00016736877,0.00004701988,0.06643876,0.00076750026,0.0012743914,0.00034282252],"about_ca_topic_score_codex":0.017472241,"about_ca_topic_score_gemma":0.018477926,"teacher_disagreement_score":0.07273787,"about_ca_system_score_codex":0.0018116798,"about_ca_system_score_gemma":0.0017086414,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W1999498806","doi":"10.1111/j.1365-2893.2008.01063.x","title":"The influence of North American Aboriginal ethnicity on pro‐inflammatory and anti‐inflammatory cytokine responses to IFN‐alpha","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ethnic group; Cytokine; Medicine; Immunology; Alpha (finance); Sociology; Anthropology; Clinical psychology","score_opus":0.01435819948645155,"score_gpt":0.33615049332510905,"score_spread":0.3217922938386575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999498806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966165,0.00016505129,0.000016751505,0.0023920408,0.000072257004,0.00042437407,0.000031442396,0.000018028983,0.0002635553],"genre_scores_gemma":[0.9946869,0.0035242117,0.0005328485,0.00080953486,0.0002601699,0.0000063759094,0.0000010990327,0.000022848519,0.0001560146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687403,0.00030357644,0.00093049713,0.00021854992,0.0012335884,0.00043973702],"domain_scores_gemma":[0.99738365,0.00038172118,0.00059684896,0.00038840782,0.000795369,0.00045402188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001046349,0.00022778781,0.0006166234,0.00039323478,0.00017324784,0.000041713443,0.00030802572,0.000058297188,0.000010899601],"category_scores_gemma":[0.0010795508,0.00015652056,0.0001388492,0.0004895293,0.00044354575,0.00025215707,0.000042461408,0.00073568965,0.000017672583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023776237,0.00012002994,0.87525165,0.00004830561,0.000066915934,0.0006913379,0.00031699394,0.00006622651,0.011546906,0.000095669675,0.00081910857,0.10859921],"study_design_scores_gemma":[0.00082604977,0.005365491,0.97288775,0.00031756726,0.000040440864,0.00012351033,0.000017208167,0.000042286378,0.0051963474,0.000028036984,0.015011911,0.00014338594],"about_ca_topic_score_codex":0.0003758008,"about_ca_topic_score_gemma":0.0010326019,"teacher_disagreement_score":0.10845582,"about_ca_system_score_codex":0.0002024825,"about_ca_system_score_gemma":0.0006348453,"threshold_uncertainty_score":0.63827235},"labels":[],"label_agreement":null},{"id":"W2000668130","doi":"10.1111/j.1365-2893.2007.00921.x","title":"Antiviral therapy: chronic hepatitis C","year":2007,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ribavirin; Medicine; Dosing; Viral load; Internal medicine; Chronic hepatitis; Pegylated interferon; Hepatitis C virus; Interferon; Hepatitis C; Combination therapy; Immunology; Pharmacology; Gastroenterology; Virus","score_opus":0.09674840743502618,"score_gpt":0.42822321448295797,"score_spread":0.3314748070479318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000668130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073184416,0.9899281,0.00015182226,0.00008811945,0.0012054637,0.001179278,0.00013348444,0.000049964245,0.006531898],"genre_scores_gemma":[0.0008815514,0.9919375,0.00095677224,0.00019889779,0.004026483,0.000026904288,0.000086884815,0.00024947047,0.0016355179],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929014,0.0005390189,0.002856874,0.0005071755,0.0021164962,0.0010790721],"domain_scores_gemma":[0.99556553,0.00041846442,0.001809179,0.00076633866,0.000819277,0.0006212159],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016771703,0.0008649731,0.0046929345,0.001701691,0.00014881848,0.0001256243,0.00072983943,0.00089728367,0.0012311562],"category_scores_gemma":[0.0004169858,0.00065014785,0.0024595838,0.001011143,0.00031029177,0.00044949687,0.00016469325,0.002926143,0.00064477],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007189241,0.00022375173,0.0045469385,0.006177095,0.00081567385,0.004790661,0.0000380022,7.8857745e-8,0.0000060436923,0.00004546241,0.0076310188,0.9756534],"study_design_scores_gemma":[0.0014119509,0.0037973768,0.0008293057,0.023168435,0.00070390664,0.0015777354,0.0000015985645,0.000011998262,0.000036576515,0.000039631883,0.96789914,0.00052232365],"about_ca_topic_score_codex":0.0011162548,"about_ca_topic_score_gemma":0.0005197966,"teacher_disagreement_score":0.97513103,"about_ca_system_score_codex":0.0020295824,"about_ca_system_score_gemma":0.0038517492,"threshold_uncertainty_score":0.99968183},"labels":[],"label_agreement":null},{"id":"W2001237435","doi":"10.1111/j.1365-2893.2005.00615.x","title":"Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Vancouver General Hospital","funders":"National Institutes of Health; Bayer HealthCare","keywords":"Viral load; BDNA test; Medicine; Ribavirin; Viral hepatitis; Hepatitis C virus; Internal medicine; Immunology; Virology; Antiviral therapy; Virus; Chronic hepatitis","score_opus":0.07804766127706947,"score_gpt":0.3928171565902463,"score_spread":0.31476949531317683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001237435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994624,0.0006036454,0.00012230928,0.00050622463,0.00027178318,0.0006246105,0.00003384476,0.000019417035,0.0031941673],"genre_scores_gemma":[0.98930496,0.008276658,0.0012088605,0.0003240081,0.00072998897,0.000013117185,0.000008936019,0.000044411587,0.00008906968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942505,0.00070577307,0.0018294716,0.0003452681,0.0023374981,0.0005315413],"domain_scores_gemma":[0.9974994,0.0001842563,0.0008478706,0.00040761987,0.0008020613,0.00025880767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003200322,0.00031090414,0.0010967132,0.00055856345,0.00006993264,0.00003587562,0.0002346808,0.0002697579,0.0004592377],"category_scores_gemma":[0.000559763,0.00024141473,0.00036049954,0.00048536726,0.000304712,0.000618326,0.00005329417,0.0012481816,0.000052955987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081507507,0.0010669146,0.74021876,0.000049569073,0.00019975136,0.00007083551,0.00012577997,0.000014548673,0.00060397247,0.000009302107,0.00078210304,0.25604337],"study_design_scores_gemma":[0.008233624,0.011617056,0.96174026,0.0008505274,0.000055341672,0.00004752886,0.0000028978295,0.0004963506,0.008724697,0.00005948033,0.0079703955,0.00020183911],"about_ca_topic_score_codex":0.0050920392,"about_ca_topic_score_gemma":0.011726828,"teacher_disagreement_score":0.25584152,"about_ca_system_score_codex":0.00090171874,"about_ca_system_score_gemma":0.001353712,"threshold_uncertainty_score":0.9844607},"labels":[],"label_agreement":null},{"id":"W2001800161","doi":"10.1111/j.1365-2893.2005.00676.x","title":"Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Wellcome Trust","keywords":"Epitope; Biology; Virology; Virus; CD8; Hepatitis C virus; Cytotoxic T cell; Immune system; Human leukocyte antigen; Immunology; T cell; Mutation; Antigen; Genetics; Gene","score_opus":0.013805997180324719,"score_gpt":0.30073659733851255,"score_spread":0.28693060015818783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001800161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994551,0.0020039477,0.00024833193,0.000395088,0.0002829493,0.00057574216,0.0003419612,0.00006223222,0.0015387548],"genre_scores_gemma":[0.98230433,0.013347971,0.0024749753,0.0004969316,0.00065575936,0.000020249101,0.00010057742,0.00010039263,0.00049882336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930534,0.00072338834,0.002274791,0.0006734964,0.0020339636,0.0012409961],"domain_scores_gemma":[0.9967508,0.00029241823,0.000949717,0.00062591303,0.00072163076,0.0006595193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013596994,0.0006496003,0.002032399,0.0023120013,0.00027868716,0.0002182305,0.0006691152,0.00039382692,0.002663597],"category_scores_gemma":[0.0004704277,0.0006015078,0.00086458854,0.0027134928,0.0003222098,0.0011958372,0.00018721467,0.0012121899,0.00027250018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032614445,0.00088070123,0.78138226,0.00008888672,0.0012454089,0.0017723568,0.00073456427,0.00010294837,0.13997342,0.00002238289,0.0075992667,0.06587165],"study_design_scores_gemma":[0.011312038,0.0052602733,0.6198472,0.0008887446,0.0026752008,0.00022672227,0.00016379172,0.014683687,0.3273641,0.00023451768,0.015682623,0.0016611756],"about_ca_topic_score_codex":0.020768797,"about_ca_topic_score_gemma":0.025935145,"teacher_disagreement_score":0.18739066,"about_ca_system_score_codex":0.0016960544,"about_ca_system_score_gemma":0.0005634976,"threshold_uncertainty_score":0.9996436},"labels":[],"label_agreement":null},{"id":"W2002437041","doi":"10.1046/j.1365-2893.2001.00262.x","title":"Impact of chronic hepatitis B and interferon‐α therapy on growth of children","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Percentile; Internal medicine; Hepatitis B virus; Population; Gastroenterology; Interferon; Alpha interferon; Chronic hepatitis; Hepatitis B; Immunology; Pediatrics; Virus","score_opus":0.01066734556377695,"score_gpt":0.28321368442010825,"score_spread":0.2725463388563313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002437041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568325,0.003643061,0.000009724315,0.00016200618,0.00006458648,0.00017327035,0.000053318494,0.0000035801709,0.00020722038],"genre_scores_gemma":[0.96069837,0.038974628,0.000058825142,0.00006164361,0.0001651145,0.0000023855673,0.000008273169,0.000013576131,0.00001718074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905187,0.00004032793,0.00041683152,0.00009482037,0.0002652351,0.00013091645],"domain_scores_gemma":[0.9991418,0.000048180682,0.00035987495,0.0001231758,0.00018447511,0.00014249573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000768691,0.0001353332,0.00045582626,0.00015834722,0.000019613457,0.0000073424326,0.00006464241,0.000045583474,0.00028399614],"category_scores_gemma":[0.00002188266,0.000088584646,0.00030322137,0.000089175366,0.000067898654,0.00011658273,0.00001533135,0.000110396795,0.0000027096848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006726365,0.0011373068,0.9704695,0.000023301975,0.0007602673,0.000105540996,0.00013454171,0.0000025279298,0.0005345544,0.00004204366,0.00059727865,0.02552054],"study_design_scores_gemma":[0.0034945384,0.02162099,0.96887255,0.00046462443,0.00016121418,0.00019446459,0.0000020808561,0.00002290287,0.004985506,0.0001037485,0.00001279202,0.00006460491],"about_ca_topic_score_codex":0.003704547,"about_ca_topic_score_gemma":0.00008923623,"teacher_disagreement_score":0.035331566,"about_ca_system_score_codex":0.00018082937,"about_ca_system_score_gemma":0.00013034245,"threshold_uncertainty_score":0.56001914},"labels":[],"label_agreement":null},{"id":"W2009763040","doi":"10.1111/jvh.12165_16","title":"O224: What is in the pipeline for treatment of Hepatitis B? (IFN‐lambda, TLR‐agonists, entry inhibitors etc.)","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Interferon; Hepatitis B virus; Immune system; Entecavir; Immunology; Innate immune system; Hepatitis B; Medicine; Virology; Virus; Biology","score_opus":0.01966474117332188,"score_gpt":0.29137233980506455,"score_spread":0.27170759863174265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009763040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977524,0.009439931,0.00018126807,0.00992991,0.00088273996,0.0013278312,0.00009029703,0.000013928684,0.00061013416],"genre_scores_gemma":[0.935519,0.059194464,0.0016335242,0.0017476727,0.00092264125,0.000120675104,0.000019305726,0.000042723008,0.00080002897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968873,0.00015568195,0.0015027302,0.00024663247,0.00073173334,0.00047591046],"domain_scores_gemma":[0.9976654,0.00039184582,0.00074190745,0.00036969746,0.0006604238,0.0001707478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347772,0.0003469292,0.0011084003,0.00030835875,0.00012413754,0.00009724874,0.00022874618,0.0001633554,0.00033201158],"category_scores_gemma":[0.00023294995,0.00022740736,0.00054230524,0.00029141753,0.00018786613,0.0007312972,0.00004208741,0.00021595423,0.00004316103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027766413,0.0013061281,0.73329145,0.00022504845,0.00032365034,0.0002487997,0.006281303,0.0000042852153,0.0015208488,0.00009993533,0.06770846,0.18871245],"study_design_scores_gemma":[0.014129112,0.015650881,0.80442244,0.0031226266,0.00093118433,0.0007500706,0.0020689347,0.001363151,0.034725904,0.0025096165,0.11955322,0.0007728422],"about_ca_topic_score_codex":0.016731068,"about_ca_topic_score_gemma":0.0070213424,"teacher_disagreement_score":0.18793961,"about_ca_system_score_codex":0.00043262655,"about_ca_system_score_gemma":0.0002130672,"threshold_uncertainty_score":0.9898166},"labels":[],"label_agreement":null},{"id":"W2010537550","doi":"10.1111/j.1365-2893.2006.00828.x","title":"<i>Staphylococcus aureus</i> bacteremia in patients receiving pegylated interferon‐alpha and ribavirin for chronic hepatitis C virus infection","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Disease Control Laboratory; University of Alberta","funders":"","keywords":"Medicine; Bacteremia; Neutropenia; Internal medicine; Ribavirin; Staphylococcus aureus; Hepatitis C virus; Cirrhosis; Gastroenterology; Sepsis; Septic arthritis; Hepatitis C; Pegylated interferon; Immunology; Antibiotics; Virus; Arthritis; Chemotherapy; Microbiology","score_opus":0.006741975035148963,"score_gpt":0.24877676462486784,"score_spread":0.24203478958971889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010537550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965884,0.00060812035,0.0010846845,0.00015131336,0.0005445714,0.0006576725,0.000066101675,0.000026996446,0.00027211383],"genre_scores_gemma":[0.9959798,0.0021345534,0.00095192716,0.00014869154,0.0005137006,0.00001590298,0.000043302938,0.000054671116,0.00015748128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769455,0.00008803637,0.0011430993,0.00028606175,0.0003414005,0.00044686094],"domain_scores_gemma":[0.99838346,0.00012595764,0.00069038395,0.0001937345,0.0004643551,0.00014208523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034337118,0.00029752427,0.0006896945,0.0004359204,0.000099198274,0.00006653732,0.000113842645,0.00021815598,0.000054299726],"category_scores_gemma":[0.00020039947,0.00028064346,0.00023319952,0.0002914877,0.000119559634,0.00046872773,0.000052974836,0.00050505565,0.000006210816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008703639,0.00029746367,0.93763584,0.00019851053,0.000056463025,0.00005886073,0.00007445445,0.000031109543,0.041388094,0.000019136194,0.0043096514,0.015060048],"study_design_scores_gemma":[0.004799358,0.0031242042,0.97331244,0.0010838648,0.000103801656,0.0000260303,0.0000028930033,0.00015761639,0.012714394,0.00023200976,0.004184594,0.00025878326],"about_ca_topic_score_codex":0.0062758317,"about_ca_topic_score_gemma":0.022599002,"teacher_disagreement_score":0.035676606,"about_ca_system_score_codex":0.0009584874,"about_ca_system_score_gemma":0.00018729262,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2012666090","doi":"10.1111/j.1365-2893.2008.01058.x","title":"Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Immunogenicity; Immune system; Medicine; Ribavirin; Immunology; Virology; Antigen; Hepatitis C virus; Vaccination; Immunization; Antibody; Virus","score_opus":0.08496060564450485,"score_gpt":0.44551583001582556,"score_spread":0.3605552243713207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012666090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968107,0.00085185724,0.00013282563,0.0004463977,0.00024990184,0.0010366562,0.000025798452,0.000012613744,0.00043326803],"genre_scores_gemma":[0.99365723,0.0050104004,0.00060634606,0.00023741786,0.00036485883,0.000022505637,0.000015886413,0.00003054882,0.00005481132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99373394,0.0010139142,0.0034823266,0.00026846965,0.0010597318,0.00044162123],"domain_scores_gemma":[0.99717605,0.00060679513,0.0009898223,0.00038773817,0.00059309276,0.00024648543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028968372,0.00022954533,0.0014031258,0.0007615995,0.000049853654,0.000017203301,0.00030743013,0.00030975946,0.00048443233],"category_scores_gemma":[0.0026454113,0.0001958578,0.00042064005,0.00083894096,0.0001740674,0.00038132077,0.00008733388,0.0011849552,0.000018684832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041085392,0.004954099,0.9235713,0.000055245288,0.00028777655,0.0009165361,0.0007011233,0.000019583807,0.003052212,0.000030363051,0.0007215411,0.024604827],"study_design_scores_gemma":[0.17256968,0.022175536,0.79911065,0.0004399488,0.00010506893,0.00023748372,0.000013212293,0.0008678143,0.0016998115,0.00023602383,0.002338029,0.00020677176],"about_ca_topic_score_codex":0.0010527503,"about_ca_topic_score_gemma":0.0017810632,"teacher_disagreement_score":0.13148428,"about_ca_system_score_codex":0.00038439894,"about_ca_system_score_gemma":0.0018884706,"threshold_uncertainty_score":0.79868495},"labels":[],"label_agreement":null},{"id":"W2016081542","doi":"10.1111/j.1365-2893.2005.00583.x","title":"Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992–2002","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Sexual intercourse; Hepatitis C virus; Human immunodeficiency virus (HIV); Logistic regression; Sexual transmission; Cohort; Transmission (telecommunications); Hepatitis C; Virology; Demography; Immunology; Virus; Internal medicine; Population; Environmental health","score_opus":0.011324378981427158,"score_gpt":0.26571898428657514,"score_spread":0.254394605305148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016081542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969784,0.0009840252,0.00019507787,0.00009220469,0.00026933054,0.0005369059,0.00035388395,0.00001723953,0.0005729598],"genre_scores_gemma":[0.9883071,0.010401978,0.00042981308,0.000045269673,0.00015074582,0.0000024285505,0.0000075266503,0.000034120843,0.0006209898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965712,0.00047177525,0.0010557779,0.00030976877,0.0011943916,0.00039710748],"domain_scores_gemma":[0.99716437,0.00011352691,0.0013687928,0.00047012614,0.0007212246,0.00016197443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006023544,0.00028690865,0.0007036314,0.00029839133,0.0002683655,0.000027904767,0.0003913156,0.00021537441,0.00031032853],"category_scores_gemma":[0.00036575572,0.0002343584,0.00021816831,0.00038415493,0.0007660444,0.0011509608,0.00025410572,0.00060227775,0.000008723757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017929652,0.0006618549,0.96780664,0.00028547755,0.0001956378,0.000025716075,0.0020259698,0.000030861473,0.00794588,0.000016889027,0.0008307024,0.01999509],"study_design_scores_gemma":[0.002370816,0.0037605804,0.9825917,0.00054213,0.00030014355,0.00001973707,0.000069202455,0.00032224058,0.008624313,0.000049361355,0.0011447881,0.00020499052],"about_ca_topic_score_codex":0.06587301,"about_ca_topic_score_gemma":0.011323269,"teacher_disagreement_score":0.054549742,"about_ca_system_score_codex":0.00033862557,"about_ca_system_score_gemma":0.00017688905,"threshold_uncertainty_score":0.95568585},"labels":[],"label_agreement":null},{"id":"W2016445976","doi":"10.1111/jvh.12243","title":"Pegylated interferons <scp>L</scp>ambda‐1a and alfa‐2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Peripheral blood mononuclear cell; Chemokine; Cytokine; Interferon alfa; Immunology; Ex vivo; Pharmacology; Interferon; Medicine; Alpha interferon; In vivo; Biology; Inflammation; In vitro","score_opus":0.01228368342395859,"score_gpt":0.259426318141343,"score_spread":0.2471426347173844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016445976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738747,0.0014512195,0.00003288416,0.0004468116,0.0000715456,0.00044189306,0.000048524053,0.000020660338,0.000098997014],"genre_scores_gemma":[0.99294454,0.005682139,0.0005857655,0.000105064675,0.0003112841,0.000013650963,0.000021268192,0.000059548714,0.0002767637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977321,0.000223913,0.00075219653,0.00039948782,0.00045490777,0.0004373973],"domain_scores_gemma":[0.99864656,0.00014897445,0.00030550014,0.00020663398,0.00017888732,0.0005134261],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004347729,0.00034490527,0.0007897412,0.00038363523,0.000171871,0.00014461235,0.000097845055,0.00021515132,0.00003646451],"category_scores_gemma":[0.00028520357,0.00028410292,0.00006916794,0.00014344355,0.0003338895,0.00039028082,0.00018408838,0.0008099488,0.0000018240303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001713245,0.00038108663,0.5498003,0.00024420864,0.0001647224,0.00029864456,0.0009421191,0.0000021745916,0.43822688,0.00002689827,0.00025496562,0.009486677],"study_design_scores_gemma":[0.009770273,0.0076084435,0.84608173,0.00088220474,0.00041900284,0.0012273348,0.0001896283,0.0042974004,0.12786764,0.00022718713,0.0011693075,0.0002598726],"about_ca_topic_score_codex":0.00090946525,"about_ca_topic_score_gemma":0.0005023143,"teacher_disagreement_score":0.31035924,"about_ca_system_score_codex":0.00007996709,"about_ca_system_score_gemma":0.000046159887,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2017232326","doi":"10.1111/jvh.12248","title":"The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Health Sciences Centre; Capital District Health Authority; University Health Network; Dalhousie University; University of Toronto; Western University; University of Manitoba; BC Centre for Disease Control; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Université de Montréal; University of Calgary","funders":"National Institute for Health and Care Research; Gilead Sciences; Bristol-Myers Squibb","keywords":"Hepatitis C virus; Medicine; Liver disease; Hepatitis C; Disease; Disease burden; Population; Immunology; Virology; Intensive care medicine; Internal medicine; Virus; Environmental health","score_opus":0.012134175936430834,"score_gpt":0.28715979167180156,"score_spread":0.2750256157353707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017232326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876697,0.0021556804,0.0002622372,0.0069114375,0.00024253853,0.00045498065,0.00003509973,0.000014166441,0.0011568783],"genre_scores_gemma":[0.9488542,0.04847855,0.000292469,0.000064537104,0.0019152631,0.000022246606,0.0000071314757,0.000029973233,0.00033563303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978859,0.00027711128,0.00056048634,0.00017650028,0.0007953206,0.00030469982],"domain_scores_gemma":[0.9983394,0.00020074834,0.0003833903,0.0003279692,0.00030475485,0.0004437238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041521544,0.00020772076,0.00048097185,0.00016589463,0.00018393513,0.00006109236,0.00010765956,0.00007876813,0.00008211584],"category_scores_gemma":[0.00010877198,0.000117421136,0.00016452631,0.00017850156,0.00022814807,0.00023374548,0.000038954637,0.0002753017,0.000008368977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001050844,0.00020241439,0.67635953,0.00009774226,0.00029078187,0.0002126012,0.00036744407,0.000038353464,0.00027328084,0.00059273466,0.0014770721,0.31903723],"study_design_scores_gemma":[0.0025798262,0.006988263,0.6435147,0.00027620056,0.00028488177,0.00013935022,0.000018679475,0.0017867318,0.0011246195,0.00052324747,0.34260833,0.00015516319],"about_ca_topic_score_codex":0.011995886,"about_ca_topic_score_gemma":0.0031072618,"teacher_disagreement_score":0.34113124,"about_ca_system_score_codex":0.00022546241,"about_ca_system_score_gemma":0.00025530762,"threshold_uncertainty_score":0.9945833},"labels":[],"label_agreement":null},{"id":"W2020046525","doi":"10.1111/j.1365-2893.2006.00820.x","title":"Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population‐based laboratory surveillance in Alberta, Canada (1998–2001)","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Provincial Laboratory of Public Health; Public Health Agency of Canada","funders":"","keywords":"Population; Medicine; Hepatitis a virus; Virology; Environmental health; Hepatitis C virus; Demography; Virus","score_opus":0.0225665442839153,"score_gpt":0.3030930953763737,"score_spread":0.2805265510924584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020046525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975974,0.00011274795,0.000017849123,0.00032789304,0.0002455515,0.00024470716,0.0013403241,0.000010772861,0.00010277078],"genre_scores_gemma":[0.99818087,0.00017116142,0.00078162464,0.00013410355,0.00018046149,0.000016407275,0.0003979243,0.00003768961,0.00009973557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717337,0.00026991736,0.0012401358,0.00027109825,0.00059089315,0.00045456356],"domain_scores_gemma":[0.9977112,0.0009525944,0.0006311913,0.00016262264,0.00037472823,0.00016768424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083175354,0.00021226176,0.0006363505,0.0007038909,0.00008610483,0.000044672597,0.00008534258,0.00018124102,0.000019622807],"category_scores_gemma":[0.002644635,0.0002167779,0.000077959085,0.0008576928,0.000038029506,0.00029339152,0.000021419703,0.00042981113,7.6143385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002458201,0.00016350792,0.9816953,0.000017164579,0.000014757456,0.00038764975,0.000033323195,0.00017315503,0.000319022,7.39419e-7,0.001439114,0.015510478],"study_design_scores_gemma":[0.0045970855,0.0005469447,0.9832724,0.00046567444,0.000027873706,0.000010574173,0.0000023068042,0.010038454,0.00042553613,0.000041526353,0.00037645973,0.00019521713],"about_ca_topic_score_codex":0.99666154,"about_ca_topic_score_gemma":0.99948126,"teacher_disagreement_score":0.015315261,"about_ca_system_score_codex":0.0015662576,"about_ca_system_score_gemma":0.00078659435,"threshold_uncertainty_score":0.88399464},"labels":[],"label_agreement":null},{"id":"W2026508243","doi":"10.1111/j.1365-2893.2007.00873.x","title":"Spontaneous clearance of childhood hepatitis C virus infection","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Clearance; Clearance rate; Hepatitis C virus; Internal medicine; Multivariate analysis; Immunology; Univariate analysis; Antibody; Gastroenterology; Virus","score_opus":0.013348510035869704,"score_gpt":0.30626299883579433,"score_spread":0.29291448879992465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026508243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099654,0.00060711626,0.0017606177,0.00017195626,0.000529653,0.0002870356,0.000028929835,0.000026607664,0.0055915243],"genre_scores_gemma":[0.985807,0.010901756,0.0020798917,0.00024975845,0.00065207796,0.0000020527666,0.000005896274,0.000046116023,0.00025547025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968404,0.00011363253,0.0012267677,0.00018775012,0.0011682395,0.00046319424],"domain_scores_gemma":[0.9977732,0.00016589521,0.00063766784,0.00029111328,0.0007750556,0.0003570727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011450698,0.0002077693,0.0007004912,0.0005911967,0.00008412114,0.000022779766,0.00016852295,0.00019019801,0.0005397505],"category_scores_gemma":[0.00069040665,0.00018882788,0.00035829638,0.00047372314,0.00015690042,0.00033170093,0.000051047205,0.000731463,0.00007900843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086645695,0.00060854346,0.79803795,0.00014153184,0.00019178662,0.0083043,0.00040034702,0.000017418759,0.012827089,0.00011369688,0.0012119997,0.17727888],"study_design_scores_gemma":[0.0016977742,0.0035985443,0.952198,0.0005174728,0.00009243836,0.0061505404,0.000008706239,0.000094230825,0.026730537,0.00020887361,0.008531588,0.00017128862],"about_ca_topic_score_codex":0.010538339,"about_ca_topic_score_gemma":0.008977702,"teacher_disagreement_score":0.17710759,"about_ca_system_score_codex":0.0003442722,"about_ca_system_score_gemma":0.00030345295,"threshold_uncertainty_score":0.9960506},"labels":[],"label_agreement":null},{"id":"W2027110018","doi":"10.1111/jvh.12163","title":"<i><scp>HCV E1E</scp>2‐<scp>MF</scp>59</i> vaccine in chronic hepatitis <scp>C</scp> patients treated with <scp>PEG</scp>‐<scp>IFN</scp>α2a and <scp>R</scp>ibavirin: a randomized controlled trial","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Virology; Immunology; Medicine","score_opus":0.010235792786872203,"score_gpt":0.262370488722732,"score_spread":0.2521346959358598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027110018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94385886,0.0129358275,0.00036221524,0.0003660667,0.0023798295,0.018994361,0.00066949916,0.00054310006,0.019890238],"genre_scores_gemma":[0.91493404,0.04319845,0.001489823,0.0019596026,0.0049969708,0.0032886774,0.0007770025,0.0012155372,0.028139891],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.96595687,0.0058838474,0.010061602,0.003489907,0.007891541,0.006716257],"domain_scores_gemma":[0.9452693,0.03417371,0.007375362,0.0028715502,0.005441639,0.0048684296],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007992602,0.004300376,0.014036557,0.0049918224,0.0013535697,0.0017868819,0.0027754845,0.0027460968,0.00021992],"category_scores_gemma":[0.07117984,0.0035208822,0.0035269153,0.0044710073,0.0016579519,0.0042829574,0.0011785283,0.0070051164,0.0011771511],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016973637,0.007024973,0.55269605,0.00182197,0.009005406,0.0063655153,0.008701529,0.0002877078,0.0047632656,0.00018554305,0.38180184,0.010372552],"study_design_scores_gemma":[0.7717631,0.019779244,0.08445937,0.0036702843,0.0034404795,0.0008320593,0.0016057752,0.006182477,0.0053556003,0.00069503917,0.10181631,0.00040027386],"about_ca_topic_score_codex":0.013960353,"about_ca_topic_score_gemma":0.008833249,"teacher_disagreement_score":0.7547895,"about_ca_system_score_codex":0.003792321,"about_ca_system_score_gemma":0.0041360836,"threshold_uncertainty_score":0.99994653},"labels":[],"label_agreement":null},{"id":"W2027908402","doi":"10.1111/jvh.12098","title":"Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two‐centre, masked, case–control study","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Occult; Hepatitis C virus; Peripheral blood mononuclear cell; Virology; Medicine; RNA; Hepatitis C; Virus; Nested polymerase chain reaction; Polymerase chain reaction; Immunology; Biology; In vitro; Pathology; Gene; Genetics","score_opus":0.020047125962811642,"score_gpt":0.31630163439434483,"score_spread":0.29625450843153317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027908402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629897,0.00046399448,0.0001360333,0.0002233492,0.00036040496,0.0017856676,0.00030266453,0.000036859736,0.0003920625],"genre_scores_gemma":[0.997939,0.0008105087,0.00065127504,0.00016926943,0.0002304534,0.00004251976,0.000016169375,0.000048908427,0.000091906484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944309,0.0009437539,0.002055742,0.00040908856,0.0013806439,0.00077986927],"domain_scores_gemma":[0.9958472,0.00055030466,0.001031742,0.0004933981,0.0015646163,0.00051271834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011380732,0.000418797,0.001355626,0.0010550689,0.00012224943,0.000105175845,0.00037505763,0.00014136724,0.0013320368],"category_scores_gemma":[0.0016007489,0.00036871538,0.00032877733,0.0011051324,0.00016844155,0.0009566883,0.00014170677,0.0012551484,0.0001131167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027411574,0.0012010734,0.95166314,0.00013761775,0.00028818168,0.009710341,0.002620981,0.0000643027,0.0020361328,0.000006301552,0.0022439654,0.029753828],"study_design_scores_gemma":[0.016341988,0.0036462734,0.9667163,0.0014770086,0.000355812,0.0023007572,0.001505959,0.0044828276,0.0021760515,0.000070042646,0.0003780143,0.0005489744],"about_ca_topic_score_codex":0.08854657,"about_ca_topic_score_gemma":0.05458644,"teacher_disagreement_score":0.03396013,"about_ca_system_score_codex":0.0005332138,"about_ca_system_score_gemma":0.00052444474,"threshold_uncertainty_score":0.9998765},"labels":[],"label_agreement":null},{"id":"W2029574678","doi":"10.1111/j.1365-2893.2009.01076.x","title":"Comprehensive longitudinal analysis of hepatitis C virus (HCV)‐specific T cell responses during acute HCV infection in the presence of existing HIV‐1 infection","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hepatitis C virus; CD8; T cell; Virology; Immunology; Cell; Medicine; Hepacivirus; Hepatitis C; Virus; Immune system; Biology","score_opus":0.06139752535879556,"score_gpt":0.36319730192926075,"score_spread":0.3017997765704652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029574678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682564,0.000497583,0.0006304463,0.00020214223,0.00015015341,0.00035209832,0.000068124275,0.000014079668,0.0012597208],"genre_scores_gemma":[0.98292494,0.016039278,0.0006666563,0.0000472521,0.00017796324,0.000006854459,0.000016150414,0.000018543387,0.000102343096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590087,0.0006924558,0.0014785487,0.0002669533,0.0012752118,0.00038595678],"domain_scores_gemma":[0.9968342,0.0005477465,0.0010783385,0.000405492,0.0009972369,0.000136943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009178085,0.00024722927,0.0010087349,0.0019132727,0.00013614011,0.000046487618,0.00022768226,0.00015183171,0.00014004554],"category_scores_gemma":[0.00046287978,0.00020033834,0.00051565625,0.002255047,0.0001891695,0.00050559064,0.00005881196,0.0007720431,0.000007154779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010190109,0.00044705355,0.94224954,0.00013534543,0.00042863138,0.0006313803,0.00090181525,0.00066344376,0.04653142,0.00003512479,0.00022628898,0.00673096],"study_design_scores_gemma":[0.0012951224,0.0019315077,0.9703735,0.00040549404,0.00064412644,0.00012364058,0.000028235992,0.0013487712,0.022990825,0.000063881846,0.0006464116,0.00014848563],"about_ca_topic_score_codex":0.011013393,"about_ca_topic_score_gemma":0.0033628165,"teacher_disagreement_score":0.028123973,"about_ca_system_score_codex":0.00032944107,"about_ca_system_score_gemma":0.00017289064,"threshold_uncertainty_score":0.9955723},"labels":[],"label_agreement":null},{"id":"W2033302237","doi":"10.1111/jvh.12166_31","title":"P32: Hepatitis B screening prior to chemotherapy initiation in a tertiary care center in Québec, Canada","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; HBsAg; Hepatitis B virus; Rituximab; Serology; Hepatitis B; Hepatology; Gastroenterology; Oncology; Immunology; Lymphoma; Antibody; Virus","score_opus":0.009227095587365865,"score_gpt":0.2539717818547663,"score_spread":0.24474468626740045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033302237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891472,0.00082698127,0.00011160445,0.008567507,0.00025422245,0.0005752851,0.000024174733,0.000010789213,0.00048224808],"genre_scores_gemma":[0.98892045,0.0009849308,0.002579703,0.007107394,0.00023942092,0.000040686173,0.000009283371,0.000037887585,0.00008027246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997786,0.00009706763,0.0009547802,0.00019767041,0.00056039734,0.00040408538],"domain_scores_gemma":[0.9988541,0.00008234709,0.00027212594,0.00016997133,0.000395983,0.00022548855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016228069,0.00022165659,0.00056957535,0.0004277726,0.00005776037,0.000032145457,0.00014194498,0.000086488595,0.00034517457],"category_scores_gemma":[0.00025994037,0.00020212022,0.00010326738,0.00028407102,0.000030630592,0.00039412463,0.000052090123,0.00040708782,0.00001980416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067727924,0.00007522274,0.94272757,0.0000618575,0.000039889717,0.00045836536,0.0024582315,0.000015119219,0.0003743436,0.0000019659458,0.007978141,0.045741558],"study_design_scores_gemma":[0.0023526724,0.00037858664,0.98907727,0.0009594086,0.000016266833,0.00008169384,0.00020265853,0.00014871104,0.0007864999,0.000013405669,0.005795474,0.00018738226],"about_ca_topic_score_codex":0.97802305,"about_ca_topic_score_gemma":0.99615175,"teacher_disagreement_score":0.046349663,"about_ca_system_score_codex":0.0015165902,"about_ca_system_score_gemma":0.00089573435,"threshold_uncertainty_score":0.8242223},"labels":[],"label_agreement":null},{"id":"W2037406883","doi":"10.1111/jvh.12087","title":"The effects of nucleoside analogue prophylactic treatment on <scp>HBV</scp> activation in <scp>HB</scp>c<scp>A</scp>b+ patients undergoing immunosuppressive therapy","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Alberta Innovates - Health Solutions","keywords":"Seroconversion; Medicine; Nucleoside analogue; Antibody; Gastroenterology; Group B; Hepatitis B virus; Internal medicine; Hepatitis B; Group A; Immunology; Nucleoside; Virus; Biology","score_opus":0.010536952532643818,"score_gpt":0.24951124765383978,"score_spread":0.23897429512119597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037406883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933465,0.0020698707,0.0000381459,0.00023268312,0.0008090332,0.0019079712,0.000021641223,0.00003195882,0.0015421642],"genre_scores_gemma":[0.98546785,0.012553547,0.0002728,0.0003968205,0.00034851348,0.00015438092,0.00002139317,0.00009471025,0.0006900112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995645,0.0005610885,0.0014370461,0.00040046705,0.0011656844,0.00079070136],"domain_scores_gemma":[0.9882124,0.008364045,0.0017934896,0.0005213571,0.00085381843,0.00025487438],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037323698,0.00059002684,0.0011622531,0.0005379454,0.00036935465,0.00012242186,0.0003424254,0.0002532824,0.000008426019],"category_scores_gemma":[0.008578283,0.00038853803,0.00044105554,0.0005086577,0.00023586104,0.00075622275,0.00009466724,0.00072418625,0.000067050474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012326785,0.002946512,0.8886133,0.00048968475,0.001561356,0.00024332815,0.010896518,0.000072716604,0.040934183,0.00013327996,0.012527883,0.04145799],"study_design_scores_gemma":[0.0073577515,0.014946968,0.8663459,0.0016656831,0.00018967073,0.000026746815,0.0008571494,0.000116203235,0.10507269,0.00072672,0.0026258167,0.000068696376],"about_ca_topic_score_codex":0.0039464664,"about_ca_topic_score_gemma":0.0013078947,"teacher_disagreement_score":0.06413851,"about_ca_system_score_codex":0.0010215897,"about_ca_system_score_gemma":0.0003470231,"threshold_uncertainty_score":0.99985665},"labels":[],"label_agreement":null},{"id":"W2038448062","doi":"10.1111/jvh.12121","title":"A paucity of liver disease in <scp>C</scp>anadian <scp>I</scp>nuit with chronic hepatitis <scp>B</scp> virus, subgenotype <scp>B</scp>6 infection","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"Health Canada; Gilead Sciences","keywords":"Hepatitis B virus; Medicine; Serology; Viral load; Genotype; Hepatitis B; Liver disease; Internal medicine; HBsAg; Virus; Chronic liver disease; Immunology; Gastroenterology; Virology; Biology; Antibody; Gene","score_opus":0.012073174647026928,"score_gpt":0.23879984859277334,"score_spread":0.22672667394574642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038448062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813645,0.011469071,0.00046459842,0.00021915536,0.0011104065,0.002114247,0.00047148828,0.00016851239,0.0026180092],"genre_scores_gemma":[0.9606899,0.030895326,0.0011798457,0.0009416512,0.001716119,0.00021798897,0.00011068264,0.0002956046,0.0039528627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99032784,0.0007683989,0.002961022,0.0011776729,0.0024716577,0.0022934077],"domain_scores_gemma":[0.9886646,0.0034103964,0.0025370962,0.0012003795,0.0020833425,0.0021041445],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012485645,0.0014078089,0.0027712889,0.0018657041,0.00054983975,0.00027624017,0.00078494265,0.0007361218,0.00019298111],"category_scores_gemma":[0.011792719,0.0012715167,0.00094799843,0.0019223479,0.00087751227,0.002124784,0.00039058976,0.0022732504,0.00073064456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028740287,0.0010042553,0.92723584,0.0008852782,0.0008919135,0.0019615206,0.0046425145,0.0001797918,0.002740715,0.00013769534,0.05684235,0.003449406],"study_design_scores_gemma":[0.003736311,0.0046971,0.93336284,0.0021324374,0.0009078573,0.00036237924,0.00016895439,0.0012623484,0.004499893,0.0006032337,0.048097726,0.00016890654],"about_ca_topic_score_codex":0.33008966,"about_ca_topic_score_gemma":0.54032004,"teacher_disagreement_score":0.2102304,"about_ca_system_score_codex":0.00238795,"about_ca_system_score_gemma":0.0020836652,"threshold_uncertainty_score":0.9998672},"labels":[],"label_agreement":null},{"id":"W2038454674","doi":"10.1111/j.1365-2893.2009.01111.x","title":"Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell‐culture‐derived H77/JFH1 chimeric infectious virus particles","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Infectivity; Virology; Biology; Viral entry; CD81; Lipid bilayer fusion; Mutant; Virus; Retrovirus; Peptide; Glycoprotein; Hepatitis C virus; Viral replication; Molecular biology; Gene; Genetics; Biochemistry","score_opus":0.011838931500617227,"score_gpt":0.28477066896766146,"score_spread":0.27293173746704424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038454674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973011,0.00094228535,0.00015207664,0.00061845407,0.00010404998,0.0003925442,0.00006549631,0.000017168733,0.0004068235],"genre_scores_gemma":[0.9955495,0.0025307983,0.0012231244,0.00045775998,0.00012566062,0.000011529771,0.000008759798,0.000022117874,0.00007077757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965351,0.00039789494,0.0012302329,0.00027937727,0.0011022498,0.00045514613],"domain_scores_gemma":[0.9981781,0.00013341827,0.0006859391,0.00032186738,0.0004126844,0.00026795772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060795294,0.0002645568,0.0009052351,0.00070118014,0.00014016507,0.00006596387,0.00023570821,0.00015367162,0.00019381658],"category_scores_gemma":[0.0005576871,0.00019509181,0.0004200454,0.0018226715,0.00028601984,0.0004153924,0.00007230976,0.00063319743,0.000008748203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002803727,0.00040742225,0.7008005,0.000033151773,0.00030490872,0.00024595964,0.00088115677,0.0002477459,0.28070948,0.000072964605,0.00015616325,0.015860204],"study_design_scores_gemma":[0.0019103858,0.0018898756,0.86498713,0.00012655667,0.0005539983,0.00010499672,0.000039340615,0.004385327,0.12509397,0.000617621,0.00011597629,0.00017482939],"about_ca_topic_score_codex":0.0072386675,"about_ca_topic_score_gemma":0.007605041,"teacher_disagreement_score":0.16418666,"about_ca_system_score_codex":0.0002551014,"about_ca_system_score_gemma":0.00026594254,"threshold_uncertainty_score":0.99937224},"labels":[],"label_agreement":null},{"id":"W2046752962","doi":"10.1111/jvh.12245","title":"Lower life expectancy among people with an <scp>HCV</scp> notification: a population‐based linkage study","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Janssen Biotech; Department of Health and Ageing, Australian Government; Bristol-Myers Squibb Canada; AbbVie; Roche","keywords":"Medicine; Life expectancy; Interquartile range; Population; Hepatitis C; Cause of death; Liver disease; Cohort; Demography; Mortality rate; Internal medicine; Disease; Environmental health","score_opus":0.020139504259094766,"score_gpt":0.30210496439090834,"score_spread":0.28196546013181356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046752962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437416,0.00007619424,0.0024071713,0.0003427558,0.00026437227,0.00066810905,0.000010516681,0.00005023617,0.0018064948],"genre_scores_gemma":[0.9951633,0.000038041566,0.0030568459,0.00033617805,0.00089375244,0.00003473405,0.000030229523,0.00007024341,0.00037663797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638253,0.00042938546,0.00091437943,0.0003250546,0.001530462,0.00041816212],"domain_scores_gemma":[0.9969407,0.00028339349,0.00057760224,0.00062003726,0.0008703989,0.0007078668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091740495,0.00026018245,0.0007002498,0.000493443,0.0001910302,0.00012341698,0.00029725622,0.00013481721,0.0002187568],"category_scores_gemma":[0.0014621613,0.00020496557,0.00016784243,0.00057266944,0.000071399394,0.0006587939,0.000036157882,0.00065856066,0.000058704823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014488283,0.0011131743,0.99177843,0.0000491589,0.000097223674,0.0002951914,0.0010157394,0.000073621195,0.00012810242,0.000025405863,0.0010697815,0.0042092875],"study_design_scores_gemma":[0.0033224144,0.008766101,0.98111206,0.00021538774,0.00013530265,0.000037837683,0.00027988717,0.0046166778,0.00020481546,0.000038611157,0.0011622742,0.00010861358],"about_ca_topic_score_codex":0.0018871012,"about_ca_topic_score_gemma":0.004842823,"teacher_disagreement_score":0.010666354,"about_ca_system_score_codex":0.00021118208,"about_ca_system_score_gemma":0.00035569925,"threshold_uncertainty_score":0.8358254},"labels":[],"label_agreement":null},{"id":"W2047272500","doi":"10.1111/j.1365-2893.2007.00863.x","title":"Characteristics and survival of HIV‐infected patients not screened for hepatitis C virus infection in a hospital‐based cohort","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Hepatitis C virus; Cohort; Proportional hazards model; Hepatitis C; Incidence (geometry); Confidence interval; Prospective cohort study; Cohort study; Immunology; Virus","score_opus":0.01677538457266991,"score_gpt":0.30599449202695844,"score_spread":0.2892191074542885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047272500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304986,0.000034791377,0.004944352,0.00016200695,0.0004222265,0.0009020559,0.0002715438,0.0000151910945,0.00019799173],"genre_scores_gemma":[0.9953983,0.002161241,0.0018981539,0.00011996437,0.00022757122,0.000014680293,0.00010279969,0.000045514626,0.000031801686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703676,0.00012435515,0.0013234105,0.00022323545,0.0008598917,0.00043236112],"domain_scores_gemma":[0.9971104,0.000382682,0.0007141999,0.00019805378,0.0013081242,0.0002865129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001305113,0.00022642188,0.0008457454,0.00074622914,0.00006317576,0.000028730617,0.00009884273,0.00020615026,0.000065077395],"category_scores_gemma":[0.001687735,0.00021562427,0.00020175679,0.00038359477,0.0001424699,0.00029679027,0.000043156557,0.00042042998,0.0000042429797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001158839,0.0007914834,0.97528327,0.0002015606,0.00009406771,0.00011198358,0.000081406426,0.0000021386536,0.002134918,0.000026043088,0.00022415591,0.019890144],"study_design_scores_gemma":[0.005232116,0.0051353415,0.97921246,0.0004028708,0.0001063177,0.000009021078,0.000002528675,0.0010267602,0.007823745,0.00002719976,0.00083615567,0.00018550643],"about_ca_topic_score_codex":0.006803003,"about_ca_topic_score_gemma":0.0066696866,"teacher_disagreement_score":0.019704638,"about_ca_system_score_codex":0.00034862116,"about_ca_system_score_gemma":0.00025002833,"threshold_uncertainty_score":0.99981076},"labels":[],"label_agreement":null},{"id":"W2047791700","doi":"10.1111/j.1365-2893.2009.01136.x","title":"Prognosis of hepatitis C virus‐infected Canadian post‐transfusion compensation claimant cohort","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; Canadian Blood Services; University of Toronto; Toronto Public Health; University Health Network","funders":"","keywords":"Medicine; Cohort; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Liver disease; Epidemiology; Hepatitis C virus; Blood transfusion; Hepatitis C; Stage (stratigraphy); Cohort study; Virus; Virology; Biology","score_opus":0.015163781740740376,"score_gpt":0.2908237837670969,"score_spread":0.2756600020263565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047791700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919169,0.00027573307,0.00022320733,0.00256956,0.00026124442,0.0007768755,0.00013796933,0.000026427231,0.0038120847],"genre_scores_gemma":[0.98983556,0.0071570547,0.0017180247,0.0008324574,0.00025554816,0.0000072179123,0.00007663847,0.000034453013,0.00008306201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965177,0.0002178364,0.0012360365,0.00023933282,0.0012553675,0.00053370773],"domain_scores_gemma":[0.9965986,0.000091129856,0.00047535784,0.00028706115,0.0018299156,0.00071794726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007160641,0.00025452027,0.00083051267,0.0009741461,0.00014745106,0.000043742497,0.00022707784,0.00023452134,0.0009350692],"category_scores_gemma":[0.0004445462,0.0002283614,0.00034207548,0.0005732009,0.00012390075,0.0004279455,0.000019291594,0.00065583765,0.000046549616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002510434,0.0003105821,0.8971125,0.00006819912,0.0001430591,0.0006150934,0.0002640439,0.000007593331,0.044096015,0.00015206885,0.0019861474,0.05499364],"study_design_scores_gemma":[0.0015069401,0.00472805,0.96818084,0.0005089353,0.00018053156,0.00025597922,0.000011205869,0.00068434357,0.020311655,0.00016013617,0.0032708813,0.00020051192],"about_ca_topic_score_codex":0.37032962,"about_ca_topic_score_gemma":0.34373555,"teacher_disagreement_score":0.07106832,"about_ca_system_score_codex":0.0006804668,"about_ca_system_score_gemma":0.0013068625,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W2049037429","doi":"10.1111/jvh.12131","title":"Micro<scp>RNA</scp>‐130a inhibits <scp>HCV</scp> replication by restoring the innate immune response","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Innate immune system; Replicon; Hepatitis C virus; Virology; Interferon; Biology; Immune system; TLR3; RIG-I; Viral replication; Ribavirin; TLR7; RNA interference; RNA; Immunology; Cancer research; Virus; Gene; Toll-like receptor; Genetics","score_opus":0.009506902693502474,"score_gpt":0.24035488364438548,"score_spread":0.23084798095088302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049037429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802751,0.01580865,0.00013597526,0.001091022,0.0014195013,0.00032658348,0.000029059678,0.00003960318,0.0008744897],"genre_scores_gemma":[0.96559334,0.002309866,0.00013363667,0.00061392994,0.00013839477,0.000029224304,0.000023950714,0.000048497528,0.031109175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964855,0.0013258221,0.0011429257,0.0003133151,0.00015034726,0.00058209366],"domain_scores_gemma":[0.9962238,0.0013915226,0.0010490093,0.0007497734,0.00052658713,0.00005931534],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018267382,0.00031834407,0.00050120725,0.00028433153,0.0004104569,0.0001190623,0.00074118265,0.0003469042,0.00009328061],"category_scores_gemma":[0.0035769413,0.00023319521,0.00030251555,0.00025635108,0.00029513467,0.00047843115,0.00020131718,0.0010353941,0.0008665305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022866818,0.00009652074,0.0013598412,0.00000976585,0.00016616164,0.000011120889,0.0010157482,0.0000016728553,0.85785276,0.000051908308,0.1344819,0.0047239177],"study_design_scores_gemma":[0.0010166224,0.0010125235,0.049780384,0.000141624,0.000041825995,0.00049471756,0.00041978684,0.000003995263,0.70651805,0.00010047124,0.24041136,0.00005863517],"about_ca_topic_score_codex":0.00067206245,"about_ca_topic_score_gemma":0.000014556757,"teacher_disagreement_score":0.1513347,"about_ca_system_score_codex":0.0001862967,"about_ca_system_score_gemma":0.00014910795,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W2050052235","doi":"10.1111/j.1365-2893.2005.00709.x","title":"Comparison of two PEG‐interferon alpha‐2b doses (1.0 or 1.5 <i>μ</i>g/kg) combined with ribavirin in interferon‐naïve patients with chronic hepatitis C and up to moderate fibrosis","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ribavirin; Medicine; Gastroenterology; Alpha interferon; Internal medicine; Pegylated interferon; Adverse effect; Hepatitis C; Hepatitis C virus; Pharmacology; PEG ratio; Interferon; Immunology; Virus","score_opus":0.020598205768235442,"score_gpt":0.329723925479694,"score_spread":0.3091257197114585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050052235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675,0.00037423894,0.00094599114,0.00039752532,0.00017320545,0.00090958417,0.00010429392,0.000021457623,0.00032371908],"genre_scores_gemma":[0.99603474,0.00037478036,0.0026894712,0.00013081168,0.00014823383,0.000034033084,0.00004231313,0.000084605905,0.00046103486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603134,0.00023533449,0.0014662823,0.0004149646,0.001202827,0.0006492724],"domain_scores_gemma":[0.99761754,0.00018601814,0.0006504393,0.00036619935,0.000800045,0.00037976223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034258913,0.00044524853,0.0014685917,0.000714128,0.000093180046,0.0000967646,0.00027711262,0.00013001355,0.00021580722],"category_scores_gemma":[0.00009454237,0.00030925675,0.000117532734,0.0005709573,0.0002615533,0.0005732357,0.0001444011,0.00069661887,0.000014388302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015411776,0.0007372354,0.96834004,0.00026347802,0.00015355593,0.00019789119,0.0006700811,0.0003036096,0.001703046,0.000032320568,0.0018336857,0.010353287],"study_design_scores_gemma":[0.02006947,0.068417504,0.8813899,0.0040342817,0.00019538998,0.00008635251,0.00006647214,0.004116327,0.020310378,0.00007351426,0.0007118717,0.00052849774],"about_ca_topic_score_codex":0.01533677,"about_ca_topic_score_gemma":0.0787065,"teacher_disagreement_score":0.08695009,"about_ca_system_score_codex":0.00075324863,"about_ca_system_score_gemma":0.0004568803,"threshold_uncertainty_score":0.9999359},"labels":[],"label_agreement":null},{"id":"W2054938157","doi":"10.1111/jvh.12247","title":"Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in selected countries","year":2014,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Calgary; University of Toronto; Western University; BC Centre for Disease Control; University of British Columbia; University of Manitoba; Université de Montréal; Dalhousie University; Capital District Health Authority; Health Sciences Centre; University Health Network; Toronto General Hospital","funders":"Public Health England; National Institute for Health and Care Research; Gilead Sciences","keywords":"Virology; Epidemiology; Hepatitis C virus; Hepatitis virus; Virus; Hepatitis a virus; Environmental health; Medicine; Internal medicine","score_opus":0.06849872591365258,"score_gpt":0.3888201373881694,"score_spread":0.3203214114745168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054938157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004442624,0.99158007,0.00029603473,0.00015880467,0.0010545681,0.00092720654,0.00014804963,0.000030944073,0.0013617014],"genre_scores_gemma":[0.0010385786,0.99417615,0.0017679431,0.00019694549,0.0011697662,0.000054643206,0.000065818116,0.00015831056,0.0013718175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885753,0.0026292722,0.0057270196,0.00057372986,0.0013857037,0.0011090115],"domain_scores_gemma":[0.9878474,0.005250622,0.003966448,0.0006963288,0.0015778332,0.0006613926],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003920856,0.00079677236,0.00955477,0.0022286938,0.00007994876,0.000018040013,0.0007602528,0.0012964177,0.00020992225],"category_scores_gemma":[0.018589359,0.0006485699,0.0014965507,0.0014317005,0.00036575523,0.0002591364,0.00018374143,0.0030155438,0.00014489461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067291585,0.00039721772,0.33475932,0.018732939,0.0006925634,0.0016048305,0.00014486366,0.0000019160254,0.0000062360677,0.00023701738,0.04357791,0.5997779],"study_design_scores_gemma":[0.0011145107,0.0026604098,0.0116552515,0.01737707,0.0008292383,0.00071556563,0.0000022112158,0.000040749972,0.000015519705,0.0001549048,0.9652128,0.00022171972],"about_ca_topic_score_codex":0.016617255,"about_ca_topic_score_gemma":0.0044423793,"teacher_disagreement_score":0.9216349,"about_ca_system_score_codex":0.003971929,"about_ca_system_score_gemma":0.0030246605,"threshold_uncertainty_score":0.999916},"labels":[],"label_agreement":null},{"id":"W2057007354","doi":"10.1046/j.1365-2893.2003.00484.x","title":"Improving the accuracy of long‐term prognostic estimates in hepatitis C virus infection","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Statistics; Stage (stratigraphy); Monte Carlo method; Cirrhosis; Series (stratigraphy); Mathematics; Algorithm; Medicine; Internal medicine; Biology","score_opus":0.023947388897651408,"score_gpt":0.33285299865214707,"score_spread":0.30890560975449566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057007354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956772,0.0006516236,0.0020646353,0.0004884695,0.00028729936,0.00055721716,0.000016174039,0.000018009117,0.00023938455],"genre_scores_gemma":[0.9924643,0.0056994706,0.0013669553,0.00013345869,0.00025139865,0.000019333294,0.00000709026,0.00003570364,0.00002226851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974044,0.00012351283,0.0010689559,0.00017612975,0.00083072536,0.00039626137],"domain_scores_gemma":[0.9979504,0.00040773122,0.0006803742,0.0002808222,0.00050542835,0.00017525302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074466015,0.00020347424,0.0005600039,0.00046744963,0.000090944326,0.00005614989,0.00021884532,0.00013012487,0.00014000517],"category_scores_gemma":[0.0033849506,0.0001448789,0.00022745869,0.000506273,0.00019533,0.0005781734,0.00008958202,0.0007508977,0.000026743777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013868055,0.00030288627,0.9036819,0.00021961922,0.00006735366,0.00078519515,0.0003532559,0.00012928656,0.011845443,0.000041000778,0.00004837517,0.08238701],"study_design_scores_gemma":[0.0020237532,0.0018564938,0.9638299,0.0010794257,0.000096971555,0.00046473162,0.0000063502475,0.00050890143,0.029561203,0.00039297246,0.000051677565,0.00012764634],"about_ca_topic_score_codex":0.036436923,"about_ca_topic_score_gemma":0.01713171,"teacher_disagreement_score":0.08225936,"about_ca_system_score_codex":0.00047564012,"about_ca_system_score_gemma":0.00062281196,"threshold_uncertainty_score":0.9699795},"labels":[],"label_agreement":null},{"id":"W2060096504","doi":"10.1111/jvh.12185","title":"The number needed to treat to prevent mortality and cirrhosis‐related complications among patients with cirrhosis and <scp>HCV</scp> genotype 1 infection","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Santen","keywords":"Medicine; Internal medicine; Cirrhosis; Hazard ratio; Gastroenterology; Number needed to treat; Hepatitis C; Ribavirin; Cohort; Hepatitis C virus; Adverse effect; Liver disease; Confidence interval; Immunology; Relative risk; Virus","score_opus":0.016455812651438015,"score_gpt":0.297714568539418,"score_spread":0.28125875588798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060096504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515367,0.00006538213,0.00011931653,0.0011953673,0.00008278745,0.0011421564,0.000020201318,0.00001829437,0.0022028547],"genre_scores_gemma":[0.99788487,0.0006112776,0.0004963927,0.00040735077,0.00006563617,0.00008398198,0.000009445706,0.000029934032,0.00041111352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981951,0.00014544593,0.0005504477,0.00021226791,0.0005746812,0.00032202163],"domain_scores_gemma":[0.9979197,0.00021295623,0.00023638684,0.00026742127,0.0007810217,0.0005825562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003003838,0.00018043038,0.00034248256,0.0001673074,0.000275968,0.00014296695,0.0001004387,0.00009429155,0.00006811856],"category_scores_gemma":[0.00046105334,0.00011911778,0.00006714962,0.0003784382,0.00012731864,0.00034595773,0.0000871831,0.00033075103,0.000077707926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002306221,0.00018596342,0.9695981,0.000028736116,0.00013891322,0.00000646381,0.00046785784,0.0000062051936,0.0002779555,0.000024833382,0.0049840133,0.024257855],"study_design_scores_gemma":[0.00091231277,0.001159384,0.99456203,0.00016518692,0.0001257826,0.000022409675,0.00004259411,0.00013269424,0.00039665814,0.00013455946,0.002277155,0.00006923361],"about_ca_topic_score_codex":0.014133874,"about_ca_topic_score_gemma":0.0020533705,"teacher_disagreement_score":0.02496389,"about_ca_system_score_codex":0.00019653441,"about_ca_system_score_gemma":0.000075099844,"threshold_uncertainty_score":0.9924311},"labels":[],"label_agreement":null},{"id":"W2061757533","doi":"10.1111/j.1365-2893.2012.01648.x","title":"Factors associated with <scp>HCV</scp> antiviral treatment uptake among participants of a community‐based <scp>HCV</scp> programme for marginalized patients","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; University of Toronto; Regent Park Community Health Centre; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Ribavirin; Hepatitis C; Hepatitis C virus; Methadone; Internal medicine; Pegylated interferon; Context (archaeology); Population; Cohort; Immunology; Psychiatry; Virus; Environmental health; Biology","score_opus":0.146859740633206,"score_gpt":0.35291418746467745,"score_spread":0.20605444683147145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061757533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960811,0.00019341498,0.00022938674,0.00005692584,0.00027510917,0.0018245785,0.00046672425,0.000053987533,0.0008187304],"genre_scores_gemma":[0.99744457,0.00012546309,0.0009943853,0.00012244277,0.00018032838,0.00012951744,0.00036178093,0.0001286506,0.0005128342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993921,0.0009587004,0.0015260015,0.00023285368,0.0016253332,0.0017361263],"domain_scores_gemma":[0.9934887,0.0019414069,0.0016156808,0.0005275404,0.0014496027,0.0009770528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016924085,0.00058973033,0.0016693476,0.0005866993,0.00032261453,0.00008339713,0.00038549278,0.00032487474,0.000030336047],"category_scores_gemma":[0.0044562807,0.00042096424,0.0006436622,0.00063163537,0.00038377807,0.00073168456,0.00008164493,0.00084648404,0.0000095371915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017857546,0.004207258,0.97378474,0.00019712701,0.001062247,0.000041829866,0.0031836845,0.0000056426557,0.000413329,0.000011384183,0.0018244705,0.015089701],"study_design_scores_gemma":[0.014006671,0.014657039,0.9483023,0.0007702803,0.0008502161,0.0000032445694,0.0007343698,0.00032777758,0.010722553,0.000032841795,0.009478469,0.000114201095],"about_ca_topic_score_codex":0.0015744229,"about_ca_topic_score_gemma":0.0014178699,"teacher_disagreement_score":0.025482414,"about_ca_system_score_codex":0.0009405901,"about_ca_system_score_gemma":0.00058077363,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W2065145796","doi":"10.1046/j.1365-2893.2002.00343.x","title":"Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis","year":2002,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fibrosis; Medicine; Gastroenterology; Liver biopsy; Hepatitis C virus; Internal medicine; Cytokine; Biopsy; Tumor necrosis factor alpha; Hepatic fibrosis; Chronic hepatitis; Inflammation; Pathology; Immunology; Virus","score_opus":0.043283181199984935,"score_gpt":0.32510723903434213,"score_spread":0.2818240578343572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065145796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373907,0.0015947828,0.00003105902,0.0020368986,0.00015429857,0.0003381775,0.00010842914,0.000007295085,0.0019899989],"genre_scores_gemma":[0.98989123,0.008143626,0.0011230672,0.0001247406,0.0004800255,0.000008361997,0.000003661252,0.000030159163,0.00019512065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673367,0.00035254756,0.0010784037,0.00017780419,0.0012175774,0.0004399894],"domain_scores_gemma":[0.9979842,0.00030909484,0.0007136814,0.00035956714,0.0005128309,0.00012063105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063199794,0.00020396711,0.0007626353,0.00045378794,0.000044650635,0.00002395697,0.00039629958,0.00014849797,0.0008257915],"category_scores_gemma":[0.0006668638,0.0001523299,0.00024747427,0.0006566367,0.0002275762,0.00021442046,0.00010455424,0.0005659384,0.000007501167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011199104,0.0005731319,0.8988352,0.000651235,0.000113731585,0.00038229773,0.0014186496,0.000015749865,0.032635804,0.000021950395,0.002577968,0.06266233],"study_design_scores_gemma":[0.0016977736,0.0052783797,0.8726262,0.00102013,0.000116245414,0.00031041904,0.00006574173,0.0026895087,0.111667655,0.00007858139,0.00427921,0.00017017375],"about_ca_topic_score_codex":0.0021076286,"about_ca_topic_score_gemma":0.0068051084,"teacher_disagreement_score":0.079031855,"about_ca_system_score_codex":0.00021443976,"about_ca_system_score_gemma":0.00008062427,"threshold_uncertainty_score":0.9041838},"labels":[],"label_agreement":null},{"id":"W2067333579","doi":"10.1111/j.1365-2893.2005.00613.x","title":"Response to long‐term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lamivudine; Genotype; HBeAg; Hepatitis B virus; Medicine; Virology; Cirrhosis; Genotyping; Hepatitis B; Gastroenterology; Internal medicine; HBsAg; Virus; Biology; Genetics; Gene","score_opus":0.0061573420393609924,"score_gpt":0.24741681213275285,"score_spread":0.24125947009339185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067333579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962148,0.0015529824,0.000017376233,0.001345451,0.00008914965,0.0005442127,0.0000727109,0.000009938296,0.00015335808],"genre_scores_gemma":[0.99422663,0.001331522,0.0025724426,0.00030191673,0.00015265286,0.000015703556,0.0000050185317,0.000036524652,0.0013575619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981262,0.00012150513,0.0006662182,0.00023038595,0.00053066434,0.00032502605],"domain_scores_gemma":[0.9987911,0.00009219301,0.00027801676,0.0002473822,0.00032590624,0.00026540636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028093328,0.00022812329,0.0006898943,0.00038879106,0.000051924075,0.000016001923,0.00010685874,0.000059270587,0.000069658505],"category_scores_gemma":[0.0001522691,0.00018631975,0.00007942431,0.00030805523,0.000060555598,0.00019725338,0.00006441724,0.0001588542,0.000023744735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006030825,0.0002413501,0.95762664,0.000041527088,0.0001264281,0.00012654414,0.00267356,0.000024930367,0.0008221849,0.000007838014,0.0011541392,0.031124044],"study_design_scores_gemma":[0.004611734,0.0051709763,0.9791682,0.0008423188,0.00008461671,0.00002500708,0.000011783229,0.000006062257,0.0014704923,0.000010855725,0.00841638,0.00018158127],"about_ca_topic_score_codex":0.0019457752,"about_ca_topic_score_gemma":0.0906061,"teacher_disagreement_score":0.08866032,"about_ca_system_score_codex":0.0011053398,"about_ca_system_score_gemma":0.00024133446,"threshold_uncertainty_score":0.92598796},"labels":[],"label_agreement":null},{"id":"W2068074952","doi":"10.1111/j.1365-2893.2004.00544.x","title":"Survival in HIV‐infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Hepatitis C virus; Internal medicine; Hepatitis C; Incidence (geometry); Antiretroviral therapy; Human immunodeficiency virus (HIV); Mortality rate; Cause of death; Viral load; Immunology; Virus; Disease","score_opus":0.07244793788210502,"score_gpt":0.3135545069130945,"score_spread":0.24110656903098948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068074952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804664,0.00004845413,0.00008358163,0.0006833647,0.00011770944,0.00068334595,0.00030531638,0.000010903018,0.00002066126],"genre_scores_gemma":[0.9955072,0.0033411265,0.00035239285,0.00054940453,0.0000793266,0.00001382024,0.00010623549,0.000033637243,0.000016886936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963599,0.0008156197,0.00088084344,0.0002439803,0.0013312998,0.0003683998],"domain_scores_gemma":[0.9969222,0.0011260093,0.000745088,0.00026842766,0.0008394143,0.00009888781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010347491,0.00025234578,0.0005562053,0.00044838956,0.00014996917,0.000115578405,0.00017307642,0.00012385161,0.000018756593],"category_scores_gemma":[0.0022813203,0.0001567015,0.00010811156,0.0010957919,0.0002324736,0.0017574271,0.000065316555,0.0010336568,0.0000016166517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008776244,0.00074528443,0.98976517,0.00002255767,0.00011980275,0.00016830333,0.0021600772,0.00013812412,0.0011765003,0.000057866997,0.00012731271,0.004641397],"study_design_scores_gemma":[0.005596738,0.0023829506,0.98814374,0.00072426617,0.000041470277,0.000025567653,0.000038632614,0.0005062189,0.0021622363,0.000050543225,0.00017306344,0.00015456851],"about_ca_topic_score_codex":0.10436967,"about_ca_topic_score_gemma":0.08035118,"teacher_disagreement_score":0.024018496,"about_ca_system_score_codex":0.00057424064,"about_ca_system_score_gemma":0.00042041592,"threshold_uncertainty_score":0.93643004},"labels":[],"label_agreement":null},{"id":"W2073634698","doi":"10.1111/j.1365-2893.2009.01086.x","title":"Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec","funders":"","keywords":"Hypervariable region; Biology; Genetics; Genotype; Genome; Phylogenetic tree; Whole genome sequencing; Gene","score_opus":0.01812975023117602,"score_gpt":0.2971612069482752,"score_spread":0.27903145671709917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073634698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635184,0.00041630218,0.0021853636,0.00061622343,0.00007697256,0.0001900136,0.000042994816,0.0000056767162,0.000114644645],"genre_scores_gemma":[0.99307954,0.0043171104,0.0020987766,0.00015114092,0.0001799681,6.4422795e-7,0.000026968675,0.000011954139,0.00013388331],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985219,0.00012076594,0.0006585417,0.0001231105,0.00043255775,0.00014307174],"domain_scores_gemma":[0.9987472,0.000033217853,0.00058666803,0.000117177755,0.00034638488,0.00016932895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043913897,0.00011364945,0.00040488353,0.00023855976,0.000033880908,0.000022294696,0.000077960016,0.00008551749,0.000103407445],"category_scores_gemma":[0.000094170595,0.00009788456,0.000050083636,0.00015252916,0.00005898884,0.000333348,0.00002282096,0.0002143654,0.0000012370309],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017278973,0.00007058754,0.43294966,0.0001231015,0.000054067186,0.00006702244,0.0011573647,0.000004026546,0.5333557,0.0003182323,0.000014054424,0.031713363],"study_design_scores_gemma":[0.0011733862,0.0020199434,0.97064614,0.0003411879,0.00007980911,0.00009207786,0.000012357143,0.00040440055,0.024234314,0.0006647856,0.00024101268,0.00009058436],"about_ca_topic_score_codex":0.0017810703,"about_ca_topic_score_gemma":0.00025077874,"teacher_disagreement_score":0.5376965,"about_ca_system_score_codex":0.00006783621,"about_ca_system_score_gemma":0.0002830584,"threshold_uncertainty_score":0.39916164},"labels":[],"label_agreement":null},{"id":"W2074985863","doi":"10.1111/j.1365-2893.2006.00834.x","title":"Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Hepatitis C virus; Biology; Immunology; Immune system; Viral replication; Virology; Viral load; Interferon; Ex vivo; Downregulation and upregulation; Tumor necrosis factor alpha; T cell; Virus; In vivo; Gene","score_opus":0.015654438648006835,"score_gpt":0.30025496597443085,"score_spread":0.28460052732642405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074985863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977294,0.0005857609,0.00032466894,0.000058668054,0.0002861931,0.0002470666,0.000021626583,0.000010982109,0.0007356206],"genre_scores_gemma":[0.98956376,0.0093457885,0.00072788046,0.00005116448,0.00017077745,0.0000029471246,0.000004727896,0.000028131624,0.00010480901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975473,0.00012399693,0.0010518435,0.00020434214,0.00069120195,0.00038126518],"domain_scores_gemma":[0.99867743,0.00011744727,0.00043409475,0.00017794479,0.00031400094,0.0002790857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000784156,0.00019277562,0.00057520246,0.00071306655,0.000073835385,0.000027633621,0.000099868346,0.00015619633,0.00014261539],"category_scores_gemma":[0.00023198429,0.00017106242,0.00020843685,0.00027227186,0.00013944398,0.00033786317,0.00009061842,0.0004470321,0.000009443445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000704061,0.00020344947,0.60524184,0.00021960084,0.000035279598,0.00054858974,0.0004078661,0.000012706975,0.38493598,0.000004166621,0.000075701486,0.007610742],"study_design_scores_gemma":[0.0023808172,0.0023023128,0.5639769,0.0011077661,0.000054165983,0.00046066023,0.00004220452,0.00023984603,0.42884895,0.000017323844,0.00043605804,0.0001329979],"about_ca_topic_score_codex":0.008452529,"about_ca_topic_score_gemma":0.0036272726,"teacher_disagreement_score":0.043912955,"about_ca_system_score_codex":0.0005883228,"about_ca_system_score_gemma":0.00013383669,"threshold_uncertainty_score":0.9981503},"labels":[],"label_agreement":null},{"id":"W2076102296","doi":"10.1111/jvh.12019","title":"Chronic hepatitis <scp>B</scp> virus (<scp>HBV</scp>) infection in children: 25 years' experience","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute of Health Services and Policy Research; Hospital for Sick Children; University of Toronto","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Seroconversion; Medicine; HBeAg; HBsAg; Internal medicine; Hepatitis B virus; Immunology; Hepatitis B; Gastroenterology; Viral load; Antibody; Virus","score_opus":0.01353684405594725,"score_gpt":0.27980358130641075,"score_spread":0.2662667372504635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076102296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712635,0.008145773,0.0002373012,0.00007334428,0.0015289192,0.00050927803,0.000043537384,0.00007181393,0.0022636957],"genre_scores_gemma":[0.97150046,0.023513649,0.0007383172,0.0004678945,0.0029657553,0.000050010894,0.00001671145,0.00008377486,0.0006634013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959252,0.00024198793,0.0013475224,0.00034817075,0.0010497218,0.001087409],"domain_scores_gemma":[0.99756384,0.0003636059,0.00081145397,0.0004075238,0.0003246376,0.00052893657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007257048,0.00045967137,0.0010447765,0.0007089499,0.00018279557,0.00007156992,0.00026250217,0.00030692687,0.00011495919],"category_scores_gemma":[0.0019831075,0.00044329732,0.00039738856,0.0007154678,0.00025673246,0.0013266929,0.00017474998,0.0010291521,0.00030446277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007517227,0.0003562923,0.9772127,0.000055550063,0.00017940326,0.00019390605,0.003798668,0.000011843361,0.0024099443,0.00009274391,0.008015297,0.0076661175],"study_design_scores_gemma":[0.0018149706,0.0014243696,0.9585389,0.00047047003,0.00014027147,0.0009236344,0.00006276278,0.000058228914,0.007021543,0.00008122251,0.029356353,0.000107312815],"about_ca_topic_score_codex":0.021166699,"about_ca_topic_score_gemma":0.011056401,"teacher_disagreement_score":0.021341054,"about_ca_system_score_codex":0.001137952,"about_ca_system_score_gemma":0.0003029982,"threshold_uncertainty_score":0.9998019},"labels":[],"label_agreement":null},{"id":"W2076368506","doi":"10.1111/jvh.12218","title":"Loss of intrahepatic <scp>HB</scp>s<scp>A</scp>g expression predicts sustained response to peginterferon and is reflected by pronounced serum <scp>HB</scp>s<scp>A</scp>g decline","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hepatitis B; Hepatitis B virus; Gastroenterology; Immunology; Virus","score_opus":0.011445824521247526,"score_gpt":0.27479550720275375,"score_spread":0.2633496826815062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076368506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669636,0.0029346524,0.002347162,0.001518917,0.0012153671,0.00226945,0.0006351388,0.00025400516,0.002128922],"genre_scores_gemma":[0.97692215,0.0041922685,0.0046587433,0.0022430292,0.001261924,0.0001433027,0.000103384285,0.00033900113,0.010136198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9875252,0.0017701092,0.003953166,0.0014627759,0.0029194774,0.0023692483],"domain_scores_gemma":[0.98274547,0.008054297,0.0030117957,0.0014391678,0.0028374381,0.0019118368],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0036259303,0.0015914227,0.0035260278,0.001548157,0.0006339656,0.000283156,0.0011430401,0.0009595507,0.000042477397],"category_scores_gemma":[0.045268353,0.0014013674,0.0007235474,0.001435471,0.0007612453,0.0012286747,0.0010038596,0.0020751401,0.00010614738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083248655,0.0014540337,0.41676003,0.0015932841,0.0011234708,0.0008168079,0.019331567,0.00004493039,0.16131638,0.000051206327,0.39338633,0.0032894623],"study_design_scores_gemma":[0.01960265,0.030469846,0.42668808,0.008639668,0.001940515,0.001387788,0.0056951763,0.0032222846,0.26069617,0.0012023603,0.23998028,0.00047517524],"about_ca_topic_score_codex":0.0011266748,"about_ca_topic_score_gemma":0.001297557,"teacher_disagreement_score":0.15340605,"about_ca_system_score_codex":0.0010893643,"about_ca_system_score_gemma":0.0009711697,"threshold_uncertainty_score":0.9996834},"labels":[],"label_agreement":null},{"id":"W2077606460","doi":"10.1111/jvh.12236","title":"Infected hematopoietic stem cells and with integrated <scp>HBV DNA</scp> generate defective <scp>T</scp> cells in chronic <scp>HBV</scp> infection patients","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Peking University Health Science Center; Peking University; University of Toronto; Ministry of Education of the People's Republic of China; National Natural Science Foundation of China","keywords":"Haematopoiesis; Virology; Stem cell; Biology; Cell biology","score_opus":0.008363379964173183,"score_gpt":0.22478419587147122,"score_spread":0.21642081590729803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077606460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939433,0.0010080625,0.0011012605,0.000027624685,0.0009526654,0.0011226814,0.00008562267,0.000115577015,0.001643206],"genre_scores_gemma":[0.99339825,0.004031299,0.00054748374,0.00033613073,0.00056374376,0.00006323615,0.000036029247,0.00016130292,0.00086255214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945102,0.000776553,0.0017115208,0.0007237217,0.0011359625,0.0011420748],"domain_scores_gemma":[0.99445623,0.001462913,0.0015245295,0.0004658936,0.0014732041,0.0006172333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009294702,0.00088872673,0.001816814,0.0010453264,0.00031341065,0.00017894471,0.00024063002,0.00047429456,0.000014571558],"category_scores_gemma":[0.0012434849,0.0007198312,0.00032627792,0.0012021192,0.0003638841,0.00080312527,0.0001895952,0.0014996958,0.000117170224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034713015,0.0007275349,0.9546278,0.00054142106,0.00058156956,0.00030165754,0.003942817,0.00033759853,0.026058177,0.000050509243,0.008966326,0.0038298867],"study_design_scores_gemma":[0.010435426,0.012230073,0.7795686,0.0026264128,0.00079057564,0.00036036945,0.0004037182,0.0023543055,0.17330961,0.00022676293,0.017476259,0.00021786873],"about_ca_topic_score_codex":0.003622225,"about_ca_topic_score_gemma":0.010372877,"teacher_disagreement_score":0.17505917,"about_ca_system_score_codex":0.0015364968,"about_ca_system_score_gemma":0.0005734525,"threshold_uncertainty_score":0.99952525},"labels":[],"label_agreement":null},{"id":"W2078178324","doi":"10.1111/j.1365-2893.2007.00942.x","title":"Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review","year":2008,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université de Sherbrooke; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Transmission (telecommunications); Drug; Hepatitis C; Cohort; Hepatitis C virus; Cohort study; Confounding; Confidence interval; Relative risk; Internal medicine; Environmental health; Virology; Pharmacology; Virus; Computer science","score_opus":0.13032436202156428,"score_gpt":0.44953812826403317,"score_spread":0.3192137662424689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078178324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034942426,0.99314255,0.002014422,0.00010869947,0.00020247564,0.0033798718,0.00017793068,0.000023174569,0.00060143246],"genre_scores_gemma":[0.00009063448,0.9852512,0.013751893,0.00015898605,0.00023960591,0.000119052886,0.000051826715,0.00008505701,0.00025178003],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9874864,0.005180474,0.0045515057,0.00048243874,0.0018344771,0.0004646816],"domain_scores_gemma":[0.9921644,0.00181067,0.0042874417,0.0005937321,0.0007267824,0.00041700364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034774242,0.0006837005,0.007948889,0.00047338445,0.00014879215,0.000034770303,0.0003996455,0.00048898306,0.00029091426],"category_scores_gemma":[0.003245052,0.00044409872,0.0017756212,0.0006226978,0.00027115463,0.00043362737,0.000120279445,0.0015108385,0.000035101282],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009098399,0.00022665536,0.00042542035,0.55111253,0.0009866573,0.0007001887,0.0003213176,3.5253544e-7,0.0000073819674,0.000028990446,0.0061038365,0.43999568],"study_design_scores_gemma":[0.00069801824,0.0019035691,0.000094488045,0.5074672,0.0053842207,0.0030532074,0.0000032193086,0.00003802368,0.00003668884,0.0001293067,0.48084733,0.00034471776],"about_ca_topic_score_codex":0.0014719713,"about_ca_topic_score_gemma":0.000101556674,"teacher_disagreement_score":0.4747435,"about_ca_system_score_codex":0.00043748744,"about_ca_system_score_gemma":0.0008793367,"threshold_uncertainty_score":0.9998011},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2080010723","doi":"10.1111/jvh.12279","title":"<scp>APRI</scp> and <scp>FIB</scp>‐4 are good predictors of the stage of liver fibrosis in chronic hepatitis <scp>B</scp>: the Chronic Hepatitis Cohort Study (<scp>CH</scp>e<scp>CS</scp>)","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Genentech; AbbVie Canada; Vertex Pharmaceuticals; Centers for Disease Control and Prevention Foundation; AbbVie; Bristol-Myers Squibb","keywords":"Fibrosis; Liver biopsy; Medicine; Liver fibrosis; Internal medicine; Gastroenterology; Stage (stratigraphy); Chronic hepatitis; Biopsy; Immunology; Biology; Virus","score_opus":0.011076889738527787,"score_gpt":0.24399053213968858,"score_spread":0.2329136424011608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080010723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97017246,0.017001167,0.00020430218,0.00021164004,0.0021044333,0.004602566,0.0012696737,0.00018142353,0.0042523458],"genre_scores_gemma":[0.9457674,0.04321039,0.00040588304,0.00057142484,0.0022247324,0.00034625543,0.000071345516,0.00043459394,0.006967976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9823503,0.0026041802,0.0053747003,0.0018607837,0.0048674005,0.0029426173],"domain_scores_gemma":[0.9776677,0.010351598,0.0060670837,0.0026354722,0.0021065853,0.0011715783],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004616462,0.002182664,0.005030295,0.0014354212,0.0011329676,0.00034687578,0.0024064698,0.00112708,0.000063500505],"category_scores_gemma":[0.01755179,0.0016609182,0.0016552125,0.0025173768,0.002220563,0.0015069348,0.0017038309,0.003566476,0.00010323233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001474817,0.001376968,0.9419737,0.0014641489,0.0023348788,0.00046184912,0.008919321,0.0002903513,0.0030420732,0.00019325396,0.038619943,0.001308774],"study_design_scores_gemma":[0.0063649956,0.008789639,0.90899473,0.0031746733,0.0019304962,0.00031670087,0.002188832,0.0016560241,0.011185976,0.00024785002,0.054974876,0.00017520513],"about_ca_topic_score_codex":0.034383297,"about_ca_topic_score_gemma":0.09102214,"teacher_disagreement_score":0.056638844,"about_ca_system_score_codex":0.0027481401,"about_ca_system_score_gemma":0.0018895325,"threshold_uncertainty_score":0.9990914},"labels":[],"label_agreement":null},{"id":"W2081137746","doi":"10.1111/j.1365-2893.2009.01097.x","title":"Treatment of hepatitis C infection for current or former substance abusers in a community setting","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Yorkville University; University of Toronto; Toronto Public Health; University Health Network","funders":"","keywords":"Medicine; Hepatitis C; Substance abuse; Context (archaeology); Internal medicine; Urine; Ribavirin; Hepatitis C virus; Psychiatry; Immunology; Virus; Biology","score_opus":0.05819071225426575,"score_gpt":0.3903572395361643,"score_spread":0.33216652728189855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081137746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996676,0.000649453,0.0009740757,0.00043316983,0.0002207194,0.00065916276,0.00004625985,0.000011532334,0.00032960027],"genre_scores_gemma":[0.9816141,0.015632508,0.0023735343,0.000074671196,0.00018071623,0.000022676864,0.000016874354,0.000019434188,0.00006545974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979042,0.00022085097,0.0009473167,0.000113408736,0.0004659392,0.00034832666],"domain_scores_gemma":[0.99837065,0.0002774302,0.000478799,0.00022694538,0.00048011512,0.00016604281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005610301,0.00018128392,0.0006515111,0.00044316216,0.000104469356,0.000018403258,0.00010735793,0.0000928703,0.000058718328],"category_scores_gemma":[0.00038454845,0.00013875257,0.000265653,0.0003578044,0.00006361258,0.00034476127,0.000009133974,0.000421222,0.0000033651738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089991774,0.00095627416,0.65270835,0.0001460944,0.000050093335,0.000074039075,0.0015937296,0.000013200281,0.0010130003,0.000028865663,0.0003308527,0.3421856],"study_design_scores_gemma":[0.0073748752,0.019875212,0.9515362,0.0012410681,0.00010711889,0.00014260705,0.00006299379,0.0013069906,0.007194025,0.0005362054,0.010435522,0.00018721096],"about_ca_topic_score_codex":0.00428738,"about_ca_topic_score_gemma":0.013046128,"teacher_disagreement_score":0.34199837,"about_ca_system_score_codex":0.00084366556,"about_ca_system_score_gemma":0.00030866935,"threshold_uncertainty_score":0.7280045},"labels":[],"label_agreement":null},{"id":"W2082200384","doi":"10.1111/j.1365-2893.2006.00753.x","title":"HCV‐related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon<i>α</i>‐2a and ribavirin","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Ribavirin; Pegylated interferon; Gastroenterology; Internal medicine; Tolerability; Cirrhosis; Hepatitis C virus; Hepatitis C; Adverse effect; Randomized controlled trial; Immunology; Virus","score_opus":0.007071358825222683,"score_gpt":0.2841870347743046,"score_spread":0.27711567594908193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082200384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886315,0.0031332604,0.0001731203,0.00074559747,0.00049869966,0.0025784527,0.00002148043,0.000028317561,0.004189562],"genre_scores_gemma":[0.9930418,0.0041087936,0.0011412173,0.000060806306,0.00025850773,0.00006391059,0.000013787199,0.0000466511,0.0012644968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948332,0.0008270106,0.0027129077,0.00024320856,0.0009784973,0.00040521496],"domain_scores_gemma":[0.99648833,0.00084262737,0.001384012,0.00026345623,0.00076902896,0.00025252547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021168555,0.00031034226,0.003210799,0.0005741641,0.00006138298,0.000044695204,0.00018315703,0.00026764034,0.00034305436],"category_scores_gemma":[0.0015744764,0.00022569076,0.00087798265,0.00031761517,0.00037521578,0.00034740372,0.0000694579,0.00074143044,0.000014077736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9646787,0.00053751905,0.004375562,0.00009431047,0.000662456,0.00021566801,0.00016027597,0.000023746163,0.013684345,0.00022490056,0.0007738649,0.014568665],"study_design_scores_gemma":[0.9827623,0.00559903,0.0031582518,0.0008658198,0.00066293415,0.00009448213,0.000020796531,0.0014346502,0.0037272451,0.000635528,0.00083871745,0.00020028368],"about_ca_topic_score_codex":0.0007398644,"about_ca_topic_score_gemma":0.000082930084,"teacher_disagreement_score":0.018083574,"about_ca_system_score_codex":0.00012864676,"about_ca_system_score_gemma":0.00021071831,"threshold_uncertainty_score":0.92034024},"labels":[],"label_agreement":null},{"id":"W2085673843","doi":"10.1111/jvh.12166_19","title":"P20: Understanding the impact of a cure for hepatitis C from the patient perspective","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thematic analysis; Hepatitis C; Qualitative research; Quality of life (healthcare); Asymptomatic; Stigma (botany); Disease; Family medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.04967900589149202,"score_gpt":0.3565578193475997,"score_spread":0.3068788134561077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085673843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856688,0.0011315924,0.0037037146,0.0060867914,0.00023611104,0.00120496,0.0002638616,0.000009733462,0.0016944394],"genre_scores_gemma":[0.99671644,0.0015651422,0.0007870426,0.0003090333,0.00047284804,0.00003854766,0.000008389063,0.00003680818,0.00006573352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976859,0.00022311641,0.00072027993,0.00016623737,0.00082641334,0.00037803964],"domain_scores_gemma":[0.99674356,0.0009475704,0.00058069185,0.0003532368,0.0011768531,0.00019808636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043533475,0.00020281598,0.0005297863,0.00013743842,0.00020707567,0.00008158038,0.00031963145,0.0001043276,0.00095716014],"category_scores_gemma":[0.0009177265,0.00009974023,0.00066258135,0.0002676145,0.0002589892,0.00032883883,0.00007370328,0.0005640193,0.000023994517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060439185,0.00036716854,0.8605563,0.00004233503,0.0015029176,0.000087294546,0.010944854,0.0000755516,0.0035261298,0.0020837735,0.10009351,0.020115746],"study_design_scores_gemma":[0.004848473,0.013357021,0.907349,0.0010466151,0.00044747943,0.00019172985,0.0075285956,0.008253962,0.0022325695,0.051932573,0.0024142794,0.0003977192],"about_ca_topic_score_codex":0.051188685,"about_ca_topic_score_gemma":0.0013744102,"teacher_disagreement_score":0.09767923,"about_ca_system_score_codex":0.0012341448,"about_ca_system_score_gemma":0.0005022078,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2088738784","doi":"10.1111/j.1365-2893.2004.00507.x","title":"Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Antibody; Medicine; Immunology; Serology; Hepatitis C virus; Fibrosis; Hepatic fibrosis; Immunoglobulin G; Immunoglobulin A; Immunoglobulin M; Gastroenterology; Internal medicine; Virus","score_opus":0.00877060117949128,"score_gpt":0.264208526295404,"score_spread":0.2554379251159127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088738784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707747,0.0005419358,0.00045548502,0.00043985457,0.00029533322,0.0008394772,0.000096595155,0.00001868429,0.00023516279],"genre_scores_gemma":[0.99179685,0.007169469,0.0005637995,0.000118130636,0.00021464794,0.000025446127,0.000019435976,0.00005187594,0.000040361334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962521,0.00022028227,0.0012749371,0.00023818233,0.0015041168,0.00051033456],"domain_scores_gemma":[0.99774563,0.000107343076,0.0007299871,0.00045912652,0.00074588344,0.00021203017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006068323,0.00028936123,0.0007535397,0.0004947679,0.00012136854,0.000041717627,0.00026961046,0.00015788175,0.0002237489],"category_scores_gemma":[0.0003018268,0.00019187985,0.0002738073,0.0007476515,0.00026687334,0.0005208743,0.00009414431,0.0008144759,0.000027369319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068038696,0.0007351509,0.9788979,0.00018640592,0.00019831175,0.00011837356,0.00029909212,0.00069610076,0.0008040785,0.00003034518,0.000097507815,0.017256338],"study_design_scores_gemma":[0.006583503,0.00987624,0.9750102,0.0015934522,0.00014003456,0.00005458577,0.0000056182475,0.00023406105,0.005675581,0.00015531699,0.0004961303,0.00017525666],"about_ca_topic_score_codex":0.039464075,"about_ca_topic_score_gemma":0.029230852,"teacher_disagreement_score":0.01708108,"about_ca_system_score_codex":0.0015164897,"about_ca_system_score_gemma":0.00090211735,"threshold_uncertainty_score":0.98848313},"labels":[],"label_agreement":null},{"id":"W2095079937","doi":"10.1111/jvh.12402","title":"Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; HBsAg; Rituximab; Hepatitis B virus; Internal medicine; Hepatitis B; Prospective cohort study; Meta-analysis; Gastroenterology; Immunology; Lymphoma; Virology; Virus","score_opus":0.07986019504834359,"score_gpt":0.36813493434342764,"score_spread":0.28827473929508407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095079937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022471973,0.99182695,0.0005691667,0.00016891731,0.00060787075,0.0027229977,0.0010475463,0.000035515583,0.0007738153],"genre_scores_gemma":[0.007280393,0.9850885,0.0055712895,0.00016952475,0.00050929066,0.00037793015,0.0005185084,0.00015708584,0.00032745666],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99288225,0.0008515123,0.0034044082,0.0006937642,0.0014442495,0.0007238302],"domain_scores_gemma":[0.9910421,0.0013932458,0.003894127,0.00050996675,0.0027637815,0.00039681615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017852292,0.0009952186,0.010368256,0.002554496,0.00016997481,0.00009132388,0.0003808332,0.0006052678,0.00008190138],"category_scores_gemma":[0.002777586,0.0007848609,0.004787165,0.0020637857,0.00015688005,0.00079122174,0.00015932639,0.0007888703,0.00004065943],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035717705,0.0021545293,0.049202263,0.0066557406,0.16314958,0.0004513377,0.0010581162,0.000004413651,5.4239706e-7,0.000053190368,0.0039051103,0.773008],"study_design_scores_gemma":[0.010185534,0.0042347894,0.053613123,0.013687198,0.59353054,0.00021366714,0.000032620424,0.00011362219,0.000019355399,0.00067779375,0.32215235,0.0015393931],"about_ca_topic_score_codex":0.0075817616,"about_ca_topic_score_gemma":0.012355391,"teacher_disagreement_score":0.7714686,"about_ca_system_score_codex":0.0029516956,"about_ca_system_score_gemma":0.00128104,"threshold_uncertainty_score":0.9994602},"labels":[],"label_agreement":null},{"id":"W2095416281","doi":"10.1111/j.1365-2893.2008.00985.x","title":"Health care costs of persons with newly diagnosed hepatitis C virus: a population‐based, observational study","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; University of Alberta; Alberta Health","funders":"","keywords":"Medicine; Observational study; Health care; Population; Hepatitis C; Family medicine; Medical record; Demography; Environmental health; Emergency medicine; Internal medicine","score_opus":0.07009147985287144,"score_gpt":0.3625939495572139,"score_spread":0.29250246970434246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095416281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995622,0.0006885988,0.00053993834,0.0015068206,0.00014538602,0.00096829305,0.00026129922,0.00002543963,0.00024222306],"genre_scores_gemma":[0.98910517,0.0009984059,0.008501526,0.0008259606,0.00027548664,0.00003003229,0.00011130872,0.000057482175,0.000094612806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956663,0.00036538855,0.0012076099,0.0002712,0.0020554974,0.0004339725],"domain_scores_gemma":[0.9966896,0.0002737768,0.0008569288,0.0003696366,0.0013428654,0.00046719646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042812066,0.00027303345,0.0010075701,0.00057491875,0.000267126,0.000023975577,0.00023637913,0.00010044342,0.00026557883],"category_scores_gemma":[0.00043776716,0.00022623353,0.00025085668,0.000655974,0.00014430564,0.00041531754,0.00004312204,0.00056657667,0.000012734325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005769351,0.000928961,0.9818618,0.00011717959,0.0001869139,0.0013995313,0.002580197,0.00016666386,0.000073445546,0.00003030178,0.0034924361,0.008585622],"study_design_scores_gemma":[0.005931202,0.009910048,0.981439,0.0005715031,0.00008550161,0.000238584,0.00035844345,0.00040175862,0.0001403226,0.000007519472,0.0007250718,0.00019104674],"about_ca_topic_score_codex":0.07679462,"about_ca_topic_score_gemma":0.044008166,"teacher_disagreement_score":0.032786448,"about_ca_system_score_codex":0.0011087211,"about_ca_system_score_gemma":0.0022307427,"threshold_uncertainty_score":0.9734362},"labels":[],"label_agreement":null},{"id":"W2095538783","doi":"10.1111/j.1365-2893.2007.00846.x","title":"Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus‐coinfected patients treated with interferon plus ribavirin","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Sidaction","keywords":"Ribavirin; Medicine; Internal medicine; Zidovudine; Hepatitis C virus; Gastroenterology; Discontinuation; Hepatitis C; Adverse effect; Combination therapy; Incidence (geometry); Virology; Virus; Viral disease","score_opus":0.01963728474974307,"score_gpt":0.3152238943803466,"score_spread":0.2955866096306035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095538783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545336,0.00017332705,0.0015856611,0.000027383732,0.00021566878,0.0011584832,0.0002999698,0.000049231432,0.0010369378],"genre_scores_gemma":[0.99728495,0.0011871,0.00082075497,0.000077402365,0.00015328004,0.00002314943,0.00015916095,0.00010856054,0.0001856286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953694,0.00023723718,0.0017691876,0.0004351158,0.0012008529,0.000988243],"domain_scores_gemma":[0.9966963,0.00037344565,0.0009816586,0.00043757874,0.0010766546,0.00043437575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001167911,0.00049040304,0.0011466021,0.0013455698,0.0002521418,0.000081870974,0.00037403364,0.00030453416,0.00025199715],"category_scores_gemma":[0.000809961,0.00038432775,0.00035848495,0.00088578055,0.00023599922,0.000621896,0.000087877124,0.001156451,0.000019601239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021551226,0.00087013515,0.97220397,0.00007520406,0.00018606351,0.00037544483,0.0007276455,0.000028020793,0.009151439,0.000026098834,0.00040559573,0.013795247],"study_design_scores_gemma":[0.008543692,0.014282279,0.94984573,0.0005486202,0.0001757122,0.00003098482,0.000050225564,0.00039504573,0.02457871,0.000049151382,0.0011030778,0.00039679272],"about_ca_topic_score_codex":0.051171415,"about_ca_topic_score_gemma":0.04339384,"teacher_disagreement_score":0.022358272,"about_ca_system_score_codex":0.0018003715,"about_ca_system_score_gemma":0.0003404363,"threshold_uncertainty_score":0.9998609},"labels":[],"label_agreement":null},{"id":"W2097829796","doi":"10.1046/j.1365-2893.2000.00013.x","title":"Hepatitis C and the British Columbia experience with hepatitis A vaccination","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatitis A; Outbreak; Hepatitis C virus; Hepatitis a virus; Virology; Medicine; Vaccination; Hepatitis C; Hepatitis; Hepatitis A vaccine; Environmental health; Immunology; Virus","score_opus":0.01151688928095262,"score_gpt":0.27702706888914796,"score_spread":0.26551017960819534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097829796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227303,0.0010073567,0.00015494284,0.000920138,0.00016188208,0.0004363907,0.00002932148,0.000032018797,0.004984923],"genre_scores_gemma":[0.97333384,0.01810186,0.0014632433,0.00092270423,0.0003621004,0.000028972658,0.000008212564,0.00004194315,0.0057371147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976966,0.0001767151,0.00074519956,0.0002513342,0.00079750846,0.00033268242],"domain_scores_gemma":[0.9985183,0.00016492912,0.00038527747,0.00027007164,0.0004026578,0.00025875348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041211862,0.0001806852,0.00062668265,0.000065862914,0.0004402228,0.000600658,0.00019963681,0.00010714576,0.0024461886],"category_scores_gemma":[0.0002087654,0.00016470607,0.00012861457,0.00031149748,0.00028508762,0.0006111623,0.00003288811,0.00044926858,0.000025901298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035598385,0.0001171567,0.73308635,0.000038298393,0.00008941887,0.00088473177,0.0034784006,0.0000057132493,0.00003528367,0.000020153122,0.006667987,0.25522053],"study_design_scores_gemma":[0.006854089,0.0020648448,0.97307795,0.0005614107,0.00021095488,0.006667859,0.0006261846,0.0008293295,0.00009282449,0.00045670685,0.008304854,0.0002529895],"about_ca_topic_score_codex":0.1228756,"about_ca_topic_score_gemma":0.1843005,"teacher_disagreement_score":0.25496754,"about_ca_system_score_codex":0.00014762793,"about_ca_system_score_gemma":0.00015134134,"threshold_uncertainty_score":0.9984657},"labels":[],"label_agreement":null},{"id":"W2100256719","doi":"10.1111/j.1365-2893.2010.01321.x","title":"Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of California, San Francisco; American Association for the Study of Liver Diseases","keywords":"cccDNA; Virology; Hepatitis B virus; Viral quasispecies; Adefovir; Lamivudine; Biology; Peripheral blood mononuclear cell; Orthohepadnavirus; Virus; Hepatitis B; Liver transplantation; HBsAg; Molecular biology; Medicine; Hepatitis C virus; Transplantation; In vitro; Internal medicine","score_opus":0.008832522639236154,"score_gpt":0.2566557498223033,"score_spread":0.24782322718306718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100256719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796605,0.00013457818,0.000047307516,0.00030275987,0.0005691573,0.00062969304,0.0001040255,0.00001544196,0.00023097008],"genre_scores_gemma":[0.9940461,0.0047094733,0.00060580915,0.0003518093,0.00014926489,0.000018251301,0.000038753282,0.000057622627,0.000022910914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692935,0.00021510018,0.0013130109,0.00030020057,0.00084975304,0.00039260116],"domain_scores_gemma":[0.99774456,0.00015366696,0.0009456326,0.00034494876,0.0006281199,0.00018304249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004110458,0.00035196057,0.0010185823,0.0006316395,0.000077665296,0.000035537447,0.00019992315,0.00021384971,0.00008974068],"category_scores_gemma":[0.000652291,0.00030210614,0.00019411594,0.00035140212,0.00026353833,0.0004779669,0.00007284848,0.0007824425,0.00000767857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006088956,0.00063632644,0.8092192,0.00009211162,0.00010892611,0.00020948713,0.0006068179,0.0000011953688,0.17322609,0.00008760956,0.00005215504,0.015151184],"study_design_scores_gemma":[0.0034250305,0.0038302958,0.9025684,0.0005625977,0.000070572896,0.000026969623,0.0000061846335,0.00026203258,0.088627,0.00022101816,0.00017109896,0.00022877846],"about_ca_topic_score_codex":0.00346784,"about_ca_topic_score_gemma":0.0036339671,"teacher_disagreement_score":0.09334921,"about_ca_system_score_codex":0.00010642805,"about_ca_system_score_gemma":0.00013711363,"threshold_uncertainty_score":0.9999431},"labels":[],"label_agreement":null},{"id":"W2100451620","doi":"10.1111/j.1365-2893.2009.01092.x","title":"Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Hepatitis C virus; Immune system; Immunology; Virology; Peripheral blood mononuclear cell; Hepatitis C; Biology; Hepacivirus; Cytokine; Virus; Viral replication; Occult; Medicine; Pathology; In vitro","score_opus":0.013761526060327565,"score_gpt":0.27713380734680065,"score_spread":0.2633722812864731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100451620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908736,0.0052982033,0.00057986827,0.00093006075,0.00035468367,0.0008933685,0.00035914886,0.00006924167,0.00064185675],"genre_scores_gemma":[0.9463581,0.05083346,0.0006087712,0.0002566704,0.0009986499,0.000042503896,0.00015707182,0.0000624547,0.0006823426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99589455,0.0003272125,0.0013651482,0.00046635282,0.0012485384,0.00069820497],"domain_scores_gemma":[0.997124,0.00009974492,0.0011067387,0.00040375488,0.00067345257,0.0005923159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005459067,0.00049096416,0.0011764508,0.00045160344,0.00032367904,0.00016462014,0.00022289625,0.0003042254,0.0005935299],"category_scores_gemma":[0.00026209943,0.00041933308,0.00052690244,0.000359303,0.00019180888,0.0008234824,0.00010958313,0.0009952631,0.000056114804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040872366,0.0005513421,0.57105684,0.0002967038,0.00009890822,0.0005351394,0.00015610585,0.0000020316963,0.36954987,0.0000029301502,0.0032923748,0.054049052],"study_design_scores_gemma":[0.004245135,0.00823576,0.8242167,0.0013875002,0.00021732411,0.0004644165,0.000012032766,0.00042149183,0.13601302,0.000036553647,0.024283428,0.0004666536],"about_ca_topic_score_codex":0.0058641727,"about_ca_topic_score_gemma":0.0010576538,"teacher_disagreement_score":0.25315988,"about_ca_system_score_codex":0.0009066842,"about_ca_system_score_gemma":0.00028891518,"threshold_uncertainty_score":0.99982584},"labels":[],"label_agreement":null},{"id":"W2102025275","doi":"10.1046/j.1365-2893.2003.00397.x","title":"Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope","year":2003,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Provincial Health Services Authority","keywords":"Epitope; Immunogenicity; Virology; Antigen; Hepatitis B virus; Antibody; Epitope mapping; Conformational epitope; Chemistry; Biology; Virus; Immunology","score_opus":0.025721647244376113,"score_gpt":0.26744970095454634,"score_spread":0.24172805371017023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102025275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550647,0.0018226871,0.00018650024,0.0008109371,0.0007082106,0.0006845808,0.000056215664,0.000009716472,0.0002146583],"genre_scores_gemma":[0.9975511,0.0006610954,0.001211392,0.000118078904,0.00012423306,0.0000055766445,0.000002640107,0.000033594064,0.0002923076],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973448,0.00052683195,0.0011036978,0.00016493091,0.0005791748,0.00028056387],"domain_scores_gemma":[0.9969111,0.00019058002,0.001915316,0.0004578672,0.0004698888,0.00005525172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011114113,0.00021216673,0.0006252216,0.000078519195,0.0005528589,0.000020111005,0.00028781622,0.00011981276,0.000040314808],"category_scores_gemma":[0.00081653835,0.00011345773,0.00047845082,0.00039396505,0.0003260262,0.00020527007,0.000095282005,0.00044534274,0.0000012288424],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028678,0.000059846676,0.5702027,0.00008207484,0.00030730927,0.000007664177,0.002643106,0.000054052434,0.42505515,0.0001827986,0.0007263148,0.00039221352],"study_design_scores_gemma":[0.0022133796,0.0010950397,0.38746676,0.0009782858,0.0004475368,0.00039365244,0.00033523113,0.00024808722,0.60540503,0.00035903096,0.0008783979,0.00017955937],"about_ca_topic_score_codex":0.002073858,"about_ca_topic_score_gemma":0.0012894894,"teacher_disagreement_score":0.18273593,"about_ca_system_score_codex":0.00014632591,"about_ca_system_score_gemma":0.000224117,"threshold_uncertainty_score":0.4626672},"labels":[],"label_agreement":null},{"id":"W2103399712","doi":"10.1111/j.1365-2893.2005.00600.x","title":"Treatment of hepatitis C","year":2005,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ribavirin; Medicine; Pegylated interferon; Hepatitis C; Internal medicine; Combination therapy; Intensive care medicine; Chronic hepatitis; Virology; Virus","score_opus":0.08876473411177735,"score_gpt":0.4253372981562146,"score_spread":0.33657256404443725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103399712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059860124,0.99344754,0.000031542797,0.00011747121,0.00046464615,0.0008662779,0.0002574065,0.000016634729,0.004199892],"genre_scores_gemma":[0.0005068941,0.9932127,0.0022894728,0.000032025244,0.0017923007,0.00003383918,0.00006357614,0.00012264539,0.001946549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949005,0.00035056754,0.0026230188,0.00030559313,0.0013057342,0.0005145554],"domain_scores_gemma":[0.9960706,0.00029901965,0.0018786581,0.0005914424,0.0006656564,0.0004945799],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003333502,0.0005899649,0.0048188884,0.0010513172,0.00005631354,0.000032785305,0.00034747776,0.0004944793,0.0012032724],"category_scores_gemma":[0.00027849618,0.0004165063,0.0022553015,0.00049328146,0.00018182231,0.00021478946,0.000061830986,0.00066630996,0.00021810071],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050348888,0.00059090863,0.0039956677,0.0045943134,0.00093141414,0.0017164719,0.0000790825,2.7675046e-7,0.0000020511843,0.000039023358,0.002071613,0.98592883],"study_design_scores_gemma":[0.0013161442,0.0062771444,0.00044226847,0.012571457,0.0020534971,0.001664237,0.0000025746406,0.000013509685,0.00002143536,0.000016614185,0.9753508,0.00027032202],"about_ca_topic_score_codex":0.0013410351,"about_ca_topic_score_gemma":0.00032110678,"teacher_disagreement_score":0.9856585,"about_ca_system_score_codex":0.001535222,"about_ca_system_score_gemma":0.002011851,"threshold_uncertainty_score":0.9998287},"labels":[],"label_agreement":null},{"id":"W2103723704","doi":"10.1111/j.1365-2893.2005.00553.x","title":"Patient concerns regarding chronic hepatitis C infections","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cirrhosis; Marital status; Disease; Hepatitis C; Transmission (telecommunications); Viral hepatitis; Liver disease; Hepatitis C virus; Family medicine; Ethnic group; Internal medicine; Virus; Immunology; Population; Environmental health","score_opus":0.02393388098074745,"score_gpt":0.3313626379925439,"score_spread":0.30742875701179645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103723704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027754,0.0016626999,0.0009536585,0.0023899833,0.0006270982,0.00035433803,0.00003719711,0.000051033236,0.013646442],"genre_scores_gemma":[0.98732436,0.0068900217,0.002138988,0.00056349416,0.002299028,0.000015227568,0.000008848465,0.000049976254,0.00071006175],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971209,0.00015195689,0.0009927101,0.00021336101,0.0010116661,0.00050937955],"domain_scores_gemma":[0.9979535,0.00012476392,0.0004402461,0.00031357032,0.0007160005,0.00045196476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038320417,0.00022244891,0.000591938,0.00046115907,0.00018349553,0.00006811384,0.00015424464,0.00015075087,0.0016783029],"category_scores_gemma":[0.0004960233,0.00019610174,0.00038323997,0.00035973242,0.00014212007,0.00062636787,0.000085175234,0.00081849087,0.0002935491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101566,0.0003594722,0.60181856,0.000079216545,0.00025893663,0.00067805604,0.00044183803,0.00017337785,0.003197274,0.00030523085,0.026405452,0.366181],"study_design_scores_gemma":[0.004742928,0.010386016,0.14128646,0.0011900667,0.0002614711,0.0017335119,0.0000409074,0.0038733052,0.015819196,0.00021471214,0.81994146,0.00050997216],"about_ca_topic_score_codex":0.0017837571,"about_ca_topic_score_gemma":0.0032566946,"teacher_disagreement_score":0.793536,"about_ca_system_score_codex":0.0015755169,"about_ca_system_score_gemma":0.00072429347,"threshold_uncertainty_score":0.9992343},"labels":[],"label_agreement":null},{"id":"W2111431831","doi":"10.1111/jvh.12430","title":"Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies","year":2015,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Nanfang Hospital","keywords":"Observational study; Medicine; Meta-analysis; Hepatitis a virus; Virology; Chronic hepatitis; Internal medicine; Virus","score_opus":0.22572006750610205,"score_gpt":0.4322159152598758,"score_spread":0.20649584775377375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111431831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047841292,0.9471828,0.00007694086,0.000033678232,0.0001484277,0.0009817352,0.003579515,0.000020942784,0.00013470005],"genre_scores_gemma":[0.013831859,0.98466957,0.00048993586,0.000040073326,0.0002724649,0.00008603698,0.0003373394,0.00009862081,0.00017407723],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9912612,0.0016853359,0.0033178935,0.0004445391,0.002820227,0.0004708206],"domain_scores_gemma":[0.9856876,0.0013320455,0.0068876296,0.0006295716,0.005092398,0.0003707553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030029896,0.0007033297,0.010351712,0.002574441,0.00009920768,0.000032502034,0.00035984462,0.0005114395,0.00066356035],"category_scores_gemma":[0.0030347295,0.00048147838,0.0041499017,0.0032790154,0.00041568204,0.00043514158,0.00014518657,0.0012732295,0.000009949961],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017452553,0.00044447384,0.2916993,0.010051808,0.58336914,0.0002886243,0.00030481248,0.00004764715,0.0000071664863,0.000012710557,0.0012456367,0.11235416],"study_design_scores_gemma":[0.0023340944,0.007602396,0.06241087,0.013310097,0.79744107,0.00011271633,0.000006405804,0.00047509882,0.00008141673,0.000085008185,0.1154767,0.00066411565],"about_ca_topic_score_codex":0.020386701,"about_ca_topic_score_gemma":0.027357342,"teacher_disagreement_score":0.22928843,"about_ca_system_score_codex":0.0019036876,"about_ca_system_score_gemma":0.0037437095,"threshold_uncertainty_score":0.99976367},"labels":[],"label_agreement":null},{"id":"W2112837294","doi":"10.1111/jvh.12436","title":"Clinical course of 161 untreated and tenofovir‐treated chronic hepatitis<scp>B</scp>pregnant patients in a low hepatitis<scp>B</scp>virus endemic region","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health; Government of Alberta; University of Calgary","funders":"Public Health Agency; Canadian Institutes of Health Research; Centers for Disease Control and Prevention; Bristol-Myers Squibb","keywords":"Medicine; Hepatitis B virus; Gastroenterology; Hepatitis B; Internal medicine; Tenofovir; Viral load; Pregnancy; Immunology; Virus; Biology; Human immunodeficiency virus (HIV)","score_opus":0.02907699896041154,"score_gpt":0.30535829767616685,"score_spread":0.2762812987157553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112837294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868715,0.009276013,0.00011667146,0.0001410573,0.0010116453,0.0011278522,0.00030185332,0.00008569223,0.0010677374],"genre_scores_gemma":[0.9343943,0.06312707,0.0005599065,0.00035957646,0.0006244392,0.00003934122,0.000105877596,0.00014322388,0.000646256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918336,0.00087625935,0.003736182,0.0008085502,0.0015295014,0.0012158551],"domain_scores_gemma":[0.9921588,0.0014560623,0.00251522,0.0007229382,0.0020397003,0.001107303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001456617,0.0008816067,0.0028385604,0.00088696607,0.00017011884,0.00007222208,0.00046688554,0.0007217094,0.000020894684],"category_scores_gemma":[0.0055817547,0.0007519753,0.0005778929,0.0009758809,0.0008600245,0.00082849077,0.00031779453,0.0014991959,0.00006075025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016292147,0.0016747137,0.96398425,0.00031388405,0.0006188792,0.00196794,0.0017310083,0.000022503438,0.00027476417,0.000032145286,0.01574922,0.01346774],"study_design_scores_gemma":[0.012106601,0.009466666,0.96419084,0.004562146,0.00065696164,0.00051184645,0.0001914167,0.0012175911,0.00207617,0.0003059377,0.00447842,0.00023538503],"about_ca_topic_score_codex":0.029783724,"about_ca_topic_score_gemma":0.033267055,"teacher_disagreement_score":0.05385106,"about_ca_system_score_codex":0.0012217303,"about_ca_system_score_gemma":0.0012919573,"threshold_uncertainty_score":0.9994931},"labels":[],"label_agreement":null},{"id":"W2116187238","doi":"10.1111/jvh.12249","title":"Strategies to manage hepatitis<scp>C</scp>virus (<scp>HCV</scp>) disease burden","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Health Sciences Centre; University Health Network; Nova Scotia Health Authority; University of Calgary; University of Toronto; Western University; University of British Columbia; BC Centre for Disease Control; Calgary Laboratory Services; University of Manitoba; Queen Elizabeth II Health Sciences Centre; Université de Montréal","funders":"Bundesamt für Gesundheit; National Institute for Health and Care Research; Gilead Sciences","keywords":"Medicine; Hepatitis C virus; Disease; Hepatitis C; Burden of disease; Disease burden; Internal medicine; Mortality rate; Virus; Intensive care medicine; Immunology","score_opus":0.017995024039105963,"score_gpt":0.3051082130545049,"score_spread":0.28711318901539895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116187238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452959,0.0011023947,0.004403238,0.0013117208,0.0008706365,0.0008077102,0.00016867556,0.00011887894,0.04592089],"genre_scores_gemma":[0.9808899,0.004537878,0.0033734944,0.0016706692,0.002243349,0.000048844504,0.0000427794,0.00015972667,0.007033353],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99373,0.0005039611,0.0014932291,0.0005955645,0.002406285,0.0012709495],"domain_scores_gemma":[0.994326,0.0009804609,0.0006185939,0.0008774289,0.0009800186,0.002217475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012958031,0.00059258885,0.0012461289,0.0010385298,0.00027841298,0.00042834005,0.00081960275,0.00026961186,0.00024346804],"category_scores_gemma":[0.004803209,0.000535225,0.0005980279,0.0007769684,0.0002585349,0.0011023387,0.00031169414,0.0012105588,0.001177504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026021883,0.00096493796,0.59624964,0.0011522627,0.001008111,0.010226987,0.004622436,0.000687561,0.01087586,0.0048992094,0.25535262,0.113700144],"study_design_scores_gemma":[0.0028788326,0.003549235,0.35911983,0.00094946485,0.00037734117,0.00017818574,0.00051184883,0.002477517,0.0023200314,0.003325129,0.6241065,0.00020609614],"about_ca_topic_score_codex":0.0050583463,"about_ca_topic_score_gemma":0.0018838324,"teacher_disagreement_score":0.3687539,"about_ca_system_score_codex":0.00047632222,"about_ca_system_score_gemma":0.0006278236,"threshold_uncertainty_score":0.9997099},"labels":[],"label_agreement":null},{"id":"W2120204078","doi":"10.1111/j.1365-2893.2011.01530.x","title":"Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development","year":2011,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"","keywords":"Autophagy; Homeostasis; Biology; Hepatitis C virus; Disease; Drug development; Drug; Virus; Immunology; Virology; Medicine; Cell biology; Pharmacology; Genetics; Apoptosis; Pathology","score_opus":0.047604243975815426,"score_gpt":0.3409367641357718,"score_spread":0.29333252015995637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120204078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012375114,0.98345745,0.0007087045,0.000022511742,0.0010518308,0.0013373233,0.00023217977,0.000039242965,0.00077564706],"genre_scores_gemma":[0.0020570685,0.98835856,0.007008797,0.00020599995,0.00079712085,0.00015163395,0.0001418856,0.00013800821,0.0011409438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957006,0.00013577325,0.0025343127,0.000421311,0.00057261507,0.00063537306],"domain_scores_gemma":[0.99700963,0.00017353136,0.0017346519,0.0003849571,0.00033495086,0.00036227363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006412414,0.00073152845,0.0032255133,0.0008876083,0.00012531663,0.00010089738,0.0004926508,0.0004543147,0.00046261135],"category_scores_gemma":[0.00007912382,0.0005749391,0.0012671553,0.00034793536,0.00011124908,0.00055436476,0.000071994975,0.0008574264,0.00005320087],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043942526,0.0012873884,0.00046503817,0.011018327,0.0014182837,0.0009927886,0.0009876628,0.0000015565261,0.000034573593,0.0016594814,0.0028797027,0.9788158],"study_design_scores_gemma":[0.0038795634,0.0011980721,0.002734151,0.021228129,0.0013126363,0.0006080366,0.000039699808,0.000022991126,0.00034381167,0.0015102577,0.9663634,0.00075926026],"about_ca_topic_score_codex":0.00082175474,"about_ca_topic_score_gemma":0.0005488297,"teacher_disagreement_score":0.9780565,"about_ca_system_score_codex":0.00068532035,"about_ca_system_score_gemma":0.0043411674,"threshold_uncertainty_score":0.9996702},"labels":[],"label_agreement":null},{"id":"W2120349387","doi":"10.1111/j.1365-2893.2007.00889.x","title":"Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; University of Toronto; Dalhousie University; University of British Columbia; BC Centre for Disease Control","funders":"","keywords":"Ribavirin; Chronic hepatitis; Peginterferon alfa-2a; Genotype; Virology; Medicine; Alpha (finance); Gastroenterology; Biology; Genetics; Gene; Virus; Surgery","score_opus":0.09088054876083444,"score_gpt":0.33883364993056286,"score_spread":0.2479531011697284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120349387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972456,0.0011443732,0.00016340787,0.00085260323,0.000054204913,0.000394692,0.000014875764,0.000009069318,0.00012114565],"genre_scores_gemma":[0.990231,0.0084220795,0.00092336285,0.00004934287,0.00021342572,0.000020063237,0.0000021051578,0.000028973938,0.00010967329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979138,0.00019752895,0.0006632856,0.0002632789,0.00048041833,0.00048169008],"domain_scores_gemma":[0.99883246,0.00037782788,0.00014120503,0.00015866173,0.00010142517,0.00038844024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010113198,0.00022822164,0.00068598404,0.00094083784,0.000050305684,0.000048044712,0.00009704015,0.00007824447,0.00003500419],"category_scores_gemma":[0.00015165855,0.00017278425,0.0000480559,0.00032962137,0.00011286881,0.0003911321,0.00006302098,0.00037261425,0.0000068021714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021304744,0.000069241585,0.8178421,0.0000403786,0.00005008951,0.0014924316,0.0014543917,0.0000018422398,0.0028684416,0.000004969393,0.000007288679,0.1740383],"study_design_scores_gemma":[0.0031317482,0.0142993815,0.9770774,0.0008981706,0.000035791334,0.000118274635,0.000094008734,0.000065741355,0.0028226015,0.000021290181,0.0012708843,0.00016469162],"about_ca_topic_score_codex":0.010249792,"about_ca_topic_score_gemma":0.048686873,"teacher_disagreement_score":0.17387362,"about_ca_system_score_codex":0.0012735637,"about_ca_system_score_gemma":0.00028834888,"threshold_uncertainty_score":0.99634105},"labels":[],"label_agreement":null},{"id":"W2126038515","doi":"10.1111/j.1365-2893.2004.00520.x","title":"A multicentre study of the usefulness of liver biopsy in hepatitis C","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Royal Victoria Hospital; University of Toronto; Toronto General Hospital; University of Alberta","funders":"National Institutes of Health; F. Hoffmann-La Roche","keywords":"Medicine; Liver biopsy; Biopsy; Internal medicine; Stage (stratigraphy); Gastroenterology; Hepatitis C; Liver disease; Hepatitis; Fibrosis; Prospective cohort study","score_opus":0.03652881888214431,"score_gpt":0.31080989815375715,"score_spread":0.2742810792716128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126038515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818474,0.00024329637,0.00004687164,0.00030834487,0.00028682814,0.0006411989,0.000020969215,0.0000048694496,0.00026285116],"genre_scores_gemma":[0.9984883,0.0006259554,0.0006023315,0.000063392654,0.00010762601,0.0000075566622,9.47752e-7,0.000025826472,0.00007807324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694574,0.00025598521,0.001157622,0.00015781418,0.0011892089,0.00029360497],"domain_scores_gemma":[0.99812514,0.000114532384,0.000629213,0.00037954317,0.000605157,0.0001464103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005329512,0.00016728441,0.00070030504,0.00040295374,0.000044839653,0.00001325865,0.0003476329,0.000104561725,0.00016870315],"category_scores_gemma":[0.00059187354,0.00011574316,0.0002327534,0.00066557666,0.00016163655,0.00022713013,0.00012547424,0.0005524937,0.000008977825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002806309,0.0021211628,0.98148215,0.00014925702,0.00012637826,0.0009578426,0.004402246,0.00017058857,0.002642023,0.000052589636,0.000089364745,0.0075257462],"study_design_scores_gemma":[0.0069331825,0.002447154,0.9792409,0.00095673616,0.00010449928,0.00015911837,0.0004507273,0.00021700226,0.00912786,0.00009604063,0.00015944967,0.000107328546],"about_ca_topic_score_codex":0.029138532,"about_ca_topic_score_gemma":0.014594354,"teacher_disagreement_score":0.014544178,"about_ca_system_score_codex":0.0003137485,"about_ca_system_score_gemma":0.00042856025,"threshold_uncertainty_score":0.9773265},"labels":[],"label_agreement":null},{"id":"W2126206366","doi":"10.1111/j.1365-2893.2011.01445.x","title":"Granulocyte colony‐stimulating factor for hepatitis C therapy‐associated neutropenia: systematic review and economic evaluation","year":2011,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Novartis Pharmaceuticals Canada; Astellas Foundation for Research on Metabolic Disorders; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Neutropenia; Adverse effect; Pegylated interferon; Internal medicine; Ribavirin; Hepatitis C virus; Granulocyte colony-stimulating factor; Hepatitis C; Febrile neutropenia; Gastroenterology; Immunology; Virus; Chemotherapy","score_opus":0.13174327557101573,"score_gpt":0.41769939208295237,"score_spread":0.28595611651193664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126206366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094513537,0.986558,0.000036125697,0.00007142665,0.00041113724,0.011079002,0.0006155454,0.000026041347,0.00025754498],"genre_scores_gemma":[0.0017445517,0.9961396,0.00035942002,0.00022107286,0.00031167045,0.00065044244,0.00014873111,0.00016653787,0.00025797912],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933479,0.0014040732,0.0034058008,0.00046511655,0.00082181627,0.00055532105],"domain_scores_gemma":[0.99329114,0.0008790251,0.003676009,0.0005098447,0.0012486039,0.00039535676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003284651,0.00068491575,0.0070181238,0.0005569433,0.0001823303,0.000112810936,0.00040018355,0.00048958487,0.0006092219],"category_scores_gemma":[0.0025877743,0.0005089433,0.0013374576,0.0002439395,0.00010619298,0.00040051618,0.00008868587,0.0009055007,0.00006565486],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055691427,0.00011810374,0.0020924387,0.63436264,0.0022005234,0.00006754544,0.00010974271,4.7001413e-7,0.0000014095835,0.000021605958,0.0012998233,0.35967],"study_design_scores_gemma":[0.0040254444,0.0048172395,0.0014098509,0.8372747,0.02403654,0.00059396686,0.0000035573034,0.0007151138,0.0000036456154,0.00008475169,0.12614383,0.0008914007],"about_ca_topic_score_codex":0.0007664532,"about_ca_topic_score_gemma":0.0005020441,"teacher_disagreement_score":0.3587786,"about_ca_system_score_codex":0.0017958541,"about_ca_system_score_gemma":0.0016659097,"threshold_uncertainty_score":0.9997362},"labels":[],"label_agreement":null},{"id":"W2131792659","doi":"10.1111/j.1365-2893.2009.01080.x","title":"Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Simon Fraser University; Actua; Centre for Addiction and Mental Health; AIDS Vancouver; University of British Columbia; BC Centre for Disease Control; University of Waterloo","funders":"","keywords":"Inner city; Virology; Hepatitis C virus; Medicine; Internal medicine; Virus; Geography","score_opus":0.06125686948558456,"score_gpt":0.38032338058063586,"score_spread":0.3190665110950513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131792659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779636,0.000076583376,0.0003881709,0.0001269651,0.0001298148,0.0011343784,0.00013600918,0.00001012894,0.00020159499],"genre_scores_gemma":[0.99776125,0.001248118,0.00061103783,0.00014754524,0.00009473363,0.00002695981,0.000024610003,0.00002422259,0.000061524835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967252,0.00055298686,0.0014793096,0.000175669,0.0007191689,0.00034766024],"domain_scores_gemma":[0.99761355,0.00023015456,0.0007189677,0.00049707893,0.0007694528,0.00017079804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015886867,0.00021549089,0.0009764193,0.0008326416,0.000102984115,0.000016730091,0.00017928422,0.00014077169,0.0000958736],"category_scores_gemma":[0.000738394,0.00018552765,0.00028957243,0.0005057457,0.000050672785,0.00026029433,0.000035001685,0.0005164596,0.0000024243313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013066301,0.008568555,0.9608224,0.0001443624,0.00014842996,0.00012504819,0.0012911641,0.00007216394,0.004539281,0.000010240926,0.00022826015,0.022743478],"study_design_scores_gemma":[0.011546549,0.037010763,0.9339165,0.0005928718,0.00012546885,0.000012538576,0.000060509334,0.000693221,0.0154752545,0.00015708871,0.00029298585,0.000116215095],"about_ca_topic_score_codex":0.06263492,"about_ca_topic_score_gemma":0.109375305,"teacher_disagreement_score":0.04674038,"about_ca_system_score_codex":0.0007584547,"about_ca_system_score_gemma":0.00041757245,"threshold_uncertainty_score":0.9436071},"labels":[],"label_agreement":null},{"id":"W2133941144","doi":"10.1111/j.1365-2893.2005.00618.x","title":"SEN virus infection in patients with hepatocellular carcinoma","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hepatocellular carcinoma; HBsAg; Medicine; Hepatitis B virus; Virology; Antibody; Virus; Hepatitis C virus; Internal medicine; Gastroenterology; Immunology","score_opus":0.010563529657196799,"score_gpt":0.20124534880588166,"score_spread":0.19068181914868487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133941144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910265,0.000091906935,0.000008485399,0.00015003156,0.00009056514,0.00009705896,0.000010623469,0.000011212477,0.0004374601],"genre_scores_gemma":[0.999224,0.00020185605,0.00013050289,0.000093760194,0.00030604753,0.000002654177,0.0000034211885,0.0000011544101,0.00003661167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913645,0.000054890646,0.00030906004,0.00009897569,0.00023391168,0.00016670776],"domain_scores_gemma":[0.99951047,0.000036664314,0.00021263231,0.000025423757,0.00016142779,0.000053375297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013029603,0.00010679254,0.00018996012,0.000039227358,0.00011135429,0.000024701478,0.000076164266,0.000052310377,0.00015098331],"category_scores_gemma":[0.000027181502,0.000040649345,0.00007557839,0.00023551451,0.000039439492,0.00034119104,0.000029632785,0.00017167447,0.000026504722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076442404,0.00017596847,0.98015505,0.0000017954507,0.000012211267,0.0000084042795,0.000041692983,0.000018539176,0.0011847618,0.000017140712,0.00019890288,0.018109072],"study_design_scores_gemma":[0.00036126582,0.0014969303,0.9921899,0.000023094288,0.000012666973,0.000009055368,0.00000769491,0.000056017063,0.0009243464,0.000046676643,0.0047703814,0.000101969374],"about_ca_topic_score_codex":0.003870529,"about_ca_topic_score_gemma":0.014123952,"teacher_disagreement_score":0.018007103,"about_ca_system_score_codex":0.00013044894,"about_ca_system_score_gemma":0.000008347594,"threshold_uncertainty_score":0.78814965},"labels":[],"label_agreement":null},{"id":"W2138460161","doi":"10.1111/jvh.12388","title":"Clinical course of chronic hepatitis B (<scp>CHB</scp>) presented with normal <scp>ALT</scp> in Asian American patients","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Bristol-Myers Squibb Canada; Gilead Sciences; Roche; American Association for the Study of Liver Diseases; Novartis; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Gastroenterology; Liver biopsy; Stage (stratigraphy); Hepatitis B virus; Hepatocellular carcinoma; Hepatitis B; Liver disease; Fibrosis; Biopsy; Immunology; Virus","score_opus":0.02096439274670802,"score_gpt":0.3179002201296275,"score_spread":0.29693582738291946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138460161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932602,0.0012005266,0.00024264441,0.00036488048,0.0008044541,0.0006561301,0.00014266996,0.000037856807,0.0032906295],"genre_scores_gemma":[0.99223924,0.003746688,0.0020701755,0.00037045102,0.00088237174,0.00002281542,0.00004005923,0.00009482613,0.0005333687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99403226,0.00053489924,0.0024509802,0.00044312692,0.0016356187,0.00090309454],"domain_scores_gemma":[0.9940222,0.00064713875,0.002200813,0.000519832,0.0017277518,0.00088226853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011419662,0.0005164135,0.0020415878,0.0005279501,0.00009095201,0.000038434107,0.00042433853,0.00022291103,0.000017615284],"category_scores_gemma":[0.0029701162,0.0004132903,0.00041670026,0.00087245007,0.00089298707,0.0005998028,0.00019866269,0.0011956729,0.00004380148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000127354,0.0017400874,0.95242465,0.000120599565,0.000484215,0.0007025781,0.0014374711,0.00003922331,0.00004113539,0.000020132384,0.020534324,0.022328245],"study_design_scores_gemma":[0.0076971697,0.017449053,0.9555124,0.00096823956,0.0003137353,0.00017665703,0.00041649226,0.00058252783,0.0005534081,0.000058525,0.016163867,0.00010790737],"about_ca_topic_score_codex":0.0151284,"about_ca_topic_score_gemma":0.039012436,"teacher_disagreement_score":0.023884036,"about_ca_system_score_codex":0.0006764858,"about_ca_system_score_gemma":0.0013989588,"threshold_uncertainty_score":0.9998319},"labels":[],"label_agreement":null},{"id":"W2141766413","doi":"10.1111/jvh.12346","title":"Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase <scp>II</scp>b and <scp>III</scp> studies","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Salix Pharmaceuticals; Bristol-Myers Squibb Canada; Genentech; Vertex Pharmaceuticals; Janssen Biotech; Roche; GlaxoSmithKline; Novartis; Pfizer; AbbVie; Sanofi; Human Genome Sciences","keywords":"Simeprevir; Tolerability; Medicine; Internal medicine; Gastroenterology; Ribavirin; Rash; Placebo; Neutropenia; Adverse effect; Virology; Hepatitis C virus; Virus; Toxicity; Pathology","score_opus":0.028980802424859373,"score_gpt":0.3425990692856471,"score_spread":0.3136182668607877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141766413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814363,0.009013955,0.007365161,0.0001856774,0.00025319136,0.0009259805,0.0004508752,0.00003811396,0.00033075843],"genre_scores_gemma":[0.93948036,0.056319773,0.0020131404,0.00011163971,0.00092154084,0.000072327646,0.00012597535,0.00007582064,0.00087939034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960613,0.00036255262,0.0014658291,0.000549839,0.0009080928,0.0006523776],"domain_scores_gemma":[0.9950852,0.0016044473,0.0010808632,0.0005662983,0.0011689124,0.0004942893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070148805,0.000547328,0.0023222205,0.0008487766,0.00033198483,0.000067610825,0.00020629045,0.00022016269,0.00006121723],"category_scores_gemma":[0.0011063229,0.00041492042,0.000674931,0.00075409596,0.00040318543,0.0004422301,0.00011777462,0.0003305734,0.000013111432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010553001,0.002739502,0.77287513,0.0004918652,0.020631492,0.00031984586,0.0039347843,0.0004040863,0.014381294,0.000121371944,0.0027185814,0.18032673],"study_design_scores_gemma":[0.04568158,0.11750128,0.50444216,0.0016623283,0.019052563,0.00024094012,0.0003508275,0.018603943,0.11971432,0.00047011935,0.17185989,0.00042006615],"about_ca_topic_score_codex":0.01122795,"about_ca_topic_score_gemma":0.026921231,"teacher_disagreement_score":0.268433,"about_ca_system_score_codex":0.0011153701,"about_ca_system_score_gemma":0.00042480195,"threshold_uncertainty_score":0.99983025},"labels":[],"label_agreement":null},{"id":"W2143057229","doi":"10.1111/jvh.12393","title":"Visits to primary care physicians among persons who inject drugs at high risk of hepatitis <scp>C</scp> virus infection: room for improvement","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Police Service; Université de Sherbrooke; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Université de Sherbrooke","keywords":"Medicine; Logistic regression; Odds ratio; Hepatitis C; Cohort; Family medicine; Internal medicine","score_opus":0.014953127130666878,"score_gpt":0.28686619712652006,"score_spread":0.2719130699958532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143057229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925574,0.00063054817,0.0015327107,0.00018472226,0.0007551298,0.001339697,0.0008865701,0.00003877697,0.0020744388],"genre_scores_gemma":[0.9921307,0.0024084882,0.0020725036,0.00051154743,0.0011366896,0.000092245165,0.00008297119,0.00010195241,0.0014629179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590397,0.00023073274,0.0011285784,0.00039565444,0.0016560676,0.00068498345],"domain_scores_gemma":[0.99549073,0.0003469178,0.00094060565,0.0004638208,0.0020216333,0.0007362784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078109995,0.00038293775,0.0011687749,0.0006178779,0.00022222164,0.00006353065,0.00028485074,0.00022359073,0.0000418279],"category_scores_gemma":[0.0010397128,0.00035547945,0.0005846385,0.0005467753,0.0001185434,0.00052754505,0.00023113826,0.0006339547,0.0000406194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028706342,0.00029071898,0.86658585,0.00046339678,0.00048769926,0.00012153068,0.00940512,0.00016616324,0.004410063,0.000012438138,0.03589109,0.081878886],"study_design_scores_gemma":[0.0067303414,0.019242182,0.8931018,0.0013623284,0.00059172953,0.000052586598,0.00087715435,0.0005994175,0.048795518,0.00014294367,0.028211944,0.00029203555],"about_ca_topic_score_codex":0.032396704,"about_ca_topic_score_gemma":0.015010664,"teacher_disagreement_score":0.08158685,"about_ca_system_score_codex":0.0021460762,"about_ca_system_score_gemma":0.00070648507,"threshold_uncertainty_score":0.99988973},"labels":[],"label_agreement":null},{"id":"W2143641481","doi":"10.1111/j.1365-2893.2005.00636.x","title":"Silymarin treatment of viral hepatitis: a systematic review","year":2005,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Milk Thistle; Silybum marianum; Medicine; Viral hepatitis; Viral load; Internal medicine; Hepatitis; Hepatitis B; Gastroenterology; Hepatitis C; Liver disease; Immunology; Virology; Pharmacology; Traditional medicine; Virus","score_opus":0.1469577002209933,"score_gpt":0.46104103941205554,"score_spread":0.31408333919106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143641481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033232738,0.99266475,0.0000380322,0.000105560146,0.002106324,0.0033683332,0.00031134894,0.000036780548,0.0010365221],"genre_scores_gemma":[0.00068460946,0.9959892,0.00023027926,0.00043946397,0.0011940649,0.00032536997,0.000052732437,0.00008643916,0.0009978125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913027,0.0030746027,0.0040836004,0.00038129094,0.0005934918,0.0005643125],"domain_scores_gemma":[0.99288034,0.0007029858,0.005192528,0.00047709947,0.0003798923,0.00036716796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017607153,0.0008654666,0.006286819,0.00055256934,0.00020046189,0.000036330384,0.000653498,0.0010961874,0.0008096851],"category_scores_gemma":[0.0003256925,0.0006510558,0.0023894056,0.00045220772,0.00015925089,0.00035409708,0.00007768272,0.0015597304,0.00025200643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039924304,0.00068983575,0.00010347169,0.4429795,0.0016101659,0.0002577154,0.00013766297,0.0000040080627,0.0000074066993,0.00009449207,0.0008234829,0.55325234],"study_design_scores_gemma":[0.00086766883,0.00172064,0.000011289349,0.26737356,0.011948627,0.001190462,0.000005170206,0.00003960353,0.00009909989,0.00008503436,0.71613914,0.0005197108],"about_ca_topic_score_codex":0.00040834828,"about_ca_topic_score_gemma":0.00022186532,"teacher_disagreement_score":0.71531564,"about_ca_system_score_codex":0.0012266088,"about_ca_system_score_gemma":0.0006987826,"threshold_uncertainty_score":0.9995941},"labels":[],"label_agreement":null},{"id":"W2144076650","doi":"10.1111/jvh.12384","title":"Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC<sup>3</sup> study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; Department of Health and Ageing, Australian Government; National Institute of Diabetes and Digestive and Kidney Diseases; Australian Government","keywords":"Medicine; Hepatitis C virus; Odds ratio; Genotype; Chronic hepatitis; Internal medicine; Immunology; Chronic infection; Virus; Population; Interferon; Logistic regression; Gastroenterology; Virology; Immune system; Biology; Gene","score_opus":0.09150540897415632,"score_gpt":0.3413177435910063,"score_spread":0.24981233461684998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144076650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735117,0.00031872146,0.00007397664,0.0004148339,0.0002522124,0.0008923274,0.000055325876,0.000073123556,0.00056828937],"genre_scores_gemma":[0.9985099,0.00043636988,0.00003463185,0.00014591907,0.00048224916,0.000029731145,0.000009230149,0.00010782937,0.00024416065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511755,0.000831522,0.0010979637,0.00029244437,0.0020158102,0.00064473704],"domain_scores_gemma":[0.997125,0.0003271359,0.0005618367,0.00042066182,0.0010692937,0.000496026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018040611,0.00036743467,0.00090841565,0.0005849341,0.0001740788,0.00013555553,0.00034501392,0.00020062504,0.00015686933],"category_scores_gemma":[0.001380448,0.00022915109,0.00018857671,0.0010431019,0.0002148561,0.0007396945,0.00012489727,0.0015287545,0.00006330395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016211497,0.0007384845,0.9861337,0.00001708895,0.00040548726,0.0010394106,0.004300743,0.0002697152,0.00007023449,0.0000096349795,0.0012856863,0.0055676806],"study_design_scores_gemma":[0.0054602013,0.011306243,0.97920233,0.000366546,0.00015162792,0.000054700038,0.00022289707,0.0010158827,0.00045552338,0.00007322373,0.001443536,0.0002472608],"about_ca_topic_score_codex":0.04048443,"about_ca_topic_score_gemma":0.06204667,"teacher_disagreement_score":0.021562241,"about_ca_system_score_codex":0.0021952027,"about_ca_system_score_gemma":0.001450525,"threshold_uncertainty_score":0.9659051},"labels":[],"label_agreement":null},{"id":"W2144935009","doi":"10.1046/j.1365-2893.2001.00288.x","title":"Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Fibrosis; Cirrhosis; Liver biopsy; Internal medicine; Gastroenterology; Liver fibrosis; Chronic hepatitis; Biopsy; Predictive value; Hepatitis C; Alcohol consumption; Hepatic fibrosis; Alcohol; Immunology; Biology; Virus","score_opus":0.010407406627937453,"score_gpt":0.2480797741382426,"score_spread":0.23767236751030513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144935009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596626,0.0016076369,0.000013477406,0.00076251774,0.00028627127,0.00037702042,0.000079429694,0.000009794862,0.00089761714],"genre_scores_gemma":[0.9945533,0.0038446942,0.00041700943,0.00015024829,0.00037016638,0.0000092588225,0.000015545456,0.00004561296,0.00059413724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970015,0.00013754734,0.0008184981,0.00022132287,0.0011765533,0.0006445586],"domain_scores_gemma":[0.99769944,0.000083156425,0.00047251646,0.00025058148,0.00072562584,0.0007686624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029662484,0.00023411302,0.00076920755,0.0009878544,0.00006924929,0.000022340937,0.00023910773,0.00020246499,0.00045383436],"category_scores_gemma":[0.0003939269,0.00018826587,0.0001890998,0.00061454665,0.00011404277,0.00035147212,0.000037807,0.00069268205,0.0000133792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039682505,0.00025370537,0.9769209,0.00011546682,0.00010220301,0.0015660265,0.00017422342,0.000014447873,0.00009095531,0.000008016701,0.010448783,0.009908434],"study_design_scores_gemma":[0.002470296,0.003717253,0.9590028,0.00086163054,0.000072075825,0.00009757441,0.000004942794,0.00007721809,0.00027455777,0.000008992672,0.033246674,0.00016597979],"about_ca_topic_score_codex":0.6972773,"about_ca_topic_score_gemma":0.8557956,"teacher_disagreement_score":0.15851834,"about_ca_system_score_codex":0.0052419626,"about_ca_system_score_gemma":0.0014353278,"threshold_uncertainty_score":0.99857676},"labels":[],"label_agreement":null},{"id":"W2146563024","doi":"10.1111/j.1365-2893.2010.01319.x","title":"Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Alanine aminotransferase; Alanine transaminase; Viral load; Immunology; Hepatitis C virus; Virus","score_opus":0.017143314785509883,"score_gpt":0.2920755157901849,"score_spread":0.274932201004675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146563024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758774,0.000029893788,0.000030249545,0.0005576238,0.00015513499,0.0013865104,0.00012224399,0.000020873666,0.00010974035],"genre_scores_gemma":[0.9989048,0.00003467086,0.0005729612,0.000166731,0.000098150675,0.000024063624,0.000011209958,0.000046965357,0.00014039567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994779,0.001534713,0.0012662159,0.00031706668,0.0015316119,0.0005714147],"domain_scores_gemma":[0.99664634,0.0007823742,0.00038303912,0.000405964,0.0013038538,0.0004784339],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025099106,0.00031734622,0.0008895713,0.000900584,0.0000760394,0.00003408607,0.00029487084,0.00022075039,0.0009156192],"category_scores_gemma":[0.004387339,0.00022847965,0.00023305208,0.0005269147,0.00027928603,0.0003866363,0.0000849015,0.0013791688,0.000014858869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18557483,0.003963325,0.78477776,0.000046114306,0.00020334848,0.0029536413,0.0020879293,0.0000038031787,0.01838223,0.0000018447192,0.00005498876,0.0019501591],"study_design_scores_gemma":[0.026760628,0.047978226,0.92240524,0.00018906532,0.00015125197,0.000064725726,0.0003417111,0.00027585318,0.0012847418,0.0000026176979,0.00035574182,0.00019020781],"about_ca_topic_score_codex":0.0004842304,"about_ca_topic_score_gemma":0.00078446884,"teacher_disagreement_score":0.1588142,"about_ca_system_score_codex":0.0002653745,"about_ca_system_score_gemma":0.000736775,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W2149727205","doi":"10.1046/j.1365-2893.2001.00286.x","title":"Pilot study of interferon‐α and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"Fondation pour la Recherche Médicale; University of Calgary","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Transaminase; Concomitant; Alanine transaminase; Interferon; Chronic hepatitis; Elevated transaminases; Hepatitis C; Alpha interferon; Immunology; Virus; Biology; Enzyme","score_opus":0.022120838383474527,"score_gpt":0.29604399577565016,"score_spread":0.27392315739217565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149727205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981952,0.00066805794,0.0000330995,0.00007967551,0.00006053237,0.0007518426,0.00002309728,0.0000062745116,0.00018225405],"genre_scores_gemma":[0.9947944,0.0047527356,0.00019691163,0.00002317407,0.00007567932,0.000015686608,0.000005469813,0.000028717039,0.00010721337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979559,0.00018957742,0.00072269223,0.00021213939,0.0006119036,0.000307792],"domain_scores_gemma":[0.9990166,0.00008711906,0.00023543293,0.00018284879,0.00024072199,0.00023731151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002689258,0.00022333986,0.0006833491,0.00042910507,0.00005181449,0.000025334033,0.000087350665,0.000040202543,0.00009051834],"category_scores_gemma":[0.000049968774,0.00016389202,0.000046707588,0.00022040085,0.00015774273,0.00034356196,0.000036762074,0.00028753091,0.0000019657443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028779588,0.0031584746,0.9120319,0.00006952818,0.00016375148,0.00065228506,0.0010077493,0.0000072940356,0.0001969418,0.0000026275716,0.00001928801,0.079812236],"study_design_scores_gemma":[0.013758507,0.14638597,0.8385269,0.00037266576,0.000118797325,0.00007539273,0.00006498682,0.00016771501,0.00029038178,0.000009889442,0.000109449735,0.000119363234],"about_ca_topic_score_codex":0.014382071,"about_ca_topic_score_gemma":0.036390353,"teacher_disagreement_score":0.1432275,"about_ca_system_score_codex":0.000401792,"about_ca_system_score_gemma":0.00017252592,"threshold_uncertainty_score":0.99218124},"labels":[],"label_agreement":null},{"id":"W2151615087","doi":"10.1046/j.1365-2893.2000.00205.x","title":"Statistical models for predicting response to interferon‐α and spontaneous seroconversion in children with chronic hepatitis B","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Seroconversion; Medicine; Interferon; Chronic hepatitis; Immunology; Virology; Human immunodeficiency virus (HIV); Virus","score_opus":0.010020810156779256,"score_gpt":0.26147077712953415,"score_spread":0.2514499669727549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151615087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455667,0.00037861182,0.0033086003,0.00068100303,0.00006237509,0.00077145227,0.00013163162,0.000018796756,0.00009083995],"genre_scores_gemma":[0.98892456,0.0014735633,0.008759755,0.00034419732,0.00020177125,0.000025614207,0.000009016988,0.00003898599,0.00022252859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982591,0.00011841917,0.00062664563,0.00024738902,0.00037694065,0.00037147186],"domain_scores_gemma":[0.9990109,0.00025451925,0.0001480365,0.00014200463,0.00017721253,0.00026729805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004656577,0.00021498384,0.0005886509,0.00026228558,0.00009670355,0.000030547828,0.000094835654,0.00008624051,0.00016588824],"category_scores_gemma":[0.00019246232,0.00017689416,0.000066473935,0.0001444115,0.00009017124,0.0002784691,0.000039990766,0.0003031532,0.0000096398235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012132181,0.0001219924,0.9386782,0.00007237657,0.00017662358,0.0014690713,0.0010275033,0.00042605738,0.00039956588,0.000031206077,0.0006889582,0.044776246],"study_design_scores_gemma":[0.004707924,0.017911585,0.95966864,0.0011262889,0.0001727719,0.0071635186,0.000022050352,0.0077861017,0.00030013008,0.00021515865,0.000679554,0.00024628488],"about_ca_topic_score_codex":0.004343918,"about_ca_topic_score_gemma":0.010953587,"teacher_disagreement_score":0.044529963,"about_ca_system_score_codex":0.00053245923,"about_ca_system_score_gemma":0.00022137209,"threshold_uncertainty_score":0.7213535},"labels":[],"label_agreement":null},{"id":"W2152583616","doi":"10.1111/j.1365-2893.2011.01505.x","title":"Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Virology; Replication (statistics); Viral replication; Hepatitis C virus; RNA; Thalidomide; Hepatitis B virus; Biology; Medicine; Virus; Genetics; Immunology; Gene","score_opus":0.03780795160599469,"score_gpt":0.3125469292247264,"score_spread":0.2747389776187317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152583616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344826,0.00088997005,0.0007146122,0.00022028315,0.00014959418,0.00037938138,0.00021721714,0.0000573572,0.0039233034],"genre_scores_gemma":[0.987364,0.008671046,0.0030531553,0.00033649997,0.00025494857,0.000019644362,0.00004868668,0.00008029214,0.0001717625],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967214,0.0002720368,0.0013238558,0.0002903683,0.0010317109,0.00036062812],"domain_scores_gemma":[0.9969659,0.0001313723,0.00095887325,0.00059040455,0.0009556393,0.00039783822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093112374,0.00023331078,0.00070775585,0.00044995488,0.000083968356,0.000023528395,0.00020577692,0.00018556224,0.00062018295],"category_scores_gemma":[0.0012061065,0.00020983936,0.0003106269,0.00037663814,0.00022020821,0.0005889805,0.00007735731,0.00048092654,0.000076063785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011474267,0.0013078799,0.6439889,0.00021725753,0.00022558434,0.00083645206,0.00060653186,7.752337e-7,0.26108092,0.0003092104,0.02595307,0.06432599],"study_design_scores_gemma":[0.0029020354,0.0037544065,0.24943371,0.00079170783,0.00021403057,0.00033208588,0.000038412378,0.00014854806,0.73636913,0.0011622544,0.0045768274,0.0002768718],"about_ca_topic_score_codex":0.035447553,"about_ca_topic_score_gemma":0.001272585,"teacher_disagreement_score":0.47528818,"about_ca_system_score_codex":0.00029185237,"about_ca_system_score_gemma":0.0003043373,"threshold_uncertainty_score":0.97097546},"labels":[],"label_agreement":null},{"id":"W2159537180","doi":"10.1111/jvh.12432","title":"Disease burden of chronic hepatitis C among immigrants in Canada","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Toronto Public Health","funders":"Canadian Institutes of Health Research; University of Toronto; Canadian Liver Foundation","keywords":"Medicine; Cirrhosis; Disease burden; Quality-adjusted life year; Hepatitis C; Liver disease; Cohort; Epidemiology; Chronic liver disease; Pegylated interferon; Hepatocellular carcinoma; Ribavirin; Demography; Internal medicine; Disease; Cost effectiveness; Chronic hepatitis; Immunology","score_opus":0.02099045651050379,"score_gpt":0.2891378608831087,"score_spread":0.2681474043726049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159537180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955521,0.0020122293,0.000038387414,0.00077903806,0.00038571953,0.00028067754,0.000081706436,0.0000056445306,0.0008644525],"genre_scores_gemma":[0.9965946,0.00234109,0.00019658555,0.000100961275,0.00043417976,0.0000075441803,0.000010924015,0.000033725115,0.00028040682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658525,0.00017815008,0.0010614356,0.00017439669,0.0015469595,0.0004538074],"domain_scores_gemma":[0.9975797,0.00008782066,0.00043348182,0.00030282052,0.0006560994,0.0009400999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053925137,0.00018820635,0.000715701,0.00038722827,0.000026266636,0.000015817901,0.00026979073,0.00007172902,0.00026861698],"category_scores_gemma":[0.0007766159,0.00016730998,0.00016004499,0.00039867006,0.00012445064,0.00033243978,0.000074214906,0.00052491686,0.000014734758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002738852,0.0000968133,0.967445,0.00013606605,0.00006770117,0.0039811023,0.0002500729,0.00020864447,0.00022435312,0.000012930231,0.0059918193,0.021311622],"study_design_scores_gemma":[0.0030106667,0.0010754671,0.9847031,0.0009582308,0.00006711258,0.000061361876,0.00008340698,0.0054572523,0.00076658634,0.00012648331,0.003517978,0.00017234444],"about_ca_topic_score_codex":0.986129,"about_ca_topic_score_gemma":0.9804359,"teacher_disagreement_score":0.021139279,"about_ca_system_score_codex":0.0028515377,"about_ca_system_score_gemma":0.009834055,"threshold_uncertainty_score":0.9957793},"labels":[],"label_agreement":null},{"id":"W2160138172","doi":"10.1111/j.1365-2893.2008.01045.x","title":"Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control","funders":"British Columbia Centre for Disease Control; Public Health Agency of Canada","keywords":"Genotype; Hepatitis B virus; Transmission (telecommunications); Virology; Medicine; Biology; Demography; Virus; Gene; Genetics","score_opus":0.010313060521055203,"score_gpt":0.24082968831966475,"score_spread":0.23051662779860954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160138172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754673,0.00041973175,0.00021415355,0.00013965963,0.0006347193,0.00039707002,0.00003449897,0.00005564738,0.00055778364],"genre_scores_gemma":[0.9609739,0.03569411,0.0012819225,0.00035489385,0.0004011307,0.000021733686,0.0000141622095,0.000058437738,0.0011997155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975187,0.0001369408,0.00090784905,0.00027518734,0.0007370097,0.00042431115],"domain_scores_gemma":[0.99837255,0.00005778634,0.00055389124,0.00019954864,0.00059323007,0.0002229763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029210662,0.00021271656,0.0007884681,0.00030120654,0.0002995957,0.00010195776,0.00010277817,0.0001463495,0.00024578575],"category_scores_gemma":[0.0001571478,0.00027058172,0.00019939711,0.0006300128,0.00024098437,0.0007582387,0.00004884951,0.0006899126,0.000034644643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019107215,0.00026978663,0.97508425,0.000038493992,0.0002892534,0.006412752,0.0006522691,0.00003465294,0.00040864001,0.0000013428988,0.0120685175,0.0045489813],"study_design_scores_gemma":[0.0023771205,0.0025667318,0.98175675,0.0005505607,0.00021035786,0.009937911,0.00001594626,0.0000882804,0.00041284217,0.000058007394,0.0017564357,0.00026906817],"about_ca_topic_score_codex":0.80045193,"about_ca_topic_score_gemma":0.9704604,"teacher_disagreement_score":0.1700085,"about_ca_system_score_codex":0.00070420426,"about_ca_system_score_gemma":0.00035722813,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W2166935665","doi":"10.1111/jvh.12468","title":"Peginterferon add‐on results in more HBsAg decline compared to monotherapy in HBeAg‐positive chronic hepatitis B patients","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Foundation for Liver Research; Novartis; F. Hoffmann-La Roche; Abbott Fund; Roche; Merck; Gilead Sciences; Medtronic; Boehringer Ingelheim","keywords":"HBsAg; Medicine; Entecavir; Gastroenterology; PEG ratio; HBeAg; Combination therapy; Internal medicine; Discontinuation; Lamivudine; Hepatitis B virus; Peginterferon alfa-2a; Hepatitis B; Chronic hepatitis; Immunology; Virus","score_opus":0.03004416677783156,"score_gpt":0.32291296686259346,"score_spread":0.2928688000847619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166935665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284565,0.0005396916,0.000086055545,0.0035114454,0.00066016754,0.00074995303,0.00019699277,0.00002160829,0.0013884366],"genre_scores_gemma":[0.9946963,0.0012887757,0.0010659925,0.0021897855,0.00046044492,0.000028393108,0.000050302373,0.000057091194,0.00016289146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962223,0.00023774,0.0016315466,0.0003751988,0.0009723661,0.00056082103],"domain_scores_gemma":[0.9977761,0.00018379286,0.00055062474,0.0003251378,0.00070681435,0.0004575682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000705445,0.00037618147,0.0011350036,0.00085575535,0.000049515023,0.000037270518,0.0002653099,0.00015155766,0.000040051957],"category_scores_gemma":[0.0008694658,0.00033332448,0.00018566665,0.0005372066,0.000098486154,0.0003224938,0.000122034966,0.0006626252,0.000084138555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062500346,0.0008455926,0.9512417,0.00003140596,0.00009918265,0.00064203696,0.0041044424,0.0004584165,0.00015978204,0.000014385327,0.019255485,0.016897546],"study_design_scores_gemma":[0.01595018,0.011106276,0.9636873,0.0020635417,0.00003770978,0.000038452137,0.000067691886,0.0009042593,0.0013168728,0.00010444562,0.0044122282,0.0003110638],"about_ca_topic_score_codex":0.019558035,"about_ca_topic_score_gemma":0.09728323,"teacher_disagreement_score":0.077725194,"about_ca_system_score_codex":0.0024855314,"about_ca_system_score_gemma":0.0003760305,"threshold_uncertainty_score":0.9999119},"labels":[],"label_agreement":null},{"id":"W2168450731","doi":"10.1111/j.1365-2893.2010.01248.x","title":"Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Toronto Western Hospital; University Health Network","funders":"National Medical Research Council; National Health and Medical Research Council; University Health Network","keywords":"Ribavirin; Medicine; Body mass index; Internal medicine; Gastroenterology; Viral load; Pegylated interferon; Dosing; Chronic hepatitis; Immunology; Virus","score_opus":0.010605427978216711,"score_gpt":0.28787421311950767,"score_spread":0.27726878514129094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168450731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967367,0.00023859109,0.00026806904,0.0018760918,0.0001418329,0.00060712855,0.000027061027,0.000018848013,0.00008569942],"genre_scores_gemma":[0.99710107,0.001204691,0.0011402605,0.0002696636,0.00016034995,0.0000155707,0.000004759567,0.000046145313,0.000057474972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961601,0.0008142655,0.0012146176,0.00034607094,0.0008863469,0.00057858514],"domain_scores_gemma":[0.99737656,0.0008797093,0.00055610784,0.00040195297,0.00044868243,0.0003369584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015511679,0.00035264998,0.0008926613,0.00068174425,0.000117910815,0.00009734865,0.00032504066,0.00035867855,0.00010152432],"category_scores_gemma":[0.0012733099,0.00024567646,0.00014746498,0.00039978782,0.00075130747,0.0003342178,0.00014295951,0.0019813422,0.0000044363937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02958151,0.00023999097,0.59041786,0.00013456521,0.00011601287,0.0016716232,0.00037639504,0.0011508381,0.37101257,0.00010227794,0.000055777542,0.0051406003],"study_design_scores_gemma":[0.0101309875,0.013480482,0.9300574,0.00060456403,0.000080909755,0.00012732545,0.000013774001,0.029638676,0.015096451,0.00020428012,0.0003172997,0.00024783314],"about_ca_topic_score_codex":0.002127634,"about_ca_topic_score_gemma":0.0008267452,"teacher_disagreement_score":0.3559161,"about_ca_system_score_codex":0.0005379692,"about_ca_system_score_gemma":0.000604465,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W2181253693","doi":"10.1111/jvh.12485","title":"Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis <scp>C</scp> virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirin","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Gilead Sciences; Roche; Boehringer Ingelheim","keywords":"Ribavirin; Virology; Hepatitis C virus; Medicine; Genotype; Placebo; Open label; Hepatitis C; Internal medicine; Virus; Gastroenterology; Clinical trial; Biology; Gene; Pathology","score_opus":0.05525933149872614,"score_gpt":0.3410306568169238,"score_spread":0.28577132531819766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181253693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411666,0.0011922254,0.00009034034,0.00014040455,0.00038519088,0.0025352484,0.00009955506,0.000037469523,0.0014028916],"genre_scores_gemma":[0.9948946,0.0033425346,0.00051473593,0.00014253617,0.0001722225,0.00006239466,0.000028265049,0.0001378501,0.00070486456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940258,0.0009687012,0.001997803,0.00069003896,0.0015051608,0.00081249804],"domain_scores_gemma":[0.99578565,0.00048171377,0.0010128885,0.00060703256,0.0011934652,0.000919266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016449352,0.00061190483,0.0020675375,0.0010081702,0.00010859041,0.00025129304,0.00070660055,0.00031337875,0.000051052626],"category_scores_gemma":[0.0021721062,0.00055196456,0.0001240949,0.00060179277,0.00030102252,0.0012499678,0.0010474983,0.0012837212,0.000028413791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024440484,0.0022037227,0.96557033,0.00023535213,0.00032185658,0.00068362406,0.006626837,0.000031622858,0.0008087886,0.00001934019,0.004518692,0.016535768],"study_design_scores_gemma":[0.055860113,0.027831212,0.90499806,0.001381931,0.0002777606,0.00012971753,0.0008930923,0.003913073,0.001075313,0.00009451385,0.0032054775,0.0003397102],"about_ca_topic_score_codex":0.020225512,"about_ca_topic_score_gemma":0.022603102,"teacher_disagreement_score":0.06057226,"about_ca_system_score_codex":0.0012104985,"about_ca_system_score_gemma":0.0007568474,"threshold_uncertainty_score":0.9996932},"labels":[],"label_agreement":null},{"id":"W2192613407","doi":"10.1111/jvh.12492","title":"Epidemiological characteristics of the carriers with coexistence of <scp>HB</scp>sAg and anti‐<scp>HB</scp>s based on a community cohort study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Centers for Disease Control and Prevention; National Natural Science Foundation of China","keywords":"Serology; HBsAg; Epidemiology; Medicine; Cohort; Virology; Hepatitis B virus; Internal medicine; Immunology; Virus; Antibody","score_opus":0.04793896082211583,"score_gpt":0.30385966656315694,"score_spread":0.2559207057410411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192613407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969141,0.00025647396,0.00010231067,0.00020344304,0.0002718391,0.00076389144,0.00015243985,0.000015639818,0.0013198886],"genre_scores_gemma":[0.9978797,0.00046869557,0.0008002013,0.0005878669,0.00011898072,0.000013352867,0.0000069836738,0.000030308676,0.00009393584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956242,0.0013973824,0.00131069,0.00021530036,0.00107402,0.000378423],"domain_scores_gemma":[0.9942081,0.0021470624,0.0015874865,0.00060285424,0.0010935514,0.00036097088],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029945634,0.0003436987,0.0017670285,0.00016708836,0.00021561595,0.000018666524,0.00038221944,0.0001575482,0.00000546951],"category_scores_gemma":[0.010990035,0.00020300831,0.0002108729,0.0003100986,0.0008583174,0.0001372383,0.00018012681,0.0011388571,0.000002653544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111094705,0.0008096543,0.992848,0.00012778034,0.00033255844,0.00017028996,0.00258257,0.000022001443,0.00030133626,0.000022119735,0.0022574302,0.00041519664],"study_design_scores_gemma":[0.0024176862,0.0085885,0.9841799,0.0007589093,0.00050161267,0.00014592819,0.0015601048,0.0003916976,0.00073952926,0.000053656033,0.000602938,0.00005952003],"about_ca_topic_score_codex":0.003698876,"about_ca_topic_score_gemma":0.0010825692,"teacher_disagreement_score":0.008668049,"about_ca_system_score_codex":0.0001841098,"about_ca_system_score_gemma":0.00036391267,"threshold_uncertainty_score":0.9973408},"labels":[],"label_agreement":null},{"id":"W2205764163","doi":"10.1111/jvh.12494","title":"Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Toronto Liver Centre; University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; University of Illinois at Chicago; University of Arkansas; Boehringer Ingelheim; Gilead Sciences; University of Arkansas for Medical Sciences; Merck; AbbVie; Bristol-Myers Squibb","keywords":"Telaprevir; Ribavirin; Boceprevir; Interferon; Hepatitis C virus; Staining; Medicine; Biomarker; Internal medicine; Hepatitis C; Alpha interferon; Immunology; Virology; Biology; Pathology; Virus","score_opus":0.022002266286612907,"score_gpt":0.29283231500097673,"score_spread":0.27083004871436384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205764163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961844,0.00038360554,0.00013761477,0.001421075,0.00036907813,0.0009648085,0.0000245377,0.000017285718,0.0004975812],"genre_scores_gemma":[0.99812037,0.00021373558,0.0004919946,0.00033486672,0.00051811535,0.000033621676,0.000011856342,0.00005453806,0.00022090731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622583,0.00054178096,0.000915392,0.00023349327,0.0015554162,0.00052810187],"domain_scores_gemma":[0.99765843,0.00014304783,0.00041856518,0.00040630723,0.00087368,0.0004999541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013379398,0.0002649199,0.00057843165,0.000391772,0.000073081836,0.00007576465,0.00031295494,0.00012792963,0.00019253544],"category_scores_gemma":[0.0009724844,0.0001656272,0.00014343347,0.00049049396,0.00021437791,0.0005464059,0.00011965971,0.0009439907,0.00009595275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004937567,0.00045979203,0.9689916,0.00005094491,0.000087310946,0.0005746264,0.0005737305,0.00006177213,0.00013580883,0.000019310946,0.0029198723,0.021187682],"study_design_scores_gemma":[0.008150161,0.013870309,0.96634537,0.00079926144,0.000070547656,0.000046619058,0.000022592505,0.00045558796,0.0007875149,0.000088833964,0.009131527,0.00023168627],"about_ca_topic_score_codex":0.004034579,"about_ca_topic_score_gemma":0.006809514,"teacher_disagreement_score":0.020955997,"about_ca_system_score_codex":0.0013049634,"about_ca_system_score_gemma":0.0015918997,"threshold_uncertainty_score":0.6754081},"labels":[],"label_agreement":null},{"id":"W2289412129","doi":"10.1111/jvh.12525","title":"<i><scp>HLA</scp>‐C</i> and <i><scp>KIR</scp></i> combined genotype as new response marker for <scp>HB</scp>eAg‐positive chronic hepatitis B patients treated with interferon‐based combination therapy","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cilag; F. Hoffmann-La Roche; Alnylam Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb","keywords":"Genotype; Medicine; Immunology; Human leukocyte antigen; SNP; Internal medicine; Gastroenterology; Single-nucleotide polymorphism; Antigen; Biology; Gene; Genetics","score_opus":0.006820369655337944,"score_gpt":0.21896902490829837,"score_spread":0.21214865525296042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289412129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108005,0.0018253053,0.002513755,0.00039227883,0.0023177536,0.0009034898,0.000088297114,0.00007277339,0.0008063276],"genre_scores_gemma":[0.96694666,0.0028128736,0.00015680048,0.001427397,0.00013761774,0.000048852133,0.00024993677,0.00009679681,0.028123075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676985,0.000857295,0.0010153002,0.00047349624,0.000219972,0.00066410884],"domain_scores_gemma":[0.99467206,0.00255635,0.0012508237,0.00032823355,0.0010131308,0.00017942266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006081585,0.00054338656,0.00076383125,0.00048049356,0.00040696142,0.00011013246,0.00030608603,0.0004595424,0.00016817101],"category_scores_gemma":[0.0013023674,0.00039241737,0.00030960893,0.00027158298,0.00029136945,0.0008807772,0.00006331993,0.0005364848,0.00017661504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009490291,0.0016783973,0.23217933,0.000068456524,0.0017313297,0.000056849178,0.0013887279,0.000009548195,0.42008165,0.00020995185,0.30615523,0.02695024],"study_design_scores_gemma":[0.030776884,0.043032665,0.29395628,0.0007551813,0.00027405017,0.00021672569,0.00013991671,0.00006940983,0.37625274,0.000211805,0.25414208,0.00017226905],"about_ca_topic_score_codex":0.000812385,"about_ca_topic_score_gemma":0.00017396308,"teacher_disagreement_score":0.061776947,"about_ca_system_score_codex":0.000542142,"about_ca_system_score_gemma":0.00047864567,"threshold_uncertainty_score":0.9998528},"labels":[],"label_agreement":null},{"id":"W2508631962","doi":"10.1111/jvh.12579","title":"Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Entecavir; Internal medicine; HBsAg; Gastroenterology; Lamivudine; Viral load; HBeAg; Viral hepatitis; Hepatitis B; Clinical significance; Hepatitis B virus; Creatinine; Proportional hazards model; Immunology; Virus","score_opus":0.014152145221737649,"score_gpt":0.2608634613009652,"score_spread":0.24671131607922756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508631962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976058,0.0008334452,0.00033203134,0.00014020107,0.00012182672,0.0006090174,0.0002695907,0.000024724082,0.00006335652],"genre_scores_gemma":[0.9793904,0.019334326,0.0008064881,0.000058680984,0.00019791469,0.000023358305,0.000008420895,0.00004516056,0.00013526577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978595,0.0001214971,0.000815614,0.0002925612,0.00045655016,0.00045428963],"domain_scores_gemma":[0.99817234,0.00033955064,0.0006636554,0.00018633435,0.00043241083,0.00020571849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027384592,0.00030406847,0.00073908817,0.00037908103,0.00013529335,0.00003061378,0.00012451778,0.00011289591,0.000050080886],"category_scores_gemma":[0.000664267,0.00018349543,0.00015041212,0.00018738327,0.00020562504,0.00060583756,0.00005196878,0.00023717833,0.0000053078875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036213786,0.00012108088,0.9838535,0.00017832273,0.00022309231,0.00007342582,0.00036962738,0.0000021153303,0.00063590123,0.000016763344,0.00028234755,0.013881676],"study_design_scores_gemma":[0.005139575,0.0066888216,0.9832997,0.0019686997,0.0002951327,0.00003064678,0.000011075296,0.00011911957,0.0016999615,0.0000987225,0.00040878868,0.00023980941],"about_ca_topic_score_codex":0.007815146,"about_ca_topic_score_gemma":0.014850815,"teacher_disagreement_score":0.018500881,"about_ca_system_score_codex":0.00073672214,"about_ca_system_score_gemma":0.00017091593,"threshold_uncertainty_score":0.9987919},"labels":[],"label_agreement":null},{"id":"W2521531894","doi":"10.1111/jvh.12615","title":"Analysis of resistance‐associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; University of New South Wales","keywords":"NS3; NS5B; NS5A; Virology; Hepatitis C virus; Genotype; Ribavirin; Population; Biology; Deep sequencing; Medicine; Hepacivirus; Virus; Genome; Genetics; Gene; Environmental health","score_opus":0.019892182873816545,"score_gpt":0.32140015806416883,"score_spread":0.3015079751903523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521531894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950186,0.00080561574,0.0028480436,0.00035176604,0.00012637787,0.00021611757,0.0004454208,0.000015247678,0.0001728058],"genre_scores_gemma":[0.9832809,0.016039265,0.00029218174,0.00006314258,0.000051198353,0.000009004344,0.000027837,0.000021970902,0.00021449226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973586,0.00017963944,0.0010639188,0.0002330036,0.0007371442,0.00042767785],"domain_scores_gemma":[0.9979911,0.00022264165,0.0006502933,0.00021624003,0.0007032804,0.00021645398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008229477,0.00019276392,0.00089290465,0.0006744376,0.00011913321,0.0000360217,0.0001241795,0.00018694652,0.00014253106],"category_scores_gemma":[0.000945672,0.00014773857,0.00026087824,0.0011437632,0.00025924997,0.0005062105,0.00006023441,0.00032339295,0.000006486314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022569025,0.00012227654,0.94009674,0.00003017714,0.0014263968,0.00022552651,0.00031623853,0.00001194533,0.049065676,0.000025588859,0.00024650551,0.008207261],"study_design_scores_gemma":[0.0022862954,0.00047130318,0.98768324,0.00046539344,0.00080474676,0.00001828034,0.000010445694,0.0006451139,0.006885855,0.00012866339,0.00044470336,0.00015596313],"about_ca_topic_score_codex":0.026024004,"about_ca_topic_score_gemma":0.36429626,"teacher_disagreement_score":0.33827224,"about_ca_system_score_codex":0.0008964512,"about_ca_system_score_gemma":0.00021218116,"threshold_uncertainty_score":0.9804618},"labels":[],"label_agreement":null},{"id":"W2547009557","doi":"10.1111/jvh.12616","title":"Phylogenetic analysis of full‐length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> Study","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; National Health and Medical Research Council; Medical Research Council; Fonds de Recherche du Québec - Santé; National Institutes of Health; Canadian Institutes of Health Research; University of New South Wales; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Phylogenetic tree; Hepatitis C virus; Molecular epidemiology; Genome; Biology; Phylogenetics; Virology; Evolutionary biology; Genetics; Virus; Genotype; Gene","score_opus":0.013055118956338567,"score_gpt":0.269022471669071,"score_spread":0.25596735271273247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547009557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972344,0.000374945,0.0007679722,0.00034491898,0.00011102477,0.0008906849,0.0001382288,0.000027443328,0.00011040485],"genre_scores_gemma":[0.9917639,0.0070122136,0.00037401993,0.00008178119,0.00030012405,0.000042636653,0.0000082741935,0.000071338196,0.00034572024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99502957,0.0007515551,0.0014295336,0.00038869944,0.0017972,0.0006034262],"domain_scores_gemma":[0.99572873,0.00062768464,0.00091636006,0.00076928234,0.0015541741,0.0004037586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011842725,0.0003853051,0.0013564427,0.0013005288,0.00024692703,0.000113016366,0.00042168336,0.00014215928,0.00068123685],"category_scores_gemma":[0.000518773,0.0002140506,0.0004443675,0.0019414035,0.00041757242,0.00059227843,0.00014328168,0.000642063,0.000035735087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045685904,0.0007793132,0.9586975,0.00003953474,0.0041405074,0.00037461973,0.00477259,0.00028830935,0.0014654414,0.000011217091,0.00031492877,0.028659208],"study_design_scores_gemma":[0.0022461389,0.0062773037,0.9860571,0.0001939792,0.0025710196,0.00010906411,0.00015656132,0.0007898491,0.000757468,0.00002929476,0.0005566211,0.00025557732],"about_ca_topic_score_codex":0.07788138,"about_ca_topic_score_gemma":0.12725505,"teacher_disagreement_score":0.049373664,"about_ca_system_score_codex":0.00040399295,"about_ca_system_score_gemma":0.00044677843,"threshold_uncertainty_score":0.9282591},"labels":[],"label_agreement":null},{"id":"W2554587175","doi":"10.1111/jvh.12650","title":"Role of primary T‐cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario HIV Treatment Network; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Coinfection; Medicine; Virology; Hepatitis C; Hepatitis; Cohort; Hepatitis B; Hepatitis A; Immunology; Human immunodeficiency virus (HIV); Internal medicine","score_opus":0.008161408965611678,"score_gpt":0.24690461486346602,"score_spread":0.23874320589785433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554587175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756135,0.0020949803,0.00024245924,0.0006032707,0.000376822,0.0007989443,0.0001868131,0.000028476126,0.008106864],"genre_scores_gemma":[0.95345116,0.044889737,0.0005804277,0.00025848404,0.0001953016,0.000023046392,0.0000091695265,0.00007511699,0.00051758386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995094,0.0004297677,0.0017230156,0.00041437254,0.0017409661,0.0005978647],"domain_scores_gemma":[0.99591744,0.00082959374,0.0012812996,0.0006785105,0.0010090759,0.00028406424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011340235,0.0004127186,0.0012592626,0.0005340979,0.0001899991,0.000043986194,0.00041412338,0.00024056458,0.000357962],"category_scores_gemma":[0.0006775241,0.00027092913,0.00041747306,0.00048596328,0.0007472879,0.00049845275,0.00014538177,0.0006342266,0.00004548045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007054048,0.0004111744,0.83234286,0.00024262961,0.00016154526,0.00050970167,0.00032464718,0.000009348847,0.05471249,0.0001323027,0.00054185675,0.10990602],"study_design_scores_gemma":[0.002383725,0.0067261304,0.95822257,0.0015521183,0.00020799805,0.0015111929,0.000029144587,0.00025505282,0.025593733,0.00031634222,0.0029036312,0.00029836837],"about_ca_topic_score_codex":0.021337623,"about_ca_topic_score_gemma":0.0024996328,"teacher_disagreement_score":0.12587968,"about_ca_system_score_codex":0.0006102982,"about_ca_system_score_gemma":0.00048528408,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2560230732","doi":"10.1111/jvh.12641","title":"Time to viral suppression is not related to achievement of <scp>SVR</scp>12 in <scp>HCV GT</scp>1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; AbbVie","keywords":"Ombitasvir; Paritaprevir; Dasabuvir; Ritonavir; Medicine; Ribavirin; Virology; Internal medicine; Gastroenterology; Hepatitis C virus; Viral load; Virus","score_opus":0.013586254011132443,"score_gpt":0.28386933062461717,"score_spread":0.2702830766134847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537814,0.000100356105,0.000062412524,0.0007028784,0.00007675988,0.0019106813,0.00028406244,0.000042902164,0.0014418166],"genre_scores_gemma":[0.99143356,0.00046044265,0.0019112144,0.00059196673,0.00008475339,0.00006595925,0.00003579294,0.00014300035,0.005273284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99391806,0.0005122358,0.0017518227,0.0007136482,0.0020782473,0.0010259973],"domain_scores_gemma":[0.99573493,0.0007230507,0.00078365504,0.0006454284,0.0010022117,0.0011107275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008579157,0.0006523222,0.0016647787,0.0011475944,0.00013218305,0.00007539583,0.0004224895,0.00034369493,0.00023064046],"category_scores_gemma":[0.0016565282,0.00038229686,0.00016943952,0.0010248072,0.0003010716,0.00075802533,0.00027119392,0.00079584925,0.00019867596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021086563,0.0011906426,0.9200183,0.00015691348,0.0003500746,0.00054357003,0.0013258331,0.0000109859975,0.048441935,0.0000064463675,0.007064313,0.018782333],"study_design_scores_gemma":[0.017689925,0.029895928,0.88129735,0.005820004,0.0002957024,0.00014393259,0.000084615065,0.00021775119,0.04997873,0.000018955221,0.014314537,0.00024258917],"about_ca_topic_score_codex":0.00087509194,"about_ca_topic_score_gemma":0.0007743357,"teacher_disagreement_score":0.03872096,"about_ca_system_score_codex":0.0005863489,"about_ca_system_score_gemma":0.0004335938,"threshold_uncertainty_score":0.9998629},"labels":[],"label_agreement":null},{"id":"W2582003424","doi":"10.1111/jvh.12684","title":"Shift in disparities in hepatitis C treatment from interferon to <scp>DAA</scp> era: A population‐based cohort study","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; Merck; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Sofosbuvir; Pegylated interferon; Hepatitis C; Hepatitis C virus; Ledipasvir; Ribavirin; Boceprevir; Telaprevir; Gastroenterology; Population; Ombitasvir; Odds ratio; Cohort; Virology; Virus","score_opus":0.03185741129124091,"score_gpt":0.3480021526909063,"score_spread":0.31614474139966536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582003424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995873,0.0001672855,0.000104258776,0.0011385533,0.0004163806,0.001399221,0.00017768166,0.000017029468,0.00070663233],"genre_scores_gemma":[0.99757373,0.0005183965,0.0008246681,0.00025566487,0.00033415918,0.0001207054,0.00004256114,0.00005260416,0.00027749033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640256,0.00033503948,0.0012501387,0.0003959044,0.0010625201,0.00055386004],"domain_scores_gemma":[0.99783945,0.00033627957,0.00047985374,0.00072766474,0.00020342942,0.00041330993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007340292,0.00033221373,0.0011527784,0.00089670555,0.00017115641,0.00019098065,0.00044489506,0.00015331246,0.0001570079],"category_scores_gemma":[0.0014101027,0.00029046534,0.00021014475,0.0002166512,0.00007336434,0.00059012964,0.00013770752,0.00063206657,0.000061735336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024336277,0.0012526102,0.98242617,0.00002439454,0.00013774377,0.0021275922,0.0011152538,0.000049994935,0.000084290055,0.0000140446655,0.00047148217,0.01205306],"study_design_scores_gemma":[0.0051001036,0.005610856,0.9864548,0.000660691,0.00008446558,0.000009819991,0.00007275767,0.0006908822,0.00028407542,0.000246161,0.00066696265,0.000118437514],"about_ca_topic_score_codex":0.33554488,"about_ca_topic_score_gemma":0.3448929,"teacher_disagreement_score":0.011934623,"about_ca_system_score_codex":0.0017294838,"about_ca_system_score_gemma":0.00034184437,"threshold_uncertainty_score":0.99995476},"labels":[],"label_agreement":null},{"id":"W2588513563","doi":"10.1111/jvh.12697","title":"Endemic prevalence of hepatitis B and C in Mongolia: A nationwide survey amongst Mongolian adults","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada","keywords":"Medicine; Population; Hepatitis B virus; Hepatitis B; Hepatitis C; Demography; Hepatitis C virus; Inner mongolia; Virology; Environmental health; Virus; Geography; China","score_opus":0.02259305661452256,"score_gpt":0.29871559047339946,"score_spread":0.2761225338588769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588513563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967152,0.0014507148,0.00003268751,0.0004364645,0.0002925255,0.0003035629,0.00014792869,0.000009215827,0.00061170425],"genre_scores_gemma":[0.97571206,0.022736548,0.0009802569,0.00007978816,0.0001551754,0.00000978611,0.0000039705524,0.000026709851,0.00029570755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758255,0.00017213792,0.0010888443,0.00023725441,0.00060746586,0.00031174385],"domain_scores_gemma":[0.9971853,0.00021704198,0.0012537366,0.00041378196,0.0007319,0.00019826347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009340581,0.00022527509,0.0008163141,0.00033590128,0.00015927358,0.00004360764,0.00030401553,0.0001469525,0.000050262865],"category_scores_gemma":[0.0031222254,0.00020349422,0.00013655823,0.00012385244,0.00036885092,0.0006410093,0.00014899153,0.00043445022,0.00000636373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034217045,0.00012961026,0.98996896,0.00040888952,0.00008747955,0.00026792867,0.0007286796,0.000002143494,0.00050873845,0.000026972002,0.0005046215,0.007023793],"study_design_scores_gemma":[0.001890969,0.00078317226,0.99301255,0.0017237125,0.000080419755,0.00015213403,0.00002067766,0.0005187066,0.0013845986,0.00018251225,0.00008809668,0.00016247705],"about_ca_topic_score_codex":0.062335283,"about_ca_topic_score_gemma":0.10462364,"teacher_disagreement_score":0.042288356,"about_ca_system_score_codex":0.00014060148,"about_ca_system_score_gemma":0.00017292252,"threshold_uncertainty_score":0.9439087},"labels":[],"label_agreement":null},{"id":"W2606603910","doi":"10.1111/jvh.12716","title":"<scp>NK</scp> cells in self‐limited <scp>HCV</scp> infection exhibit a more extensively differentiated, but not memory‐like, repertoire","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Rijksinstituut voor Volksgezondheid en Milieu; Virgo Consortium; Stichting Sanquin Bloedvoorziening; Universiteit van Amsterdam","keywords":"Immunology; Biology; Phenotype; Immune system; Cell; Interleukin 21; Janus kinase 3; Population; Innate immune system; Natural killer cell; Cytotoxic T cell; T cell; Medicine; In vitro; Genetics; Gene","score_opus":0.012309827046355956,"score_gpt":0.23697697390559988,"score_spread":0.22466714685924394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606603910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851731,0.00075564615,0.0001726457,0.00016650451,0.01068906,0.00024862026,0.000017539638,0.000068755966,0.0027080923],"genre_scores_gemma":[0.9697096,0.0026209317,0.00008615651,0.00064651016,0.00024038758,0.000011518119,0.000048379832,0.000045910114,0.026590608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975741,0.00030160043,0.0010612995,0.00036401607,0.00016336884,0.00053564756],"domain_scores_gemma":[0.9968978,0.00030728642,0.0015965563,0.0005204535,0.00060107914,0.000076811586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003887383,0.00038141417,0.00069712236,0.0005334137,0.0006216988,0.00016373969,0.00037483452,0.00055644644,0.00020472889],"category_scores_gemma":[0.00089446857,0.00034022395,0.0004168451,0.00013340532,0.00018477089,0.0010109721,0.00014491864,0.001285827,0.00044649674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001790057,0.00074139435,0.04981953,0.000077792545,0.0005139217,0.0002796641,0.0018931889,0.00003805583,0.82343274,0.000028446986,0.11754652,0.0054497123],"study_design_scores_gemma":[0.004148959,0.0012417731,0.4302205,0.00041578856,0.00019817619,0.0009141117,0.0006176752,0.00019611142,0.45394763,0.000043157994,0.10791881,0.00013728092],"about_ca_topic_score_codex":0.0021709155,"about_ca_topic_score_gemma":0.0004700961,"teacher_disagreement_score":0.380401,"about_ca_system_score_codex":0.0002541982,"about_ca_system_score_gemma":0.000103700135,"threshold_uncertainty_score":0.999905},"labels":[],"label_agreement":null},{"id":"W2610278579","doi":"10.1111/jvh.12719","title":"Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment‐naïve, noncirrhotic <scp>HCV</scp> genotype 3‐infected patients","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hillsborough Hospital","funders":"Merck","keywords":"Medicine; Ribavirin; Tolerability; NS5A; Internal medicine; Gastroenterology; Potency; Virology; Hepatitis C virus; Adverse effect; Hepacivirus; Virus; Chemistry; In vitro","score_opus":0.04107651794239327,"score_gpt":0.33570293041657584,"score_spread":0.2946264124741826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610278579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940644,0.00027292088,0.000048635895,0.000071110844,0.00019552557,0.0009097714,0.00007204703,0.000017505741,0.0043481183],"genre_scores_gemma":[0.9955433,0.0022160406,0.0011829565,0.00003829124,0.0001695086,0.000014209517,0.00002153633,0.00008578951,0.0007283381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626476,0.00023486224,0.0014096983,0.00030208132,0.001219677,0.00056893576],"domain_scores_gemma":[0.99586433,0.00045579684,0.0016168053,0.0008101937,0.0008731907,0.00037971072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046826413,0.0003666308,0.0014519112,0.00062844047,0.00011291116,0.00004828474,0.0004968609,0.00021439632,0.00016939171],"category_scores_gemma":[0.00225115,0.00025090374,0.0003069856,0.00031104576,0.0003783756,0.0004890221,0.0001172356,0.00055110053,0.00002492618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018590161,0.0015546585,0.9479535,0.00025325027,0.00036312058,0.0007987143,0.00055747735,0.000032084405,0.0016295044,0.0000133975145,0.0005573077,0.044427954],"study_design_scores_gemma":[0.019075325,0.014563495,0.9550983,0.0013650012,0.00026489145,0.00005587491,0.000022513988,0.0002749773,0.0067275176,0.000026542473,0.0024092316,0.00011638604],"about_ca_topic_score_codex":0.004694903,"about_ca_topic_score_gemma":0.0052673016,"teacher_disagreement_score":0.04431157,"about_ca_system_score_codex":0.00063067285,"about_ca_system_score_gemma":0.0010696118,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W2620280314","doi":"10.1111/jvh.12727","title":"Prediction of long‐term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE‐B score","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; University of Toronto; Institute of Health Services and Policy Research; University Health Network","funders":"Foundation for Liver Research","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Liver biopsy; Gastroenterology; Biopsy; Milan criteria; Stage (stratigraphy); Liver transplantation; Hepatitis B; Population; Chronic hepatitis; Hepatitis C; Transplantation; Oncology; Immunology","score_opus":0.0561928007277373,"score_gpt":0.3431533523911885,"score_spread":0.2869605516634512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620280314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796015,0.0007097745,0.000004080371,0.00029871907,0.00053151237,0.0002547605,0.00009744341,0.0000029325272,0.00014061185],"genre_scores_gemma":[0.99739826,0.0021206553,0.000057138594,0.000042396994,0.0003200776,0.0000043365894,0.000009995251,0.000009399914,0.000037761238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998324,0.000083638406,0.0009520193,0.00010990575,0.00041077155,0.00011969235],"domain_scores_gemma":[0.9981473,0.00005031631,0.001157004,0.00037624058,0.00016674503,0.00010236209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026004252,0.00010594985,0.000490605,0.00008292764,0.00008132964,0.0000149703965,0.0001877198,0.00008261353,0.00011986122],"category_scores_gemma":[0.00017906788,0.000069278285,0.00041565846,0.000050616807,0.00012360179,0.00025369422,0.00008137156,0.0001975233,0.0000027204987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012227349,0.0005764845,0.9796006,0.000084845145,0.00015025682,0.00014162336,0.0000839702,0.000005492724,0.00004999764,0.000039604376,0.00008919089,0.019055663],"study_design_scores_gemma":[0.0028979292,0.0011959779,0.99391,0.00092540035,0.00037653046,0.000032728087,0.000008970458,0.00011825,0.00034836607,0.000120481556,0.00001935975,0.000046002075],"about_ca_topic_score_codex":0.0032558339,"about_ca_topic_score_gemma":0.0019247989,"teacher_disagreement_score":0.01900966,"about_ca_system_score_codex":0.00019898669,"about_ca_system_score_gemma":0.0001324288,"threshold_uncertainty_score":0.49218687},"labels":[],"label_agreement":null},{"id":"W2622579634","doi":"10.1111/jvh.12732","title":"Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences","keywords":"Medicine; Antiviral treatment; Chronic hepatitis; Drug resistance; Drug; Antiviral drug; Virology; Hepatitis B; Antiviral therapy; Hepatitis C; Hepatitis; Immunology; Pharmacology; Virus; Biology; Genetics","score_opus":0.011923265706360433,"score_gpt":0.26654468292745215,"score_spread":0.2546214172210917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622579634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662423,0.00048525128,0.000047757,0.00046805426,0.00043774545,0.00074724393,0.00039914917,0.000024725798,0.0007658354],"genre_scores_gemma":[0.97726345,0.018621197,0.0028085804,0.00009280949,0.00031171343,0.000029318036,0.000018193727,0.00008068632,0.00077404553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555886,0.00027372892,0.0015896206,0.0005552211,0.0012471224,0.0007754413],"domain_scores_gemma":[0.9949068,0.00019330086,0.0029233696,0.00094672677,0.0008067398,0.00022307044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004260477,0.0005753562,0.0017583511,0.0004590198,0.00039010338,0.000094129915,0.0005636194,0.00008819198,0.000041080228],"category_scores_gemma":[0.00053030887,0.0004665302,0.00032635356,0.0003957658,0.0008569537,0.0011893577,0.00016570465,0.00051093136,0.000015231043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096872996,0.00072094804,0.9702927,0.0004828825,0.00032530577,0.000800749,0.00093859574,0.0000037555528,0.00018893089,0.000018691095,0.00026306004,0.024995683],"study_design_scores_gemma":[0.0049835537,0.0045969975,0.98488855,0.0025514641,0.0003158326,0.000022841708,0.000009302923,0.000079331214,0.0018105045,0.00001518607,0.00029042904,0.0004359993],"about_ca_topic_score_codex":0.043996014,"about_ca_topic_score_gemma":0.419988,"teacher_disagreement_score":0.375992,"about_ca_system_score_codex":0.0012648907,"about_ca_system_score_gemma":0.0006041814,"threshold_uncertainty_score":0.9997786},"labels":[],"label_agreement":null},{"id":"W2644043742","doi":"10.1111/jvh.12738","title":"<scp>HB</scp>sAg loss after peginterferon‐nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow‐up","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Janssen Pharmaceuticals; Innogenetics; MedImmune; Abbott Fund; Roche; AbbVie; Merck; Bristol-Myers Squibb; Gilead Sciences; Medtronic; Boehringer Ingelheim","keywords":"Medicine; HBsAg; HBeAg; Adefovir; Internal medicine; Gastroenterology; Chronic hepatitis; Immunology; Hepatitis B virus; Virus; Lamivudine","score_opus":0.014536731288873705,"score_gpt":0.2779753366387037,"score_spread":0.26343860534983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2644043742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960355,0.00086968753,0.000037245743,0.00034008492,0.0010769607,0.00049118843,0.00010476526,0.000014313964,0.0010302372],"genre_scores_gemma":[0.99190396,0.006393518,0.00031918957,0.00010331283,0.0002679978,0.00003464426,0.000016953978,0.000052259995,0.00090815197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973419,0.00012166772,0.0011409158,0.0002650138,0.0006857678,0.00044474954],"domain_scores_gemma":[0.99740344,0.00014723543,0.0012002118,0.0005229957,0.00053383363,0.00019227681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002865658,0.0003086803,0.0010209982,0.00040074522,0.00012628865,0.00006388237,0.00029029412,0.00014674505,0.000097217504],"category_scores_gemma":[0.0008056354,0.0002832944,0.00039849107,0.00011160079,0.0003163724,0.0006668838,0.0001296097,0.00031487018,0.00005493942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015923833,0.00057734683,0.9722379,0.00010431652,0.0002625898,0.0006781507,0.0012896205,0.0000040899977,0.00021739598,0.000057640027,0.0015177586,0.022893967],"study_design_scores_gemma":[0.007615895,0.0060464167,0.97809154,0.0010666435,0.00020489875,0.00003774181,0.00002521359,0.00011409755,0.0017973544,0.00024927544,0.0046360004,0.00011493941],"about_ca_topic_score_codex":0.016734757,"about_ca_topic_score_gemma":0.038992595,"teacher_disagreement_score":0.022779027,"about_ca_system_score_codex":0.0016747346,"about_ca_system_score_gemma":0.0003160476,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W2738751588","doi":"10.1111/jvh.12758","title":"Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Simon Fraser University; AIDS Vancouver; St. Paul's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; National Health and Medical Research Council; National Institutes of Health; International AIDS Society; Canadian Institutes of Health Research; Ministry of Health, British Columbia; Simon Fraser University; University of British Columbia; World Health Organization; Department of Health and Aged Care, Australian Government; UNICEF; U.S. President’s Emergency Plan for AIDS Relief; Michael Smith Health Research BC","keywords":"Latent class model; Drug; Phylogenetic tree; Medicine; Drug class; Virology; Cluster analysis; Injection drug use; Hepatitis C virus; Class (philosophy); Virus; Biology; Pharmacology; Genetics; Computer science; Artificial intelligence; Machine learning; Gene","score_opus":0.02270081102480592,"score_gpt":0.27440464096603495,"score_spread":0.25170382994122903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738751588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983478,0.00015148133,0.0005065778,0.00007819567,0.00032718177,0.0003487272,0.000076245786,0.000006699171,0.00015708897],"genre_scores_gemma":[0.9902422,0.00815396,0.0009865933,0.00005634999,0.00010672613,0.000012655608,0.000009940583,0.000035747606,0.00039583174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695957,0.00025092004,0.0010453925,0.0003004827,0.0010134599,0.00043019332],"domain_scores_gemma":[0.9974194,0.00017009059,0.00095477165,0.0005373508,0.00055555283,0.00036282727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065309484,0.0002545854,0.0011476089,0.0008050946,0.00019556729,0.00018380645,0.00022141279,0.00014212535,0.000039547747],"category_scores_gemma":[0.0007667348,0.00023624352,0.00025470983,0.00044997415,0.00018417965,0.0010161093,0.00020145538,0.0006115395,6.297442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015321845,0.00014832526,0.99154943,0.00017204722,0.00051109446,0.00021823219,0.000904229,0.0011044178,0.00043700894,0.0000029680382,0.0009998832,0.003799157],"study_design_scores_gemma":[0.0014933796,0.00028055554,0.9467204,0.0003023507,0.0004306713,0.000023640489,0.000033220243,0.04972765,0.0005508184,0.000008853139,0.00024031987,0.00018813282],"about_ca_topic_score_codex":0.9776875,"about_ca_topic_score_gemma":0.99576217,"teacher_disagreement_score":0.048623234,"about_ca_system_score_codex":0.00070396037,"about_ca_system_score_gemma":0.0005311838,"threshold_uncertainty_score":0.9633731},"labels":[],"label_agreement":null},{"id":"W2749525663","doi":"10.1111/jvh.12782","title":"Efficacy and safety results of patients with <scp>HCV</scp> genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (<scp>QUARTZ II</scp>‐<scp>III</scp>)","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"AbbVie","keywords":"Ombitasvir; Sofosbuvir; Paritaprevir; Ritonavir; Ribavirin; Medicine; Cirrhosis; Gastroenterology; Internal medicine; Hepatitis C; Hepatitis C virus; Virology; Viral load; Virus","score_opus":0.02093166805568696,"score_gpt":0.2985401554194128,"score_spread":0.27760848736372584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749525663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932704,0.00055652874,0.00018858674,0.000110809444,0.00013660896,0.0019445763,0.00032014702,0.00006875282,0.0034036078],"genre_scores_gemma":[0.98879486,0.0045545236,0.002268041,0.000117762684,0.00035045922,0.000040925155,0.00010258248,0.00017741778,0.003593427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938415,0.00043613705,0.001723101,0.00087361573,0.00205287,0.00107276],"domain_scores_gemma":[0.99238074,0.0014304945,0.0023469427,0.0011000418,0.0017290266,0.0010127432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012095079,0.00085856416,0.0020410868,0.00067486824,0.0009758324,0.00032563732,0.0004735517,0.0004414981,0.00001401297],"category_scores_gemma":[0.0044172974,0.0005228477,0.00016460037,0.00060262746,0.0011603246,0.0016817173,0.00029738306,0.0014295824,0.000016267591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006992882,0.0012431517,0.9594217,0.00043680065,0.0009964973,0.00081108784,0.0016757547,0.000020719672,0.0006493579,0.000014818617,0.0028841249,0.024853094],"study_design_scores_gemma":[0.036392055,0.035194706,0.89617115,0.0026546936,0.0008755052,0.00046536155,0.00017606297,0.00024730005,0.004993118,0.000017294311,0.022648374,0.00016437039],"about_ca_topic_score_codex":0.0044398378,"about_ca_topic_score_gemma":0.0066026775,"teacher_disagreement_score":0.06325055,"about_ca_system_score_codex":0.00032943915,"about_ca_system_score_gemma":0.000836707,"threshold_uncertainty_score":0.9997223},"labels":[],"label_agreement":null},{"id":"W2767655913","doi":"10.1111/jvh.12825","title":"Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir‐containing regimens","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Biotechnology and Biological Sciences Research Council; Medical Research Council","keywords":"Sofosbuvir; Hepatitis C virus; NS5B; Ribavirin; Internal medicine; Virology; NS5A; Medicine; Viral load; Biology; Immunology; Virus; Hepacivirus","score_opus":0.03820688759225106,"score_gpt":0.31148254359654215,"score_spread":0.2732756560042911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767655913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790204,0.000041115258,0.00004782422,0.00026745413,0.0003108266,0.0005588919,0.00004045112,0.0000162209,0.00081515795],"genre_scores_gemma":[0.9972009,0.0018577663,0.00041655055,0.00018014865,0.0001753846,0.000009362899,0.0000123421105,0.000034672736,0.00011288734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975302,0.00014942574,0.0006691589,0.00031229694,0.00089321553,0.00044570377],"domain_scores_gemma":[0.9980998,0.00007717292,0.0006843074,0.0004468484,0.0003592613,0.0003325815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037888566,0.00030236618,0.00072425866,0.0004737899,0.00083098427,0.000099952056,0.00017564386,0.00015041383,0.000078339035],"category_scores_gemma":[0.00032089683,0.00023118376,0.00014463872,0.000095090596,0.00020066692,0.00065893464,0.00027094202,0.0005320659,0.000019869005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002188002,0.00058538665,0.9299506,0.000026615335,0.00016217999,0.0004984418,0.000775264,0.0000130981425,0.000044655106,0.000046720757,0.00005481445,0.06565421],"study_design_scores_gemma":[0.0076132854,0.01922369,0.9713177,0.00029894695,0.00011257554,0.000020071093,0.000008351651,0.00015643526,0.00031388085,0.000056658846,0.0006640186,0.00021435964],"about_ca_topic_score_codex":0.039894674,"about_ca_topic_score_gemma":0.017606605,"teacher_disagreement_score":0.06543985,"about_ca_system_score_codex":0.0011706153,"about_ca_system_score_gemma":0.00013547426,"threshold_uncertainty_score":0.9824898},"labels":[],"label_agreement":null},{"id":"W2772783926","doi":"10.1111/jvh.12837","title":"Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"National Health and Medical Research Council; Scottish Government; NSW Ministry of Health; Department of Health and Aged Care, Australian Government; Seventh Framework Programme; University of Sydney; Canadian Institutes of Health Research; Cancer Institute NSW","keywords":"Medicine; Hepatocellular carcinoma; Incidence (geometry); Internal medicine; Proportional hazards model; Hepatitis C; Hepatitis C virus; Demography; Immunology; Virus","score_opus":0.031534039559084015,"score_gpt":0.33764214387609737,"score_spread":0.30610810431701335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772783926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968509,0.00007179083,0.000055119537,0.00042656597,0.0003280128,0.00030816748,0.000022112334,0.000012085184,0.0019252482],"genre_scores_gemma":[0.9981365,0.0005499106,0.0005540819,0.0000389516,0.0003482144,0.000017016862,0.000011393023,0.000041742776,0.00030213944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700147,0.00022626143,0.0007210715,0.00034405658,0.0013260852,0.00038107316],"domain_scores_gemma":[0.99783057,0.000066427645,0.00056249375,0.00060275354,0.00051888457,0.0004188986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010269141,0.00024535175,0.00070778915,0.00075190637,0.00023099086,0.0002735188,0.00056318287,0.000106206186,0.000285377],"category_scores_gemma":[0.00036226478,0.00020256043,0.000098799246,0.00020098538,0.00024447843,0.0017508204,0.00019720904,0.0006688398,0.0000059055437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041053188,0.00049831724,0.96815586,0.000019485047,0.00009694875,0.005319303,0.0013171929,0.0000031537154,0.00014301864,0.000026031339,0.000049938524,0.023960209],"study_design_scores_gemma":[0.0038914117,0.0044767885,0.98638374,0.0001931256,0.00006558788,0.0002695524,0.00018763877,0.003995725,0.00016041684,0.0000351421,0.00013814251,0.0002027564],"about_ca_topic_score_codex":0.052343916,"about_ca_topic_score_gemma":0.11077343,"teacher_disagreement_score":0.058429513,"about_ca_system_score_codex":0.00026653992,"about_ca_system_score_gemma":0.00020919944,"threshold_uncertainty_score":0.9539666},"labels":[],"label_agreement":null},{"id":"W2773970116","doi":"10.1111/jvh.12846","title":"Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysis","year":2017,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Queen's University; Public Health Ontario; University of Toronto; Centre for Global Health Research; Toronto Public Health","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada","keywords":"Transient elastography; Cirrhosis; Medicine; Fibrosis; Internal medicine; Liver biopsy; Meta-analysis; Hepatitis C; Gastroenterology; Biopsy; Pathology; Liver fibrosis","score_opus":0.09517543472396635,"score_gpt":0.3740154189432479,"score_spread":0.2788399842192816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773970116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011400938,0.99542433,0.00037300077,0.00008033187,0.000120617195,0.0035285435,0.000327174,0.000019243533,0.000012768887],"genre_scores_gemma":[0.001621783,0.9934882,0.0039499714,0.00016345129,0.00015750281,0.00044869844,0.00007276319,0.00007803024,0.000019627962],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952337,0.0005654191,0.0024249684,0.0004971318,0.00087971665,0.0003990414],"domain_scores_gemma":[0.9938422,0.0003045626,0.004165428,0.0006936725,0.00052019715,0.000473931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069156184,0.0008241315,0.012197557,0.0009480216,0.0002610861,0.00017905107,0.0003163602,0.00022265855,0.00023814717],"category_scores_gemma":[0.00018209462,0.0005210239,0.007614958,0.00057383365,0.00014131595,0.00031245511,0.000054709682,0.00047528886,0.000007952019],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058054384,0.00036578847,0.00044394648,0.77675015,0.20286895,0.0009696486,0.00002357728,0.000008739507,4.0360085e-8,0.0000022531838,0.000047898156,0.01851322],"study_design_scores_gemma":[0.00040281293,0.00044033516,0.00033455403,0.2877539,0.70843285,0.00037038853,8.894605e-7,0.0006306739,3.1595505e-7,0.0000015900996,0.0013324197,0.00029929055],"about_ca_topic_score_codex":0.0007964239,"about_ca_topic_score_gemma":0.00018667607,"teacher_disagreement_score":0.50556386,"about_ca_system_score_codex":0.00051484513,"about_ca_system_score_gemma":0.0008538672,"threshold_uncertainty_score":0.99972415},"labels":[],"label_agreement":null},{"id":"W2778790736","doi":"10.1111/jvh.12853","title":"Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for <scp>HCV</scp> genotype 1 infection","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Janssen Research and Development","keywords":"Daclatasvir; Sofosbuvir; Simeprevir; Medicine; Internal medicine; Tolerability; Regimen; Gastroenterology; Cirrhosis; Adverse effect; Discontinuation; Hepatitis C virus; Ribavirin; Virology; Virus","score_opus":0.04462316308482335,"score_gpt":0.3649741482884431,"score_spread":0.32035098520361976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778790736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940208,0.0007224593,0.0014225015,0.0002519184,0.00028498113,0.0006834436,0.00013475912,0.000008850582,0.00247029],"genre_scores_gemma":[0.98761815,0.0084426515,0.002802192,0.00004843907,0.00038669427,0.0000073049296,0.000011886743,0.000037447797,0.0006452317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776244,0.00010740574,0.001025146,0.00019042326,0.0006035623,0.00031103392],"domain_scores_gemma":[0.996703,0.0006179628,0.0012121451,0.0004880369,0.00073002925,0.00024878638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010020058,0.00018641738,0.00083992135,0.00028441247,0.00020635374,0.000042129883,0.00024962187,0.00018589699,0.00011154005],"category_scores_gemma":[0.004909186,0.00014426744,0.00023393503,0.00009766563,0.00030845165,0.00045738497,0.00013090445,0.0003978714,0.000007931847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026007486,0.0005379456,0.63061434,0.0011341281,0.000581462,0.00012683532,0.00046967762,0.000016216482,0.022630246,0.0002903943,0.0058379094,0.3351601],"study_design_scores_gemma":[0.008001839,0.00707286,0.9085601,0.0009776106,0.0003270554,0.00010854776,0.000014584961,0.00052718364,0.020316955,0.00035774487,0.053643674,0.00009182642],"about_ca_topic_score_codex":0.0011469896,"about_ca_topic_score_gemma":0.00038733683,"teacher_disagreement_score":0.3350683,"about_ca_system_score_codex":0.00009815363,"about_ca_system_score_gemma":0.00035022918,"threshold_uncertainty_score":0.58830553},"labels":[],"label_agreement":null},{"id":"W2782793576","doi":"10.1111/jvh.12860","title":"Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐<scp>HBV</scp> prophylaxis","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"cccDNA; Virology; HBsAg; Viral quasispecies; Hepatitis B virus; Hepatitis B immune globulin; Medicine; Hepatocellular carcinoma; Peripheral blood mononuclear cell; Liver disease; Immunology; Biology; Virus; Hepatitis C virus; Internal medicine","score_opus":0.026527118647823273,"score_gpt":0.25820195808777674,"score_spread":0.23167483943995346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782793576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989885,0.0024096176,0.0036392151,0.00023885447,0.0014755527,0.00068416365,0.00042223735,0.00007958503,0.0011658006],"genre_scores_gemma":[0.9789471,0.010319762,0.0068992255,0.0014628295,0.0017181317,0.000018311152,0.0000265528,0.00012942159,0.0004786354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945791,0.0003225712,0.001719131,0.0006243423,0.0016285226,0.00112638],"domain_scores_gemma":[0.9955274,0.00025976356,0.00096364616,0.0005151564,0.0020171185,0.00071691227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008283136,0.00069814135,0.0014992537,0.00067781453,0.0005389047,0.00012001904,0.00049244246,0.00039250666,0.00041441226],"category_scores_gemma":[0.0008555515,0.00059771416,0.00082272466,0.0005463103,0.0005128,0.00080906565,0.00014237288,0.0009960104,0.00044724657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003750142,0.00063740904,0.7423357,0.0005461564,0.0016708584,0.012847309,0.01082571,0.00002158604,0.18803705,0.000068584864,0.0023872054,0.040247437],"study_design_scores_gemma":[0.0033375104,0.010442429,0.90829027,0.0018281356,0.0010169242,0.0058248616,0.00016979476,0.0024054858,0.06455555,0.00015128023,0.0014812556,0.00049652706],"about_ca_topic_score_codex":0.016159995,"about_ca_topic_score_gemma":0.025664495,"teacher_disagreement_score":0.16595457,"about_ca_system_score_codex":0.0012612885,"about_ca_system_score_gemma":0.00084002304,"threshold_uncertainty_score":0.99964744},"labels":[],"label_agreement":null},{"id":"W2783785638","doi":"10.1111/jvh.12856","title":"Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Ottawa Hospital","funders":"National Research Council Canada","keywords":"Virology; Hepatitis C virus; Antigen; Recombinant DNA; Immune system; Virus; Biology; Vaccination; Population; Immunology; Medicine; Gene","score_opus":0.025406869781014734,"score_gpt":0.30388171757036053,"score_spread":0.2784748477893458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783785638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452984,0.00037553033,0.0043509854,0.00002257257,0.0004953539,0.00013722359,0.00003011559,0.0000056255312,0.000052750605],"genre_scores_gemma":[0.94013005,0.00067200675,0.058617204,0.000087678454,0.00035719122,0.0000022301558,0.000011329603,0.000043818225,0.0000784571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978061,0.0001259614,0.0008857858,0.0002606224,0.0004931713,0.00042838906],"domain_scores_gemma":[0.9981814,0.000011209666,0.0006192358,0.000280067,0.00072946533,0.00017863886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000457044,0.00024815922,0.00041550124,0.00019553512,0.00020290859,0.00003925424,0.00038723083,0.00014300503,0.00006921968],"category_scores_gemma":[0.000040903993,0.00022490326,0.00020506988,0.00014551773,0.00021744745,0.000030426248,0.000180904,0.0002023068,0.000005690341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008107023,0.00009522591,0.0072834934,0.000029221968,0.000110104804,0.0000358395,0.00032868714,0.0003041073,0.98132443,0.0000022423208,0.00033029326,0.009345666],"study_design_scores_gemma":[0.0008816925,0.0021921124,0.0022805703,0.00015228917,0.000024518455,0.00013885368,0.000024476898,0.00990683,0.98370874,0.000095738724,0.00033842775,0.00025575885],"about_ca_topic_score_codex":0.00029436292,"about_ca_topic_score_gemma":0.0014702284,"teacher_disagreement_score":0.05439976,"about_ca_system_score_codex":0.000103155304,"about_ca_system_score_gemma":0.0006553291,"threshold_uncertainty_score":0.91712886},"labels":[],"label_agreement":null},{"id":"W2791741379","doi":"10.1111/jvh.12894","title":"The burden of hepatitis C virus in Cameroon: Spatial epidemiology and historical perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Agence Nationale de Recherches sur le Sida et les Hépatites Virales","keywords":"Medicine; Cohort; Demography; Epidemiology; Population; Hepatitis C; Logistic regression; Environmental health; Immunology; Internal medicine","score_opus":0.045373459725036404,"score_gpt":0.3587749477966967,"score_spread":0.3134014880716603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791741379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98315704,0.0040981546,0.0005533753,0.008726797,0.0005797686,0.00026789974,0.000017586668,0.0000076582055,0.002591695],"genre_scores_gemma":[0.9842817,0.012464828,0.0011483271,0.00019475225,0.0015165469,0.0000065515355,0.0000010694749,0.00002357821,0.00036259982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970952,0.0005733107,0.0011406454,0.00021713652,0.0005316505,0.0004420558],"domain_scores_gemma":[0.997096,0.00091151235,0.0005433433,0.00025883675,0.00092672365,0.0002635833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016943897,0.00017155561,0.00084660505,0.0003207231,0.00012683413,0.000012142647,0.0002158619,0.00016695616,0.0001660121],"category_scores_gemma":[0.0043861023,0.00012017988,0.00017487764,0.0002655725,0.00069008104,0.0001522678,0.00010376026,0.00067528454,0.000017773193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010548924,0.0001519369,0.8726518,0.000044307984,0.00017036831,0.00048643886,0.0025075942,0.0000037061059,0.0029531785,0.0012277168,0.009174807,0.109573245],"study_design_scores_gemma":[0.004206947,0.013728692,0.89460945,0.0005640663,0.00015710178,0.0007958465,0.00044882068,0.0040331986,0.0033820758,0.007241125,0.07048231,0.00035037685],"about_ca_topic_score_codex":0.19366476,"about_ca_topic_score_gemma":0.028553298,"teacher_disagreement_score":0.16511147,"about_ca_system_score_codex":0.0012511598,"about_ca_system_score_gemma":0.00036796145,"threshold_uncertainty_score":0.98917305},"labels":[],"label_agreement":null},{"id":"W2794154499","doi":"10.1111/jvh.12875","title":"Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe","year":2018,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"AbbVie; Gilead Sciences","keywords":"European union; Summit; Manifesto; Public health; Hepatitis C; Political science; Medicine; Virology; Environmental health; Economic growth; Public administration; Business; Geography; International trade; Economics; Law","score_opus":0.06459612109104892,"score_gpt":0.3943094733706154,"score_spread":0.32971335227956644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794154499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028258793,0.9466084,0.00026615866,0.0016199271,0.0010545343,0.0038141904,0.00076657743,0.000018095167,0.017593317],"genre_scores_gemma":[0.021030415,0.97631985,0.001100129,0.00027045657,0.00074469205,0.000042951844,0.000025460204,0.00009495853,0.00037105844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951969,0.0008981309,0.0018157169,0.00030287434,0.0013458049,0.00044059905],"domain_scores_gemma":[0.9960617,0.00049376424,0.0012593941,0.00034876424,0.0016536597,0.00018270944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029166033,0.0003711743,0.0013517301,0.0005527533,0.00016646634,0.00013621681,0.00076700875,0.00012463963,0.000091906586],"category_scores_gemma":[0.0019804263,0.00021218913,0.0003971173,0.00082185795,0.0003239461,0.00028990753,0.0003403889,0.0008274618,0.000020435977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010792578,0.00015098929,0.03417043,0.006713094,0.00047974798,0.0002071062,0.00087283173,0.0000040399837,0.000017305138,0.00082904054,0.008404046,0.94804347],"study_design_scores_gemma":[0.00083516823,0.0013290794,0.025837867,0.015738823,0.0003629477,0.00015890675,0.000039175462,0.000052486655,0.000014516258,0.00015133234,0.95525414,0.00022553398],"about_ca_topic_score_codex":0.00071492995,"about_ca_topic_score_gemma":0.0012958769,"teacher_disagreement_score":0.9478179,"about_ca_system_score_codex":0.0002953277,"about_ca_system_score_gemma":0.0013877462,"threshold_uncertainty_score":0.8652822},"labels":[],"label_agreement":null},{"id":"W2802560552","doi":"10.1111/jvh.12920","title":"Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Foundation for Liver Research","keywords":"Family medicine; Medicine; Psychology","score_opus":0.031183487596938834,"score_gpt":0.3355747015587564,"score_spread":0.30439121396181756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802560552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697614,0.00040225327,0.00003563592,0.00091055065,0.0004950104,0.00036034468,0.00006133004,0.0000197365,0.000739018],"genre_scores_gemma":[0.99418867,0.0014308409,0.0010458365,0.0014749886,0.00047231955,0.000016818543,0.0000053560548,0.00003333132,0.0013318363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790126,0.00018139603,0.00080791616,0.0002672333,0.00046819018,0.00037401586],"domain_scores_gemma":[0.9983663,0.0001850123,0.00041441724,0.00020015554,0.00035979907,0.0004743422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046948416,0.00025121434,0.00092993915,0.0002245647,0.00010281905,0.00003615603,0.000101397,0.00013494823,0.0002051713],"category_scores_gemma":[0.0012851078,0.00018265411,0.00014393154,0.00029360384,0.00025522258,0.00021889435,0.00005183136,0.00029224288,0.000041967636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000464286,0.00014906647,0.9804315,0.000012486133,0.00029274795,0.0044445125,0.0031391494,3.235857e-7,0.00017924485,0.0000066030816,0.0029486062,0.00793149],"study_design_scores_gemma":[0.0042708386,0.009974779,0.98132056,0.00089391187,0.00018065507,0.00012031519,0.00019503133,0.00003154921,0.00032927995,0.000027096461,0.002457213,0.00019875167],"about_ca_topic_score_codex":0.010594538,"about_ca_topic_score_gemma":0.13755314,"teacher_disagreement_score":0.12695861,"about_ca_system_score_codex":0.00045179683,"about_ca_system_score_gemma":0.00023613356,"threshold_uncertainty_score":0.995994},"labels":[],"label_agreement":null},{"id":"W2805832713","doi":"10.1111/jvh.12942","title":"Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Gilead Sciences","keywords":"Medicine; HBsAg; Internal medicine; HBeAg; Adverse effect; Placebo; Seroconversion; Gastroenterology; Hepatitis B; Hepatitis B virus; Immunology; Antibody; Virus; Pathology","score_opus":0.012914301300578987,"score_gpt":0.2726024275393045,"score_spread":0.25968812623872556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805832713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765354,0.0005308956,0.000027112634,0.00029999242,0.00029471045,0.00050186116,0.0001408859,0.0000123586715,0.0005386421],"genre_scores_gemma":[0.9939532,0.0051063765,0.00024188295,0.00015697695,0.00040167806,0.0000057039074,0.000011682941,0.000040511073,0.00008194291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753344,0.00012598911,0.0009585298,0.00028942656,0.0006906384,0.00040195227],"domain_scores_gemma":[0.99817705,0.00013528885,0.0007840993,0.0002748541,0.00045800194,0.00017072605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018500301,0.0003444827,0.001204737,0.00037654757,0.000110020585,0.000019091765,0.0001106767,0.000106175794,0.00006317909],"category_scores_gemma":[0.00015477142,0.00024912567,0.00015655353,0.00026823132,0.00035809114,0.00025717594,0.000056348938,0.00029001402,0.000016621605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028274574,0.0009787302,0.9503777,0.00008721253,0.00024905716,0.00013568794,0.00073315925,0.0000033727163,0.00005440008,0.00005106672,0.000232982,0.044269156],"study_design_scores_gemma":[0.012481246,0.024066119,0.95684016,0.002448908,0.00018445635,0.00002205462,0.000009122769,0.00007793004,0.0021993585,0.000013868345,0.0014419077,0.0002148985],"about_ca_topic_score_codex":0.0030836612,"about_ca_topic_score_gemma":0.013116586,"teacher_disagreement_score":0.04405426,"about_ca_system_score_codex":0.0007877374,"about_ca_system_score_gemma":0.00022672903,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2806844008","doi":"10.1111/jvh.12936","title":"Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Prison; Seroprevalence; Hepatitis C; Imprisonment; Transmission (telecommunications); Substance abuse; Drug; Psychiatry; Family medicine; Internal medicine; Immunology; Psychology","score_opus":0.022256771351357212,"score_gpt":0.3304150852127518,"score_spread":0.3081583138613946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806844008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978269,0.0005810014,0.000068092166,0.00013381337,0.000185184,0.0007038803,0.000016679109,0.000012748748,0.00047170895],"genre_scores_gemma":[0.9944713,0.0039996975,0.0010030649,0.000045201115,0.0002025603,0.00001903812,0.0000036497686,0.00003664737,0.00021884912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667484,0.0004525968,0.0011507494,0.00027334044,0.0010563363,0.00039213416],"domain_scores_gemma":[0.9980393,0.00014681049,0.000547588,0.00032294125,0.00070114696,0.00024222318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001070632,0.00021467339,0.0009794206,0.0007455948,0.0001341313,0.000047598314,0.00021074465,0.00012564426,0.00018988248],"category_scores_gemma":[0.00068305637,0.0001925453,0.00010103548,0.0008116662,0.00022513146,0.0006517795,0.00012016597,0.00069128716,0.000008575178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002450997,0.00054069445,0.9771476,0.00017866235,0.00006842075,0.00015923212,0.00893282,0.000020758305,0.0004826456,0.000019414007,0.0005044989,0.011700195],"study_design_scores_gemma":[0.0033670706,0.005745407,0.98530984,0.000900736,0.000068328685,0.00006426558,0.0010445073,0.0024817411,0.0006612774,0.00011854713,0.000070545306,0.0001677604],"about_ca_topic_score_codex":0.040221203,"about_ca_topic_score_gemma":0.06068265,"teacher_disagreement_score":0.02046145,"about_ca_system_score_codex":0.00024375113,"about_ca_system_score_gemma":0.0002377163,"threshold_uncertainty_score":0.9661701},"labels":[],"label_agreement":null},{"id":"W2883668852","doi":"10.1111/jvh.12977","title":"Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Cancer Agency; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; British Columbia Centre for Disease Control; Provincial Health Services Authority; Michael Smith Health Research BC","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Hazard ratio; Incidence (geometry); Hepatitis C; Gastroenterology; Population; Confidence interval; Proportional hazards model; Immunology; Virus","score_opus":0.02861234463262334,"score_gpt":0.33705895714977546,"score_spread":0.3084466125171521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883668852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579567,0.00038295134,0.00087173533,0.00018264371,0.0004252801,0.00044726796,0.00012192904,0.000021371474,0.0017511242],"genre_scores_gemma":[0.9945007,0.0008430111,0.002938051,0.00012589566,0.001393798,0.000008128302,0.000003708119,0.00006971054,0.00011702954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960867,0.00045198694,0.0012088275,0.00027537427,0.0013892249,0.0005878742],"domain_scores_gemma":[0.9963723,0.00030513044,0.0011137413,0.00065626105,0.0011864756,0.00036608794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094326976,0.00032396635,0.00084460847,0.00038101623,0.0002787474,0.000068167996,0.000487101,0.00017024305,0.000600553],"category_scores_gemma":[0.0012059098,0.00020915717,0.00068967964,0.00054712157,0.0005504058,0.00033750196,0.00009697937,0.0010997013,0.00019590411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096361176,0.00021719086,0.95680207,0.000044107815,0.00025627343,0.00042348084,0.0006912803,0.00008069481,0.004665349,0.000031763117,0.0021566688,0.033667512],"study_design_scores_gemma":[0.0015487956,0.01412408,0.9369442,0.0005074572,0.0001249204,0.0001981671,0.000012262153,0.034028757,0.011671449,0.00038832973,0.00025892525,0.0001926854],"about_ca_topic_score_codex":0.056701913,"about_ca_topic_score_gemma":0.00085981237,"teacher_disagreement_score":0.0558421,"about_ca_system_score_codex":0.00041444614,"about_ca_system_score_gemma":0.00055007107,"threshold_uncertainty_score":0.9495796},"labels":[],"label_agreement":null},{"id":"W2888185171","doi":"10.1111/jvh.12985","title":"Real‐world impact of direct acting antiviral therapy on health‐related quality of life in <scp>HIV</scp>/Hepatitis C co‐infected individuals","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; HIV Legal Network; University Health Network; University of Ottawa; Regina Qu'Appelle Health Region; Centre Hospitalier de l’Université de Montréal; McGill University; Alberta Hip and Knee Clinic; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Medicine; Quality of life (healthcare); Hepatitis C; Cohort; Internal medicine; Human immunodeficiency virus (HIV); Viral load; Antiviral therapy; Clinical trial; Immunology; Chronic hepatitis; Virus","score_opus":0.06605167108538555,"score_gpt":0.416898689276676,"score_spread":0.35084701819129044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888185171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97910523,0.00036183122,0.0000135421315,0.0003731873,0.00023265702,0.00067805185,0.00033543786,0.000035336616,0.018864736],"genre_scores_gemma":[0.9892847,0.009400265,0.00047402753,0.00022067875,0.00034325404,0.0000075668895,0.000046194906,0.0000772575,0.00014605901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99199086,0.0017258273,0.0033398892,0.0003619823,0.0017598603,0.0008215653],"domain_scores_gemma":[0.993034,0.0018376987,0.003059289,0.00051875645,0.0010326091,0.00051763677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039543486,0.00041415266,0.0023200759,0.0018487353,0.00012056603,0.000038135386,0.0003637759,0.00026827818,0.00031682372],"category_scores_gemma":[0.0050268685,0.00033888384,0.0006694601,0.0016837505,0.00042891345,0.00046865482,0.000073189476,0.0011904967,0.000038478585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000533497,0.00082173134,0.95017374,0.00015932554,0.00054732186,0.00008306721,0.0022011849,0.000010180113,0.0053211325,0.000040119572,0.005378775,0.034729946],"study_design_scores_gemma":[0.005365342,0.010225965,0.9700942,0.0012954834,0.000027826105,0.000011479761,0.000053182084,0.00020581966,0.011595643,0.00010513345,0.0008844608,0.00013543441],"about_ca_topic_score_codex":0.06641774,"about_ca_topic_score_gemma":0.010839563,"teacher_disagreement_score":0.055578172,"about_ca_system_score_codex":0.0007532878,"about_ca_system_score_gemma":0.0018076381,"threshold_uncertainty_score":0.9999063},"labels":[],"label_agreement":null},{"id":"W2890807462","doi":"10.1111/jvh.12997","title":"Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for <scp>HB</scp>eAg‐positive chronic hepatitis B infection: <scp>ARES</scp> long‐term follow‐up","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Internal medicine; Gastroenterology; Peginterferon alfa-2a; Clinical endpoint; Chronic hepatitis; Clinical trial; Immunology; Virus","score_opus":0.015727983318895748,"score_gpt":0.27578360970140137,"score_spread":0.2600556263825056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890807462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265736,0.0017141557,0.0009878806,0.00008950048,0.001469792,0.0018385969,0.000490304,0.000073094285,0.0006793236],"genre_scores_gemma":[0.986697,0.00967973,0.00018860135,0.00039320908,0.0012645348,0.00012008578,0.00015159213,0.00014811219,0.0013570985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955008,0.00025935282,0.0014945621,0.0006870844,0.0011201048,0.0009381097],"domain_scores_gemma":[0.9945936,0.0006780898,0.0015813812,0.00053147913,0.002123833,0.0004916128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042138726,0.0008350291,0.0017280803,0.0007045358,0.00043662463,0.000115416784,0.00029457244,0.00035237437,0.00008368772],"category_scores_gemma":[0.0006489428,0.0006592684,0.00062496506,0.0004821888,0.0006739955,0.000739086,0.00013156758,0.0006414978,0.000026312284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012840055,0.00076431927,0.9549589,0.00027997122,0.0016680728,0.00020543067,0.0021693932,0.0000013181192,0.000969096,0.00001506491,0.0063813687,0.031303022],"study_design_scores_gemma":[0.017765548,0.053006243,0.8992021,0.0024755446,0.00065308966,0.00018608618,0.000024108047,0.000051791434,0.024683088,0.000033769775,0.0017280647,0.00019056219],"about_ca_topic_score_codex":0.002872759,"about_ca_topic_score_gemma":0.019694949,"teacher_disagreement_score":0.055756833,"about_ca_system_score_codex":0.0008689681,"about_ca_system_score_gemma":0.0003477602,"threshold_uncertainty_score":0.99958587},"labels":[],"label_agreement":null},{"id":"W2900758126","doi":"10.1111/jvh.13043","title":"Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; British Columbia Centre for Disease Control; BC Cancer Agency; Provincial Health Services Authority; Hologic","keywords":"Geography; Demography; Downtown; Hepatitis C; Cartography; Medicine; Virology; Archaeology","score_opus":0.021442678423611337,"score_gpt":0.3194305612134829,"score_spread":0.29798788278987154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900758126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659485,0.00017914991,0.0016547607,0.00007834032,0.00061883376,0.00044695052,0.000115072675,0.00001718805,0.00029485437],"genre_scores_gemma":[0.99663496,0.00095307647,0.0003347663,0.0008399955,0.00075178506,0.000027451668,0.000025746678,0.000035399218,0.00039684845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975519,0.00015343094,0.00088063144,0.00030018864,0.00074202364,0.0003718005],"domain_scores_gemma":[0.99825525,0.0001612049,0.0004260899,0.00023149989,0.0005074959,0.0004184281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007895899,0.000171054,0.0007557506,0.00041424375,0.000174855,0.00016964367,0.00013077947,0.00013331382,0.000589943],"category_scores_gemma":[0.00074436166,0.00023539712,0.00014994809,0.00090756774,0.00011918955,0.00025955902,0.000080524675,0.00044287427,0.000010597502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112694055,0.0000786552,0.891178,0.00003417905,0.00032825535,0.0009765318,0.0005771506,0.000013792743,0.0007267607,0.000004201819,0.0036357385,0.10233406],"study_design_scores_gemma":[0.0010181284,0.0009205887,0.9934365,0.0003355105,0.0006367248,0.0004935681,0.00029146543,0.0005155982,0.00016714484,0.000386523,0.0015723049,0.00022590319],"about_ca_topic_score_codex":0.9938069,"about_ca_topic_score_gemma":0.99979544,"teacher_disagreement_score":0.102258556,"about_ca_system_score_codex":0.00063938525,"about_ca_system_score_gemma":0.00048834685,"threshold_uncertainty_score":0.9599216},"labels":[],"label_agreement":null},{"id":"W2905838688","doi":"10.1111/jvh.13051","title":"Genomic variability of within‐host hepatitis C variants in acute infection","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; National Health and Medical Research Council; Medical Research Council; National Institutes of Health; Canadian Institutes of Health Research; University of New South Wales","keywords":"Nonsynonymous substitution; Biology; Viral quasispecies; Genetics; Single-nucleotide polymorphism; Virology; Viral load; Genotype; SNP; Genetic variation; Hepatitis C virus; Virus; Genome; Gene","score_opus":0.02022682742282716,"score_gpt":0.32425549487518623,"score_spread":0.30402866745235907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905838688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939445,0.00006467836,0.0010771579,0.00029238898,0.00075595494,0.00035092336,0.000051941188,0.0000145951,0.0034478141],"genre_scores_gemma":[0.9937473,0.0016426953,0.0037217622,0.00017737715,0.0005267725,0.000006447439,0.0000061999785,0.0000345485,0.00013692706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681735,0.0003772861,0.0014019699,0.00024314981,0.00077981973,0.00038042152],"domain_scores_gemma":[0.9975921,0.00014693699,0.00066493574,0.00037751868,0.000961155,0.00025735435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018939292,0.00020125201,0.0007706688,0.00060459226,0.00006869186,0.000027474289,0.00019728788,0.00020594914,0.0006525742],"category_scores_gemma":[0.0010408442,0.00018012982,0.00021134249,0.000581285,0.0003050825,0.00044469011,0.00009754839,0.0006561325,0.00007619192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047843298,0.00032673552,0.9602293,0.000073659096,0.00018636213,0.0003507163,0.00056342856,0.000003945348,0.031432442,0.00016920411,0.00059751474,0.0055882665],"study_design_scores_gemma":[0.0020498342,0.0035017864,0.97946215,0.00030185058,0.00011622785,0.00030685417,0.000006150564,0.0012103821,0.011296836,0.00075521844,0.00084689236,0.00014582685],"about_ca_topic_score_codex":0.011289809,"about_ca_topic_score_gemma":0.004198277,"teacher_disagreement_score":0.020135608,"about_ca_system_score_codex":0.00059138855,"about_ca_system_score_gemma":0.00067627255,"threshold_uncertainty_score":0.9952941},"labels":[],"label_agreement":null},{"id":"W2911954308","doi":"10.1111/jvh.13067","title":"Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences","keywords":"Regimen; Medicine; Sofosbuvir; Hepatitis C virus; Internal medicine; Gastroenterology; Virus; Immunology; Ribavirin","score_opus":0.01914237510934283,"score_gpt":0.2974786450502149,"score_spread":0.278336269940872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911954308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891445,0.00065692625,0.00022085985,0.0006202837,0.00048379193,0.005891755,0.0012524829,0.00006797925,0.0016613968],"genre_scores_gemma":[0.9895175,0.0010159679,0.0060309824,0.0004270674,0.00056938385,0.00017298052,0.0004892257,0.00018603008,0.0015908646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924624,0.00059089356,0.002393731,0.0010284506,0.0023635624,0.0011609542],"domain_scores_gemma":[0.9935614,0.00091128924,0.0017753725,0.0013455113,0.0016264146,0.00078000635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018115147,0.0007569694,0.0020984206,0.0006087125,0.0002730963,0.00019660428,0.00066438585,0.00030295938,0.0003511607],"category_scores_gemma":[0.0015961548,0.00057456456,0.00052351685,0.0005429704,0.00014792505,0.001115088,0.00021957562,0.0010970115,0.00018151468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023081727,0.0030919677,0.8928866,0.00016585102,0.0017629678,0.0007189914,0.0036941746,0.000021862828,0.00026156666,0.000016544558,0.0064686188,0.067829125],"study_design_scores_gemma":[0.0839879,0.10600946,0.7570955,0.004648361,0.0018144058,0.00006942847,0.0011600736,0.0010723079,0.0010171316,0.000246267,0.0415031,0.0013760661],"about_ca_topic_score_codex":0.003077745,"about_ca_topic_score_gemma":0.0010346835,"teacher_disagreement_score":0.13579111,"about_ca_system_score_codex":0.0011558791,"about_ca_system_score_gemma":0.00089363736,"threshold_uncertainty_score":0.99967057},"labels":[],"label_agreement":null},{"id":"W2917824734","doi":"10.1111/jvh.13084","title":"Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced <scp>HB</scp>eAg seroconversion","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Seroconversion; Virology; Medicine; Antigen; Immunology; Virus","score_opus":0.007113304482053324,"score_gpt":0.23128351596715147,"score_spread":0.22417021148509814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917824734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964911,0.0003425856,0.000030476904,0.0006817995,0.00031841043,0.0015381679,0.00022376912,0.00005610094,0.00031764372],"genre_scores_gemma":[0.99645364,0.0013282017,0.0004623954,0.0008157903,0.00011935828,0.000013986119,0.000083777726,0.00011501439,0.00060786214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957444,0.00034244428,0.0011712773,0.0005635632,0.001227705,0.00095059717],"domain_scores_gemma":[0.99627274,0.0003421037,0.0012437105,0.00042496822,0.0013328008,0.0003836958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039047678,0.0006759173,0.0018322564,0.0004009398,0.00021162801,0.000083625484,0.00024984824,0.00027836734,0.000112112444],"category_scores_gemma":[0.00025060467,0.0004975813,0.00026171678,0.0006502426,0.0001496232,0.00082728744,0.00007665578,0.00060274155,0.00008066799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001074019,0.0008044033,0.9913403,0.0000783953,0.0011219397,0.001165723,0.001536365,0.00011696901,0.0010270147,0.000013177626,0.0007974062,0.0009242867],"study_design_scores_gemma":[0.022104941,0.012735139,0.9591655,0.0012328505,0.00035376335,0.00005175291,0.0002990396,0.0005717133,0.0027377964,0.000039587732,0.00040901222,0.00029887902],"about_ca_topic_score_codex":0.0167783,"about_ca_topic_score_gemma":0.016869683,"teacher_disagreement_score":0.032174777,"about_ca_system_score_codex":0.001669236,"about_ca_system_score_gemma":0.00052055105,"threshold_uncertainty_score":0.9997476},"labels":[],"label_agreement":null},{"id":"W2924489617","doi":"10.1111/jvh.13097","title":"Relationship between hepatitis B core‐related antigen levels and sustained <scp>HB</scp>eAg seroconversion in patients treated with nucleo(s)tide analogues","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Fujirebio Europe; Bristol-Myers Squibb","keywords":"Seroconversion; Medicine; Internal medicine; Antigen; Hazard ratio; Gastroenterology; Hepatitis B; Hepatitis B virus; Virology; Immunology; Antibody; Confidence interval; Virus","score_opus":0.02228793486487363,"score_gpt":0.2614412727985077,"score_spread":0.23915333793363408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924489617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976697,0.0003070258,0.000022149261,0.00019384825,0.00014104029,0.0007538058,0.000112641115,0.000042668373,0.0007571469],"genre_scores_gemma":[0.9976668,0.0005989463,0.00068036816,0.00015626967,0.00009319919,0.0000049767514,0.00010613297,0.00006333652,0.0006300112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970613,0.0001924717,0.0011548602,0.00035001026,0.0007314116,0.00050991337],"domain_scores_gemma":[0.99735314,0.00061319565,0.00079420145,0.00026417527,0.0006779924,0.00029731682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046802897,0.00037137183,0.0010749967,0.00070985884,0.00015569592,0.00004159234,0.00015020973,0.00025804844,0.000055845427],"category_scores_gemma":[0.00075333775,0.000304004,0.00014883686,0.00065670925,0.00019836948,0.0006769187,0.00008974661,0.000667745,0.000064092776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013491706,0.00014570878,0.9960885,0.0001245835,0.00023468956,0.00028234522,0.0011471008,0.000006294277,0.00012194552,0.000071448994,0.00081964734,0.00082281366],"study_design_scores_gemma":[0.0064589195,0.0037309134,0.9873691,0.00075237494,0.00023112466,0.00004102493,0.00018699259,0.00011234062,0.0003576723,0.0002338203,0.00035724964,0.00016842851],"about_ca_topic_score_codex":0.004475949,"about_ca_topic_score_gemma":0.0017427906,"teacher_disagreement_score":0.008719367,"about_ca_system_score_codex":0.00042420786,"about_ca_system_score_gemma":0.00017332497,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W2939003214","doi":"10.1111/jvh.13104","title":"Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; National Center for Research Resources; Roche","keywords":"HBeAg; Medicine; Genotype; Cohort; Hepatitis B virus; Hepatitis B; Immunology; Serology; Internal medicine; Virology; Virus; HBsAg; Antibody; Biology; Gene","score_opus":0.005595835323454534,"score_gpt":0.22866011245685397,"score_spread":0.22306427713339944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939003214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192935,0.0062530967,0.000019701496,0.00053562596,0.00007355171,0.00086794083,0.00013498607,0.000015901509,0.00016981528],"genre_scores_gemma":[0.9664581,0.03236281,0.00035023337,0.00018707104,0.00011467133,0.000011499498,0.0000102118875,0.0000468516,0.00045855198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976491,0.0001932311,0.00068576494,0.00033445124,0.0007265725,0.000410933],"domain_scores_gemma":[0.9979874,0.00018205341,0.000966685,0.0002912195,0.00042474899,0.00014790773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044644406,0.00033070947,0.0009909668,0.00022428848,0.00010735777,0.000038238144,0.00018828639,0.00013378446,0.0000813433],"category_scores_gemma":[0.00019035765,0.00021063525,0.000085426334,0.00033188754,0.00041073008,0.00038881175,0.00010600757,0.0005469888,0.0000048868924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048328994,0.00012640932,0.992841,0.00033340356,0.00040512707,0.00027838643,0.0009863807,0.0000126476725,0.0002828933,0.000018090404,0.00028353962,0.003948844],"study_design_scores_gemma":[0.0042025377,0.005536118,0.98540217,0.003238368,0.0002561424,0.00041050222,0.000025385856,0.00016894472,0.0003912173,0.000021481103,0.00009663359,0.00025050415],"about_ca_topic_score_codex":0.011944511,"about_ca_topic_score_gemma":0.064996555,"teacher_disagreement_score":0.05305204,"about_ca_system_score_codex":0.00024188776,"about_ca_system_score_gemma":0.00022803855,"threshold_uncertainty_score":0.99463505},"labels":[],"label_agreement":null},{"id":"W2943994554","doi":"10.1111/jvh.13119","title":"Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck Sharp and Dohme; Department of Health and Ageing, Australian Government","keywords":"Opioid; Medicine; Scope (computer science); Agonist; Intensive care medicine; Internal medicine; Receptor","score_opus":0.024889504192536622,"score_gpt":0.3058115625959304,"score_spread":0.2809220584033938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943994554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928271,0.00027337027,0.000010533753,0.00016718319,0.00018682392,0.0016519721,0.000006118502,0.0000137355255,0.004863133],"genre_scores_gemma":[0.9957334,0.0029491638,0.00025144866,0.00007803285,0.000073675365,0.000024478906,0.0000016997187,0.000027817441,0.0008602783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831,0.00020076825,0.00051986915,0.00018301092,0.00055551133,0.00023082847],"domain_scores_gemma":[0.9989563,0.00008852367,0.0002788861,0.00026536657,0.00024968744,0.00016121486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034097323,0.00016495376,0.0004270456,0.0002147969,0.0001321121,0.00004974766,0.00010236354,0.000047440513,0.00010295286],"category_scores_gemma":[0.0000984318,0.00010818254,0.00011434827,0.0003105484,0.00008602671,0.00017874483,0.00004774828,0.0002084738,0.000013584785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018216325,0.00031295395,0.8409428,0.00003273098,0.00037234978,0.00009771438,0.0037856973,0.000054904478,0.0015133014,0.0000059164063,0.0001364998,0.15256298],"study_design_scores_gemma":[0.0027798142,0.011907552,0.98098683,0.00043392536,0.00013486225,0.000012251674,0.0005294082,0.00033135738,0.00062106195,0.000021383232,0.0021445837,0.00009696902],"about_ca_topic_score_codex":0.0040599722,"about_ca_topic_score_gemma":0.00052389933,"teacher_disagreement_score":0.15246601,"about_ca_system_score_codex":0.00026267272,"about_ca_system_score_gemma":0.00008710998,"threshold_uncertainty_score":0.613749},"labels":[],"label_agreement":null},{"id":"W2945358100","doi":"10.1111/jvh.13129","title":"Hepatitis E during pregnancy: Maternal and foetal case‐fatality rates and adverse outcomes—A systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Case fatality rate; Medicine; Obstetrics; Pregnancy; Adverse effect; Hepatitis E; Intensive care medicine; Internal medicine; Epidemiology; Biology","score_opus":0.060634703763913105,"score_gpt":0.3758537019380733,"score_spread":0.3152189981741602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945358100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01684559,0.97982496,0.000010538691,0.00012594281,0.0006317324,0.002216847,0.00023025117,0.000019885867,0.000094263036],"genre_scores_gemma":[0.0008579307,0.99773234,0.00031789817,0.00032848894,0.00020497174,0.000074886724,0.000018263205,0.00007944068,0.0003857988],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994477,0.0007393397,0.0033750718,0.00045940685,0.00043640935,0.0005127778],"domain_scores_gemma":[0.99545175,0.00055260875,0.002862154,0.00049706176,0.0002669997,0.00036941652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008216869,0.0007450486,0.009138536,0.00026626675,0.0001645532,0.00003578996,0.00018090791,0.00035516088,0.000091568385],"category_scores_gemma":[0.0012227877,0.00048425098,0.0010937894,0.0001573564,0.00017532721,0.0003008765,0.00027014114,0.00084106566,0.000041698262],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010699278,0.000032358737,0.13596319,0.83283675,0.0014136304,0.011632229,0.000033353786,2.9982456e-8,1.2569441e-7,0.000022351865,0.0002428867,0.017812405],"study_design_scores_gemma":[0.00088812166,0.00064912735,0.010447383,0.8629505,0.012816299,0.10349108,0.000009212019,0.000007617281,4.2023e-7,0.000018473258,0.00827294,0.0004488206],"about_ca_topic_score_codex":0.0028691432,"about_ca_topic_score_gemma":0.00080328586,"teacher_disagreement_score":0.1255158,"about_ca_system_score_codex":0.00031402937,"about_ca_system_score_gemma":0.00019868935,"threshold_uncertainty_score":0.9997609},"labels":[],"label_agreement":null},{"id":"W2945683743","doi":"10.1111/jvh.13125","title":"Persistence of <scp>HB</scp>sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"GlaxoSmithKline","keywords":"Immunogenicity; Vaccination; Medicine; Immunology; Immunization; Booster dose; Antibody; Immune system; Hepatitis B; Hepatitis B vaccine; Virology; Hepatitis B virus; HBsAg; Virus","score_opus":0.012804609847132171,"score_gpt":0.2617573074249085,"score_spread":0.24895269757777633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945683743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870345,0.009849551,0.00010217785,0.00040234128,0.00046113422,0.00053927617,0.000040123978,0.000013909304,0.0015569971],"genre_scores_gemma":[0.9850646,0.0111050885,0.0031611063,0.0001879745,0.00018078246,0.000014642186,0.0000042209886,0.000034753943,0.0002467769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974609,0.00009546578,0.0011169076,0.00029204044,0.0006598551,0.00037484276],"domain_scores_gemma":[0.99814683,0.00025910433,0.0005275064,0.0002770986,0.0006159976,0.00017343828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004974636,0.0002768094,0.00097476674,0.00062896434,0.000058226084,0.000030824755,0.00017271833,0.00011316291,0.0001245911],"category_scores_gemma":[0.00044279898,0.00024460015,0.00020955058,0.00036589656,0.00009184286,0.00049924577,0.00013659282,0.0003741425,0.000043177624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025903346,0.00013574625,0.9724607,0.0003291864,0.00010366642,0.00024017661,0.0034337072,0.000011934367,0.005080051,0.000056576366,0.00047676452,0.017412499],"study_design_scores_gemma":[0.0025300647,0.0017095881,0.98590285,0.0021609021,0.000070341586,0.00016673995,0.00034717363,0.00019213054,0.00616194,0.00021402232,0.0004243996,0.000119874574],"about_ca_topic_score_codex":0.0039364095,"about_ca_topic_score_gemma":0.0131967785,"teacher_disagreement_score":0.017292624,"about_ca_system_score_codex":0.000233674,"about_ca_system_score_gemma":0.00008968731,"threshold_uncertainty_score":0.9974505},"labels":[],"label_agreement":null},{"id":"W2946475694","doi":"10.1111/jvh.13132","title":"Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"Merck Sharp and Dohme","keywords":"Tolerability; Medicine; Regimen; Ribavirin; Adverse effect; Internal medicine; Hepatitis C virus; Drug; Hepatitis C; Gastroenterology; Cirrhosis; Pharmacology; Virology; Virus","score_opus":0.01534624440452465,"score_gpt":0.29956091935133894,"score_spread":0.2842146749468143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946475694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934313,0.0016072997,0.00014680573,0.00040134566,0.00020062613,0.0017404654,0.000113450886,0.000021419537,0.0023372802],"genre_scores_gemma":[0.98355114,0.012354516,0.0029452045,0.00012654327,0.00032812412,0.000026658805,0.000018476125,0.00008729427,0.00056202855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964732,0.00025772527,0.0012344873,0.00048085986,0.00086261885,0.0006911009],"domain_scores_gemma":[0.9975121,0.00061381666,0.0007777964,0.0003785661,0.000382778,0.0003349323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010872311,0.0003892825,0.0012875905,0.0005419731,0.00012031993,0.000058936846,0.00021560998,0.000163272,0.000144908],"category_scores_gemma":[0.0004353851,0.0002965946,0.00015723894,0.00036134242,0.00023078614,0.00054904923,0.00014607985,0.0007237855,0.000012331023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015748348,0.00039793152,0.79006404,0.001199366,0.00038215212,0.0006686803,0.0018975192,0.00002820417,0.0091603715,0.000067458874,0.0005460125,0.17983994],"study_design_scores_gemma":[0.047093246,0.01744233,0.8965712,0.008045182,0.00034465018,0.00034261073,0.00011433455,0.0054752575,0.008669016,0.000082835395,0.015035925,0.00078340794],"about_ca_topic_score_codex":0.010539748,"about_ca_topic_score_gemma":0.031748354,"teacher_disagreement_score":0.17905653,"about_ca_system_score_codex":0.0005097557,"about_ca_system_score_gemma":0.0006701768,"threshold_uncertainty_score":0.9999486},"labels":[],"label_agreement":null},{"id":"W2947135426","doi":"10.1111/jvh.13146","title":"Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Seventh Framework Programme; Agence Nationale de Recherches sur le Sida et les Hépatites Virales; European Commission; Augustinus Fonden; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Hepatitis C; Hepatitis B virus; Hepatitis C virus; Observational study; Incidence (geometry); Hepatitis B; Epidemiology; Gastroenterology; Virology; Virus","score_opus":0.03428191584304353,"score_gpt":0.30802785572219,"score_spread":0.27374593987914647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947135426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523044,0.0002770752,0.0014952181,0.00039889707,0.00013897018,0.0011145056,0.00014176623,0.000040527062,0.0011625943],"genre_scores_gemma":[0.9890575,0.0007056751,0.008771665,0.0005598768,0.00021485706,0.000024552746,0.000095904754,0.00012282947,0.000447154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493206,0.00023907196,0.0014672976,0.000500381,0.002032434,0.00082876236],"domain_scores_gemma":[0.99560106,0.00015867283,0.00079979753,0.00058862596,0.002345793,0.0005060605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005719445,0.0004953453,0.0012954241,0.0008028558,0.0001123816,0.000095072966,0.00038823494,0.00020709664,0.0007666593],"category_scores_gemma":[0.00028030766,0.00037640173,0.00021768687,0.00089135364,0.000200658,0.00074875285,0.000085201296,0.0010278095,0.00018237557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014673739,0.0004203541,0.98185897,0.00023879665,0.00017959058,0.0014189413,0.0001480005,0.000104842606,0.0014123004,0.000011125578,0.0012395933,0.011500086],"study_design_scores_gemma":[0.00936469,0.004997117,0.9674152,0.002902933,0.000095662166,0.00014950617,0.000017991157,0.007534274,0.004303488,0.0000100924335,0.0027500174,0.0004589953],"about_ca_topic_score_codex":0.008866496,"about_ca_topic_score_gemma":0.00298317,"teacher_disagreement_score":0.014443762,"about_ca_system_score_codex":0.0004928513,"about_ca_system_score_gemma":0.0005299145,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W2947243310","doi":"10.1111/jvh.13117","title":"Hepatitis B core‐related antigen monitoring during peginterferon alfa treatment for HBeAg‐negative chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Fujirebio Europe; Roche; National Science Foundation","keywords":"Medicine; Chronic hepatitis; Internal medicine; Gastroenterology; HBeAg; Hepatitis B; Antigen; Hepatitis B virus; Immunology; HBsAg; Virus","score_opus":0.025324806295111902,"score_gpt":0.30469062024816,"score_spread":0.2793658139530481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947243310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904241,0.0038628606,0.00015700563,0.000419769,0.0026340755,0.0014885531,0.00016925806,0.00008514063,0.0007592488],"genre_scores_gemma":[0.9417616,0.05173936,0.0025781114,0.000061768,0.0012993811,0.000078682315,0.000026901847,0.00013057076,0.0023235907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961769,0.000118572985,0.0015753665,0.0005204183,0.00075412454,0.00085462787],"domain_scores_gemma":[0.9968803,0.00039554262,0.0010878956,0.0004740337,0.0007894326,0.00037282606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032281197,0.00061110273,0.0016104081,0.0004875909,0.00029655857,0.00007426011,0.0002672185,0.0002589822,0.00045450046],"category_scores_gemma":[0.00029391918,0.00053122436,0.00080684555,0.00030850997,0.00015663519,0.0006272606,0.00010699671,0.00048879726,0.00020609557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000554624,0.00027779836,0.9671283,0.00032075893,0.0012750017,0.00046666755,0.0013920509,0.00006469805,0.016251085,0.00006667738,0.0004534398,0.011748946],"study_design_scores_gemma":[0.008168552,0.01165607,0.9266044,0.0023026483,0.00044757227,0.000430798,0.000069205,0.0008211556,0.046242077,0.00025067714,0.002471815,0.0005350684],"about_ca_topic_score_codex":0.013689276,"about_ca_topic_score_gemma":0.007412617,"teacher_disagreement_score":0.048662458,"about_ca_system_score_codex":0.0028764445,"about_ca_system_score_gemma":0.0005224773,"threshold_uncertainty_score":0.99971396},"labels":[],"label_agreement":null},{"id":"W2947594352","doi":"10.1111/jvh.13147","title":"Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Steatosis; Metabolic syndrome; Body mass index; Liver steatosis; Chronic hepatitis; Internal medicine; Medicine; Gastroenterology; Fatty liver; Obesity; Virology; Disease","score_opus":0.0037935660453478812,"score_gpt":0.2097693988871236,"score_spread":0.2059758328417757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947594352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615794,0.002622603,0.000003811375,0.00012088032,0.00023081093,0.0005201295,0.00007280682,0.000008099326,0.0002629414],"genre_scores_gemma":[0.9955738,0.0037933872,0.000120403616,0.00020733524,0.00006809316,0.000015457403,0.000021833865,0.00003163918,0.00016801515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836767,0.00006835121,0.0004531502,0.00023757212,0.00057164865,0.00030162855],"domain_scores_gemma":[0.9989859,0.000039164534,0.0003061941,0.00021425838,0.00016510648,0.0002893896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090788984,0.00024096211,0.0006703375,0.00026142807,0.00004468945,0.000032742762,0.00008505929,0.00009208486,0.0006966811],"category_scores_gemma":[0.000013547235,0.00017261427,0.00015366107,0.00016788684,0.00005351365,0.00037655627,0.00005110413,0.00021909067,0.0000710986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046324212,0.0006814878,0.99376166,0.000093219904,0.00041707954,0.0017200357,0.00007669795,0.0000069884595,0.00002324155,0.000018535065,0.00017084091,0.002567001],"study_design_scores_gemma":[0.0069961245,0.004046405,0.9864464,0.0006393914,0.00042796636,0.00019487612,0.000005996447,0.000114014096,0.00013032067,0.000012956393,0.00080230617,0.00018327068],"about_ca_topic_score_codex":0.001712968,"about_ca_topic_score_gemma":0.0011334794,"teacher_disagreement_score":0.007315258,"about_ca_system_score_codex":0.0004922161,"about_ca_system_score_gemma":0.00014810695,"threshold_uncertainty_score":0.76281697},"labels":[],"label_agreement":null},{"id":"W2952804340","doi":"10.1111/jvh.13159","title":"Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"Gilead Sciences","keywords":"Genotype; Fixed-dose combination; Virology; Sofosbuvir; Medicine; Virus; Chronic hepatitis; Internal medicine; Biology; Ribavirin; Genetics; Gene","score_opus":0.021699968799874153,"score_gpt":0.30862028692575816,"score_spread":0.28692031812588403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952804340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959764,0.000981906,0.0010526563,0.00018024453,0.00020845425,0.00110738,0.00011279195,0.000015788404,0.00036440062],"genre_scores_gemma":[0.98769486,0.009934683,0.0016073646,0.000052766565,0.00016929676,0.00003868984,0.000051291754,0.000044339373,0.00040673593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981477,0.00010267506,0.0006535847,0.00021936437,0.0005673395,0.0003093084],"domain_scores_gemma":[0.9982707,0.00015813064,0.00050469645,0.0002400844,0.00063085504,0.00019553713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030049914,0.00022125784,0.00067441177,0.0003897994,0.00007531511,0.000033648987,0.0000781469,0.00013673458,0.00018503219],"category_scores_gemma":[0.00011059366,0.0001706268,0.00017764982,0.00022764612,0.00010474383,0.0003875101,0.000030979463,0.00021834856,0.000022239441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013767142,0.00049073907,0.84744614,0.00035866766,0.0003505202,0.00006088039,0.00025788404,0.000020194348,0.021780329,0.00011884631,0.00032800357,0.12741105],"study_design_scores_gemma":[0.013762992,0.0513671,0.8891003,0.0006688624,0.00038313924,0.00027729367,0.000012330058,0.0032541337,0.02867104,0.00025456998,0.011972162,0.00027609308],"about_ca_topic_score_codex":0.008034765,"about_ca_topic_score_gemma":0.0077963253,"teacher_disagreement_score":0.12713496,"about_ca_system_score_codex":0.0007144271,"about_ca_system_score_gemma":0.00054890336,"threshold_uncertainty_score":0.9985708},"labels":[],"label_agreement":null},{"id":"W2963753270","doi":"10.1111/jvh.13180","title":"Kinetics of hepatitis B surface antigen quasispecies during REP 2139‐Ca therapy in HBeAg‐positive chronic HBV infection","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Viral quasispecies; HBsAg; Virology; HBeAg; Population; Immunology; Medicine; Entecavir; Seroconversion; Hepatitis B virus; Biology; Virus; Hepatitis C virus","score_opus":0.011822478141709225,"score_gpt":0.27239599971128076,"score_spread":0.26057352156957153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963753270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943482,0.0028317757,0.00009248141,0.0003497791,0.000659202,0.00049352605,0.000038162056,0.000019829838,0.0011669868],"genre_scores_gemma":[0.9383244,0.060229287,0.0006056612,0.00008924781,0.000336155,0.0000037191169,0.000007562002,0.00004390201,0.00036006782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972405,0.00018219765,0.0012347683,0.00025118538,0.00069279934,0.00039859454],"domain_scores_gemma":[0.9979542,0.00014664474,0.00084337976,0.00029997583,0.000636138,0.00011968683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033137584,0.0002859898,0.0010259498,0.00037629253,0.00006036712,0.000024840123,0.00013465082,0.00016390771,0.00044231268],"category_scores_gemma":[0.00019358828,0.00025605198,0.0003133554,0.0004379391,0.00014186796,0.00039246443,0.00007222521,0.00049896486,0.000050777933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028735324,0.0002915756,0.8909435,0.00016058236,0.00023295949,0.00018700694,0.00081329327,0.00025664497,0.103930935,0.000030739142,0.00024946922,0.0026158951],"study_design_scores_gemma":[0.0025569238,0.004633242,0.87271386,0.0010943266,0.000047378326,0.00016672681,0.000025943446,0.0001481981,0.11747988,0.0000620322,0.0008709878,0.0002005226],"about_ca_topic_score_codex":0.01568023,"about_ca_topic_score_gemma":0.0110974135,"teacher_disagreement_score":0.05739751,"about_ca_system_score_codex":0.0007569677,"about_ca_system_score_gemma":0.00015255791,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W2969950817","doi":"10.1111/jvh.13194","title":"Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Université de Montréal; Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Seroconversion; Demography; Incidence (geometry); Hepatitis C; Cohort; Confidence interval; Hepatitis C virus; Men who have sex with men; Rate ratio; Cohort study; Needle sharing; Proportional hazards model; Heroin; Internal medicine; Condom; Human immunodeficiency virus (HIV); Immunology; Drug; Psychiatry; Virus","score_opus":0.011614459158976704,"score_gpt":0.28566978180335256,"score_spread":0.2740553226443759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969950817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689984,0.00013564872,0.0000711026,0.00014234219,0.0009589584,0.000854236,0.00054794986,0.00002284575,0.00036705684],"genre_scores_gemma":[0.99637,0.0012965492,0.00014621139,0.00018009696,0.0004094145,0.000026031255,0.000028539524,0.00006693707,0.0014761899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971558,0.00017132564,0.0010209588,0.0003134978,0.0008296128,0.0005088338],"domain_scores_gemma":[0.99782956,0.0002748592,0.00083424675,0.0003041509,0.0004037973,0.0003533982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039271143,0.00032516546,0.0009685806,0.00041044023,0.00009833009,0.000051738207,0.00016466597,0.0002096527,0.0004232414],"category_scores_gemma":[0.00048579174,0.00029736914,0.00019547381,0.00034985525,0.00003970486,0.00053402735,0.000049341343,0.0007807019,0.000035391437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032515216,0.000184643,0.9685666,0.00009233584,0.00010398981,0.00013176113,0.0061969575,0.00009162605,0.00033596033,0.000002420798,0.0033861597,0.020582419],"study_design_scores_gemma":[0.003159692,0.003336044,0.98898256,0.00025558472,0.00016072392,0.00013290941,0.0011967496,0.0010856821,0.00094777456,0.000059031066,0.00039271204,0.00029052637],"about_ca_topic_score_codex":0.9864309,"about_ca_topic_score_gemma":0.99557096,"teacher_disagreement_score":0.020415995,"about_ca_system_score_codex":0.0010675534,"about_ca_system_score_gemma":0.0010365782,"threshold_uncertainty_score":0.99994785},"labels":[],"label_agreement":null},{"id":"W2970398492","doi":"10.1111/jvh.13196","title":"Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; Medical Research Council; Abbott Diagnostics; Department of Health and Aged Care, Australian Government; Merck","keywords":"Medicine; Dried blood spot; Hepatitis C virus; Venipuncture; Hepatitis C; Internal medicine; Cohort; Window period; Viral load; Hepacivirus; Virology; Virus; Immunology; Antibody; Biology; Surgery; Serology","score_opus":0.04461566110911272,"score_gpt":0.34016766279436217,"score_spread":0.2955520016852494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970398492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949967,0.0011390096,0.00005113899,0.00008372602,0.00040723392,0.002241127,0.00034400873,0.000018781651,0.000718265],"genre_scores_gemma":[0.99560213,0.0027159846,0.0010142828,0.00010766633,0.00029446752,0.000029224317,0.00007691668,0.000053638465,0.00010570864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937713,0.0008649116,0.0011971955,0.00038299602,0.0034174395,0.00036616978],"domain_scores_gemma":[0.99533314,0.00041153654,0.0007883665,0.00048506094,0.002670472,0.0003114468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003513133,0.00029939346,0.0012518311,0.0004804191,0.00009400039,0.000055538672,0.00022971643,0.00021921363,0.001828797],"category_scores_gemma":[0.0019778996,0.00025314154,0.00021161819,0.000558604,0.00012117312,0.00027849094,0.00010019857,0.00061849656,0.000027574624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039470976,0.000834644,0.96103,0.000052753374,0.0014038386,0.00026367613,0.0011864712,0.000014592016,0.025251457,0.000007414757,0.00078318943,0.008777271],"study_design_scores_gemma":[0.007802232,0.0040787095,0.97715163,0.0004187407,0.0016600151,0.00008603959,0.0001194705,0.0024298886,0.005125615,0.00036722113,0.00054536085,0.0002150797],"about_ca_topic_score_codex":0.02290867,"about_ca_topic_score_gemma":0.011140758,"teacher_disagreement_score":0.020125842,"about_ca_system_score_codex":0.00036407617,"about_ca_system_score_gemma":0.0011827277,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W2970907004","doi":"10.1111/jvh.13197","title":"Consistent high prevalence of undiagnosed blood‐borne virus infection in patients attending large urban emergency departments in England","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Gilead Sciences","keywords":"Medicine; Epidemiology; Human immunodeficiency virus (HIV); Emergency department; Family medicine; Environmental health; Virology; Emergency medicine; Internal medicine; Nursing","score_opus":0.013156862725124615,"score_gpt":0.2915969702303248,"score_spread":0.2784401075052002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970907004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980768,0.00028426413,0.000010350955,0.000046807243,0.00058815593,0.00061617186,0.000090253,0.0000063639272,0.00028086538],"genre_scores_gemma":[0.99294484,0.0066219466,0.00011518078,0.0000359335,0.00009387378,0.000011119364,0.000018701412,0.000024504357,0.00013387893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971359,0.00025251892,0.0011750509,0.00020987015,0.0008270371,0.00039962755],"domain_scores_gemma":[0.9986724,0.00009704699,0.0005197282,0.00021791042,0.0003318488,0.00016106667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071707787,0.00017274977,0.00057567883,0.0006488323,0.000026863,0.0000098013215,0.00012560017,0.00012630022,0.0008180117],"category_scores_gemma":[0.0004633674,0.00015860326,0.00014745683,0.00042188738,0.000033949644,0.00033937092,0.00006806907,0.00046975102,0.00003862582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031829695,0.0014257666,0.9943776,0.00043201496,0.00008829143,0.00019076027,0.0002315565,0.000013798582,0.0012588094,0.000026914815,0.00019179628,0.0014443585],"study_design_scores_gemma":[0.009228492,0.0028378407,0.9842703,0.0006213623,0.00007326246,0.000011875707,0.0000037804984,0.00010306983,0.0021306975,0.00005683049,0.0005362983,0.00012621784],"about_ca_topic_score_codex":0.0033102424,"about_ca_topic_score_gemma":0.0047830427,"teacher_disagreement_score":0.010107364,"about_ca_system_score_codex":0.00032918106,"about_ca_system_score_gemma":0.00013950656,"threshold_uncertainty_score":0.89566547},"labels":[],"label_agreement":null},{"id":"W2981575069","doi":"10.1111/jvh.13226","title":"Long‐term morbidity and mortality in a Canadian post‐transfusion hepatitis C cohort: Over 15 years of follow‐up","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Institute of Health Services and Policy Research; University of Ottawa; Public Health Ontario; University Health Network; University of Toronto; University of Waterloo","funders":"","keywords":"Medicine; Cohort; Population; Mortality rate; Hepatitis C; Blood transfusion; Standardized mortality ratio; Hepatitis C virus; Demography; Cohort study; Cause of death; Pediatrics; Internal medicine; Immunology; Disease; Environmental health; Virus","score_opus":0.018448782207660164,"score_gpt":0.3130967553922834,"score_spread":0.2946479731846232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981575069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970091,0.0004442,0.000010279615,0.00018417429,0.00046644435,0.00058597926,0.00016684564,0.000006580157,0.0011263714],"genre_scores_gemma":[0.9935128,0.0057336586,0.00011904728,0.00022512705,0.00011534054,0.00000466304,0.000022852495,0.00003272835,0.00023380232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729156,0.00016714334,0.00084676803,0.00024629908,0.00094714214,0.0005011114],"domain_scores_gemma":[0.9983018,0.000090572175,0.00026462652,0.0003262729,0.00038516955,0.0006315787],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008975351,0.0001850539,0.00077191315,0.0006479196,0.000035858982,0.0000302304,0.00017468308,0.00020154964,0.0012686426],"category_scores_gemma":[0.0002931762,0.0001828851,0.00020766394,0.000323278,0.00012413194,0.00038208254,0.000050838717,0.000605201,0.000029756993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018172199,0.00009159983,0.98160547,0.00017407609,0.00012462688,0.0012779969,0.0003647359,0.000001995582,0.0032889599,0.000023087707,0.0002670061,0.012598736],"study_design_scores_gemma":[0.0026545331,0.0011517529,0.9939026,0.0005033968,0.000080604026,0.00011954931,0.000010050269,0.00022225628,0.0006913192,0.00005204047,0.00045330485,0.0001585922],"about_ca_topic_score_codex":0.80122554,"about_ca_topic_score_gemma":0.8684154,"teacher_disagreement_score":0.06718986,"about_ca_system_score_codex":0.0005119008,"about_ca_system_score_gemma":0.001073378,"threshold_uncertainty_score":0.99964434},"labels":[],"label_agreement":null},{"id":"W2982065785","doi":"10.1111/jvh.13220","title":"Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HIV Legal Network; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prison; Hepatitis C; Receipt; Family medicine; Health care; Social support; Stigma (botany); MEDLINE; Nursing; Systematic review; Psychiatry; Psychology; Virology; Business; Political science; Social psychology","score_opus":0.04025520643935951,"score_gpt":0.3751487145698361,"score_spread":0.3348935081304766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982065785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017820755,0.95873827,0.0034481513,0.0005780056,0.00031903046,0.010452674,0.00851374,0.00002320502,0.00010617378],"genre_scores_gemma":[0.0020049515,0.9891895,0.0052799983,0.0011841358,0.00042999143,0.0006469298,0.00039977193,0.00011142796,0.0007533066],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99498457,0.00038315,0.00241766,0.00051314913,0.001080706,0.0006207939],"domain_scores_gemma":[0.99534315,0.0005822546,0.0007123225,0.00078426296,0.0011342134,0.0014437896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000615282,0.0006536616,0.00433885,0.0006765788,0.0003294778,0.00035656706,0.0007042639,0.0002984914,0.000314823],"category_scores_gemma":[0.003387152,0.0004346722,0.0014739829,0.0008243981,0.000037493177,0.00037707953,0.00025910663,0.00085102604,0.00020666365],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000147797,0.00003626983,0.0013335276,0.8556198,0.0012429372,0.00012963412,0.01894341,0.000007862792,0.000026547788,0.000022663582,0.038142286,0.084347256],"study_design_scores_gemma":[0.0005477817,0.004702608,0.00015688332,0.6795031,0.0036392696,0.000045212604,0.004548748,0.000027070302,0.000009917572,0.000011066136,0.3063108,0.0004975739],"about_ca_topic_score_codex":0.008007326,"about_ca_topic_score_gemma":0.0073431856,"teacher_disagreement_score":0.2681685,"about_ca_system_score_codex":0.0011195029,"about_ca_system_score_gemma":0.0013413983,"threshold_uncertainty_score":0.9998105},"labels":[],"label_agreement":null},{"id":"W2982321079","doi":"10.1111/jvh.13228","title":"Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Ombitasvir; Sofosbuvir; Paritaprevir; Ledipasvir; Medicine; Dasabuvir; Ribavirin; Ritonavir; Internal medicine; Hepatitis C; Discontinuation; Hepatitis C virus; Cohort; Gastroenterology; Viral load; Virology; Virus","score_opus":0.02395805420574037,"score_gpt":0.313854947509243,"score_spread":0.2898968933035026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982321079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123985,0.00030066766,0.00004091546,0.0024205076,0.00017645494,0.0006873244,0.000015135789,0.000008861048,0.005110296],"genre_scores_gemma":[0.99598795,0.0009693423,0.00063838967,0.00078483525,0.00023474544,0.000027507527,0.0000018667205,0.000031460877,0.0013238946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978907,0.0002277399,0.00046065263,0.00018024606,0.0008553396,0.00038529903],"domain_scores_gemma":[0.99887925,0.00027022182,0.00016717933,0.0002883142,0.00019007873,0.00020493747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063816796,0.0001860832,0.00051105133,0.00028260157,0.00006362499,0.00006177978,0.00019719005,0.00006660015,0.00030942677],"category_scores_gemma":[0.00013517756,0.00009715827,0.00016562901,0.00034333,0.00005063745,0.00018521979,0.000017614346,0.00038135218,0.00008621643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010789401,0.00025741602,0.92288554,0.000030994826,0.00023254317,0.0020614665,0.010960395,0.000023576544,0.0052124667,0.000019675934,0.0005735351,0.056663454],"study_design_scores_gemma":[0.014543255,0.036423136,0.6604636,0.0015767635,0.00027016434,0.00071270583,0.004016472,0.0003491123,0.023741337,0.00010154818,0.25716928,0.00063263474],"about_ca_topic_score_codex":0.00270065,"about_ca_topic_score_gemma":0.002528183,"teacher_disagreement_score":0.26242197,"about_ca_system_score_codex":0.00041433753,"about_ca_system_score_gemma":0.00028781925,"threshold_uncertainty_score":0.40825927},"labels":[],"label_agreement":null},{"id":"W2995694266","doi":"10.1111/jvh.13223","title":"Liver safety assessment in clinical trials of new agents for chronic hepatitis B","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada); Toronto Liver Centre; University Health Network","funders":"Janssen Pharmaceuticals; Gilead Sciences; Novartis; GlaxoSmithKline","keywords":"Medicine; Clinical trial; Chronic hepatitis; Internal medicine; Intensive care medicine; Virology; Virus","score_opus":0.28872929134994224,"score_gpt":0.5224618920925622,"score_spread":0.23373260074261998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995694266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005654735,0.99098897,0.0008773295,0.0001676337,0.0028303496,0.0035187872,0.00060827425,0.000011524492,0.00043168585],"genre_scores_gemma":[0.0005227389,0.98982054,0.0049251635,0.00014545802,0.002798004,0.00004916121,0.00010869063,0.000116983465,0.0015132576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9859098,0.0017713975,0.010269009,0.00047889573,0.0010130084,0.00055787584],"domain_scores_gemma":[0.98744166,0.0033324677,0.0076906774,0.0005692404,0.0005865804,0.00037937073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009019068,0.00066926214,0.011995374,0.0007582984,0.00005442354,0.00002868556,0.00045758247,0.0007478793,0.000646274],"category_scores_gemma":[0.005005206,0.00050145056,0.0045828647,0.00037724516,0.00013743874,0.00023877803,0.00018021978,0.0015642886,0.000056810622],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017784299,0.00035590082,0.042605475,0.019193739,0.0017499914,0.00028078735,0.00006652741,0.0000014796312,5.770774e-7,0.000111591595,0.024827002,0.9106291],"study_design_scores_gemma":[0.0047601378,0.0048615225,0.037721198,0.051856637,0.0050200224,0.00016246148,0.0000027318556,0.0000718135,0.0000019067783,0.000067588655,0.89510524,0.00036873066],"about_ca_topic_score_codex":0.004553291,"about_ca_topic_score_gemma":0.0052831243,"teacher_disagreement_score":0.9102604,"about_ca_system_score_codex":0.0018860316,"about_ca_system_score_gemma":0.0066525987,"threshold_uncertainty_score":0.9997437},"labels":[],"label_agreement":null},{"id":"W3006299716","doi":"10.1111/jvh.13272","title":"Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Virgo Consortium; F. Hoffmann-La Roche; Gilead Sciences; Foundation for Liver Research; Bristol-Myers Squibb","keywords":"Medicine; HBeAg; Lamivudine; Discontinuation; Gastroenterology; Internal medicine; cccDNA; Hepatitis B virus; Hepatitis B; Chronic hepatitis; Peginterferon alfa-2a; Immunology; Virology; Virus; HBsAg; Ribavirin","score_opus":0.020355493614961282,"score_gpt":0.2869564212684183,"score_spread":0.266600927653457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006299716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799248,0.0018264067,0.0004694083,0.014752812,0.0007510878,0.0011735866,0.00051143405,0.00018849099,0.00040196924],"genre_scores_gemma":[0.98090786,0.012505321,0.0013665005,0.0033142252,0.0013539529,0.00007459429,0.000015396472,0.00016967668,0.0002924504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518764,0.0005659244,0.001691055,0.00059805857,0.0010116296,0.0009457212],"domain_scores_gemma":[0.99704933,0.00036397888,0.00061516714,0.00040130047,0.0005013341,0.0010689144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059393194,0.00063525105,0.001644498,0.0006240741,0.00016310121,0.000078964826,0.0003321102,0.00023198323,0.00023587466],"category_scores_gemma":[0.0010833174,0.0005694267,0.0005102957,0.0007267663,0.00016212893,0.00054121646,0.0001937058,0.0006938454,0.00037051592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063137547,0.0005478312,0.92353326,0.00013497677,0.0005711354,0.007318188,0.0071262964,0.00012748524,0.018327141,0.000025573378,0.010335136,0.02563922],"study_design_scores_gemma":[0.0053681447,0.03318789,0.9159173,0.0013708594,0.0002945981,0.00037918685,0.00004819236,0.0010736603,0.028543627,0.000036210833,0.013276436,0.0005039041],"about_ca_topic_score_codex":0.033907983,"about_ca_topic_score_gemma":0.08546394,"teacher_disagreement_score":0.05155596,"about_ca_system_score_codex":0.0036788404,"about_ca_system_score_gemma":0.0010424196,"threshold_uncertainty_score":0.9996757},"labels":[],"label_agreement":null},{"id":"W3010758680","doi":"10.1111/jvh.13295","title":"The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; BC Centre for Disease Control; University of British Columbia","funders":"Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Incidence (geometry); Gastroenterology; Interferon; Hepatitis C; Cohort; Hazard ratio; Population; Hepatitis C virus; Oncology; Immunology; Confidence interval; Virus","score_opus":0.04240718566342806,"score_gpt":0.3364812395723933,"score_spread":0.29407405390896524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010758680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641407,0.00070158613,0.00037804726,0.00064454105,0.00009137367,0.0004900959,0.00035986706,0.000010344562,0.0009100672],"genre_scores_gemma":[0.9977507,0.0010408962,0.00069851417,0.00011624778,0.00030016125,0.000009571445,0.000014792067,0.000039924358,0.000029215676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981127,0.00022575873,0.00065461406,0.00020608417,0.00049090217,0.0003099735],"domain_scores_gemma":[0.99788517,0.0007736695,0.0005743735,0.00021036764,0.00027404935,0.00028237698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033391037,0.00021509119,0.0006309967,0.00012290523,0.00015188089,0.000049577022,0.00016531705,0.00008821051,0.00004834708],"category_scores_gemma":[0.0009411485,0.00013265616,0.00044224667,0.0001485743,0.000113766255,0.0001520314,0.000043248085,0.00041028095,0.000006585917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024832617,0.00012636324,0.8874021,0.00003307295,0.00048392738,0.00015124361,0.00035415246,0.000008846875,0.00395642,0.0000023439572,0.0010183115,0.10397996],"study_design_scores_gemma":[0.012663027,0.041760113,0.7712415,0.0008203443,0.00085535017,0.000010715418,0.00020282484,0.09215262,0.07648152,0.00020293794,0.0032346474,0.0003743998],"about_ca_topic_score_codex":0.0045952043,"about_ca_topic_score_gemma":0.00010649166,"teacher_disagreement_score":0.116160594,"about_ca_system_score_codex":0.00022423307,"about_ca_system_score_gemma":0.00024293717,"threshold_uncertainty_score":0.6946605},"labels":[],"label_agreement":null},{"id":"W3010933403","doi":"10.1111/jvh.13294","title":"Measuring hepatitis C virus elimination as a public health threat: Beyond global targets","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Hepatitis C; Incidence (geometry); Hepatitis C virus; Medicine; Public health; Environmental health; Baseline (sea); Global health; Virology; Political science; Virus; Pathology","score_opus":0.08677338192503313,"score_gpt":0.3447218099450807,"score_spread":0.2579484280200476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010933403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9010208,0.004554724,0.005487077,0.07763358,0.0006341202,0.00078001694,0.00020567617,0.00011018472,0.009573821],"genre_scores_gemma":[0.97840303,0.009763385,0.0035266376,0.007139838,0.00097238197,0.000012107094,0.00003563215,0.000052858522,0.00009412036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506164,0.0003728322,0.0012884593,0.00036181955,0.0021155488,0.00079971825],"domain_scores_gemma":[0.99630105,0.00008284704,0.00071323005,0.00027363843,0.0010691271,0.0015601241],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010865065,0.00031719718,0.0009324187,0.00028257424,0.00022870161,0.00014826306,0.00036127717,0.00017444037,0.00077972334],"category_scores_gemma":[0.0018654361,0.00029409426,0.0003791133,0.0007703315,0.00012956874,0.0008696258,0.00013831242,0.00078362535,0.00028633676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003959922,0.00043708683,0.6579991,0.00031370146,0.000360882,0.0020512347,0.0015726873,0.000011376233,0.0020255642,0.0014503114,0.017142827,0.3162392],"study_design_scores_gemma":[0.0077351625,0.016927544,0.86094546,0.0008029195,0.00019953259,0.0017455886,0.00018294904,0.004304355,0.006068351,0.0026120888,0.09761474,0.00086131576],"about_ca_topic_score_codex":0.0067418073,"about_ca_topic_score_gemma":0.0023718304,"teacher_disagreement_score":0.31537792,"about_ca_system_score_codex":0.0013316781,"about_ca_system_score_gemma":0.0018194764,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W3012226782","doi":"10.1111/jvh.13292","title":"New hepatitis C diagnoses in Ontario, Canada are associated with the local prescription patterns of a controlled‐release opioid","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; London Health Sciences Centre; Western University","funders":"","keywords":"Hydromorphone; Medicine; Incidence (geometry); Medical prescription; Hepatitis C; Opioid; Oxycodone; Internal medicine; Rate ratio; Methadone; Population; Hepatitis C virus; Poisson regression; Emergency medicine; Anesthesia; Pharmacology; Virology; Environmental health; Virus","score_opus":0.008500649430252328,"score_gpt":0.2102716070525585,"score_spread":0.20177095762230618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012226782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265575,0.000691471,0.0005739422,0.0053038225,0.00013994245,0.00049796485,0.000060123446,0.000006504414,0.00007047099],"genre_scores_gemma":[0.99786496,0.00032282496,0.00009145776,0.0013954815,0.00009241845,0.000014344824,0.000022377993,0.000020922902,0.00017519819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827194,0.00010872204,0.0006141078,0.00013766707,0.0006526486,0.00021488414],"domain_scores_gemma":[0.9985736,0.00015481972,0.00067445927,0.00012780621,0.00023066268,0.00023864946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009351671,0.00018911895,0.0007521536,0.00006586472,0.00003490662,0.000017036411,0.00012585353,0.000061788014,0.00032454095],"category_scores_gemma":[0.00022310454,0.00011835401,0.00014592413,0.00013993857,0.000030536325,0.00013022819,0.000023410315,0.00039939364,0.0000012009933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011463735,0.0002370408,0.98612607,0.00004200744,0.00034023813,0.0010956147,0.0015642934,0.000188716,0.00002602549,0.000007857259,0.0069807353,0.00224502],"study_design_scores_gemma":[0.0114393,0.0023798482,0.9830825,0.0007272783,0.00034959122,0.000030251129,0.00046600986,0.00034005404,0.00030988437,0.000014813323,0.0007514668,0.00010901818],"about_ca_topic_score_codex":0.9806266,"about_ca_topic_score_gemma":0.9972177,"teacher_disagreement_score":0.016591182,"about_ca_system_score_codex":0.00090368197,"about_ca_system_score_gemma":0.0021338689,"threshold_uncertainty_score":0.48263365},"labels":[],"label_agreement":null},{"id":"W3014424706","doi":"10.1111/jvh.13297","title":"High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre‐exposure prophylaxis","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Medicine; Men who have sex with men; Pre-exposure prophylaxis; Incidence (geometry); Hepatitis C; Sexual health clinic; Transmission (telecommunications); Cohort; Human immunodeficiency virus (HIV); Sexual transmission; Demography; Internal medicine; Virology","score_opus":0.03282720399102692,"score_gpt":0.31268522179301655,"score_spread":0.27985801780198966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014424706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776435,0.00024398127,0.00029172847,0.0007298564,0.00006191173,0.0007614423,0.000032499163,0.000006193333,0.00010805853],"genre_scores_gemma":[0.9985314,0.0007779098,0.00027583024,0.0000659142,0.00017073077,0.000021486112,0.0000051274837,0.000012344778,0.00013927445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973682,0.0004331062,0.0010484357,0.00012986458,0.0008473682,0.00017303655],"domain_scores_gemma":[0.9984839,0.00009472105,0.00056752213,0.00019649882,0.0005368367,0.000120546385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061577104,0.000121432364,0.0004966159,0.00020511482,0.000043864067,0.000018530849,0.00022989654,0.00006750989,0.00018441326],"category_scores_gemma":[0.0010617934,0.00008137369,0.0002262709,0.0005787012,0.000080157726,0.00032884072,0.000058223155,0.0005584896,0.0000062258373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050670403,0.0015560117,0.9741705,0.00029827055,0.000116044925,0.00018798825,0.004153203,0.00004271139,0.008902852,0.000026778165,0.0020854059,0.007953513],"study_design_scores_gemma":[0.0020275551,0.061082274,0.9299129,0.0005132111,0.000073522286,0.00005023782,0.0002792154,0.0004296406,0.0053615537,0.00008430736,0.00011906968,0.00006650046],"about_ca_topic_score_codex":0.019941954,"about_ca_topic_score_gemma":0.011494793,"teacher_disagreement_score":0.05952626,"about_ca_system_score_codex":0.00007567882,"about_ca_system_score_gemma":0.00015312395,"threshold_uncertainty_score":0.98658437},"labels":[],"label_agreement":null},{"id":"W3081171819","doi":"10.1111/jvh.13373","title":"Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population‐based cohort studies","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia; Public Health Ontario; University of Guelph; University Health Network; University of Toronto; University of Waterloo","funders":"Canadian Liver Foundation","keywords":"Medicine; Cohort; Population; Retrospective cohort study; Hepatitis C; Natural history; Cohort study; Demography; Disease burden; Subclinical infection; Hepatitis C virus; Environmental health; Internal medicine; Immunology; Virus","score_opus":0.035962498560340735,"score_gpt":0.3156574725540833,"score_spread":0.27969497399374255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081171819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645597,0.0021959583,0.00014583772,0.00045552407,0.00022029896,0.000422678,0.00004501445,0.000011046183,0.000047653448],"genre_scores_gemma":[0.9889118,0.0010324646,0.0090092905,0.0005781522,0.00029928164,0.000008048504,0.000009343525,0.000029826128,0.00012176406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737847,0.00014414237,0.0009235413,0.0002620318,0.0009224545,0.00036934332],"domain_scores_gemma":[0.998618,0.00013601608,0.00036550124,0.00012745732,0.00040655053,0.00034649365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041282485,0.00014251299,0.0007096325,0.000091643735,0.0001514099,0.00013327577,0.00012821576,0.00007801441,0.00046005537],"category_scores_gemma":[0.0010371519,0.00020196258,0.000079741854,0.00028387003,0.00008698228,0.00034238692,0.00007557658,0.0005954127,0.0000011613954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022351402,0.000023870334,0.9863991,0.0005515149,0.00011110013,0.0018232872,0.00018341688,0.00072566606,0.00011393277,4.5316352e-7,0.0016128762,0.0084323995],"study_design_scores_gemma":[0.001225321,0.00065950066,0.9426617,0.0018517313,0.00011641762,0.00022119787,0.000015947293,0.05276368,0.00002681349,0.000023972441,0.00026764625,0.0001660979],"about_ca_topic_score_codex":0.9974351,"about_ca_topic_score_gemma":0.9996983,"teacher_disagreement_score":0.052038014,"about_ca_system_score_codex":0.004083611,"about_ca_system_score_gemma":0.0037447612,"threshold_uncertainty_score":0.9997395},"labels":[],"label_agreement":null},{"id":"W3081354703","doi":"10.1111/jvh.13378","title":"Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre on Substance Use; University of British Columbia","funders":"Sidaction; National Institute on Drug Abuse; Schering-Plough; Roche","keywords":"Men who have sex with men; Medicine; Hepatitis C; Qualitative research; Human immunodeficiency virus (HIV); Quality of life (healthcare); Cohort; Gerontology; Family medicine; Internal medicine; Nursing","score_opus":0.02136681035605176,"score_gpt":0.34295642243666447,"score_spread":0.3215896120806127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081354703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265736,0.0014719925,0.00016459194,0.0039962735,0.000008683168,0.00076122774,0.0002208753,0.000022403057,0.0006965761],"genre_scores_gemma":[0.99100864,0.006503075,0.0014847177,0.00065527676,0.00006672042,0.00008290484,0.000027978844,0.000054104432,0.00011658927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962901,0.0009320457,0.00091020396,0.00056070625,0.0007793168,0.00052762404],"domain_scores_gemma":[0.9977887,0.00070125086,0.00043568056,0.00013754665,0.00026999015,0.0006668063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007094573,0.00039816566,0.0015077294,0.00048872613,0.00017788216,0.00014436358,0.00009999803,0.00014501957,0.000108108055],"category_scores_gemma":[0.0005973479,0.00030688598,0.000052848784,0.0007174392,0.0004469834,0.0009842499,0.000082165716,0.0008432546,0.0000022453878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007226343,0.00006546618,0.6482874,0.00011176753,0.000103497325,0.00021916858,0.34815836,0.0000032766218,0.00014582938,0.0000033992214,0.0005318609,0.0016473585],"study_design_scores_gemma":[0.004486626,0.0053205285,0.85235834,0.0018485984,0.00005038131,0.00002844911,0.12770787,0.0075903405,0.00018671343,0.000013212828,0.00007730514,0.00033160884],"about_ca_topic_score_codex":0.042620588,"about_ca_topic_score_gemma":0.017523142,"teacher_disagreement_score":0.22045048,"about_ca_system_score_codex":0.00021952194,"about_ca_system_score_gemma":0.0004651229,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W3084259013","doi":"10.1111/jvh.13401","title":"Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Centre for Global Health Research; Toronto General Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Renal function; Tenofovir; Urology; Internal medicine; Kidney disease; Dialysis; Kidney; Gastroenterology; Pharmacology; Human immunodeficiency virus (HIV); Immunology","score_opus":0.0127172482292829,"score_gpt":0.24093377155432524,"score_spread":0.22821652332504233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084259013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954639,0.0005932007,0.00035541973,0.0026276566,0.0001718592,0.00053721364,0.000033259246,0.000039285933,0.00017822244],"genre_scores_gemma":[0.9950689,0.0022726487,0.0010634437,0.000981051,0.00045076417,0.000022505217,0.0000341528,0.000043822005,0.00006268572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971576,0.00023765546,0.0010146721,0.00039150903,0.0007253436,0.00047323407],"domain_scores_gemma":[0.9983787,0.00008539508,0.0005828227,0.00017734354,0.00035000048,0.00042573197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150655,0.00035162078,0.00088964094,0.00022381224,0.00014295461,0.0000462831,0.00012133685,0.00018057,0.00015137359],"category_scores_gemma":[0.00038538757,0.00024428495,0.00014685311,0.0003594051,0.00020434434,0.00047395675,0.00012820454,0.0006856386,0.000014122184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005530536,0.0003057914,0.9556237,0.00012979985,0.00016792708,0.0009599424,0.0005381387,0.000035616053,0.017123314,0.000029638315,0.0015472163,0.018008415],"study_design_scores_gemma":[0.0073473076,0.024050023,0.9637979,0.0006725951,0.00019062593,0.00013637076,0.000019804045,0.0014198588,0.0012983303,0.00013043695,0.00067109405,0.00026562516],"about_ca_topic_score_codex":0.0012304357,"about_ca_topic_score_gemma":0.0023936098,"teacher_disagreement_score":0.023744233,"about_ca_system_score_codex":0.00041065554,"about_ca_system_score_gemma":0.00026330634,"threshold_uncertainty_score":0.9961651},"labels":[],"label_agreement":null},{"id":"W3088941285","doi":"10.1111/jvh.13412","title":"The case for simplifying and using absolute targets for viral hepatitis elimination goals","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Shengjing Hospital; College of Medicine, King Saud University; Yonsei University College of Medicine; Weill Cornell Medical College; Sorbonne Université; Alfaisal University; King Abdullah International Medical Research Center; Kaohsiung Medical University Chung-Ho Memorial Hospital; Humanitas University; Qassim University; School of Medicine, Stanford University; Institut National de la Santé et de la Recherche Médicale; National Taiwan University; Academia Sinica; Universidade Estadual de Campinas; Universidad de Cantabria; Universitat de Barcelona; Göteborgs Universitet; Hamad Medical Corporation; Università di Pisa; Universidade Federal de Goiás; National Yang-Ming University; National Taiwan University Hospital; Chinese University of Hong Kong; Kaohsiung Medical University; Wayne State University; Queen Mary University of London; I-Shou University; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; University of Hong Kong; Macquarie University; University of Toronto; Sultan Qaboos University; Örebro Universitet; Trimbos-instituut; Cairo University; Odense Universitetshospital; Northwestern University; Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa; Yonsei University; Burnet Institute; Weill Cornell Medicine - Qatar; Feinberg School of Medicine; Ain Shams University; Theodor Bilharz Research Institute; Johns Hopkins University; Università degli Studi di Palermo; National Center for Global Health and Medicine; Università degli Studi di Milano; King Faisal Specialist Hospital and Research Centre; Universidad del Rosario; China Medical University; Universidade Nova de Lisboa; University of Dundee; University College London; Saint Louis University; Istituto Superiore di Sanità; University of Ottawa; National and Kapodistrian University of Athens; Hallym University; King Saud University","keywords":"Absolute (philosophy); Viral hepatitis; Virology; Computer science; Medicine; Philosophy","score_opus":0.04923049613192292,"score_gpt":0.33216916521148987,"score_spread":0.28293866907956694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088941285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96231115,0.0033453016,0.024377916,0.008154899,0.0005071199,0.001022099,0.00019050387,0.000024648114,0.00006639065],"genre_scores_gemma":[0.9765142,0.002990612,0.017828014,0.0013962651,0.0011272811,0.00003546988,0.000008025776,0.00004844735,0.000051667692],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982002,0.00006574775,0.00084780523,0.00020948787,0.00028643332,0.00039037308],"domain_scores_gemma":[0.9978179,0.00056747295,0.00058081734,0.00011902151,0.0006732999,0.00024149804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005525215,0.0002192473,0.00057007076,0.000093033756,0.00065215206,0.00009399101,0.00010083939,0.00009745714,0.000010112493],"category_scores_gemma":[0.0015779071,0.00016544411,0.00026207897,0.00011075084,0.000120759796,0.00036184324,0.000067018496,0.00022314243,0.0000019466584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049916035,0.00042881677,0.39693362,0.0032430277,0.0027608622,0.01014053,0.0108400965,0.0002556922,0.041584615,0.005388644,0.05924222,0.46419027],"study_design_scores_gemma":[0.031171385,0.03306303,0.24793781,0.0024827968,0.0054547447,0.026275365,0.001713609,0.3981117,0.027776025,0.013765487,0.20962335,0.002624692],"about_ca_topic_score_codex":0.0010880285,"about_ca_topic_score_gemma":0.0017171274,"teacher_disagreement_score":0.46156558,"about_ca_system_score_codex":0.0001800226,"about_ca_system_score_gemma":0.00012956705,"threshold_uncertainty_score":0.6746615},"labels":[],"label_agreement":null},{"id":"W3092819238","doi":"10.1111/jvh.13419","title":"Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Cirrhosis; Medicine; Sofosbuvir; Chronic hepatitis; Internal medicine; Gastroenterology; Intensive care medicine; Virology; Ribavirin; Virus","score_opus":0.03347749955496587,"score_gpt":0.32914820685684276,"score_spread":0.2956707073018769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092819238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760795,0.0005200143,0.0006314909,0.00026937437,0.000046769692,0.00060554733,0.00017962858,0.000011877743,0.00012733135],"genre_scores_gemma":[0.99719006,0.0017972842,0.0006387796,0.00018454745,0.00006574517,0.00001531154,0.00006690222,0.00003690956,0.0000044866883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970898,0.00035887922,0.0009377908,0.00030471786,0.0009312999,0.00037752642],"domain_scores_gemma":[0.99784356,0.00029970624,0.000520289,0.00022289185,0.00069479394,0.00041874553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000490844,0.00024743826,0.0013206222,0.00091390236,0.000050317376,0.000030634368,0.00018232844,0.00012791333,0.00023216738],"category_scores_gemma":[0.0004300593,0.00020333882,0.00022395438,0.0018598769,0.00018509018,0.00037297903,0.00009102738,0.00053198094,0.000007068341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001058916,0.00021829602,0.96024925,0.00024568703,0.0012216418,0.000307333,0.00034971058,0.00024266388,0.0012430628,0.000013434407,0.00006429261,0.034785736],"study_design_scores_gemma":[0.005061331,0.004504211,0.9800503,0.00045808873,0.0008584451,0.000009211097,0.000014042255,0.006289845,0.002136038,0.000010366833,0.00042256265,0.0001855084],"about_ca_topic_score_codex":0.004125974,"about_ca_topic_score_gemma":0.003624423,"teacher_disagreement_score":0.034600228,"about_ca_system_score_codex":0.00057840213,"about_ca_system_score_gemma":0.00044660096,"threshold_uncertainty_score":0.8291916},"labels":[],"label_agreement":null},{"id":"W3094920525","doi":"10.1111/jvh.13429","title":"HIV influences clustering and intracellular replication of hepatitis C virus","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; NIH Office of the Director; National Institute on Drug Abuse; Danone Institute of Canada","keywords":"Coinfection; Hepatitis C virus; RNA; Intracellular; Virology; Biology; Hepacivirus; Hepatitis C; Human immunodeficiency virus (HIV); Immunology; Virus; Genetics; Gene","score_opus":0.034759943952570746,"score_gpt":0.3173842233898246,"score_spread":0.2826242794372538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094920525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921903,0.0012068646,0.0024545258,0.0031855842,0.00007364943,0.00022102814,0.00003185578,0.000015971056,0.0006202463],"genre_scores_gemma":[0.98541653,0.008984958,0.0046529714,0.0005624447,0.00029658666,0.0000041996364,0.0000062810914,0.000023493505,0.000052508967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793,0.000106399515,0.0008725119,0.0002242848,0.00065327715,0.00021354876],"domain_scores_gemma":[0.9984043,0.00009022516,0.00048514313,0.00025186478,0.00042403705,0.00034442905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045783463,0.00014066567,0.00052362925,0.0001770839,0.00005372383,0.000032064778,0.00016418796,0.00010035871,0.00018999881],"category_scores_gemma":[0.0009734869,0.00012508626,0.000120212666,0.00026146494,0.00015602901,0.00036130377,0.00009469754,0.00039302502,0.000019688468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002553684,0.00006473754,0.8031443,0.00028180113,0.000099609206,0.00029199632,0.0008170257,0.000025425346,0.1259314,0.00006526098,0.0011595353,0.067863576],"study_design_scores_gemma":[0.0031057587,0.005342182,0.7880771,0.00094229466,0.00023463959,0.0004698353,0.00009588554,0.020698465,0.15798791,0.00032502087,0.022355642,0.000365268],"about_ca_topic_score_codex":0.0013853791,"about_ca_topic_score_gemma":0.00021813103,"teacher_disagreement_score":0.067498304,"about_ca_system_score_codex":0.00007689066,"about_ca_system_score_gemma":0.00016024846,"threshold_uncertainty_score":0.51008695},"labels":[],"label_agreement":null},{"id":"W3096397297","doi":"10.1111/jvh.13434","title":"Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studies","year":2020,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Internal medicine; Odds ratio; Observational study; Confidence interval; Publication bias; Cohort study; Kidney cancer; Hepatitis C; Hepatitis C virus; Cancer; Oncology; Immunology; Virus","score_opus":0.15077468811208952,"score_gpt":0.4380203041096482,"score_spread":0.2872456159975587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096397297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074855867,0.9955721,0.000025430007,0.00051707303,0.000071878094,0.001355749,0.0016788656,0.000004956383,0.000025403924],"genre_scores_gemma":[0.00045594343,0.9986464,0.00039799468,0.00014409804,0.00006246002,0.000099012395,0.000052675445,0.00003117689,0.00011028396],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934076,0.0013677869,0.003494052,0.00024430326,0.0013039577,0.00018229772],"domain_scores_gemma":[0.98768044,0.0012314196,0.0082612755,0.00024803617,0.0023023486,0.00027645723],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023965933,0.00035953033,0.012817115,0.0008754974,0.000047003305,0.0000130561975,0.0001329777,0.00023118858,0.00013427509],"category_scores_gemma":[0.01161498,0.00025371544,0.0020222743,0.0015072525,0.00012796608,0.00022523323,0.0001025422,0.00057800097,9.573207e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009449696,0.000054489094,0.08525892,0.6309609,0.2755295,0.000013851512,0.0001019455,8.7318136e-7,9.056752e-7,0.00001584779,0.000951794,0.0071015675],"study_design_scores_gemma":[0.00031193398,0.00061810046,0.0040760133,0.12836446,0.85468334,0.000023915183,0.000004486538,0.000058078913,0.000005307872,0.00002189136,0.011677982,0.00015448846],"about_ca_topic_score_codex":0.0037681735,"about_ca_topic_score_gemma":0.0014194872,"teacher_disagreement_score":0.57915384,"about_ca_system_score_codex":0.00046290088,"about_ca_system_score_gemma":0.0009626602,"threshold_uncertainty_score":0.99999154},"labels":[],"label_agreement":null},{"id":"W3113135622","doi":"10.1111/jvh.13453","title":"Distinct Hepatitis B and HIV co‐infected populations in Canada","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Canadian Science Centre for Human and Animal Health; University of Manitoba; Vancouver Infectious Diseases Centre; Saskatchewan Science Centre; University of Saskatchewan; University of Alberta; University of Calgary; Dalhousie University; University of Toronto; McGill University; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Cohort; Hepatitis B; Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Human immunodeficiency virus (HIV); Population; Immunology; Environmental health; Virus","score_opus":0.032040168792296535,"score_gpt":0.2841499652360542,"score_spread":0.25210979644375764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113135622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284446,0.00052121864,0.00013811221,0.005064537,0.00019143686,0.00017220815,0.00013208101,0.000012740384,0.0009232145],"genre_scores_gemma":[0.9963945,0.00094962335,0.00095850497,0.0013503123,0.00025715254,0.000003908037,0.000021709697,0.000021664862,0.0000426119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836916,0.000077679855,0.0007235954,0.00015007482,0.00043407094,0.00024542978],"domain_scores_gemma":[0.99903405,0.000087014145,0.00027821108,0.00009393188,0.00019163192,0.00031516064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105335035,0.00016606704,0.0005812118,0.000112328285,0.00007705381,0.00001849853,0.00007220616,0.00004834779,0.0002059241],"category_scores_gemma":[0.00063658017,0.0001489142,0.000074240845,0.00024671454,0.000055979992,0.00017744272,0.00004133335,0.00036010417,0.000012469032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058701255,0.000031118576,0.9843324,0.000055766024,0.000047912086,0.0009964827,0.00032192373,0.0000063297903,0.00016927061,0.000054335116,0.010945825,0.0029799805],"study_design_scores_gemma":[0.0012140684,0.0004321846,0.9919699,0.00017812259,0.000070180824,0.00016985682,0.000032559517,0.000995717,0.00011959978,0.000060589053,0.0046211514,0.00013609401],"about_ca_topic_score_codex":0.84437054,"about_ca_topic_score_gemma":0.9739338,"teacher_disagreement_score":0.12956329,"about_ca_system_score_codex":0.00051424635,"about_ca_system_score_gemma":0.0007892451,"threshold_uncertainty_score":0.6072545},"labels":[],"label_agreement":null},{"id":"W3115353623","doi":"10.1111/jvh.13460","title":"Improvement in cognitive impairment following a 12‐week aerobic exercise intervention in individuals with non‐cirrhotic chronic hepatitis C","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Cardiorespiratory fitness; Aerobic exercise; Medicine; Physical therapy; Montreal Cognitive Assessment; Cognition; Quality of life (healthcare); Depression (economics); Anthropometry; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.01351760131970038,"score_gpt":0.2672399341006473,"score_spread":0.2537223327809469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115353623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995926,0.002083008,0.00007986727,0.0006103925,0.00015010832,0.0010490767,0.000021158741,0.000009600085,0.000070738875],"genre_scores_gemma":[0.99754417,0.0014749016,0.00030304713,0.00036329188,0.00011160257,0.000114779585,0.00003129636,0.000031566688,0.000025354484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980067,0.00006503891,0.00082543347,0.0002620247,0.00051890884,0.0003219188],"domain_scores_gemma":[0.999091,0.00004403717,0.00040267757,0.00010049324,0.000093692775,0.0002680485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024298487,0.0002409178,0.00067489594,0.0002816156,0.000032436357,0.000042033913,0.000092235765,0.00005442361,0.00016025877],"category_scores_gemma":[0.000038278242,0.0001914174,0.00034648553,0.00026319077,0.000031660154,0.0003548267,0.0000530739,0.00029165676,0.000022703322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051323354,0.0022059362,0.96992445,0.0002510345,0.00041787428,0.0033463486,0.0016365559,0.000020981119,0.00013303265,0.0000022888917,0.00016636756,0.021381874],"study_design_scores_gemma":[0.018029245,0.015275312,0.95495737,0.007659856,0.00077349297,0.00003658079,0.0003269844,0.00034720305,0.002340874,0.000036416342,0.00002138883,0.00019530022],"about_ca_topic_score_codex":0.0019481266,"about_ca_topic_score_gemma":0.0022605131,"teacher_disagreement_score":0.021186573,"about_ca_system_score_codex":0.00078879576,"about_ca_system_score_gemma":0.00019879415,"threshold_uncertainty_score":0.78057754},"labels":[],"label_agreement":null},{"id":"W3119993225","doi":"10.1111/jvh.13467","title":"Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Sofosbuvir; Hepatitis C virus; Genotype; Cirrhosis; Ledipasvir; Hepatitis C; Odds ratio; Logistic regression; Multivariate analysis; Virology; Virus; Ribavirin; Biology","score_opus":0.033311035798428576,"score_gpt":0.3308294903170017,"score_spread":0.2975184545185731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119993225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017614,0.0014193888,0.004562918,0.0017640783,0.00012916738,0.0010172905,0.0007900394,0.000010512031,0.00013045],"genre_scores_gemma":[0.9821552,0.0138115445,0.0033104618,0.00010408159,0.00015671011,0.00013295255,0.0001030058,0.00004142777,0.00018460135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799836,0.00013388625,0.0008060585,0.0002947691,0.00034049887,0.0004264486],"domain_scores_gemma":[0.9977096,0.0006275872,0.00024914258,0.00020917866,0.00091740413,0.00028713496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004988614,0.00019768486,0.0005829699,0.0005685504,0.00012137318,0.00007685994,0.00011810208,0.00015349168,0.000032663123],"category_scores_gemma":[0.002525844,0.00017977407,0.00016199995,0.0005968564,0.000051425144,0.00033973384,0.000047859547,0.00034205403,0.000004650645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041668108,0.0004046673,0.8757042,0.00015128095,0.000054515473,0.00008192027,0.001011526,0.00003724486,0.030091109,0.00023173436,0.0027370607,0.08907806],"study_design_scores_gemma":[0.0030232212,0.0014546335,0.97178626,0.0002114907,0.00009035656,0.000035588455,0.00004602547,0.0005215009,0.01516849,0.000994849,0.0064905593,0.00017703963],"about_ca_topic_score_codex":0.0021903361,"about_ca_topic_score_gemma":0.018715259,"teacher_disagreement_score":0.09608205,"about_ca_system_score_codex":0.0004918071,"about_ca_system_score_gemma":0.00034475847,"threshold_uncertainty_score":0.9991906},"labels":[],"label_agreement":null},{"id":"W3126254847","doi":"10.1111/jvh.13482","title":"Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; Toronto General Hospital; Queen's University; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Decompensation; Hazard ratio; Cirrhosis; Gastroenterology; Confidence interval; Hepatocellular carcinoma; Proportional hazards model; Publication bias; Hepatitis C","score_opus":0.08816738161005287,"score_gpt":0.4238348621550416,"score_spread":0.33566748054498874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126254847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03791743,0.9591162,0.0000038815897,0.000033682594,0.000037315116,0.0022101568,0.0004935779,0.000008397939,0.00017932043],"genre_scores_gemma":[0.08230669,0.9172356,0.00011570053,0.000045847446,0.000035130128,0.000058244837,0.00007042159,0.000064602646,0.000067748544],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99315876,0.0016111264,0.0027798607,0.000527822,0.0014448892,0.0004775521],"domain_scores_gemma":[0.9945018,0.0007517055,0.0029913068,0.00075529993,0.0006866131,0.00031326775],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0017051111,0.00073689595,0.015787637,0.0011177097,0.000064694985,0.00006309805,0.00022593403,0.00026007227,0.00014305141],"category_scores_gemma":[0.0012917547,0.00043217384,0.0027840864,0.0012827506,0.00017046001,0.00033196463,0.00013683905,0.0011146065,0.0000026031637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001650936,0.00030523917,0.52176183,0.3570579,0.114072576,0.00038089705,0.000026383015,0.0000010224794,4.8160718e-8,0.0000022572235,0.00003643076,0.006338935],"study_design_scores_gemma":[0.0010631781,0.003352447,0.20049319,0.18770143,0.60653716,0.000041564825,0.0000018293563,0.000014997771,9.963126e-7,0.0000019190818,0.00031418118,0.00047709243],"about_ca_topic_score_codex":0.006674441,"about_ca_topic_score_gemma":0.0033328722,"teacher_disagreement_score":0.4924646,"about_ca_system_score_codex":0.000936864,"about_ca_system_score_gemma":0.00088552735,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W3139139960","doi":"10.1111/jvh.13500","title":"Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McGill University; University of Ottawa; Vancouver Infectious Diseases Centre; Toronto General Hospital; McMaster University; St. Paul's Hospital; University of Toronto; Western University; Regina Qu'Appelle Health Region; University of Alberta; University Health Network","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Renal function; Medicine; Internal medicine; Kidney disease; Adverse effect; Tenofovir; Gastroenterology; Hepatitis B; Chronic hepatitis; Creatinine; Urology; Immunology; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.008905847415190871,"score_gpt":0.27195863191429587,"score_spread":0.263052784499105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139139960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956578,0.0013178379,0.00011065324,0.00012874728,0.00047295447,0.0006754131,0.0000857532,0.000021744783,0.0015291144],"genre_scores_gemma":[0.9893596,0.0094236415,0.0004686823,0.00006272976,0.0002832402,0.000018480965,0.000018335175,0.000053133976,0.00031213948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620765,0.00063977815,0.0014638888,0.00037069488,0.0008977596,0.0004202121],"domain_scores_gemma":[0.9966251,0.0003949546,0.0009146774,0.00036683903,0.0014291871,0.0002692377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008523552,0.00035459388,0.0014158409,0.0003726055,0.00018595411,0.000036080677,0.00014646517,0.00010530703,0.00015914663],"category_scores_gemma":[0.0005458738,0.0003039266,0.00028237316,0.0005540398,0.00028646222,0.00045868094,0.00021187359,0.000528322,0.000008131283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005437984,0.00089216453,0.9797174,0.0003941606,0.0008042507,0.0011212006,0.00056826783,0.000019169473,0.0020460617,0.00007944641,0.00036518296,0.013448901],"study_design_scores_gemma":[0.0057243933,0.005216049,0.98064554,0.001684277,0.00052884535,0.00007598209,0.0000466196,0.000077205535,0.00514368,0.00014146026,0.00046107452,0.0002548794],"about_ca_topic_score_codex":0.013216762,"about_ca_topic_score_gemma":0.057848714,"teacher_disagreement_score":0.04463195,"about_ca_system_score_codex":0.0006932148,"about_ca_system_score_gemma":0.00054203253,"threshold_uncertainty_score":0.9999413},"labels":[],"label_agreement":null},{"id":"W3186417867","doi":"10.1111/jvh.13574","title":"Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C virus; Hepatitis C; Population; Meta-analysis; Health care; Family medicine; Environmental health; Internal medicine; Virus; Immunology; Political science","score_opus":0.0625517778424757,"score_gpt":0.4171279216271097,"score_spread":0.354576143784634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186417867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022968867,0.9936075,0.00046177037,0.00009049881,0.00015212486,0.0037982159,0.0017185585,0.000014515618,0.00013379991],"genre_scores_gemma":[0.00018781493,0.9977579,0.0007618283,0.00015241806,0.00026342113,0.00043145506,0.00018909146,0.00007265047,0.00018340623],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9932106,0.0010553487,0.003559692,0.0004817101,0.0012127154,0.00047994117],"domain_scores_gemma":[0.99332863,0.0004758595,0.0029546358,0.00074415526,0.0020651422,0.00043157756],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011683137,0.00068333617,0.017504001,0.0007740168,0.00011380055,0.00007163727,0.00031670122,0.00047143726,0.00050853315],"category_scores_gemma":[0.0012867425,0.0004903462,0.007721084,0.001981525,0.00014723008,0.00023252035,0.00015561255,0.00068530586,0.000009218955],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007359664,0.000068057634,0.0004826591,0.8357817,0.1410321,0.0003363647,0.000031722488,0.0000011225922,1.3066189e-7,0.000033565837,0.00057078426,0.021654472],"study_design_scores_gemma":[0.0003517831,0.0013001326,0.000051600033,0.18105865,0.72528243,0.0010238969,0.0000029996668,0.000009972816,0.000003211672,0.0000070702968,0.090613775,0.00029446732],"about_ca_topic_score_codex":0.0062025394,"about_ca_topic_score_gemma":0.018276734,"teacher_disagreement_score":0.654723,"about_ca_system_score_codex":0.0015122001,"about_ca_system_score_gemma":0.0021878162,"threshold_uncertainty_score":0.99975485},"labels":[],"label_agreement":null},{"id":"W3192372167","doi":"10.1111/jvh.13591","title":"Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Liver Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"HBeAg; Medicine; HBsAg; Cohort; Hepatitis B virus; Hepatitis B; Internal medicine; Gastroenterology; Prospective cohort study; Immunology; Virus","score_opus":0.005400379761502039,"score_gpt":0.24295231565172165,"score_spread":0.2375519358902196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192372167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948743,0.00300231,0.000045300116,0.00020737028,0.00014830148,0.0014228751,0.00005508568,0.000025425796,0.00021905736],"genre_scores_gemma":[0.96490383,0.033639554,0.000763789,0.00017115606,0.0002954858,0.000083532614,0.000016556678,0.00006260881,0.00006347436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964448,0.00030205795,0.0011856575,0.0005843248,0.0008836543,0.0005994765],"domain_scores_gemma":[0.998098,0.00015781079,0.0005629267,0.0003435728,0.0005965198,0.00024115577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003873961,0.00042254556,0.0014416181,0.00050205074,0.00012961151,0.00006068448,0.0001581622,0.00010412381,0.00012212792],"category_scores_gemma":[0.00049508933,0.00036994682,0.00013113263,0.0011299956,0.00024461982,0.00052934064,0.00018730026,0.00083290745,0.0000120039595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021894723,0.0010829172,0.9805543,0.00008629181,0.0005460221,0.0065501668,0.004511232,0.000023839304,0.000015066202,0.0000051557477,0.000076044504,0.0063300403],"study_design_scores_gemma":[0.0040108045,0.005162545,0.9868111,0.001951517,0.00016494081,0.0011115489,0.0001433287,0.00015126447,0.00006563092,0.000016272032,0.000040173712,0.0003709016],"about_ca_topic_score_codex":0.10353837,"about_ca_topic_score_gemma":0.7768303,"teacher_disagreement_score":0.6732919,"about_ca_system_score_codex":0.0009814388,"about_ca_system_score_gemma":0.00066870626,"threshold_uncertainty_score":0.99987525},"labels":[],"label_agreement":null},{"id":"W3195949386","doi":"10.1111/jvh.13599","title":"Mean HBsAg decline at week 24 of PEG‐IFN‐based treatment predicts subsequent rate of HBsAg clearance — suggesting a valuable endpoint for early development HBV trials","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Liver Centre; Toronto General Hospital","funders":"Janssen Research and Development","keywords":"HBsAg; Medicine; Internal medicine; HBeAg; Gastroenterology; Hepatitis B virus; Immunology; Virus","score_opus":0.10551527617482388,"score_gpt":0.3395841333538411,"score_spread":0.2340688571790172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195949386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991544,0.0037794781,0.0015912785,0.0010631931,0.00059516047,0.0009181988,0.00024299978,0.00002093152,0.00024474194],"genre_scores_gemma":[0.96368045,0.0017511933,0.03285245,0.0002796263,0.00032559564,0.0000615723,0.000041302927,0.00005776612,0.0009500234],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948525,0.0005154522,0.0029537252,0.0003294204,0.00084288453,0.0005060547],"domain_scores_gemma":[0.9946545,0.0009799326,0.0021686,0.00032929177,0.0016112796,0.00025643987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027907293,0.00037546927,0.002206026,0.00025649756,0.00016374505,0.000023872535,0.00015734028,0.00013465014,0.00019863878],"category_scores_gemma":[0.0028323056,0.00029901855,0.000705449,0.00028274764,0.00013724522,0.00017255818,0.00010318174,0.00020881595,0.000007652613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012212389,0.0036718012,0.8326479,0.0021748436,0.0038567907,0.0013762624,0.007395278,0.0007188939,0.089973316,0.00012079408,0.00633203,0.03951968],"study_design_scores_gemma":[0.015240016,0.009433882,0.36600405,0.0029281406,0.0012053045,0.00013802841,0.00010911956,0.0009542457,0.59382015,0.00020336363,0.009615064,0.00034863796],"about_ca_topic_score_codex":0.001443418,"about_ca_topic_score_gemma":0.0054711453,"teacher_disagreement_score":0.5038468,"about_ca_system_score_codex":0.0009893962,"about_ca_system_score_gemma":0.0015968346,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W3197061720","doi":"10.1111/jvh.13608","title":"Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Farnesoid X receptor; Medicine; Internal medicine; Entecavir; Placebo; HBsAg; Gastroenterology; Agonist; HBeAg; Pegylated interferon; Hepatitis B; Adverse effect; Hepatitis B virus; Viral load; Partial agonist; Pharmacology; Receptor; Lamivudine; Chronic hepatitis; Immunology; Nuclear receptor; Virus; Biology; Ribavirin; Transcription factor; Pathology","score_opus":0.025232566213175496,"score_gpt":0.31024622699669097,"score_spread":0.2850136607835155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197061720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784863,0.014761082,0.0007379433,0.0027295684,0.001323465,0.0012489008,0.00024287464,0.000018112045,0.00045177888],"genre_scores_gemma":[0.9468661,0.049030356,0.0014251993,0.00015702174,0.0010985457,0.00007328862,0.000017315218,0.00004175342,0.0012904151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975666,0.00015863456,0.0011470786,0.00023057438,0.0005669302,0.0003301885],"domain_scores_gemma":[0.9973573,0.0004916829,0.0006211337,0.00041591655,0.0009764875,0.00013746347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036592328,0.00026195878,0.0010055226,0.00010775475,0.0002715247,0.000030496181,0.00015222577,0.000079016434,0.0003919228],"category_scores_gemma":[0.00036584013,0.00016999866,0.0005863859,0.00026104835,0.00015151306,0.00011530116,0.000043645403,0.0001781569,0.000016067192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008121373,0.004033046,0.84315854,0.00016220169,0.0022317707,0.00049344334,0.003339572,0.000019240135,0.0027872487,0.00016738159,0.0044693877,0.138326],"study_design_scores_gemma":[0.011691571,0.042408414,0.6739403,0.0005099756,0.0020063054,0.00042517247,0.0006447259,0.0003634463,0.01682417,0.00017229874,0.2506628,0.00035082008],"about_ca_topic_score_codex":0.0045993486,"about_ca_topic_score_gemma":0.0263517,"teacher_disagreement_score":0.24619342,"about_ca_system_score_codex":0.0008644164,"about_ca_system_score_gemma":0.0006970676,"threshold_uncertainty_score":0.99141484},"labels":[],"label_agreement":null},{"id":"W3199012128","doi":"10.1111/jvh.13613","title":"Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto; University Health Network","funders":"","keywords":"HBsAg; Medicine; Gastroenterology; Internal medicine; Hepatitis B virus; Flare; Combination therapy; PEG ratio; Immunology; Virology; Virus","score_opus":0.005875427593792785,"score_gpt":0.2430034346520854,"score_spread":0.23712800705829262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199012128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979353,0.0009547461,0.0000101566975,0.00026025574,0.00023698124,0.0002920682,0.0000145305,0.0000071227514,0.00028884792],"genre_scores_gemma":[0.9950723,0.004335951,0.00013360385,0.00017559982,0.00014636334,0.000008371627,0.000004580723,0.000021035003,0.000102165744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986883,0.000106431995,0.0004164769,0.00015884325,0.00042510006,0.00020488712],"domain_scores_gemma":[0.9990928,0.00014118067,0.0002842069,0.00012844983,0.00024874552,0.00010461481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090195266,0.00019078006,0.00057125953,0.00021272461,0.0000515037,0.000011789963,0.000028986982,0.000069397734,0.000033243145],"category_scores_gemma":[0.00017959949,0.00013116687,0.00009284903,0.00017447081,0.000057731406,0.00012448276,0.000025594063,0.0002172358,0.0000067377277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042972644,0.0007940315,0.9641412,0.00022061901,0.00023250717,0.00047305235,0.00028047044,0.000025779405,0.0005772685,0.000023182514,0.0001738248,0.032628335],"study_design_scores_gemma":[0.005974778,0.018696787,0.94174176,0.001837379,0.00014723746,0.00002550271,0.000004224757,0.000021232921,0.03102451,0.000036228794,0.00038845968,0.000101891914],"about_ca_topic_score_codex":0.0016680072,"about_ca_topic_score_gemma":0.0072949803,"teacher_disagreement_score":0.032526445,"about_ca_system_score_codex":0.00064941606,"about_ca_system_score_gemma":0.0001807849,"threshold_uncertainty_score":0.53488296},"labels":[],"label_agreement":null},{"id":"W3212334906","doi":"10.1111/jvh.13630","title":"Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Lakehead University","funders":"","keywords":"Medicine; Gastroenterology; Hepatitis C; Internal medicine; Hepatitis","score_opus":0.03286927990297579,"score_gpt":0.35024153320887347,"score_spread":0.3173722533058977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212334906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772573,0.0014956046,0.0053650094,0.0007377012,0.0017103984,0.0005156297,0.00013556726,0.000038019964,0.002276309],"genre_scores_gemma":[0.9816446,0.004298482,0.011310438,0.0003462882,0.0010835174,0.000027253427,0.00011358684,0.00010064459,0.0010752431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954948,0.00022387803,0.0012127976,0.00042025375,0.0015387371,0.0011095379],"domain_scores_gemma":[0.9966115,0.0003459335,0.0005538137,0.00044370446,0.0015545433,0.0004905097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006798474,0.00034348984,0.00091781677,0.00058980443,0.00022626131,0.00016051071,0.0003275346,0.00022514205,0.0008839971],"category_scores_gemma":[0.0016963278,0.00034114582,0.00069179543,0.0006335763,0.00010871145,0.00067064253,0.00011183089,0.0009963205,0.00012087687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030644068,0.0011706009,0.90115917,0.0005099208,0.0012590286,0.0020030625,0.0003605711,0.000012714194,0.03265493,0.001606422,0.0126983095,0.043500897],"study_design_scores_gemma":[0.049298216,0.026647413,0.6634359,0.0015606319,0.0013755475,0.0005287583,0.0002740412,0.0023869874,0.15427755,0.0070268326,0.0914622,0.0017259507],"about_ca_topic_score_codex":0.000610043,"about_ca_topic_score_gemma":0.001068005,"teacher_disagreement_score":0.23772326,"about_ca_system_score_codex":0.0014345521,"about_ca_system_score_gemma":0.0012500328,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W3215309323","doi":"10.1111/jvh.13637","title":"The impact of the first, second and third waves of covid‐19 on hepatitis B and C testing in Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Toronto; Public Health Ontario; Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Pandemic; HBsAg; Asymptomatic; Virology; Hepatitis B virus; Hepatitis C virus; Hepatitis C; Coronavirus disease 2019 (COVID-19); Virus; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.021125514917991337,"score_gpt":0.26862758609142856,"score_spread":0.24750207117343723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215309323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951577,0.001604334,0.0000013599094,0.0014621395,0.0001533236,0.00013841999,0.000052109503,0.0000018037044,0.0014288167],"genre_scores_gemma":[0.99772626,0.0013697047,0.00017139803,0.00037084753,0.000048929625,0.0000020038678,8.6069906e-7,0.000011123258,0.00029889308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849254,0.00010276434,0.00067571737,0.00012139657,0.00040163426,0.00020592721],"domain_scores_gemma":[0.99808246,0.000784348,0.0005017242,0.00018637971,0.00030442188,0.0001406608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003666344,0.00014894421,0.00052331074,0.000064784545,0.00016887249,0.000018669547,0.0000973416,0.00005221192,0.00008445249],"category_scores_gemma":[0.0018071219,0.00008483272,0.00010713598,0.0001842218,0.00019603914,0.00008458126,0.00009869368,0.0004111306,1.3296645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007406757,0.00004280462,0.9924395,0.000085165804,0.00013909086,0.00027464368,0.0011034176,0.000022208542,0.0004471124,0.000038711598,0.0037209745,0.0016123215],"study_design_scores_gemma":[0.0009064029,0.0008148189,0.9935834,0.00053775794,0.000050096638,0.00041215526,0.000094369156,0.00010145717,0.0012340187,0.0003391898,0.0018505347,0.000075846954],"about_ca_topic_score_codex":0.9771051,"about_ca_topic_score_gemma":0.999034,"teacher_disagreement_score":0.021928947,"about_ca_system_score_codex":0.00065055746,"about_ca_system_score_gemma":0.0027485704,"threshold_uncertainty_score":0.4875846},"labels":[],"label_agreement":null},{"id":"W4230885083","doi":"10.1111/jvh.33_12922","title":"O‐038: Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Medicine; Hepatitis C; Library science; Family medicine; Virology; Computer science","score_opus":0.009710912138667614,"score_gpt":0.28190408984064474,"score_spread":0.27219317770197715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230885083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969798,0.00085944333,0.000080018355,0.00020924001,0.00037038224,0.0007574654,0.00016710185,0.000010396562,0.0005661864],"genre_scores_gemma":[0.99500585,0.0019613635,0.00088936114,0.00016763246,0.00059602194,0.00003881489,0.00002928147,0.000046711855,0.0012649613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975132,0.00014824481,0.0007989805,0.00026725125,0.000782878,0.00048949436],"domain_scores_gemma":[0.99814326,0.00013003504,0.0003145846,0.00018221831,0.000891445,0.00033845857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004529816,0.0001454441,0.0006856981,0.00017938169,0.00018408873,0.0001820098,0.00015551804,0.00015598803,0.00024313491],"category_scores_gemma":[0.0005377135,0.0002068453,0.0001425524,0.00031908366,0.00015849517,0.0004066672,0.00007047844,0.00043184182,0.0000022063978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005730574,0.000048574828,0.91373247,0.00022577477,0.000055848082,0.00027192896,0.0016159331,5.478251e-7,0.000059008053,0.0000017867645,0.012983842,0.07094697],"study_design_scores_gemma":[0.002595349,0.0024365343,0.9867343,0.0011833421,0.000057965048,0.00025282218,0.00064437115,0.00041561227,0.00031051194,0.00010418566,0.0050644684,0.00020054054],"about_ca_topic_score_codex":0.9841146,"about_ca_topic_score_gemma":0.9996574,"teacher_disagreement_score":0.07300182,"about_ca_system_score_codex":0.0009067203,"about_ca_system_score_gemma":0.0017088925,"threshold_uncertainty_score":0.84349066},"labels":[],"label_agreement":null},{"id":"W4235713874","doi":"10.1111/jvh.107_12923","title":"P1‐137: Lack of prenatal HBV and HCV screening and follow‐up in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Medicine; Prenatal screening; Library science; Family medicine; Hepatitis C; Virology; Pediatrics; Prenatal diagnosis; Computer science; Pregnancy; Biology; Genetics; Fetus","score_opus":0.04091567410141984,"score_gpt":0.31186985189441147,"score_spread":0.27095417779299164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235713874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974715,0.0003502373,0.000044711927,0.0003299228,0.00025159036,0.00010268042,0.000015925425,0.000002991293,0.0014304229],"genre_scores_gemma":[0.9966197,0.00013109697,0.0018383429,0.00023484383,0.0001828817,6.934497e-7,0.0000033924096,0.000014671376,0.00097436015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987233,0.000040808478,0.0005134193,0.00012330558,0.00039795862,0.00020115387],"domain_scores_gemma":[0.99918485,0.000070548886,0.00027207367,0.000112917434,0.00016245921,0.00019714993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002542096,0.00012247726,0.0004321225,0.00014200492,0.000038704617,0.000012676745,0.000073976466,0.00006756098,0.00013600301],"category_scores_gemma":[0.00015287241,0.000104162515,0.00003939177,0.00009629058,0.000115435,0.0001941218,0.000052655745,0.00034686376,8.3936453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036006235,0.000034455115,0.9674838,0.000059655667,0.000067921166,0.00038330848,0.0033578845,0.000001459814,0.0004170227,0.000019907513,0.0035928625,0.024221625],"study_design_scores_gemma":[0.0042426665,0.0021160457,0.9818621,0.0008889857,0.00010602598,0.0004878193,0.0011581834,0.00027265688,0.0027000098,0.00011953147,0.0058891918,0.00015675505],"about_ca_topic_score_codex":0.9131317,"about_ca_topic_score_gemma":0.99310726,"teacher_disagreement_score":0.07997555,"about_ca_system_score_codex":0.00019779368,"about_ca_system_score_gemma":0.0006452295,"threshold_uncertainty_score":0.42476243},"labels":[],"label_agreement":null},{"id":"W4236041872","doi":"10.1111/jvh.26_12923","title":"P1‐044: Hepatitis B virus therapy with nucleos(t)ide analogues significantly reduces fibrosis in a ‘Real‐world’ Canadian cohort","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Citation; Medicine; Chronic hepatitis; Virology; Hepatitis B; Library science; Internal medicine; Family medicine; Virus; Computer science","score_opus":0.020559682903340693,"score_gpt":0.28348560671111683,"score_spread":0.26292592380777613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236041872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797375,0.0008323099,0.000017575074,0.0013644118,0.0004554204,0.0005896307,0.00015715155,0.000042294883,0.008567453],"genre_scores_gemma":[0.9741339,0.020656109,0.0022878593,0.0012773168,0.0010120327,0.000031388336,0.000022603199,0.00008606607,0.00049270317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964223,0.00021326127,0.0012013393,0.0004241806,0.00088921166,0.000849718],"domain_scores_gemma":[0.9973698,0.00014689693,0.0006036383,0.0003859884,0.00080293155,0.00069071096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006302089,0.00045263238,0.0012147903,0.0012969087,0.00029108452,0.000098949175,0.00032167992,0.0001631113,0.00068548863],"category_scores_gemma":[0.00018081233,0.0003566821,0.00024058098,0.0010068615,0.000542242,0.0005077802,0.00004226402,0.00056559534,0.00008690572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058187405,0.00018990564,0.97359246,0.00002739074,0.0004899464,0.00150367,0.0012885748,0.0000028799434,0.0042255013,0.000071937226,0.007828966,0.010196923],"study_design_scores_gemma":[0.0018733225,0.004654608,0.9679833,0.00077941176,0.00017852595,0.00020739797,0.00007171021,0.000085441534,0.011911713,0.00014771601,0.011706561,0.0004002635],"about_ca_topic_score_codex":0.8449899,"about_ca_topic_score_gemma":0.97954446,"teacher_disagreement_score":0.13455454,"about_ca_system_score_codex":0.00092409126,"about_ca_system_score_gemma":0.0011996886,"threshold_uncertainty_score":0.99988854},"labels":[],"label_agreement":null},{"id":"W4237915162","doi":"10.1111/jvh.56_12923","title":"P1‐080: Prevalence of baseline NS5A resistance associated sequences (RAS) in treatment naïve patients with genotype 1 and 3 in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; Citation; NS5A; Baseline (sea); Medicine; Family medicine; Library science; Genetics; Biology; Political science; Computer science; Gene; Hepacivirus; Law","score_opus":0.013124837023297458,"score_gpt":0.2706368240545586,"score_spread":0.2575119870312611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237915162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831265,0.0006280974,0.0000066636558,0.00025549304,0.00006567012,0.0002716604,0.0001192676,0.0000021700505,0.00033830525],"genre_scores_gemma":[0.9967057,0.0022501692,0.0006520608,0.000085930646,0.000051554394,0.0000048511174,0.00000630866,0.000013776003,0.00022965738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797124,0.0002010268,0.00064267067,0.00016133873,0.0007468057,0.00027693607],"domain_scores_gemma":[0.9986652,0.00014885292,0.00035813652,0.00013716157,0.0005393543,0.00015125159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004302876,0.00013660418,0.0004627679,0.00021717367,0.000030253159,0.000008222115,0.000101723635,0.000055618268,0.00013625411],"category_scores_gemma":[0.00048789394,0.000100327736,0.000030438807,0.00034018533,0.00013229276,0.00016600903,0.0000209997,0.0002075467,0.0000013286053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075751444,0.00018887426,0.9920439,0.00008528275,0.000050431754,0.00033391378,0.00023932032,0.0000047431135,0.00019513367,0.0000032021126,0.0002471783,0.0058504813],"study_design_scores_gemma":[0.0030623025,0.002528616,0.9912926,0.0010404707,0.000035545327,0.000005814887,0.000024528192,0.00020253369,0.0012920421,0.00002552255,0.0003974059,0.00009263813],"about_ca_topic_score_codex":0.59175164,"about_ca_topic_score_gemma":0.9765426,"teacher_disagreement_score":0.38479096,"about_ca_system_score_codex":0.0017974669,"about_ca_system_score_gemma":0.0020672262,"threshold_uncertainty_score":0.47003135},"labels":[],"label_agreement":null},{"id":"W4237983440","doi":"10.1111/jvh.218_12923","title":"P2‐099: A tale of two provinces: Comparison of the successes and challenges of structured, stepwise development in two Canadian provincial research and evaluation imbedded HCV elimination strategies","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Citation impact; Computer science; Political science; Operations research; Medicine; Mathematics","score_opus":0.09450903020911175,"score_gpt":0.4338179707006881,"score_spread":0.33930894049157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237983440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569786,0.0019197651,0.000007837273,0.0005661092,0.00007351678,0.0007641034,0.000022757826,0.000001592248,0.0009464705],"genre_scores_gemma":[0.99826133,0.00070882286,0.0008874844,0.000005430743,0.00009936114,0.000011701451,0.0000034831723,0.0000117156615,0.000010686424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969264,0.00041919146,0.00083917635,0.00015579961,0.0014048055,0.0002545992],"domain_scores_gemma":[0.9967448,0.00014924815,0.0004909141,0.00015862235,0.0023156248,0.00014077692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022361104,0.00011457487,0.00045214494,0.0006270474,0.000092948794,0.00002723531,0.0001751297,0.00007144663,0.00003968606],"category_scores_gemma":[0.0005291657,0.00008354465,0.000032971686,0.00032297574,0.0005991849,0.00032425,0.00007652677,0.0003278165,3.124054e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005739172,0.00024665895,0.74537647,0.0010561951,0.000092310744,0.0000158762,0.014197555,0.000021055916,0.008383222,0.00135247,0.000041858893,0.22864242],"study_design_scores_gemma":[0.0031730335,0.002844331,0.91843516,0.0011313658,0.00006311081,0.000020836167,0.0031667692,0.0025082873,0.06676075,0.0015755391,0.00021199038,0.00010884137],"about_ca_topic_score_codex":0.117995895,"about_ca_topic_score_gemma":0.8623048,"teacher_disagreement_score":0.7443089,"about_ca_system_score_codex":0.00036550077,"about_ca_system_score_gemma":0.003810178,"threshold_uncertainty_score":0.88787746},"labels":[],"label_agreement":null},{"id":"W4238473073","doi":"10.1111/jvh.141_12923","title":"P2‐005: Hepatitis D virus infection in Canada: molecular epidemiology and clinical association","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Epidemiology; Association (psychology); Medicine; Virology; Clinical epidemiology; Molecular epidemiology; Library science; Family medicine; Biology; Computer science; Psychology; Internal medicine; Genetics","score_opus":0.039458968157309614,"score_gpt":0.3813092814373231,"score_spread":0.34185031328001353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238473073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511296,0.00039361257,0.00046772385,0.0019033366,0.00078702293,0.00020502538,0.000021250835,0.000008451723,0.0011005938],"genre_scores_gemma":[0.97850984,0.017903252,0.0010137784,0.0017331288,0.0006997369,0.0000045337956,0.000006281406,0.000023504435,0.00010595891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963304,0.0009136892,0.0014724568,0.00022841043,0.0005829189,0.00047214952],"domain_scores_gemma":[0.9974629,0.00073039765,0.0007078646,0.0001759449,0.0005586198,0.0003642342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029345101,0.00015978845,0.00083417865,0.0002891323,0.00006695866,0.000014473114,0.000093060546,0.00024095495,0.00023565581],"category_scores_gemma":[0.0069037797,0.0001476136,0.0001527638,0.00027809164,0.00012853181,0.00022633221,0.00006307003,0.00085256214,0.00002742916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106007334,0.00007731789,0.9561327,0.000022260341,0.000120066325,0.000490529,0.000031734737,0.000002723826,0.0002679694,0.00005228595,0.0050604763,0.037635934],"study_design_scores_gemma":[0.0014310249,0.0018060268,0.9864628,0.00015581197,0.00006775337,0.000119924756,0.0000032650578,0.0013304366,0.00059636106,0.0004336929,0.007479226,0.00011369689],"about_ca_topic_score_codex":0.9510172,"about_ca_topic_score_gemma":0.98427093,"teacher_disagreement_score":0.037522238,"about_ca_system_score_codex":0.002493112,"about_ca_system_score_gemma":0.0017858816,"threshold_uncertainty_score":0.8264968},"labels":[],"label_agreement":null},{"id":"W4239695775","doi":"10.1111/jvh.202_12923","title":"P2‐083: A high demand for hepatitis C education among healthcare providers in British Columbia","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Health care; Hepatitis C; Medicine; Family medicine; Political science; World Wide Web; Computer science; Virology; Law","score_opus":0.017338735525286086,"score_gpt":0.3257864348980294,"score_spread":0.3084476993727433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239695775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939444,0.0006545168,0.00034009395,0.0023053498,0.00087864225,0.0013335767,0.00008902576,0.000023253957,0.0004311407],"genre_scores_gemma":[0.9890031,0.0020723187,0.0048332675,0.0010447412,0.0014113302,0.00011630149,0.000039161263,0.00006341256,0.0014163344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969935,0.00020646756,0.0011154183,0.00031831616,0.00077672675,0.0005895623],"domain_scores_gemma":[0.997073,0.00013617109,0.0004831441,0.0002661318,0.0015747196,0.00046682358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081863394,0.00016225138,0.0006855957,0.00032813463,0.00020050745,0.00031094084,0.00022347172,0.00022496458,0.0004156301],"category_scores_gemma":[0.0010238307,0.00022687722,0.00021553936,0.0004377977,0.00028511195,0.0007315778,0.000050906066,0.0005275116,0.00002139816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110902,0.00025940634,0.80871236,0.00027046993,0.000050095845,0.00018932,0.00027372668,5.595919e-7,0.000118402015,0.000019203782,0.035705514,0.15429004],"study_design_scores_gemma":[0.0026435507,0.0041430774,0.9768921,0.0017173204,0.00005779238,0.00028951085,0.00010209386,0.00034173802,0.00025404996,0.0014829118,0.011857745,0.00021811562],"about_ca_topic_score_codex":0.41399154,"about_ca_topic_score_gemma":0.78183985,"teacher_disagreement_score":0.36784828,"about_ca_system_score_codex":0.00076069054,"about_ca_system_score_gemma":0.0018429705,"threshold_uncertainty_score":0.92517847},"labels":[],"label_agreement":null},{"id":"W4241502674","doi":"10.1111/jvh.227_12923","title":"P2‐110: Limited HCV awareness and hepatitis C virus stigma are common in a medium sized Canadian province before implementation of an elimination strategy but 2 years after DAA implementation","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stigma (botany); Citation; Hepatitis C; Hepatitis C virus; Medicine; Library science; Computer science; Virology; Family medicine; Virus; Psychiatry","score_opus":0.02135677046272398,"score_gpt":0.3606023659270675,"score_spread":0.3392455954643435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241502674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974571,0.00011308569,0.000038779785,0.00082029,0.00016346874,0.0007728532,0.0005548534,0.0000115863395,0.000068024274],"genre_scores_gemma":[0.9979026,0.00060718367,0.0006744517,0.00022480934,0.00028750775,0.000039714563,0.0001999326,0.000042429874,0.00002141493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969095,0.0003199769,0.0011539129,0.00027400444,0.0008644169,0.00047819305],"domain_scores_gemma":[0.99776685,0.00006065684,0.0006683756,0.00023755571,0.00079894176,0.00046759826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076675095,0.00022478578,0.0005789127,0.00094747014,0.00011106226,0.000075282616,0.00017180492,0.00016316291,0.0005813646],"category_scores_gemma":[0.00011268571,0.00022539958,0.00008192974,0.00040777845,0.0001876543,0.00091939507,0.000050014576,0.0003476906,0.00000634828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030974732,0.00008699028,0.7856032,0.000097417185,0.000055617642,0.00052935537,0.0012000239,0.000001757425,0.00222631,0.000022687682,0.00014440187,0.20972246],"study_design_scores_gemma":[0.0033461547,0.0040443577,0.9802681,0.0002933357,0.00009406275,0.000064908185,0.0008522358,0.0007200039,0.009692142,0.00016014816,0.00028829955,0.00017623871],"about_ca_topic_score_codex":0.626882,"about_ca_topic_score_gemma":0.98428494,"teacher_disagreement_score":0.35740295,"about_ca_system_score_codex":0.00076632196,"about_ca_system_score_gemma":0.0022302053,"threshold_uncertainty_score":0.9191528},"labels":[],"label_agreement":null},{"id":"W4241917971","doi":"10.1111/jvh.21_12935","title":"LBP‐016: Lost to follow‐up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sofosbuvir; Medicine; Cohort; Hepatitis C; Family medicine; Virology; Internal medicine; Chronic hepatitis; Ribavirin","score_opus":0.014942555951787435,"score_gpt":0.27382128668839417,"score_spread":0.2588787307366067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241917971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915618,0.0000726273,0.00003705803,0.001388728,0.0011253806,0.0010846787,0.000114425486,0.000015221457,0.00460009],"genre_scores_gemma":[0.9954933,0.0005718996,0.00019556799,0.0016686699,0.00063556526,0.00003314903,0.000024456227,0.00007467224,0.0013027502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949895,0.00034026612,0.001410839,0.00038652847,0.0019681824,0.00090467936],"domain_scores_gemma":[0.9966918,0.0002819129,0.00047223186,0.0005538996,0.0012521809,0.0007479761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007838387,0.00038267658,0.0009216855,0.0005420545,0.00019462578,0.000083237675,0.0005581597,0.00015682068,0.0008838331],"category_scores_gemma":[0.00127659,0.00027851987,0.00022592132,0.0009929911,0.0002789368,0.00046725004,0.0001664221,0.000849465,0.00024416167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003642325,0.00013741571,0.94139487,0.000025169336,0.0001776733,0.0007378701,0.00036627168,0.0000045227334,0.00014026309,0.000004960038,0.038051143,0.018595627],"study_design_scores_gemma":[0.0029703067,0.0025227906,0.9811979,0.0005041744,0.00009688542,0.000043019656,0.000055574616,0.00027272617,0.0015469859,0.000020419337,0.010492458,0.00027679052],"about_ca_topic_score_codex":0.94578665,"about_ca_topic_score_gemma":0.98358536,"teacher_disagreement_score":0.039803017,"about_ca_system_score_codex":0.0029156243,"about_ca_system_score_gemma":0.0021497519,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W4241941786","doi":"10.1111/jvh.231_12923","title":"P2‐114: Gaps in care before introduction of a coordinated elimination strategy: a Canadian provincial baseline","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baseline (sea); Citation; Library science; Viral hepatitis; Medicine; Political science; Computer science; Law; Virology","score_opus":0.011348818777393055,"score_gpt":0.30285923349892,"score_spread":0.29151041472152694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241941786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950317,0.00018635843,0.00009871188,0.0025057553,0.000300147,0.00038608274,0.000088551686,0.000008370218,0.0013943233],"genre_scores_gemma":[0.9969863,0.00013277151,0.0006534809,0.00009270847,0.0018754482,0.000005850611,0.00007271257,0.000024974204,0.00015569439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792373,0.00017862387,0.0007836126,0.00017174448,0.0005934751,0.00034879879],"domain_scores_gemma":[0.9971045,0.000023616469,0.00031202214,0.00017881909,0.0020749962,0.00030600393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007352284,0.00014130624,0.00042515298,0.0010060117,0.000067267014,0.000021644028,0.00013249562,0.0001577132,0.00049153494],"category_scores_gemma":[0.00087967823,0.00012780931,0.00010199602,0.00058322697,0.00015219428,0.00031959766,0.000021975538,0.00046180413,0.000020405632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009865147,0.00028503814,0.5496614,0.0004099276,0.00010344768,0.00084519875,0.0032703474,0.000023149581,0.010343299,0.0003506904,0.010522866,0.42319813],"study_design_scores_gemma":[0.005603161,0.016825285,0.9241319,0.00085791695,0.00016720856,0.0003620864,0.0009919422,0.004594849,0.0274347,0.0003535979,0.01834008,0.00033731104],"about_ca_topic_score_codex":0.19338185,"about_ca_topic_score_gemma":0.7203467,"teacher_disagreement_score":0.52696484,"about_ca_system_score_codex":0.001069584,"about_ca_system_score_gemma":0.0018942293,"threshold_uncertainty_score":0.8119895},"labels":[],"label_agreement":null},{"id":"W4243205864","doi":"10.1111/jvh.189_12923","title":"P2‐067: Emergence among men in Quebec, Canada of a hepatitis C virus genotype 4D lineage circulating in European HIV‐infected men","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Genotype; Lineage (genetic); Virology; Men who have sex with men; Hepatitis C virus; Citation; Hepatitis C; Medicine; Demography; Political science; Genealogy; Biology; History; Virus; Genetics; Sociology; Gene; Law","score_opus":0.016547126223810306,"score_gpt":0.28476228072225823,"score_spread":0.2682151544984479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243205864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852661,0.0002762223,0.0002024501,0.00026553601,0.00024064793,0.00040332437,0.000051660398,0.000015044718,0.013279028],"genre_scores_gemma":[0.99654216,0.0012919662,0.0008406219,0.00013960824,0.00050347607,0.000006250356,0.000018740218,0.000069680136,0.0005874859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523795,0.0006507481,0.001855854,0.00031931765,0.0012802198,0.00065589324],"domain_scores_gemma":[0.9974888,0.00015758326,0.00076711783,0.00038986644,0.00082331896,0.00037331085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012487789,0.000293134,0.00089229085,0.00067589135,0.00009306069,0.00004212702,0.000382486,0.00012966954,0.0010431631],"category_scores_gemma":[0.0012377121,0.00028087135,0.00015414036,0.0009864339,0.00026211384,0.00044279674,0.00015338878,0.0008505821,0.00002547633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015538248,0.00015676417,0.96622443,0.00010479823,0.00008501728,0.0030129394,0.0010057398,0.00006534849,0.014866471,0.00001808975,0.004131507,0.010173503],"study_design_scores_gemma":[0.0019314516,0.00066933123,0.9785038,0.0008729762,0.000040759536,0.00004462855,0.000071231145,0.008419503,0.0076569226,0.000017250966,0.0015214864,0.0002506434],"about_ca_topic_score_codex":0.9768582,"about_ca_topic_score_gemma":0.99414575,"teacher_disagreement_score":0.01728751,"about_ca_system_score_codex":0.0009959557,"about_ca_system_score_gemma":0.0017621157,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W4244280002","doi":"10.1111/jvh.62_12923","title":"P1‐088: Z‐PROFILE: real‐world utilization and effectiveness of Elbasvir/Grazoprevir in adult patients with chronic hepatitis C in Canada – final study results","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic hepatitis; Citation; Hepatitis C; Internal medicine; Family medicine; Library science; Virology; Computer science","score_opus":0.02106948965505111,"score_gpt":0.31090515612353575,"score_spread":0.28983566646848463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244280002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973532,0.0001519161,0.000018497107,0.000054015825,0.00016360299,0.0013045339,0.00012208143,0.0000055645564,0.0008266001],"genre_scores_gemma":[0.9979499,0.0015450721,0.00020436983,0.000035130353,0.00012273455,0.000029779987,0.000036344867,0.00003694754,0.000039748636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609476,0.00066481146,0.001247556,0.0003385086,0.0012183214,0.00043603184],"domain_scores_gemma":[0.99751836,0.00031927702,0.0005649992,0.000304535,0.0010766113,0.00021621773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010454957,0.00025659008,0.00087743334,0.0007208769,0.000059759986,0.000020711586,0.00018299828,0.00007790854,0.00007254244],"category_scores_gemma":[0.000579228,0.00021154125,0.000052201907,0.0010296684,0.00017214571,0.00036974053,0.0000783715,0.00053007685,0.0000028933405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034577753,0.0005204758,0.9598444,0.00033050432,0.0000730822,0.000419669,0.00026843965,0.0000122817255,0.00009628932,0.000016975377,0.00015183055,0.034808274],"study_design_scores_gemma":[0.01245018,0.008629541,0.97386104,0.0024663904,0.000053932235,0.0000119784645,0.000036240737,0.0008287672,0.001327124,0.000019615507,0.00013396655,0.0001812089],"about_ca_topic_score_codex":0.9071878,"about_ca_topic_score_gemma":0.99238276,"teacher_disagreement_score":0.08519494,"about_ca_system_score_codex":0.0020806324,"about_ca_system_score_gemma":0.0024018537,"threshold_uncertainty_score":0.8626402},"labels":[],"label_agreement":null},{"id":"W4245262142","doi":"10.1111/jvh.234_12923","title":"P2‐119: Evaluation of hepatitis C screening strategies in different community settings in a Canadian metropolitan area","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metropolitan area; Citation; Library science; Viral hepatitis; Hepatitis C; Medicine; Hepatitis; Family medicine; Computer science; Virology; Pathology","score_opus":0.07029392440580737,"score_gpt":0.38031151971677674,"score_spread":0.3100175953109694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245262142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910054,0.00025271866,0.00011811704,0.000841125,0.00013616862,0.0004186292,0.00005593788,0.000006764522,0.0071651232],"genre_scores_gemma":[0.9981816,0.0003341784,0.0010219185,0.00017654202,0.00019841465,0.000012408268,0.000022021322,0.000028717326,0.000024234916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954019,0.0012365789,0.0011603909,0.00015127682,0.0014376716,0.0006121799],"domain_scores_gemma":[0.99720824,0.00022262325,0.0004264436,0.00033975876,0.0013525696,0.00045037997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004017536,0.00021480791,0.00074835966,0.001591827,0.00012306616,0.000052357198,0.00029335901,0.00016135,0.00057313434],"category_scores_gemma":[0.001790877,0.00018887606,0.00014986786,0.0006581601,0.0002705972,0.00048793913,0.000067664325,0.001119323,0.0000072396165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012439322,0.00018995524,0.9744721,0.00008338256,0.000068636364,0.00014369567,0.0016810416,0.000017751518,0.0011666338,0.00018778583,0.00049255113,0.021372044],"study_design_scores_gemma":[0.0025815493,0.002109187,0.9781937,0.0012796114,0.00007964109,0.000054015607,0.001546659,0.0102233235,0.002023584,0.001380657,0.0003696726,0.00015840106],"about_ca_topic_score_codex":0.87562865,"about_ca_topic_score_gemma":0.9591305,"teacher_disagreement_score":0.08350186,"about_ca_system_score_codex":0.0028701804,"about_ca_system_score_gemma":0.0018457567,"threshold_uncertainty_score":0.7702142},"labels":[],"label_agreement":null},{"id":"W4245762639","doi":"10.1111/jvh.177_12923","title":"P2‐055: Screening for hepatitis C in Ontario, Canada: exploring antibody positivity in the federal and provincial correctional systems","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Medicine; Hepatitis C; Viral hepatitis; Political science; Family medicine; Computer science; Virology","score_opus":0.058835494303464554,"score_gpt":0.32052933474097545,"score_spread":0.26169384043751087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245762639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959048,0.00014218605,0.0009623921,0.0005354147,0.0009762916,0.00071262784,0.00004613766,0.000005496932,0.0007146365],"genre_scores_gemma":[0.9977821,0.00014665193,0.00068927906,0.000255074,0.000902049,0.00005372585,0.00001607662,0.000022307575,0.00013272325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755764,0.00022928606,0.0007056626,0.00020623559,0.0008589936,0.00044220497],"domain_scores_gemma":[0.99879026,0.00029571244,0.00022708598,0.00012936673,0.00040045925,0.00015711362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012133917,0.00017435207,0.0004995879,0.00029790992,0.00021312133,0.000106717074,0.00014857049,0.000085401975,0.000042280844],"category_scores_gemma":[0.00040546802,0.00013814776,0.000084157226,0.00021824775,0.000111113986,0.0004805102,0.000048724414,0.00069510884,0.0000010793366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044975066,0.000086655076,0.98610264,0.00005765904,0.0000395105,0.00065333245,0.0009456284,0.00001247334,0.00042602158,0.00007296079,0.0012988438,0.00985453],"study_design_scores_gemma":[0.0019747727,0.0016812708,0.98793393,0.0006195985,0.000021978209,0.0005317304,0.00021865584,0.002502523,0.00019956747,0.00002902276,0.0041463478,0.00014059662],"about_ca_topic_score_codex":0.9882937,"about_ca_topic_score_gemma":0.9985695,"teacher_disagreement_score":0.010275779,"about_ca_system_score_codex":0.001243843,"about_ca_system_score_gemma":0.0020483956,"threshold_uncertainty_score":0.56335026},"labels":[],"label_agreement":null},{"id":"W4248569107","doi":"10.1111/jvh.170_12923","title":"P2‐046: Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harm reduction; Citation; Harm; Medicine; Hepatitis C; Library science; Family medicine; Computer science; Political science; Virology; Human immunodeficiency virus (HIV); Law","score_opus":0.010331557507445903,"score_gpt":0.2939610406917841,"score_spread":0.28362948318433817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248569107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695724,0.00017547868,0.00003694082,0.001123484,0.0003372223,0.00015016402,0.000013760588,0.0000019728045,0.0012037153],"genre_scores_gemma":[0.99849176,0.00027768873,0.00061352924,0.00018580777,0.00033550823,0.0000017518997,0.0000013818357,0.000012000302,0.000080586375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858034,0.00014005456,0.00061100634,0.00008132316,0.0004501683,0.00013711011],"domain_scores_gemma":[0.9986822,0.00019584931,0.00063982425,0.00016061756,0.00026754738,0.000053953205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062039273,0.00009814013,0.00043175163,0.000054888467,0.00006396789,0.000012125901,0.00013436876,0.000035135818,0.00006865132],"category_scores_gemma":[0.00014424442,0.00005554846,0.00005137111,0.00021385522,0.00014200338,0.00016822739,0.000044623215,0.00026514143,0.0000013843957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091394654,0.00008834754,0.8567604,0.0004638198,0.0001702974,0.000032510336,0.10317321,0.0002104424,0.00127723,0.00012331447,0.0017257114,0.03506078],"study_design_scores_gemma":[0.0064987596,0.0008696261,0.91527766,0.0021319098,0.00029744126,0.0010776016,0.043128245,0.021359533,0.0074261418,0.0013865179,0.00033962258,0.0002069219],"about_ca_topic_score_codex":0.73770314,"about_ca_topic_score_gemma":0.46751523,"teacher_disagreement_score":0.27018788,"about_ca_system_score_codex":0.000145273,"about_ca_system_score_gemma":0.00046300975,"threshold_uncertainty_score":0.5422012},"labels":[],"label_agreement":null},{"id":"W4249706211","doi":"10.1111/jvh.127_12923","title":"P1‐163: Assessing the diagnostic accuracy of viral hepatitis B and C health administrative diagnosis and billing codes using linked laboratory and administrative health databases in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Viral hepatitis; Library science; Hepatitis C; Medicine; Family medicine; Database; Political science; Computer science; Virology","score_opus":0.14156108011796043,"score_gpt":0.43382868701110616,"score_spread":0.29226760689314574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249706211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990523,0.004477545,0.00014550249,0.0035440607,0.00017904965,0.00067411683,0.00040209756,0.000006181218,0.000048458754],"genre_scores_gemma":[0.9799162,0.014655916,0.003946877,0.0011893187,0.0002146459,0.000015822132,0.00002233779,0.00003083481,0.000008059113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963834,0.00064937596,0.0013235711,0.00034602053,0.000767477,0.0005301111],"domain_scores_gemma":[0.99520284,0.0023351936,0.0011451403,0.00024162504,0.00053124013,0.00054396567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015632961,0.00030249354,0.0010230019,0.00026703408,0.0004257512,0.0001217427,0.00013775044,0.000072156174,0.00006547023],"category_scores_gemma":[0.002395449,0.00023368896,0.000052335818,0.0003345134,0.00073478394,0.0007456275,0.00012352149,0.00084699993,2.4331382e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008735037,0.00012778514,0.98250085,0.00024931316,0.00009751633,0.00035443867,0.0025771202,0.0000018695762,0.0001854956,0.00007119229,0.000653043,0.013094049],"study_design_scores_gemma":[0.001432563,0.003306983,0.98725563,0.0029089733,0.00006400974,0.00020247498,0.0009604909,0.00071814196,0.0012337496,0.000067719535,0.0016375867,0.00021168328],"about_ca_topic_score_codex":0.9557512,"about_ca_topic_score_gemma":0.99201214,"teacher_disagreement_score":0.036260944,"about_ca_system_score_codex":0.0010997609,"about_ca_system_score_gemma":0.012764424,"threshold_uncertainty_score":0.9928323},"labels":[],"label_agreement":null},{"id":"W4250550282","doi":"10.1111/jvh.174_12923","title":"P2‐051: Can we afford not to screen for and treat HCV infection in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Hepatitis C; Medicine; Correct name; Library science; Computer science; World Wide Web; Virology; Biology","score_opus":0.030692945915890668,"score_gpt":0.3332224881548479,"score_spread":0.3025295422389572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250550282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931847,0.00007312774,0.00027928135,0.004766349,0.00020973154,0.00037412552,0.000078311336,0.0000047598187,0.0010296333],"genre_scores_gemma":[0.9954554,0.0011757287,0.0014392947,0.0008838581,0.0005775366,0.000009623844,0.0000044178514,0.000022192746,0.000431949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985994,0.000053554842,0.00043621365,0.00013825363,0.00045234623,0.00032022418],"domain_scores_gemma":[0.9989627,0.00009182405,0.000117534284,0.00012240643,0.00035183586,0.00035368287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030971674,0.00011933725,0.0003633232,0.0003202193,0.00006875479,0.000024775865,0.000071065115,0.00006044959,0.00011272633],"category_scores_gemma":[0.00033915258,0.000102269994,0.000058926984,0.00022290775,0.000048168746,0.00013696955,0.000034997218,0.00021745112,0.0000057097536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000563771,0.000033305234,0.7450292,0.000057967776,0.000032619093,0.0001641176,0.00022620067,0.000002108103,0.0013310207,0.000026708774,0.0101685,0.24236444],"study_design_scores_gemma":[0.0035385136,0.007035312,0.87999374,0.00058403244,0.0000640154,0.00015572002,0.000043730917,0.00092764833,0.01441358,0.00019306477,0.092830636,0.00022002147],"about_ca_topic_score_codex":0.9288724,"about_ca_topic_score_gemma":0.99131924,"teacher_disagreement_score":0.24214442,"about_ca_system_score_codex":0.0010470381,"about_ca_system_score_gemma":0.001246487,"threshold_uncertainty_score":0.4170449},"labels":[],"label_agreement":null},{"id":"W4250981492","doi":"10.1111/jvh.09_12922","title":"O‐012: Is hepatitis C elimination possible among HIV‐infected population in Canada?","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Citation; Hepatitis C; Population; Viral hepatitis; Medicine; Virology; Library science; Family medicine; Computer science; Environmental health","score_opus":0.014698275641492613,"score_gpt":0.2949417462772432,"score_spread":0.28024347063575056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250981492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426717,0.00010575581,0.0001783056,0.0014811193,0.0004623336,0.0003133831,0.00004641207,0.000015710377,0.0031298073],"genre_scores_gemma":[0.9967428,0.0006435811,0.0008977227,0.00055796583,0.0005964655,0.000007201688,0.000040405706,0.00003990522,0.0004739848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680495,0.00017957937,0.0010370853,0.00022615642,0.0012722543,0.00047999146],"domain_scores_gemma":[0.9978753,0.00009138349,0.00046828185,0.00025816125,0.0009797426,0.00032714327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004979942,0.00020653884,0.00054559036,0.00065173383,0.000107965345,0.00004953111,0.00017779575,0.00014284972,0.0013246294],"category_scores_gemma":[0.00058728753,0.00019432034,0.00012752475,0.000677227,0.000095325144,0.00063539733,0.000050527986,0.0005405021,0.000057481917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012010222,0.00007929756,0.95603395,0.00004380498,0.00004309938,0.00043243775,0.00026252522,0.000005826774,0.00051898253,0.00003765544,0.009262384,0.03315993],"study_design_scores_gemma":[0.0015195742,0.00091847626,0.9858304,0.00043143664,0.00004319686,0.000091008646,0.000026284148,0.0053225327,0.0037435864,0.00015936792,0.0017374717,0.00017665108],"about_ca_topic_score_codex":0.9291195,"about_ca_topic_score_gemma":0.9637748,"teacher_disagreement_score":0.034655306,"about_ca_system_score_codex":0.0023631554,"about_ca_system_score_gemma":0.0015638373,"threshold_uncertainty_score":0.9995883},"labels":[],"label_agreement":null},{"id":"W4252306638","doi":"10.1111/jvh.12332_8","title":"O213: Daclatasvir vs telaprevir in combination with peginterferon alfa/ribavirin in treatment‐naive patients with HCV genotype 1: phase 3 COMMAND‐3 results","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Telaprevir; Daclatasvir; Ribavirin; Medicine; Internal medicine; Virology; Genotype; Gastroenterology; Chronic hepatitis; Biology; Genetics; Gene","score_opus":0.01766427547604496,"score_gpt":0.30684666925407456,"score_spread":0.28918239377802957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252306638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571073,0.00013500908,0.00020733738,0.00072903355,0.00009227197,0.0007910519,0.000086921966,0.000014071567,0.0022335812],"genre_scores_gemma":[0.9977204,0.0006864618,0.0008740671,0.00016471652,0.00010404915,0.00002181991,0.00017958447,0.000049418777,0.00019948189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970127,0.0003896775,0.0009662599,0.00031155942,0.0008619485,0.00045785093],"domain_scores_gemma":[0.9982462,0.0001897547,0.00049727334,0.00037133886,0.00043165608,0.00026378606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006288644,0.00030493923,0.0008140547,0.0007084293,0.000064284475,0.00005228791,0.00020435073,0.00012986313,0.00006778468],"category_scores_gemma":[0.0002579736,0.000213062,0.000088673485,0.00045007773,0.00013801186,0.0005581221,0.000043423646,0.00061709125,0.000034832006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014678148,0.002779039,0.86197406,0.000060680843,0.00009896024,0.00056163955,0.0008103165,0.000046681274,0.00010123311,0.000044225333,0.0005997445,0.11824525],"study_design_scores_gemma":[0.07126555,0.054067124,0.85732865,0.0015034763,0.00010708817,0.00005227734,0.000039580613,0.0017306976,0.0007972651,0.000078955716,0.01270975,0.0003195728],"about_ca_topic_score_codex":0.0025288353,"about_ca_topic_score_gemma":0.007556221,"teacher_disagreement_score":0.11792567,"about_ca_system_score_codex":0.00095381297,"about_ca_system_score_gemma":0.00024221926,"threshold_uncertainty_score":0.86884165},"labels":[],"label_agreement":null},{"id":"W4252574644","doi":"10.1111/jvh.172_12923","title":"P2‐049: Relationship of hydromorphone controlled release prescribing and hepatitis C incidence in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydromorphone; Incidence (geometry); Citation; Hepatitis; Medicine; Hepatitis C; Library science; Viral hepatitis; Family medicine; Virology; Internal medicine; Computer science; Mathematics","score_opus":0.025247815494569555,"score_gpt":0.2798805814071877,"score_spread":0.25463276591261813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252574644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958572,0.0004620568,0.00007991512,0.0006083159,0.00024970534,0.00043748497,0.000020495318,0.000005847452,0.0022789785],"genre_scores_gemma":[0.9969498,0.00050585566,0.0014547308,0.00023561057,0.0001340143,0.000009333495,0.000005791327,0.000023957362,0.00068092276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968929,0.00024992318,0.0012657231,0.00020148094,0.001031764,0.00035817278],"domain_scores_gemma":[0.99761796,0.00047492742,0.0005833496,0.00025234473,0.00072351145,0.00034790445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009037456,0.00018329422,0.00089149247,0.00039005172,0.00009323328,0.000025562598,0.00016365552,0.00012089441,0.00060333556],"category_scores_gemma":[0.0024686344,0.00016455706,0.000109823624,0.0003089632,0.00024339375,0.0003670977,0.000073746945,0.0007704204,0.0000062193544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010394773,0.000091906935,0.990399,0.00005485918,0.00007367181,0.0011486924,0.0005273024,0.0000077291525,0.001640734,0.00011240797,0.0023430816,0.0025611373],"study_design_scores_gemma":[0.00696898,0.0016459336,0.98510957,0.00088307296,0.000080693346,0.00030323354,0.000030905765,0.0014869092,0.0018351403,0.00044294487,0.0010630834,0.00014951319],"about_ca_topic_score_codex":0.98533094,"about_ca_topic_score_gemma":0.99686384,"teacher_disagreement_score":0.011532921,"about_ca_system_score_codex":0.0010716374,"about_ca_system_score_gemma":0.0035681543,"threshold_uncertainty_score":0.67104423},"labels":[],"label_agreement":null},{"id":"W4280511675","doi":"10.1111/jvh.13706","title":"Internet‐guided <scp>HCV‐RNA</scp> testing: A promising tool to achieve hepatitis C micro‐elimination among men who have sex with men","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Roche Diagnostics; AbbVie; Gilead Sciences","keywords":"Men who have sex with men; Test (biology); Medicine; Hepatitis C virus; Population; Service (business); Hepatitis C; Transmission (telecommunications); Virology; Environmental health; Computer science; Biology; Business; Virus; Human immunodeficiency virus (HIV)","score_opus":0.03095591414636701,"score_gpt":0.29899713575838444,"score_spread":0.26804122161201743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280511675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438793,0.00010273072,0.0014283308,0.0012671778,0.00010575693,0.0012822385,0.00007226337,0.00006088661,0.051801313],"genre_scores_gemma":[0.96820307,0.00014050817,0.008569438,0.0006521075,0.00050072634,0.00013877178,0.000036604924,0.0001386685,0.021620085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944943,0.0005058322,0.001373443,0.00053032994,0.002262316,0.0008337594],"domain_scores_gemma":[0.996514,0.00042824235,0.00087222905,0.0004596569,0.0011223247,0.00060352124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016835397,0.00043449574,0.0009691431,0.0009129376,0.00035895253,0.00022391014,0.0005555429,0.00013610236,0.00028076806],"category_scores_gemma":[0.0019370918,0.0003912781,0.00020933084,0.0008189972,0.0001564101,0.00066191016,0.0004503774,0.0013964515,0.000034780598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033227008,0.00034278346,0.8254445,0.00014619468,0.0003646909,0.0026294643,0.004693371,0.00027326745,0.011011394,0.000035933248,0.0823616,0.07236451],"study_design_scores_gemma":[0.007543854,0.026564788,0.8367815,0.0017507634,0.00049321423,0.002041032,0.0017628464,0.05214398,0.031338174,0.00024370338,0.03869881,0.00063733855],"about_ca_topic_score_codex":0.009705565,"about_ca_topic_score_gemma":0.00080505415,"teacher_disagreement_score":0.07172717,"about_ca_system_score_codex":0.0016373888,"about_ca_system_score_gemma":0.0007069626,"threshold_uncertainty_score":0.9998539},"labels":[],"label_agreement":null},{"id":"W4281606944","doi":"10.1111/jvh.13717","title":"International multicenter validation of <scp>GES</scp> score for <scp>HCC</scp> risk stratification in chronic hepatitis C patients","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Agence Nationale de la Recherche","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Cohort; Framingham Risk Score; Genotype; Risk stratification; Ethnic group; Oncology; Disease; Virus; Immunology; Gene; Biology","score_opus":0.0253754238937506,"score_gpt":0.3154956025338403,"score_spread":0.2901201786400897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281606944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418074,0.00025447516,0.001204569,0.00018937592,0.00096497225,0.0012024005,0.000812198,0.000018106924,0.001173167],"genre_scores_gemma":[0.99406564,0.002231091,0.001978114,0.00011144705,0.00045469467,0.00014912273,0.00047142323,0.000062518666,0.00047595645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99532795,0.00041748336,0.0016346214,0.00035709207,0.0017756952,0.0004871432],"domain_scores_gemma":[0.9959475,0.00071230513,0.0015149815,0.0003337957,0.0012662658,0.00022517545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012818942,0.00026275753,0.0006480425,0.0009360218,0.00018460235,0.00006348773,0.00047761627,0.0001372923,0.00023320108],"category_scores_gemma":[0.0031667359,0.00026817646,0.00034310386,0.00048708206,0.00010955613,0.00064932567,0.00016314515,0.0008822121,0.000017528688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091633716,0.00081479724,0.9605037,0.00017158878,0.00019858699,0.000049268172,0.0010291486,0.0007104738,0.0049518105,0.000086932996,0.0065850583,0.024806974],"study_design_scores_gemma":[0.0080612255,0.004646219,0.9196373,0.00037410524,0.00015829848,0.000028164088,0.00022580051,0.013246815,0.019990537,0.00041716103,0.03312814,0.00008624107],"about_ca_topic_score_codex":0.0020923472,"about_ca_topic_score_gemma":0.0007290307,"teacher_disagreement_score":0.040866435,"about_ca_system_score_codex":0.001846835,"about_ca_system_score_gemma":0.0006341475,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W4283167288","doi":"10.1111/jvh.13723","title":"Impact of <scp>COVID</scp>‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Health and Medical Research Council; NSW Ministry of Health","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Antibody; Population; Hepatitis C; Virology; Immunology; Internal medicine; Environmental health","score_opus":0.02915872468763862,"score_gpt":0.3339948161098864,"score_spread":0.30483609142224777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283167288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573165,0.0007009157,0.000027376962,0.000115610164,0.0003191732,0.0009537439,0.0007604142,0.00004101329,0.0013501089],"genre_scores_gemma":[0.9970654,0.00021357118,0.001580751,0.00019241395,0.000358353,0.000073704134,0.00016569682,0.000073561896,0.00027651738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678636,0.00023844406,0.001133338,0.0003449227,0.00095163484,0.0005452814],"domain_scores_gemma":[0.9967437,0.00083865476,0.0010301924,0.00033839277,0.0006979783,0.0003510891],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043360319,0.00033155497,0.0009994806,0.0009069289,0.00040053888,0.00004898019,0.0003563017,0.0001290918,0.000033431414],"category_scores_gemma":[0.0007811198,0.00031075362,0.0004009779,0.0011831525,0.000045783152,0.00038353677,0.00014546954,0.0009222331,0.0000028192746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017916012,0.00021240633,0.9119453,0.0016392712,0.00010703048,0.00018325669,0.06996981,0.0049836515,0.00097289815,0.0000069676767,0.0014819497,0.008318332],"study_design_scores_gemma":[0.0037775491,0.012552882,0.91327053,0.0014514361,0.00025205247,0.0002832959,0.065185964,0.00073252054,0.0003269655,0.000074778276,0.0018925634,0.00019944705],"about_ca_topic_score_codex":0.03065982,"about_ca_topic_score_gemma":0.0055078533,"teacher_disagreement_score":0.025151966,"about_ca_system_score_codex":0.0030118648,"about_ca_system_score_gemma":0.0016306506,"threshold_uncertainty_score":0.99993443},"labels":[],"label_agreement":null},{"id":"W4293761195","doi":"10.1111/jvh.13738","title":"Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"AbbVie","keywords":"Internal medicine; Disease; Medicine; Liver disease","score_opus":0.013668682661485531,"score_gpt":0.32213102874582594,"score_spread":0.3084623460843404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293761195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985341,0.00038543198,0.000008966852,0.00009544398,0.000056211735,0.00040065034,0.0002303409,0.0000024042765,0.0002864921],"genre_scores_gemma":[0.9955108,0.0037972557,0.00046697908,0.000072033436,0.000017735794,0.000008363972,0.000049074017,0.000017274655,0.000060440016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963913,0.0005664967,0.0015479632,0.00021359966,0.0010545466,0.00022607378],"domain_scores_gemma":[0.9983328,0.00024532675,0.00066657114,0.00025283074,0.00023604522,0.00026643745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011782844,0.00013526519,0.001070916,0.0013129589,0.00003248141,0.0000052046826,0.00014593938,0.00003616458,0.0005255778],"category_scores_gemma":[0.0002958985,0.000115523086,0.00022911551,0.0015174364,0.00019796431,0.00021000401,0.0001376084,0.0005425575,4.094629e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082712,0.0008513738,0.9541799,0.00009782344,0.0004819307,0.00033641042,0.00011294225,0.00040863387,0.000013311635,0.000014364941,0.00008849723,0.03514362],"study_design_scores_gemma":[0.004969592,0.0025330514,0.98993963,0.00029002473,0.000535287,0.0000013070759,0.000022834332,0.0011999747,0.000009626524,0.00001376213,0.00038862578,0.00009627121],"about_ca_topic_score_codex":0.0032543652,"about_ca_topic_score_gemma":0.00603238,"teacher_disagreement_score":0.035759754,"about_ca_system_score_codex":0.00026124076,"about_ca_system_score_gemma":0.0002827924,"threshold_uncertainty_score":0.57547086},"labels":[],"label_agreement":null},{"id":"W4294045143","doi":"10.1111/jvh.13742","title":"Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Global Health Research; Toronto Liver Centre; University Health Network","funders":"National Natural Science Foundation of China; University Health Network","keywords":"Medicine; Internal medicine; Cumulative incidence; Gastroenterology; HBsAg; Proportional hazards model; Chronic hepatitis; Incidence (geometry); Hepatitis B; Alanine aminotransferase; Prospective cohort study; Cohort; Hepatitis B virus; Immunology; Virus","score_opus":0.005679702206272041,"score_gpt":0.21389297940996016,"score_spread":0.20821327720368812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294045143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654025,0.0012382878,0.00007843023,0.0006350013,0.0004183412,0.0006614153,0.00023580258,0.00004230372,0.00015014285],"genre_scores_gemma":[0.9968544,0.0009310465,0.0007622591,0.0007740323,0.00030524214,0.00010052029,0.000067285655,0.00007876835,0.0001264184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960147,0.00032601488,0.0011681048,0.00040904724,0.0014392319,0.0006428763],"domain_scores_gemma":[0.99841344,0.000100419624,0.00045985825,0.00036201408,0.0003627747,0.00030151432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042269117,0.0004214698,0.0010096374,0.0005971444,0.00027604465,0.00003980405,0.00028278914,0.00012345432,0.0007631174],"category_scores_gemma":[0.00013915467,0.00034399139,0.00023958235,0.00057115726,0.00023995634,0.00050544867,0.00017080254,0.0011716376,0.000024863619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029396215,0.0007160293,0.98674697,0.000092980525,0.00028350807,0.0042554853,0.0013710015,0.00014696248,0.00015255583,0.000017890312,0.00095940026,0.0023175958],"study_design_scores_gemma":[0.007901304,0.01881693,0.97058713,0.00033731636,0.00024822133,0.00017901175,0.000019610012,0.00013203373,0.000102820144,0.00009838676,0.0012380758,0.00033917057],"about_ca_topic_score_codex":0.012915103,"about_ca_topic_score_gemma":0.027246673,"teacher_disagreement_score":0.0181009,"about_ca_system_score_codex":0.001201862,"about_ca_system_score_gemma":0.0003780387,"threshold_uncertainty_score":0.99990124},"labels":[],"label_agreement":null},{"id":"W4302362273","doi":"10.1111/jvh.13753","title":"A randomized phase 1b trial of the active site polymerase inhibitor nucleotide <scp>ATI</scp>‐2173 in patients with chronic hepatitis B virus infection","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Tolerability; Medicine; Placebo; Adverse effect; Internal medicine; Hepatitis B virus; Immunology; Pharmacology; Virology; Gastroenterology; Virus; Pathology","score_opus":0.008560298899872632,"score_gpt":0.26004819006172597,"score_spread":0.2514878911618533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302362273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953387,0.00039589228,0.000048061385,0.00021249938,0.0012416162,0.0022049581,0.00028663862,0.000019636025,0.00025201374],"genre_scores_gemma":[0.9974877,0.001251733,0.000099879384,0.0002972005,0.0005011614,0.00014678587,0.000026238306,0.000058276244,0.00013102005],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995246,0.001058843,0.001543058,0.0002778434,0.0014496058,0.00042463333],"domain_scores_gemma":[0.9966304,0.0005686659,0.001856714,0.00033041948,0.00044913453,0.00016467359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000910015,0.00035004856,0.0015473372,0.0005324072,0.0003070372,0.000026362663,0.00019014346,0.000092362614,0.00016476808],"category_scores_gemma":[0.0014604201,0.00024472157,0.0005842427,0.00076605816,0.0003093793,0.0004311628,0.00020173486,0.0009761047,0.000006729925],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.257807,0.004711218,0.72314274,0.00009738554,0.00074696273,0.00017487106,0.0024467076,0.00009282323,0.0013154998,0.000023642842,0.0015154416,0.007925729],"study_design_scores_gemma":[0.72824323,0.012230148,0.24912663,0.00042347785,0.00055208744,0.000040220315,0.00002430058,0.00023077482,0.007906095,0.00006258991,0.0010234076,0.00013704643],"about_ca_topic_score_codex":0.03388225,"about_ca_topic_score_gemma":0.024123555,"teacher_disagreement_score":0.4740161,"about_ca_system_score_codex":0.001202618,"about_ca_system_score_gemma":0.0006269546,"threshold_uncertainty_score":0.9979456},"labels":[],"label_agreement":null},{"id":"W4307497565","doi":"10.1111/jvh.13761","title":"Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Department of Health and Aged Care, Australian Government","keywords":"ELISPOT; Medicine; Immune system; Hepatitis C virus; Immunology; Interferon; Virus; Virology; T cell","score_opus":0.04178207000462755,"score_gpt":0.33471341554755885,"score_spread":0.2929313455429313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307497565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866451,0.003243579,0.00025223714,0.0008415124,0.0028578949,0.0008700952,0.00031062888,0.00016128607,0.0048176576],"genre_scores_gemma":[0.9155796,0.08057006,0.0009448193,0.00028792783,0.0008377304,0.000109836525,0.00006617109,0.0001865128,0.0014173039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99023885,0.002437479,0.0025619743,0.00071826,0.002858729,0.0011846969],"domain_scores_gemma":[0.99584955,0.00058408146,0.0015099882,0.00080367835,0.000670763,0.0005819449],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036227934,0.000632721,0.0016732459,0.001585693,0.0014294492,0.0002627946,0.00051195413,0.0002300591,0.0029968615],"category_scores_gemma":[0.001667654,0.00066877634,0.0011194965,0.0014802434,0.00016600595,0.0012050258,0.0005698147,0.0021332616,0.00011636764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014709283,0.00066688017,0.77426213,0.00013620629,0.00056352286,0.007015688,0.0008216174,0.000047486254,0.13247593,0.000014068448,0.001953458,0.08057208],"study_design_scores_gemma":[0.0045611206,0.004835067,0.78792,0.000774101,0.0002806047,0.001208682,0.00008769729,0.00022777286,0.08778961,0.000086598666,0.11139835,0.0008304127],"about_ca_topic_score_codex":0.027561024,"about_ca_topic_score_gemma":0.0064671817,"teacher_disagreement_score":0.10944489,"about_ca_system_score_codex":0.0025065015,"about_ca_system_score_gemma":0.0007673031,"threshold_uncertainty_score":0.99987054},"labels":[],"label_agreement":null},{"id":"W4310638951","doi":"10.1111/jvh.13780","title":"Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross‐sectional analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Public Health Ontario; University of Toronto; Regent Park Community Health Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; St. Michael's Hospital Foundation; Public Health Agency of Canada","keywords":"Medicine; Hepatitis C; Harm reduction; Confidence interval; Cross-sectional study; Internal medicine; Family medicine; Human immunodeficiency virus (HIV); Pathology","score_opus":0.021863103675477804,"score_gpt":0.3006898689686396,"score_spread":0.2788267652931618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310638951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790984,0.0011472586,0.000008214872,0.00010269856,0.000110688714,0.00028632986,0.0002006888,0.000011504938,0.00022277483],"genre_scores_gemma":[0.9967,0.0024063017,0.0004495523,0.000106298234,0.00008098208,0.00003946342,0.000056780646,0.000021210086,0.00013940605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751705,0.00030118725,0.0007482006,0.00027527555,0.0008357443,0.00032254725],"domain_scores_gemma":[0.99867296,0.0002906271,0.00028862403,0.00014059071,0.00033934956,0.00026786374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005558968,0.00020609736,0.0006948779,0.0004237181,0.0002748049,0.00010003749,0.00010093747,0.00006613609,0.0008754823],"category_scores_gemma":[0.00015085831,0.00018705723,0.000109357105,0.00062484795,0.000083057275,0.00039531183,0.00010339929,0.00039036322,5.254108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021341046,0.00010628003,0.9855327,0.00006946153,0.00041535575,0.0003112733,0.0013961596,0.00011133016,0.00018429202,0.0000038596404,0.00003990444,0.011615983],"study_design_scores_gemma":[0.0020917712,0.0012593408,0.9669972,0.0000878719,0.00018508556,0.00016358287,0.0004611899,0.028405156,0.00006128238,0.000010323486,0.00012948313,0.00014772627],"about_ca_topic_score_codex":0.97945344,"about_ca_topic_score_gemma":0.99106115,"teacher_disagreement_score":0.028293826,"about_ca_system_score_codex":0.003521241,"about_ca_system_score_gemma":0.00085975986,"threshold_uncertainty_score":0.9585917},"labels":[],"label_agreement":null},{"id":"W4366241054","doi":"10.1111/jvh.13837","title":"A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Public Health Ontario; Toronto General Hospital; University Health Network; University of Toronto; McGill University Health Centre; Institut National de Santé Publique du Québec; Institute for Clinical Evaluative Sciences; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Public Health Agency of Canada","keywords":"Medicine; Demography; Immigration; Poisson regression; Population; Hepatitis C; Cohort; Relative risk; Cohort study; Epidemiology; Geography; Internal medicine; Environmental health; Confidence interval","score_opus":0.027263776189639804,"score_gpt":0.3194647766665211,"score_spread":0.2922010004768813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366241054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979648,0.00019013164,0.0000049773,0.0007331854,0.00022841383,0.000709915,0.00012802171,0.000011430766,0.000029129285],"genre_scores_gemma":[0.9987583,0.0005003023,0.00018844595,0.0002344128,0.00008369283,0.00002902589,0.000044564797,0.00003277351,0.00012847535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996357,0.00025128198,0.0015096647,0.00028373746,0.00120605,0.00039223142],"domain_scores_gemma":[0.9983785,0.00040141345,0.00042243578,0.0003056236,0.00019783784,0.0002941577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056203123,0.00020222235,0.0009090466,0.0011220463,0.000043385608,0.000026723814,0.00016351481,0.00009420599,0.00007258223],"category_scores_gemma":[0.0011335895,0.00018877338,0.00007307667,0.001253828,0.000028440525,0.00022591592,0.000072081144,0.0003842146,0.000007869694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030926723,0.0003967874,0.9782076,0.000049984774,0.0000742402,0.006095281,0.0010006381,0.00011095001,0.0004539309,4.541057e-7,0.0027067552,0.010594119],"study_design_scores_gemma":[0.0036509642,0.0010013161,0.9925311,0.0008006746,0.0000412879,0.000010147474,0.00031564484,0.00082147116,0.0002909995,0.000024782727,0.00035744262,0.00015417306],"about_ca_topic_score_codex":0.99849206,"about_ca_topic_score_gemma":0.99975276,"teacher_disagreement_score":0.014323504,"about_ca_system_score_codex":0.0006265489,"about_ca_system_score_gemma":0.0008973493,"threshold_uncertainty_score":0.7697955},"labels":[],"label_agreement":null},{"id":"W4381309765","doi":"10.1111/jvh.13863","title":"Contribution of alcohol use in <scp>HIV</scp>/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies","year":2023,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; Merck Sharp and Dohme; European Regional Development Fund; Stichting HIV Monitoring; Ministère des Affaires Sociales et de la Santé; Institut National de la Santé et de la Recherche Médicale; National Institute for Health and Care Research; Alberta Health; Ministerie van Volksgezondheid, Welzijn en Sport; Ministerio de Sanidad, Política Social e Igualdad; ViiV Healthcare; Wellcome Trust; Office of Research and Development; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Janssen Pharmaceuticals; Gilead Sciences; U.S. Department of Veterans Affairs","keywords":"Human immunodeficiency virus (HIV); Cohort; Virology; Hepatitis C virus; Medicine; Alcohol; Cohort study; Hepatitis C; Hepatitis virus; Virus; Environmental health; Biology; Internal medicine","score_opus":0.0977917006218127,"score_gpt":0.40795897450794394,"score_spread":0.31016727388613125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381309765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969521,0.00067737396,0.00013064763,0.00036294188,0.00032992612,0.001058687,0.00035995414,0.000030380339,0.00009798865],"genre_scores_gemma":[0.9351056,0.064154156,0.00020630712,0.00009630499,0.0001609108,0.000044962304,0.00008183589,0.000035949328,0.000113936214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612504,0.0003696989,0.0015359716,0.00029651503,0.0012488456,0.00042392468],"domain_scores_gemma":[0.99578166,0.0006634556,0.00074253895,0.00030008287,0.0022343008,0.000277958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016034925,0.00024819103,0.0010992322,0.0012480728,0.000075513635,0.000055806086,0.000103249804,0.00019286833,0.000021953772],"category_scores_gemma":[0.004562684,0.00023621236,0.00014524235,0.0015041529,0.00021255299,0.00071044755,0.000091646616,0.0004036771,0.000027729708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015966018,0.00020152876,0.94848025,0.0001714964,0.0011538487,0.0006530177,0.0010857255,0.00009191393,0.033453453,0.0001811794,0.013456178,0.0009117255],"study_design_scores_gemma":[0.0024238331,0.001794249,0.9611492,0.0006737393,0.00035141132,0.00006498668,0.00018568798,0.00042906363,0.028405743,0.00015069051,0.0042716535,0.00009970505],"about_ca_topic_score_codex":0.0048265737,"about_ca_topic_score_gemma":0.021336941,"teacher_disagreement_score":0.063476786,"about_ca_system_score_codex":0.0005349552,"about_ca_system_score_gemma":0.0002758767,"threshold_uncertainty_score":0.9965211},"labels":[],"label_agreement":null},{"id":"W4381470523","doi":"10.1111/jvh.13866","title":"Migrants and hepatitis: A tale of two worlds","year":2023,"lang":"en","type":"letter","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Data science; Computational biology; Biology","score_opus":0.030806352099571232,"score_gpt":0.33826777231802446,"score_spread":0.30746142021845324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381470523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69990927,0.0052696797,0.00013443238,0.28521338,0.0023271637,0.0012456798,0.0010692993,0.00009852028,0.0047325757],"genre_scores_gemma":[0.56391037,0.083453104,0.007900076,0.28603497,0.023177419,0.000092807124,0.0005111233,0.00094995846,0.03397016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950231,0.00030032458,0.0016135818,0.00036763604,0.0020168056,0.00067855493],"domain_scores_gemma":[0.9968479,0.00041963556,0.0010757383,0.00048382583,0.000859985,0.0003128934],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00075505674,0.00044418112,0.0017536442,0.0013185972,0.00007824336,0.00006362284,0.00037558805,0.00061683427,0.0004831455],"category_scores_gemma":[0.0006196109,0.00038842877,0.00054495427,0.00057652954,0.00038309995,0.0002707372,0.00018218387,0.003177625,0.000118855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010193687,0.00006929438,0.21898219,0.000928086,0.00047240063,0.012693824,0.00018595553,7.167406e-7,0.00037613694,0.000008388792,0.74424493,0.021936119],"study_design_scores_gemma":[0.0061093117,0.004793721,0.11542507,0.008209049,0.00093631237,0.0021207517,0.000022720513,0.00036309598,0.0013687658,0.0011662549,0.8586682,0.00081671297],"about_ca_topic_score_codex":0.007775793,"about_ca_topic_score_gemma":0.0021055208,"teacher_disagreement_score":0.13599887,"about_ca_system_score_codex":0.0002607264,"about_ca_system_score_gemma":0.0006187451,"threshold_uncertainty_score":0.99985677},"labels":[],"label_agreement":null},{"id":"W4387296246","doi":"10.1111/jvh.13889","title":"Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature","year":2023,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hepatitis D virus; Virology; Genotype; Hepatitis B virus; Hepatitis D; Virus; Hepatitis C virus; Biology; Hepatitis B; Medicine; Genetics; Gene; HBsAg","score_opus":0.056307676486900334,"score_gpt":0.342132905956778,"score_spread":0.28582522946987765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021918166,0.98344076,0.00009822825,0.0002714605,0.0021357501,0.008208097,0.0054525244,0.0000630743,0.00011091185],"genre_scores_gemma":[0.00013165658,0.9932438,0.00097048783,0.00076718983,0.0009667364,0.0010019682,0.00019375003,0.00027647574,0.0024479467],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895622,0.0011473409,0.0058689825,0.0006966037,0.0018989382,0.00082590716],"domain_scores_gemma":[0.98725206,0.0014255707,0.0068601193,0.0015074936,0.0025907126,0.00036403578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00188695,0.0012565898,0.0099876765,0.00069409236,0.00031775032,0.00012471322,0.0013263465,0.00073936797,0.0001275144],"category_scores_gemma":[0.006847634,0.00061687443,0.0041871406,0.0012911751,0.00031686027,0.00036442766,0.00044528858,0.0016235248,0.0000749832],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043975055,0.0001734128,0.0017960004,0.9632696,0.0026327115,0.00035156345,0.00043696552,1.5192582e-7,0.0000055358933,0.00007522493,0.010792663,0.0204222],"study_design_scores_gemma":[0.00058786024,0.00091173867,0.00051866716,0.8849753,0.014031765,0.00068927975,0.0000069404387,0.0000123563395,0.00004047563,0.00032784688,0.09729711,0.0006006238],"about_ca_topic_score_codex":0.00658995,"about_ca_topic_score_gemma":0.020124204,"teacher_disagreement_score":0.086504444,"about_ca_system_score_codex":0.00086835894,"about_ca_system_score_gemma":0.0015427041,"threshold_uncertainty_score":0.99962825},"labels":[],"label_agreement":null},{"id":"W4391053435","doi":"10.1111/jvh.13918","title":"Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"HBsAg; Medicine; HBeAg; Gastroenterology; Internal medicine; PEG ratio; Combination therapy; Chronic hepatitis; Hepatitis B virus; Immunology; Virus","score_opus":0.017378658277352577,"score_gpt":0.312825760864917,"score_spread":0.2954471025875644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391053435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849721,0.011477238,0.000562181,0.0015337168,0.0005311405,0.00040792837,0.00014942608,0.00002656742,0.00033968635],"genre_scores_gemma":[0.94491285,0.05296381,0.0009282207,0.0004360858,0.0005670686,0.000019525745,0.000012749822,0.000042534128,0.00011716062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757105,0.00014316179,0.0010936749,0.00030735385,0.00053606275,0.00034866983],"domain_scores_gemma":[0.9987031,0.00026033726,0.00034047963,0.00018638211,0.0003225491,0.0001871305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045030375,0.0002809394,0.0008690443,0.0005526843,0.00006927721,0.000055337347,0.00015516389,0.000116994095,0.00033239968],"category_scores_gemma":[0.0002494905,0.0002352346,0.00020458501,0.0004499752,0.00021033263,0.0004939924,0.00008752899,0.0004662375,0.000029210598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001611544,0.00028641082,0.7778958,0.0006342318,0.00047962298,0.0010577645,0.0032654267,0.00002034276,0.01717653,0.00013628579,0.00409177,0.1933443],"study_design_scores_gemma":[0.001504596,0.0068297707,0.96609575,0.0045475294,0.00008021422,0.00019570389,0.000026597017,0.0003388859,0.01846232,0.00043059947,0.0012717281,0.00021631573],"about_ca_topic_score_codex":0.005335623,"about_ca_topic_score_gemma":0.046947457,"teacher_disagreement_score":0.19312797,"about_ca_system_score_codex":0.0004587899,"about_ca_system_score_gemma":0.00023368605,"threshold_uncertainty_score":0.97044325},"labels":[],"label_agreement":null},{"id":"W4391650026","doi":"10.1111/jvh.13925","title":"Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute on Drug Abuse; Center for AIDS Research, University of Washington; National Institutes of Health; Charles A. King Trust; Novo Nordisk; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Pfizer; Patrick and Catherine Weldon Donaghue Medical Research Foundation","keywords":"Medicine; Cirrhosis; Transient elastography; Internal medicine; Fibrosis; Liver biopsy; Population; Gastroenterology; Biopsy; Radiology; Liver fibrosis","score_opus":0.014074495795338933,"score_gpt":0.2634079338953853,"score_spread":0.24933343810004638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391650026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961013,0.0015826263,0.00019028074,0.0004954154,0.00023690068,0.00042356557,0.0008317604,0.00001987459,0.00011824598],"genre_scores_gemma":[0.9905501,0.006238222,0.0023140314,0.00030099056,0.0002898728,0.00006385388,0.00007146809,0.000041698688,0.00012973275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985745,0.00003143397,0.00055077573,0.00019007773,0.00038185273,0.00027138193],"domain_scores_gemma":[0.9986444,0.00062153075,0.00022598001,0.000119914024,0.00021524538,0.00017289515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018350402,0.00021025112,0.0005362268,0.00030827028,0.00006797333,0.00013414124,0.00008117088,0.00006522198,0.00009204144],"category_scores_gemma":[0.00012520942,0.00015886484,0.00019546122,0.00016444465,0.000059957616,0.0003810261,0.000029573273,0.00021152961,0.00001057683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010331774,0.00045001722,0.98762596,0.0005600879,0.00040054417,0.0016882736,0.0017046478,0.000006127389,0.00029066455,0.00014933,0.0012334376,0.0057875807],"study_design_scores_gemma":[0.0023240212,0.0035695178,0.98257303,0.0049284804,0.0006948822,0.00013405141,0.00014471488,0.00087565446,0.003702917,0.00022268815,0.0006296302,0.00020039802],"about_ca_topic_score_codex":0.0014754841,"about_ca_topic_score_gemma":0.00040414205,"teacher_disagreement_score":0.005587183,"about_ca_system_score_codex":0.00028353865,"about_ca_system_score_gemma":0.00035152613,"threshold_uncertainty_score":0.64783204},"labels":[],"label_agreement":null},{"id":"W4392040631","doi":"10.1111/jvh.13931","title":"Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; York University; University Health Network","funders":"","keywords":"Medicine; Agonist; Hepatitis C; Opioid; Internal medicine; Pharmacology; Family medicine; Receptor","score_opus":0.03530417547312426,"score_gpt":0.3291556698091861,"score_spread":0.29385149433606184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392040631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887295,0.004860482,0.0000034265274,0.0009706428,0.0007147792,0.00043384376,0.000093065566,0.000017629958,0.0040331753],"genre_scores_gemma":[0.8677338,0.11782136,0.0005287126,0.0002723302,0.00027135265,0.000020432532,0.000017240014,0.00004246053,0.013292312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723274,0.0001334876,0.0010074155,0.00032324495,0.00085360516,0.00044948325],"domain_scores_gemma":[0.99872684,0.00024540542,0.00018314246,0.00027089883,0.00017677977,0.00039693725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046121096,0.00026998387,0.00065561314,0.00036142638,0.00010151711,0.000095123316,0.00014897114,0.00010204317,0.0012678977],"category_scores_gemma":[0.00007635,0.00021373734,0.0001697309,0.0002972863,0.00011282617,0.0002463607,0.00006014267,0.0006462701,0.00001681111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026256393,0.00011192592,0.88434166,0.000113294685,0.0001437893,0.0050883414,0.0005599868,0.0000026710527,0.00018370146,0.000053150565,0.004762718,0.10437619],"study_design_scores_gemma":[0.0013365068,0.0019403311,0.7619095,0.00066542986,0.00005430286,0.00019535612,0.000007724547,0.00036016415,0.00039705835,0.00007838607,0.23290125,0.00015398698],"about_ca_topic_score_codex":0.9827643,"about_ca_topic_score_gemma":0.9991415,"teacher_disagreement_score":0.22813852,"about_ca_system_score_codex":0.005545507,"about_ca_system_score_gemma":0.0049193525,"threshold_uncertainty_score":0.99964505},"labels":[],"label_agreement":null},{"id":"W4392810368","doi":"10.1111/jvh.13937","title":"Performance of <scp>HCV</scp> core antigen and <scp>PCR</scp> testing in a predominantly genotype 3 population","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"","keywords":"Medicine; Genotype; Internal medicine; Hepatitis C virus; Population; Antibody; Antigen; Immunology; Gastroenterology; Hepatitis C; Virology; Polymerase chain reaction; Biology; Virus; Gene","score_opus":0.037227753346706305,"score_gpt":0.31554309972679767,"score_spread":0.27831534638009137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392810368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937997,0.0031282597,0.000034504665,0.000056004825,0.00027143225,0.00033196545,0.000040280254,0.000022934959,0.002314909],"genre_scores_gemma":[0.9920873,0.0040303967,0.002976549,0.00004850964,0.00033206402,0.000005791241,0.000015302438,0.00004561173,0.0004584867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750596,0.00009411093,0.00096274517,0.00023446612,0.00078212476,0.00042059284],"domain_scores_gemma":[0.9982533,0.0006360157,0.00032667795,0.00018277454,0.000386534,0.00021471793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009627525,0.00020024386,0.0005979648,0.00069868815,0.00007203468,0.000060896175,0.0001511624,0.00016172344,0.000017126498],"category_scores_gemma":[0.0026010158,0.0001725657,0.000110146764,0.00073906715,0.000108556174,0.000536885,0.00008502237,0.00066402886,0.000018373137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025294787,0.00007120527,0.9377142,0.00065105193,0.00006104026,0.0005905975,0.0008254686,0.000038967428,0.011016793,0.000037625152,0.0010516335,0.047916107],"study_design_scores_gemma":[0.00092454243,0.0019281681,0.94796383,0.002257416,0.00006376033,0.00034348032,0.00006949734,0.04047739,0.0028732482,0.00014014659,0.0029186893,0.00003982758],"about_ca_topic_score_codex":0.0015428313,"about_ca_topic_score_gemma":0.00037523647,"teacher_disagreement_score":0.04787628,"about_ca_system_score_codex":0.00021043415,"about_ca_system_score_gemma":0.0003341332,"threshold_uncertainty_score":0.70370257},"labels":[],"label_agreement":null},{"id":"W4394809659","doi":"10.1111/jvh.13939","title":"An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Seroprevalence; Demography; Hepatitis D virus; Meta-analysis; HBsAg; Hepatitis D; Prevalence; Epidemiology; Hepatitis B virus; Virology; Internal medicine; Immunology; Virus; Serology","score_opus":0.019207641634244713,"score_gpt":0.31201870455119124,"score_spread":0.29281106291694653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394809659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235976,0.0054549766,0.00053064735,0.0004168674,0.0002919366,0.000286855,0.00034321763,0.000018671955,0.00029704836],"genre_scores_gemma":[0.9915525,0.0054407814,0.0025589739,0.00016081113,0.00010369751,0.00001841936,0.000039191793,0.000031186708,0.00009445931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964998,0.0002612328,0.0014690702,0.00031774232,0.001092387,0.00035979965],"domain_scores_gemma":[0.9981877,0.00014429622,0.00049243687,0.0003500736,0.00056208245,0.0002634141],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066616957,0.0002768939,0.0016575566,0.00079532276,0.00004815978,0.00003480887,0.00024670683,0.00008600222,0.0009502958],"category_scores_gemma":[0.000092029586,0.00022139934,0.0006652803,0.0012450047,0.000104302,0.0005381687,0.000057154564,0.00052105915,0.0000020042976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053403335,0.00015682048,0.96926844,0.00035825296,0.024872513,0.001963166,0.0003455718,0.00026985086,0.00013344611,0.000049117698,0.0011013558,0.0014280727],"study_design_scores_gemma":[0.0004998194,0.0008460098,0.9382249,0.00039922877,0.036578536,0.00006167937,0.000050981824,0.022512006,0.0004615785,0.000047822774,0.00013247422,0.00018494675],"about_ca_topic_score_codex":0.9575941,"about_ca_topic_score_gemma":0.991353,"teacher_disagreement_score":0.033758853,"about_ca_system_score_codex":0.0010506109,"about_ca_system_score_gemma":0.0021834937,"threshold_uncertainty_score":0.999963},"labels":[],"label_agreement":null},{"id":"W4398166628","doi":"10.1111/jvh.13954","title":"Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Gilead Sciences","keywords":"Medicine; Epidemiology; Poisson regression; Incidence (geometry); Population; Hepatitis B; Pregnancy; Rochester Epidemiology Project; Logistic regression; Psychological intervention; Demography; Obstetrics; Pediatrics; Internal medicine; Environmental health; Population based study","score_opus":0.01966700906849523,"score_gpt":0.298766914491631,"score_spread":0.2790999054231358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398166628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97650695,0.021990633,0.00009963391,0.00018575555,0.000539872,0.0004972278,0.000028393482,0.000023193148,0.00012835329],"genre_scores_gemma":[0.99589753,0.0006596395,0.0027705051,0.00018104361,0.00026497256,0.000019838684,0.0000086070895,0.0000369231,0.00016091786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785817,0.00018856229,0.0009864343,0.00023709261,0.00040265388,0.00032710895],"domain_scores_gemma":[0.9985889,0.00028211853,0.00040465748,0.00021598022,0.00030747193,0.00020084777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064490107,0.00021781925,0.0011198963,0.0005058406,0.00004659649,0.0000060166053,0.00011032216,0.00007811488,0.000051394803],"category_scores_gemma":[0.0005077777,0.00016700759,0.0001508226,0.00023151908,0.0001209571,0.0001670262,0.00007224498,0.00044254772,0.0000021610365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019188494,0.00010708393,0.9799185,0.0008358094,0.0003759638,0.0004892279,0.008746639,0.00005383522,0.00039679208,0.000045902758,0.00026618192,0.0085721845],"study_design_scores_gemma":[0.0012275191,0.008321509,0.98653346,0.0018805774,0.00022724735,0.00007418472,0.00017245453,0.0002597228,0.00010226781,0.000034008186,0.0010181243,0.00014891199],"about_ca_topic_score_codex":0.020232366,"about_ca_topic_score_gemma":0.020115785,"teacher_disagreement_score":0.021330994,"about_ca_system_score_codex":0.0026668704,"about_ca_system_score_gemma":0.00052444666,"threshold_uncertainty_score":0.9977645},"labels":[],"label_agreement":null},{"id":"W4398783669","doi":"10.1111/jvh.13961","title":"Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan: A case–control study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psychological intervention; Medicine; Demography; Hepatitis B; Residence; Logistic regression; Quality of life (healthcare); Family history; Environmental health; Hepatitis C; Gerontology; Multivariate analysis; Immunology; Internal medicine; Psychiatry","score_opus":0.037325076563529784,"score_gpt":0.3380228199455912,"score_spread":0.3006977433820614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398783669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631697,0.0015358031,0.00007227671,0.00011170442,0.0007398415,0.0008264288,0.00015018383,0.000024474208,0.00022233662],"genre_scores_gemma":[0.9990347,0.00044062175,0.00014063677,0.00010229802,0.0001838227,0.000011508258,0.0000030682634,0.00004510675,0.000038228474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561983,0.00066720933,0.0021904528,0.00029728262,0.00082567654,0.00039952586],"domain_scores_gemma":[0.9978844,0.0007675654,0.00056946895,0.00021956154,0.0003580873,0.0002009504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015792632,0.00031876637,0.0014999518,0.0007455403,0.00006492595,0.000049318765,0.00012414165,0.00012527463,0.00012530363],"category_scores_gemma":[0.0019598329,0.0002590379,0.00030819455,0.0006609934,0.00007665808,0.0004145109,0.0000632959,0.0007368856,0.0000059691315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002506703,0.0010711299,0.98204225,0.00037533167,0.00033000566,0.005338192,0.00627919,0.000014118292,0.00013034791,0.000024348177,0.00013075734,0.004013645],"study_design_scores_gemma":[0.0042814207,0.0033823363,0.9896244,0.0009728748,0.00013087303,0.00008618205,0.0009003396,0.0001996361,0.00012100785,0.000055549808,0.000038843715,0.0002065702],"about_ca_topic_score_codex":0.061288487,"about_ca_topic_score_gemma":0.20746587,"teacher_disagreement_score":0.14617738,"about_ca_system_score_codex":0.0006365308,"about_ca_system_score_gemma":0.00029988113,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W4399977267","doi":"10.1111/jvh.13980","title":"Impact of <scp>COVID</scp>‐19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; BC Centre for Disease Control; University of British Columbia","funders":"BC Cancer Agency; British Columbia Centre for Disease Control; Ministry of Health, British Columbia","keywords":"Hepatocellular carcinoma; Medicine; Pandemic; Cirrhosis; Cohort; Confidence interval; Internal medicine; Demography; Hepatitis C; Coronavirus disease 2019 (COVID-19); Cohort study; Infectious disease (medical specialty); Disease","score_opus":0.0325084989666425,"score_gpt":0.3319542213789906,"score_spread":0.2994457224123481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399977267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974961,0.0012351294,0.0000073158267,0.00012908208,0.00035634084,0.00048403617,0.00021200051,0.000029365616,0.00005061909],"genre_scores_gemma":[0.9984454,0.0003588363,0.000023418093,0.0003532372,0.00026636556,0.0000047285707,0.000021203321,0.00004121162,0.0004856373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997326,0.0002992869,0.0009947922,0.0002685229,0.00069254485,0.00041881736],"domain_scores_gemma":[0.998168,0.00036841724,0.00031188942,0.0002591469,0.00030323854,0.0005893212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007773068,0.00018717916,0.00087815785,0.00025642596,0.00006139241,0.00011974238,0.00018312197,0.00012030654,0.00015354993],"category_scores_gemma":[0.0009517117,0.00021816274,0.0002090225,0.00045360913,0.00006206006,0.00031086119,0.000038598737,0.0006741756,0.0000040447885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011620405,0.00032266663,0.98075974,0.0002786997,0.00013792154,0.0077522267,0.0011298385,0.000016521588,0.00046445586,4.452582e-7,0.0049990825,0.0040222225],"study_design_scores_gemma":[0.001480908,0.010257687,0.98419404,0.0006931226,0.00005109996,0.0014107432,0.00038333735,0.00071663223,0.0000120023005,0.000035983332,0.00067503034,0.000089407215],"about_ca_topic_score_codex":0.9783541,"about_ca_topic_score_gemma":0.99153227,"teacher_disagreement_score":0.013178153,"about_ca_system_score_codex":0.0026263043,"about_ca_system_score_gemma":0.0066748657,"threshold_uncertainty_score":0.9989564},"labels":[],"label_agreement":null},{"id":"W4401395414","doi":"10.1111/jvh.13979","title":"Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Public Health Agency of Canada; University of Lethbridge; University of Alberta; University of Calgary","funders":"GlaxoSmithKline Biologicals; Canadian Institutes of Health Research; Wellcome Trust","keywords":"Medicine; Disease; Viral hepatitis; Immunology; Immune system; Chronic hepatitis; Liver disease; Immune Dysfunction; Liver dysfunction; Hepatitis B; Virology; Internal medicine; Virus","score_opus":0.006639283390826784,"score_gpt":0.24508794603160533,"score_spread":0.23844866264077855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401395414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878552,0.0111206435,0.00010071094,0.00012120995,0.00019317404,0.00037556415,0.00018136033,0.000009434088,0.000042695814],"genre_scores_gemma":[0.9939057,0.005655919,0.00023993441,0.000038835144,0.000052634532,0.000013751319,0.000051569816,0.000022994871,0.000018618415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859095,0.00007537511,0.0004994887,0.00020222453,0.00044610465,0.00018588912],"domain_scores_gemma":[0.9991718,0.0000804514,0.00025106934,0.00010960021,0.00016858566,0.00021851118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018824326,0.00018762537,0.0004902727,0.00029684234,0.000041048497,0.000046592228,0.00003946565,0.00005508462,0.000058843794],"category_scores_gemma":[0.000042822197,0.00013562612,0.000112871145,0.00020611858,0.00007922713,0.00038763392,0.00003542356,0.00016377361,0.0000010319101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020519063,0.00101248,0.9887332,0.00026361799,0.0013475096,0.00040657396,0.00007913709,0.00000973585,0.0002317696,0.00029319877,0.000033932673,0.0073836558],"study_design_scores_gemma":[0.0056205336,0.0020926732,0.9851976,0.0017256655,0.001532123,0.000018915218,0.000008358095,0.0035361263,0.000061665094,0.00005684672,0.00002591817,0.00012357252],"about_ca_topic_score_codex":0.001980985,"about_ca_topic_score_gemma":0.0003200392,"teacher_disagreement_score":0.007260083,"about_ca_system_score_codex":0.0004400107,"about_ca_system_score_gemma":0.00038295548,"threshold_uncertainty_score":0.55306727},"labels":[],"label_agreement":null},{"id":"W4401550758","doi":"10.1111/jvh.13995","title":"Mixed‐Genotype <scp>HCV</scp> Direct Acting Antiviral Outcomes: A <scp>CANUHC</scp> Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Toronto; Dalhousie University; McMaster University; Ottawa Hospital; Vancouver Infectious Diseases Centre; Université Laval; University of Saskatchewan; William Osler Health System; University of Victoria; University of Calgary","funders":"Public Health Agency; Public Health Agency of Canada; Gilead Sciences","keywords":"Genotype; Hepatitis C virus; Medicine; Cohort; Hepatitis C; Virology; Hepacivirus; Antiviral therapy; Internal medicine; Immunology; Virus; Chronic hepatitis; Biology; Gene; Genetics","score_opus":0.03353887622847949,"score_gpt":0.33256066659367933,"score_spread":0.2990217903651998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401550758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93924797,0.0033635863,0.0012232378,0.0006199808,0.0015355923,0.0004005527,0.00016686342,0.00017004128,0.053272154],"genre_scores_gemma":[0.98417866,0.0029973951,0.0023745275,0.0004846769,0.0011289383,0.000015957941,0.000043456424,0.00013413164,0.008642272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939162,0.00047067495,0.0016283179,0.0006191573,0.002214123,0.0011515003],"domain_scores_gemma":[0.9952142,0.0021639636,0.0005753877,0.0006142346,0.0007260947,0.00070610346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001970883,0.0005572518,0.0018225709,0.0023352997,0.00024463274,0.00042078318,0.0005246341,0.00034565516,0.00019269166],"category_scores_gemma":[0.0053684036,0.0004494289,0.001610452,0.0028791998,0.00019973356,0.00091793644,0.00021105775,0.0017626312,0.0005051077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002254521,0.00026306018,0.82799774,0.00036080406,0.0054055694,0.0060250238,0.0015566122,0.00004425985,0.0025482422,0.000100463236,0.03836125,0.11731445],"study_design_scores_gemma":[0.0025989218,0.0029792152,0.49777353,0.0014437763,0.005618696,0.00025481507,0.00081066316,0.010538124,0.011947092,0.00036364616,0.46541032,0.00026119736],"about_ca_topic_score_codex":0.0015931734,"about_ca_topic_score_gemma":0.0014727793,"teacher_disagreement_score":0.42704907,"about_ca_system_score_codex":0.0006915864,"about_ca_system_score_gemma":0.0008333254,"threshold_uncertainty_score":0.99979573},"labels":[],"label_agreement":null},{"id":"W4401648035","doi":"10.1111/jvh.13989","title":"Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B‐Related Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Alberta; University of Manitoba; Ottawa Hospital; McGill University Health Centre; University of Ottawa; Toronto Liver Centre; University of British Columbia; University of Calgary; Western University; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Cohort; Gastroenterology; Epidemiology; Hepatitis B; Retrospective cohort study; Chronic hepatitis; HBeAg; Cohort study; Liver cancer; Stage (stratigraphy); Hepatitis B virus; Immunology; HBsAg; Virus","score_opus":0.01849142444006027,"score_gpt":0.26855844847251253,"score_spread":0.2500670240324523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401648035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989378,0.0077397283,0.00002973824,0.0012252296,0.00064617855,0.00048628912,0.00018463797,0.000025009942,0.00028519967],"genre_scores_gemma":[0.9917049,0.007400904,0.00019059368,0.00016330724,0.00023127387,0.000021105916,0.000054776803,0.000056705278,0.0001764608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974377,0.00024292535,0.0009893519,0.00034728143,0.00028316645,0.0006995565],"domain_scores_gemma":[0.9985452,0.00025026817,0.00021619714,0.00020813615,0.00020434264,0.00057581154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005278347,0.00035087977,0.001028145,0.0006587221,0.00009920665,0.000024552088,0.00009329842,0.00018250741,0.00017395076],"category_scores_gemma":[0.00018171531,0.0002557636,0.00017184322,0.00029384502,0.00015747301,0.0002596982,0.000034057175,0.00046780374,0.000025752724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006659668,0.00010131059,0.9842998,0.0001515046,0.0003308781,0.0029873543,0.00046046058,0.0000067965266,0.000008031244,0.00019706853,0.00013812637,0.0112521015],"study_design_scores_gemma":[0.0023076837,0.0045305095,0.98557496,0.00094821234,0.00023012307,0.00026180933,0.00000991788,0.0022638924,0.00004480323,0.00012514801,0.0034659102,0.00023702758],"about_ca_topic_score_codex":0.85143095,"about_ca_topic_score_gemma":0.91870326,"teacher_disagreement_score":0.06727229,"about_ca_system_score_codex":0.002485673,"about_ca_system_score_gemma":0.0010280637,"threshold_uncertainty_score":0.99998945},"labels":[],"label_agreement":null},{"id":"W4403567445","doi":"10.1111/jvh.14023","title":"Community Pop‐Up Clinic: Cascade of Care and <scp>HCV</scp> Treatment of Vancouver's Inner‐City <scp>PWID</scp> Populations","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Vancouver Infectious Diseases Centre","funders":"","keywords":"Medicine; Inner city; Internal medicine","score_opus":0.06191032226575992,"score_gpt":0.36874125980294004,"score_spread":0.3068309375371801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403567445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876311,0.00629503,0.000095338386,0.00011920664,0.001453419,0.0003496534,0.00041319753,0.00003767316,0.0036053837],"genre_scores_gemma":[0.9910385,0.0039250394,0.0019109547,0.00007872702,0.00043912418,0.0000065926556,0.000053416697,0.000053139454,0.002494499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970064,0.00038154144,0.0014155088,0.00020817704,0.000650998,0.00033738793],"domain_scores_gemma":[0.9968778,0.0010169919,0.0007371697,0.00046809186,0.0005542205,0.00034574818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050293317,0.0003214823,0.0011195826,0.00044743798,0.00017032215,0.000032478256,0.00021026934,0.00026177056,0.000034318957],"category_scores_gemma":[0.0010547835,0.00025728057,0.00040129796,0.00042260444,0.00023462142,0.00034658881,0.00009504663,0.00084650354,0.000011351098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011494709,0.0016262361,0.72575396,0.001773297,0.0012556264,0.00068476534,0.09964338,0.00008596659,0.002465414,0.00022815207,0.061564054,0.10480417],"study_design_scores_gemma":[0.009175292,0.031339653,0.7528126,0.0041786092,0.0035832862,0.0008269984,0.08245358,0.0011421873,0.018851832,0.0026502528,0.09273438,0.0002512751],"about_ca_topic_score_codex":0.005911765,"about_ca_topic_score_gemma":0.009679236,"teacher_disagreement_score":0.104552895,"about_ca_system_score_codex":0.0004405107,"about_ca_system_score_gemma":0.000373692,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W4404593012","doi":"10.1111/jvh.14037","title":"Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Mekelle University; Addis Ababa University; University of Gondar; McMaster University; Hebrew University of Jerusalem; Jimma University; University of Bristol; Government of the United Kingdom; Wellcome Trust; National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit; University of Dundee","keywords":"Seroprevalence; Demography; Medicine; Population; Public health; Confidence interval; Geography; Environmental health; Serology; Immunology","score_opus":0.07046535734050845,"score_gpt":0.37920812111244123,"score_spread":0.30874276377193277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404593012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591465,0.0014939186,0.00009245841,0.010967212,0.00026349913,0.00070814847,0.00014722931,0.000013429197,0.00039945968],"genre_scores_gemma":[0.991184,0.0073599997,0.00023572154,0.00095212145,0.00012394662,0.000015888185,0.000008202707,0.00002947793,0.00009062648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958394,0.0009335912,0.0009942546,0.00025692192,0.0016630606,0.0003127461],"domain_scores_gemma":[0.9972923,0.0014317075,0.00027005692,0.00023177179,0.0005665619,0.00020763003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006086508,0.00019026973,0.00055986125,0.00085340405,0.00011595564,0.000059657123,0.00022535096,0.000117415366,0.00019140527],"category_scores_gemma":[0.0012179416,0.0001292545,0.00014141436,0.00089637615,0.00019465946,0.00019510895,0.000055277123,0.0011818174,0.00001241784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014237413,0.00037011,0.9884369,0.00032252778,0.00008725267,0.00025680385,0.00080546417,0.00004852639,0.000028265335,0.00020986315,0.0037488956,0.0055430457],"study_design_scores_gemma":[0.001135248,0.0038883318,0.98422956,0.0024019466,0.000021858043,0.00003603628,0.000042845608,0.007406544,0.000040849183,0.00019769158,0.00049682887,0.00010224892],"about_ca_topic_score_codex":0.014330525,"about_ca_topic_score_gemma":0.054483112,"teacher_disagreement_score":0.040152587,"about_ca_system_score_codex":0.00031745218,"about_ca_system_score_gemma":0.0013320638,"threshold_uncertainty_score":0.99223316},"labels":[],"label_agreement":null},{"id":"W4406219554","doi":"10.1111/jvh.14058","title":"Resistance‐Associated Substitution Testing Trends and Impact on <scp>HCV</scp> Treatment Outcomes in Canada: A <scp>CanHepC</scp>‐<scp>CANUHC</scp> Analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; University Health Network; Dalhousie University; William Osler Health System; University of Victoria; University of Calgary; Ottawa Hospital","funders":"AbbVie; Public Health Agency; Public Health Agency of Canada; Gilead Sciences","keywords":"Substitution (logic); Food science; Computer science; Chemistry","score_opus":0.025118117911860225,"score_gpt":0.32053392030387146,"score_spread":0.2954158023920112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406219554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494524,0.001510584,0.000047932313,0.00043009434,0.0002944079,0.00040272428,0.0004648738,0.00004056697,0.011863549],"genre_scores_gemma":[0.9873725,0.0017326068,0.00038749722,0.00034030253,0.00015171277,0.00003689792,0.00009073935,0.000052429805,0.009835311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942478,0.0005330951,0.0017146812,0.0006066571,0.0016757335,0.0012220566],"domain_scores_gemma":[0.99309224,0.0039265095,0.000971656,0.0005170382,0.000751367,0.00074116926],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011143355,0.00066090503,0.002128573,0.0029816632,0.00030341925,0.0001652085,0.0003285539,0.00029862984,0.000026797159],"category_scores_gemma":[0.010626207,0.00052198063,0.00063547475,0.0041874577,0.0001718066,0.00039560176,0.00008762027,0.0010177772,0.0000085138445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029861067,0.00044889687,0.9708227,0.000064820524,0.0025222006,0.0018735325,0.0004496126,0.00040304905,0.00036460056,0.000047296282,0.009963921,0.013009514],"study_design_scores_gemma":[0.0041401703,0.001545775,0.982559,0.0006691678,0.0013080585,0.000025950783,0.00030652498,0.00245565,0.0010093235,0.00010475841,0.005810815,0.00006480322],"about_ca_topic_score_codex":0.6287912,"about_ca_topic_score_gemma":0.9098836,"teacher_disagreement_score":0.2810924,"about_ca_system_score_codex":0.009928198,"about_ca_system_score_gemma":0.0047107474,"threshold_uncertainty_score":0.9997232},"labels":[],"label_agreement":null},{"id":"W4406874429","doi":"10.1111/jvh.70004","title":"Association of <scp>MASLD</scp> Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Ottawa Hospital; Queen's University; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; Public Health Agency; Public Health Agency of Canada","keywords":"Transient elastography; Medicine; Steatosis; Internal medicine; Fatty liver; Gastroenterology; Overweight; Fibrosis; Odds ratio; Hepatitis C; Liver disease; Confounding; Diabetes mellitus; Confidence interval; Metabolic syndrome; Liver fibrosis; Obesity; Disease; Endocrinology","score_opus":0.004297691688626713,"score_gpt":0.2200469515465357,"score_spread":0.215749259857909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406874429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401325,0.004534271,0.000015764497,0.000104070474,0.00012570883,0.00022212512,0.00011325364,0.0000042967977,0.0008672448],"genre_scores_gemma":[0.9903821,0.009129272,0.00017793928,0.00003830591,0.00006382095,0.000008230768,0.000008063406,0.000010402847,0.00018190258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859345,0.00014837008,0.0005020357,0.000103480845,0.0004927696,0.00015990916],"domain_scores_gemma":[0.9982253,0.00045372915,0.00073797535,0.00015753659,0.00035955923,0.0000659238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024894698,0.00013574054,0.00058630505,0.00027582183,0.000042493055,0.0000132031855,0.000100600424,0.000072911396,0.000028782595],"category_scores_gemma":[0.00029404613,0.00008141485,0.00027099266,0.00040647225,0.00004800329,0.00014516927,0.000027439872,0.00018065795,0.0000018152233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055943547,0.00037399543,0.9902553,0.000055574896,0.0011193684,0.000017411405,0.00089282315,0.00005587692,0.00017611201,0.00009174323,0.00061342405,0.0062924433],"study_design_scores_gemma":[0.001424237,0.0006848568,0.9809,0.00038160745,0.001412072,0.0000025131014,0.00025368718,0.00008579819,0.013235094,0.0002277027,0.0013605452,0.000031906384],"about_ca_topic_score_codex":0.010504214,"about_ca_topic_score_gemma":0.001169687,"teacher_disagreement_score":0.013058982,"about_ca_system_score_codex":0.0002321256,"about_ca_system_score_gemma":0.00017753127,"threshold_uncertainty_score":0.9960849},"labels":[],"label_agreement":null},{"id":"W4410403438","doi":"10.1111/jvh.70031","title":"Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Decompensation; Cirrhosis; Liver transplantation; Hepatocellular carcinoma; Ascites; Gastroenterology; Hepatic encephalopathy; Jaundice; Adverse effect; Hepatitis; Referral; Transplantation","score_opus":0.012204622904713502,"score_gpt":0.27926232038915083,"score_spread":0.2670576974844373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410403438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878616,0.0017804886,0.005613935,0.0007980322,0.0010920562,0.0006146027,0.00019526372,0.000029887837,0.0010895667],"genre_scores_gemma":[0.98448515,0.011477651,0.002338624,0.0006066966,0.00048584293,0.00006154658,0.000086883505,0.000030336316,0.0004272506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799365,0.000086164684,0.000920358,0.00022308034,0.0004593345,0.00031739235],"domain_scores_gemma":[0.99822575,0.00017450246,0.00042346967,0.0001780326,0.0008827497,0.00011550335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025344087,0.00022996553,0.0005665505,0.0004195963,0.000143493,0.00003923366,0.00011805631,0.00014868384,0.00015121388],"category_scores_gemma":[0.00028073773,0.00020665201,0.00030461585,0.00025773337,0.00008278019,0.00045642734,0.000024617239,0.00023982137,0.000018341954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008883306,0.00018254115,0.9475848,0.0007245838,0.00029940368,0.00020071024,0.0004960355,0.000009415055,0.00032793445,0.00019192115,0.0059611,0.0431332],"study_design_scores_gemma":[0.003989748,0.0018550257,0.9805856,0.0009815829,0.00061650324,0.00003361915,0.000006974931,0.00043061978,0.001578266,0.00045460393,0.009287932,0.00017957577],"about_ca_topic_score_codex":0.0021177016,"about_ca_topic_score_gemma":0.010622708,"teacher_disagreement_score":0.04295362,"about_ca_system_score_codex":0.0006738056,"about_ca_system_score_gemma":0.00026857786,"threshold_uncertainty_score":0.84270245},"labels":[],"label_agreement":null},{"id":"W4412522284","doi":"10.1111/jvh.70057","title":"<scp>CHIME</scp> : Sofosbuvir/Velpatasvir (S/V) for the Treatment of <scp>HCV</scp> Infection Among Vulnerable Inner‐City Residents","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre; Simon Fraser University","funders":"Gilead Sciences","keywords":"Medicine; Context (archaeology); Sofosbuvir; Internal medicine; Outreach; Hepatitis C; Pill; Clinical trial; Family medicine; Immunology; Hepatitis C virus; Ribavirin; Pharmacology","score_opus":0.02751808271297786,"score_gpt":0.33581268234618883,"score_spread":0.308294599633211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878113,0.0022721025,0.0024828454,0.00037370017,0.000919194,0.001251788,0.00013418304,0.000033444085,0.0047214213],"genre_scores_gemma":[0.9722119,0.014961119,0.00079367234,0.00019734875,0.0006435107,0.00011472089,0.000031744254,0.00005155436,0.010994428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634075,0.00037837416,0.0012998327,0.00032600953,0.0010055735,0.0006494303],"domain_scores_gemma":[0.9950387,0.0023951204,0.000758323,0.00055257126,0.0009731877,0.00028210724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001375879,0.0003517219,0.0009390169,0.0006889529,0.00044604894,0.00010236011,0.00033067446,0.00026744936,0.000052461986],"category_scores_gemma":[0.0037653088,0.0002466037,0.00061156054,0.0007252288,0.00027299477,0.0005187623,0.000087341956,0.00070545665,0.000021753809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010242492,0.0009253345,0.89130473,0.00023978282,0.00091384695,0.00011246747,0.0008370913,0.000107573636,0.0024179744,0.00015336009,0.045854017,0.0570314],"study_design_scores_gemma":[0.005069067,0.005286488,0.8121089,0.00067044795,0.00063767727,0.000039174,0.00017058934,0.001579057,0.04699315,0.0010917406,0.12629175,0.00006201213],"about_ca_topic_score_codex":0.011016374,"about_ca_topic_score_gemma":0.0033348699,"teacher_disagreement_score":0.08043773,"about_ca_system_score_codex":0.0007448219,"about_ca_system_score_gemma":0.0006539446,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W4413114408","doi":"10.1111/jvh.70062","title":"Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"GlaxoSmithKline","keywords":"Discontinuation; Medicine; Internal medicine; Retrospective cohort study; Entecavir; Cohort; Chronic hepatitis; Hepatitis C; Tenofovir alafenamide; Pediatrics; Viral load; Human immunodeficiency virus (HIV); Immunology; Virus; Antiretroviral therapy","score_opus":0.009536338422640227,"score_gpt":0.27596850002608514,"score_spread":0.2664321616034449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976873,0.00025820459,0.000052490886,0.00011625201,0.00017893633,0.0012695985,0.00001518001,0.000014825308,0.00040720473],"genre_scores_gemma":[0.9977706,0.0016851018,0.00026115397,0.000049174017,0.00008412923,0.00007145454,0.0000132905925,0.000017988401,0.00004712385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980012,0.00018009968,0.0008419808,0.00028780242,0.00042542117,0.00026344924],"domain_scores_gemma":[0.9988714,0.0000904376,0.00045428576,0.00015405165,0.00035970288,0.00007011532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031545424,0.00024275038,0.0008169298,0.00060271705,0.00009663703,0.000045136883,0.0000507402,0.000074389456,0.000018015542],"category_scores_gemma":[0.00033361322,0.00019229001,0.00006765817,0.0005625841,0.00008491108,0.0004930458,0.0000452102,0.00030628082,0.000002138425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030757082,0.0010158722,0.9752679,0.000029104898,0.0002473509,0.00010993569,0.0014859462,0.000014731616,0.000017533472,0.000027227226,0.000022978713,0.021453837],"study_design_scores_gemma":[0.007659952,0.014028255,0.97654366,0.00097460876,0.00019612531,0.000009012957,0.000075647804,0.00023141064,0.000043671876,0.00007454322,0.0000149124835,0.00014822365],"about_ca_topic_score_codex":0.08601752,"about_ca_topic_score_gemma":0.4004851,"teacher_disagreement_score":0.31446755,"about_ca_system_score_codex":0.002254541,"about_ca_system_score_gemma":0.0002446287,"threshold_uncertainty_score":0.92006874},"labels":[],"label_agreement":null},{"id":"W4413696125","doi":"10.1111/jvh.70064","title":"Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis C Viruses","year":2025,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stigma (botany); Psychosocial; Shame; Psychological intervention; Blame; PsycINFO; Social stigma; Hepatitis C; Medicine; Psychology; Clinical psychology; MEDLINE; Psychiatry; Family medicine; Social psychology; Political science; Human immunodeficiency virus (HIV)","score_opus":0.05396017689478415,"score_gpt":0.3536008672767428,"score_spread":0.2996406903819586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413696125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010381198,0.991591,0.00015443377,0.000088702865,0.00031945776,0.0048668925,0.0007978505,0.000027488777,0.0011160981],"genre_scores_gemma":[0.006704409,0.99182284,0.00045428463,0.00028280835,0.00011562784,0.00020913563,0.00002049145,0.000106860534,0.00028356718],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.986504,0.0021605492,0.004773909,0.00049992,0.00536988,0.00069173385],"domain_scores_gemma":[0.98500204,0.0014702737,0.007175614,0.0012629704,0.0047270097,0.0003620863],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035413764,0.0009414181,0.009368466,0.00055282225,0.00017162427,0.000061044826,0.001185477,0.00041716683,0.00034350558],"category_scores_gemma":[0.013395985,0.00047586253,0.0016467245,0.0031248725,0.00033999677,0.00029757243,0.0003053251,0.001094967,0.000007858092],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009492016,0.00044424293,0.08000483,0.8912083,0.0039212084,0.0002664756,0.00008106776,0.0000014906499,5.7465627e-7,0.000028848908,0.0018407606,0.02210728],"study_design_scores_gemma":[0.0009006225,0.0028295438,0.008868989,0.9674613,0.014114834,0.0005000393,0.00001503566,0.000011039913,0.000008625145,0.0000070938563,0.004855151,0.00042771912],"about_ca_topic_score_codex":0.004908075,"about_ca_topic_score_gemma":0.026983282,"teacher_disagreement_score":0.07625301,"about_ca_system_score_codex":0.002527773,"about_ca_system_score_gemma":0.008787204,"threshold_uncertainty_score":0.99976933},"labels":[],"label_agreement":null},{"id":"W4413988252","doi":"10.1111/jvh.70066","title":"Early Read‐Time Performance of the <scp>OraQuick HCV</scp> Rapid Antibody Assay for the Exclusion of <scp>HCV</scp> Viremia","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Ontario Stroke Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Viremia; Medicine; Hepatitis C virus; Hepatitis C; Antibody; Confidence interval; Nat; Virology; Immunology; Whole blood; Internal medicine; Virus","score_opus":0.015128761994287516,"score_gpt":0.30971625933365265,"score_spread":0.2945874973393651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413988252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837331,0.0019320549,0.0007561472,0.0008373541,0.0007147864,0.0010926392,0.0001125079,0.000019069883,0.010802298],"genre_scores_gemma":[0.9851841,0.005799189,0.0008906307,0.00040724204,0.00043584505,0.000020746164,0.000012354822,0.000056486304,0.0071934336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995404,0.00043529845,0.0015500555,0.0002905086,0.001674602,0.00064551336],"domain_scores_gemma":[0.99388075,0.0024873812,0.0011851641,0.0008277907,0.0014139055,0.00020498765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029333779,0.00033226394,0.0010192309,0.0004744731,0.00034834287,0.000054017597,0.00097348157,0.0002929655,0.00009520904],"category_scores_gemma":[0.0043231864,0.00020121927,0.00067140185,0.00094275706,0.00048451938,0.00042038615,0.0003598466,0.0010318599,0.000029372242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025878177,0.0005279214,0.68585473,0.0010978548,0.0007717429,0.00006716163,0.0016120048,0.000080087426,0.12756392,0.00027014152,0.055095494,0.12680013],"study_design_scores_gemma":[0.004371807,0.004476668,0.77300775,0.0031543598,0.00057537045,0.000074473355,0.00019564241,0.010816263,0.082660444,0.00032676876,0.12025414,0.000086347005],"about_ca_topic_score_codex":0.00071848184,"about_ca_topic_score_gemma":0.00007128704,"teacher_disagreement_score":0.1267138,"about_ca_system_score_codex":0.0002698232,"about_ca_system_score_gemma":0.0009234573,"threshold_uncertainty_score":0.82054836},"labels":[],"label_agreement":null},{"id":"W4414081650","doi":"10.1111/jvh.70070","title":"Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"American College of Gastroenterology","keywords":"Specialty; Medical prescription; Chronic hepatitis; Hepatitis B; Workforce; Health care; MEDLINE","score_opus":0.009498336770853247,"score_gpt":0.26167136868471214,"score_spread":0.25217303191385887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414081650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913238,0.0017569403,0.00019189545,0.001536392,0.0007632274,0.0005766713,0.000039504932,0.000019433908,0.0037920787],"genre_scores_gemma":[0.9933929,0.0034717554,0.0010280106,0.0010415431,0.00041765402,0.000024117053,0.00002036197,0.000027093562,0.00057660183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973139,0.000107882166,0.0010041404,0.00024077951,0.0009203933,0.00041289537],"domain_scores_gemma":[0.9984339,0.00008903404,0.00038484315,0.00026947737,0.0006461784,0.00017655661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031705658,0.00025982168,0.0007869118,0.0005005768,0.00008998715,0.00002750934,0.00018915531,0.0001171861,0.00035431387],"category_scores_gemma":[0.00028914266,0.00019778087,0.000157082,0.00047637188,0.00016245196,0.00029114794,0.000108329965,0.0005307379,0.000018893163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025676837,0.00038915323,0.9673451,0.00019200564,0.00024759184,0.00033342926,0.00037650182,0.0000067173505,0.000027258307,0.00016392666,0.014149577,0.016511947],"study_design_scores_gemma":[0.004838012,0.0021280395,0.96967864,0.0021534176,0.00016638776,0.000011927974,0.00001788597,0.00004219265,0.00039769447,0.00022980077,0.020167245,0.00016872896],"about_ca_topic_score_codex":0.008546489,"about_ca_topic_score_gemma":0.10854412,"teacher_disagreement_score":0.09999763,"about_ca_system_score_codex":0.0012783535,"about_ca_system_score_gemma":0.00071708526,"threshold_uncertainty_score":0.9980557},"labels":[],"label_agreement":null},{"id":"W4414081815","doi":"10.1111/jvh.70079","title":"Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Massachusetts General Hospital","keywords":"HBsAg; Hepatitis B virus; Hepatitis B; Chronic hepatitis; Antiviral treatment; Cirrhosis; Antiviral therapy; Clinical trial","score_opus":0.06054938451196684,"score_gpt":0.41222115021863814,"score_spread":0.3516717657066713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414081815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137987,0.0009794143,0.015155987,0.00032362764,0.0002720672,0.0015434509,0.00014013912,0.000013610355,0.0001918542],"genre_scores_gemma":[0.9852672,0.011422343,0.0029273017,0.000030285055,0.00018794005,0.00007280188,0.00002765513,0.000031515032,0.000032939406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678147,0.0002404087,0.0019852011,0.00027821658,0.00041804052,0.00029663893],"domain_scores_gemma":[0.996069,0.00061535306,0.0014005051,0.0003293566,0.0015076149,0.00007813871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009795232,0.00026753024,0.0012846122,0.00058904645,0.00008572549,0.000019198751,0.00018718562,0.00015208744,0.000017350425],"category_scores_gemma":[0.00033019445,0.00021286719,0.00046793037,0.0006528124,0.0001834328,0.00039366767,0.000037256683,0.00035853544,6.688892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028657385,0.0009836543,0.96327734,0.00011177989,0.00089906715,0.00001168182,0.00059951027,0.0011232842,0.0006517528,0.00020714663,0.00030456056,0.028964464],"study_design_scores_gemma":[0.012650874,0.022778882,0.95459765,0.00082740356,0.000343146,0.0000063918346,0.000049956532,0.007480856,0.0006081009,0.00042419613,0.00007385856,0.00015869224],"about_ca_topic_score_codex":0.018968416,"about_ca_topic_score_gemma":0.02899639,"teacher_disagreement_score":0.028805772,"about_ca_system_score_codex":0.0006551674,"about_ca_system_score_gemma":0.0011722978,"threshold_uncertainty_score":0.9887219},"labels":[],"label_agreement":null},{"id":"W4414162671","doi":"10.1111/jvh.70080","title":"Policymaker Perspectives on the Role of Health Systems in Sustainable Hepatitis C Point‐Of‐Care Testing in Australia","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Ottawa Hospital","funders":"Fonds de Recherche du Québec - Santé; National Health and Medical Research Council; Fonds de recherche du Québec; Department of Health, New South Wales Government; Cepheid; AbbVie; Department of Health and Aged Care, Australian Government; Medical Research Future Fund; Gilead Sciences","keywords":"Sustainability; Thematic analysis; Healthcare system; Corporate governance; Health care; Health policy; Public health; Hepatitis C virus","score_opus":0.031101508926970826,"score_gpt":0.365247347827999,"score_spread":0.33414583890102817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567015,0.00471215,0.000017758864,0.0018284777,0.00009380902,0.00070646807,0.000025493573,0.0000064154933,0.0069392542],"genre_scores_gemma":[0.9977223,0.0011809947,0.00027949476,0.00010931992,0.000086995846,0.000016905042,0.0000020659202,0.000019541307,0.0005823816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996713,0.00057583634,0.0013388077,0.00018708681,0.0006790375,0.00050625124],"domain_scores_gemma":[0.9975238,0.00048765028,0.0006032923,0.00028986394,0.0009904873,0.00010494823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015862068,0.00017514447,0.0008606783,0.0011160165,0.000066052555,0.000028230235,0.00024239,0.000109611,0.000057398014],"category_scores_gemma":[0.0022978934,0.00013238957,0.00015148107,0.0012348212,0.00015162455,0.00019101684,0.00007662916,0.00073982275,0.0000038010076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018779452,0.00026003917,0.9690343,0.0008632864,0.00006131869,0.0002284044,0.006035729,0.00013467112,0.00058869034,0.014326078,0.00056099653,0.007718668],"study_design_scores_gemma":[0.0020621559,0.0036606833,0.94662565,0.0065704356,0.000028762222,0.00004841253,0.034806028,0.00079383556,0.0019349849,0.0015364847,0.0017779298,0.00015465518],"about_ca_topic_score_codex":0.13004744,"about_ca_topic_score_gemma":0.0031571563,"teacher_disagreement_score":0.12689029,"about_ca_system_score_codex":0.0012764703,"about_ca_system_score_gemma":0.0011481328,"threshold_uncertainty_score":0.87574565},"labels":[],"label_agreement":null},{"id":"W4415147410","doi":"10.1111/jvh.70094","title":"Real‐World Study for Mother‐To‐Child Transmission of Hepatitis B in Guangdong Province, 2021–2023","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"HBsAg; Transmission (telecommunications); Hepatitis B virus; Pregnancy; Hepatitis B; Logistic regression","score_opus":0.014590684903210945,"score_gpt":0.3174970634064063,"score_spread":0.30290637850319535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415147410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420507,0.0006579254,0.0017489867,0.0026314864,0.0005027977,0.0021814168,0.000077152625,0.000016391656,0.007978786],"genre_scores_gemma":[0.9885682,0.0024697375,0.0049524857,0.0003859148,0.00023900217,0.0000677857,0.0000050825433,0.000039905888,0.003271873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971106,0.0001496406,0.0015126844,0.0002847966,0.0005641048,0.00037817785],"domain_scores_gemma":[0.99838215,0.00022937814,0.00044476427,0.0002892449,0.00048435584,0.00017009724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007828675,0.00026837972,0.001145686,0.0011784306,0.00010821273,0.000020076413,0.00023292864,0.00009265215,0.00013282476],"category_scores_gemma":[0.0003460086,0.00022935701,0.00030644637,0.00089426414,0.00006862425,0.00019754554,0.000068186426,0.000381884,0.0000073781366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008092481,0.001013474,0.935747,0.0003407959,0.0002711445,0.0002425362,0.0010037138,0.000033041848,0.0010636299,0.0002700913,0.0064991126,0.052706167],"study_design_scores_gemma":[0.00448655,0.0044113947,0.9659888,0.0029365842,0.00028571163,0.000015566276,0.00014205607,0.00031729572,0.00287159,0.00041971816,0.017912284,0.00021245367],"about_ca_topic_score_codex":0.019824594,"about_ca_topic_score_gemma":0.08475822,"teacher_disagreement_score":0.06493363,"about_ca_system_score_codex":0.0003722911,"about_ca_system_score_gemma":0.00040308404,"threshold_uncertainty_score":0.9867025},"labels":[],"label_agreement":null},{"id":"W4415470278","doi":"10.1111/jvh.70098","title":"Hepatitis B Virus ( <scp>HBV</scp> ) Treatment Eligibility in the <scp>UK</scp> : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"University College London Hospitals NHS Foundation Trust; University College London; Department of Health and Social Care; National Institute for Health and Care Research; Francis Crick Institute; Home Instead Charities","keywords":"Medical prescription; Hepatitis B virus; Population; Cohort; Retrospective cohort study; Hepatitis B; Liver disease; Viral load; Chronic hepatitis; Hepatitis C","score_opus":0.16806041236078237,"score_gpt":0.4592097661135547,"score_spread":0.2911493537527723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415470278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090546,0.0029794706,0.0000845588,0.002523492,0.0005883516,0.0015004426,0.00046959694,0.000018590026,0.0009300567],"genre_scores_gemma":[0.95954984,0.037777208,0.00069293875,0.00089835323,0.00071166473,0.00009238075,0.00003949562,0.000033629614,0.00020447503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940276,0.000807778,0.0027078444,0.0006909183,0.0010759676,0.0006898662],"domain_scores_gemma":[0.99364215,0.002457591,0.0009878251,0.0015765115,0.0011155042,0.0002203905],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004702423,0.0005253352,0.0019344757,0.0005715279,0.00016719443,0.00006898253,0.0010524603,0.00023143475,0.000030039948],"category_scores_gemma":[0.014849636,0.00029368052,0.0005720557,0.0012623502,0.00038223504,0.0002985821,0.00047927175,0.0009110605,0.000015360221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081313374,0.0008172732,0.94384325,0.000039632232,0.0007162381,0.00044735867,0.0024889938,0.000027503931,0.00020578949,0.00004137321,0.04627542,0.005015876],"study_design_scores_gemma":[0.0019267527,0.004716951,0.9875531,0.00075923925,0.0003874833,0.00009745739,0.0005618035,0.00030451338,0.0005792729,0.000642884,0.0024074009,0.000063098574],"about_ca_topic_score_codex":0.09565894,"about_ca_topic_score_gemma":0.25186428,"teacher_disagreement_score":0.15620534,"about_ca_system_score_codex":0.0012645132,"about_ca_system_score_gemma":0.00078351476,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W4416763469","doi":"10.1111/jvh.70109","title":"Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( <scp>PHARM</scp> ‐C): Results From a Phase <scp>IV</scp> Nonblinded Randomised Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Maple Leaf Medical Clinic; Toronto Liver Centre; York University","funders":"AbbVie Canada","keywords":"Randomized controlled trial; Hepatitis C virus; Hepatitis C; Standard of care; Hepacivirus; Clinical trial; Phase (matter)","score_opus":0.039812007641403586,"score_gpt":0.36855772658802677,"score_spread":0.3287457189466232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416763469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531503,0.002992561,0.0002915019,0.00066094723,0.0013201808,0.006103712,0.00065628137,0.000067837806,0.012591949],"genre_scores_gemma":[0.9442748,0.04977645,0.00126584,0.0011932733,0.0006293418,0.00065339904,0.00020052277,0.00007839368,0.0019279782],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9905548,0.0029999958,0.0033411516,0.00058046664,0.0015326076,0.000990966],"domain_scores_gemma":[0.98626333,0.010165698,0.0013171998,0.0007955046,0.000710107,0.0007481418],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004837738,0.0006706071,0.002844256,0.0017589299,0.00043020363,0.0002790382,0.000729073,0.00036730288,0.00017606196],"category_scores_gemma":[0.012048247,0.0005997563,0.00083575095,0.0010878785,0.00035473684,0.00066306937,0.00034312002,0.0024217928,0.00004862262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49509618,0.011341411,0.10496462,0.00063875254,0.00713976,0.008661884,0.004245159,0.000022138696,0.0034001798,0.00008497538,0.09859013,0.2658148],"study_design_scores_gemma":[0.93976873,0.003594834,0.014303346,0.001061224,0.0012575694,0.00003645688,0.000255381,0.004182873,0.0042397506,0.00056497764,0.030597806,0.0001370786],"about_ca_topic_score_codex":0.00477251,"about_ca_topic_score_gemma":0.0012726615,"teacher_disagreement_score":0.44467252,"about_ca_system_score_codex":0.0005704839,"about_ca_system_score_gemma":0.00046877234,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W4416780202","doi":"10.1111/jvh.70112","title":"Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"","keywords":"Immigration; Cohort; Hepatitis C; Hepatitis C virus; Specialty; Retrospective cohort study; Medical record; Cohort study","score_opus":0.016583927344971997,"score_gpt":0.3206791233556869,"score_spread":0.3040951960107149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416780202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914621,0.0008789051,0.00001947703,0.0026898612,0.00015625166,0.0008932143,0.00015366604,0.000010655153,0.0037358692],"genre_scores_gemma":[0.99372506,0.0015372377,0.00096848945,0.001038168,0.00008247194,0.000042297026,0.000012826372,0.000030133997,0.0025633024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977404,0.00015755996,0.0007313578,0.00027810625,0.00046101538,0.00063154893],"domain_scores_gemma":[0.9984361,0.00017620788,0.00012684544,0.0002774193,0.00028574155,0.0006976629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045557812,0.0002767405,0.0007749712,0.0012013784,0.00012539636,0.0000740414,0.0001707501,0.0001444374,0.00060288416],"category_scores_gemma":[0.00045951272,0.00022646227,0.00018201886,0.00028937092,0.00007488982,0.00019185925,0.00008013834,0.0003942531,0.00004998013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714778,0.000090620255,0.8613774,0.000051642914,0.00021318186,0.00076836575,0.0008994325,0.0000027757237,0.0005243139,0.000011872098,0.0013604934,0.13452838],"study_design_scores_gemma":[0.0029713684,0.0017948601,0.9705334,0.0004334369,0.00010141483,0.000018423838,0.00012507066,0.0006881587,0.0005023262,0.000038914295,0.022614365,0.00017830674],"about_ca_topic_score_codex":0.6865514,"about_ca_topic_score_gemma":0.9353919,"teacher_disagreement_score":0.24884054,"about_ca_system_score_codex":0.0024003317,"about_ca_system_score_gemma":0.0011735539,"threshold_uncertainty_score":0.92348635},"labels":[],"label_agreement":null}]}